TCGA-19-1390.13	110	0_HALLMARK_E2F_TARGETS	169	41	0.0000000000000000000000000
TCGA-19-5952.11	193	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	45	0.0000000000000000000000000
TCGA-02-0038.3	199	0_HALLMARK_E2F_TARGETS	169	44	0.0000000000000000000000000
TCGA-02-0043.10	184	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	42	0.0000000000000000000000000
TCGA-19-5947.4	267	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	48	0.0000000000000000000000000
TCGA-32-2634.10	118	1_KEGG_CELL_CYCLE	114	31	0.0000000000000000000000000
TCGA-32-2634.10	118	0_HALLMARK_E2F_TARGETS	169	35	0.0000000000000000000000000
TCGA-19-1390.13	110	1_KEGG_CELL_CYCLE	114	30	0.0000000000000000000000000
TCGA-19-2624.29	130	0_HALLMARK_G2M_CHECKPOINT	174	36	0.0000000000000000000000000
TCGA-06-0129.11	110	0_HALLMARK_G2M_CHECKPOINT	174	33	0.0000000000000000000000000
TCGA-19-1390.13	110	0_HALLMARK_G2M_CHECKPOINT	174	33	0.0000000000000000000000000
TCGA-14-0781.7	155	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	37	0.0000000000000000000000000
TCGA-76-6193.13	271	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	45	0.0000000000000000000000000
TCGA-19-5960.9	134	0_HALLMARK_E2F_TARGETS	169	34	0.0000000000000000000000000
TCGA-02-0026.1	61	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000000000000000
TCGA-32-1986.8	87	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	29	0.0000000000000000000000000
TCGA-14-4157.7	101	0_HALLMARK_E2F_TARGETS	169	30	0.0000000000000000000000001
TCGA-06-0644.16	142	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	34	0.0000000000000000000000001
TCGA-32-4210.14	109	0_HALLMARK_E2F_TARGETS	169	30	0.0000000000000000000000008
TCGA-19-2625.9	146	1_KEGG_CELL_CYCLE	114	29	0.0000000000000000000000010
TCGA-41-5651.5	112	0_HALLMARK_E2F_TARGETS	169	30	0.0000000000000000000000021
TCGA-19-5960.9	134	0_HALLMARK_G2M_CHECKPOINT	174	32	0.0000000000000000000000045
TCGA-28-2501.3	51	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000000000000000070
TCGA-02-2483.10	100	1_KEGG_CELL_CYCLE	114	25	0.0000000000000000000000136
TCGA-02-0038.3	199	1_KEGG_CELL_CYCLE	114	31	0.0000000000000000000000296
TCGA-02-0114.20	132	1_KEGG_CELL_CYCLE	114	27	0.0000000000000000000000362
TCGA-06-5858.19	205	0_HALLMARK_E2F_TARGETS	169	36	0.0000000000000000000000648
TCGA-06-1804.6	30	1_KEGG_DNA_REPLICATION	32	13	0.0000000000000000000000895
TCGA-06-0881.7	203	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	36	0.0000000000000000000001659
TCGA-19-2624.29	130	0_HALLMARK_E2F_TARGETS	169	30	0.0000000000000000000002658
TCGA-14-4157.7	101	1_KEGG_CELL_CYCLE	114	24	0.0000000000000000000005979
TCGA-32-2634.10	118	0_HALLMARK_G2M_CHECKPOINT	174	29	0.0000000000000000000006147
TCGA-06-0129.11	110	0_HALLMARK_E2F_TARGETS	169	28	0.0000000000000000000006416
TCGA-06-0648.6	17	1_KEGG_CELL_CYCLE	114	14	0.0000000000000000000006797
TCGA-02-2483.10	100	0_HALLMARK_E2F_TARGETS	169	27	0.0000000000000000000008447
TCGA-02-0026.1	61	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000000000009943
TCGA-06-2559.11	101	0_HALLMARK_E2F_TARGETS	169	27	0.0000000000000000000011360
TCGA-06-1804.6	30	0_HALLMARK_E2F_TARGETS	169	18	0.0000000000000000000017004
TCGA-02-0009.6	188	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	34	0.0000000000000000000022294
TCGA-02-0038.3	199	1_KEGG_DNA_REPLICATION	32	19	0.0000000000000000000027203
TCGA-41-4097.6	48	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000000000000030238
TCGA-02-0026.1	61	1_KEGG_CELL_CYCLE	114	20	0.0000000000000000000052928
TCGA-08-0356.2	23	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	14	0.0000000000000000000080250
TCGA-02-0038.3	199	0_HALLMARK_G2M_CHECKPOINT	174	34	0.0000000000000000000129321
TCGA-02-0024.6	206	0_HALLMARK_E2F_TARGETS	169	34	0.0000000000000000000153162
TCGA-02-0060.19	281	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	39	0.0000000000000000000155185
TCGA-02-2483.10	100	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000000000434341
TCGA-14-4157.7	101	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000000000576012
TCGA-06-0129.11	110	2_CELL_CYCLE_GO_0007049	265	31	0.0000000000000000000686979
TCGA-06-2567.9	156	0_HALLMARK_E2F_TARGETS	169	30	0.0000000000000000000828093
TCGA-27-2521.10	94	1_KEGG_CELL_CYCLE	114	22	0.0000000000000000000991182
TCGA-02-0014.10	70	1_KEGG_CELL_CYCLE	114	20	0.0000000000000000001260429
TCGA-06-0174.37	141	0_HALLMARK_G2M_CHECKPOINT	174	29	0.0000000000000000001470573
TCGA-12-3653.55	255	0_HALLMARK_E2F_TARGETS	169	36	0.0000000000000000001624295
TCGA-27-1833.7	17	1_KEGG_CELL_CYCLE	114	13	0.0000000000000000002199852
TCGA-41-5651.5	112	1_KEGG_CELL_CYCLE	114	23	0.0000000000000000002430949
TCGA-76-6192.6	43	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000000000004168283
TCGA-32-2615.7	77	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000000000005754774
TCGA-19-5960.9	134	1_KEGG_CELL_CYCLE	114	24	0.0000000000000000008505533
TCGA-19-1390.13	110	2_CELL_CYCLE_GO_0007049	265	30	0.0000000000000000010347575
TCGA-41-5651.5	112	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000000010437327
TCGA-19-2619.14	100	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	25	0.0000000000000000010791939
TCGA-02-0011.1	288	0_HALLMARK_E2F_TARGETS	169	37	0.0000000000000000011093415
TCGA-32-2491.14	244	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	35	0.0000000000000000013706983
TCGA-08-0356.2	23	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000000000000000014210599
TCGA-76-6285.5	106	1_KEGG_CELL_CYCLE	114	22	0.0000000000000000017237696
TCGA-08-0389.4	56	1_KEGG_CELL_CYCLE	114	18	0.0000000000000000017977499
TCGA-06-0195.8	56	1_KEGG_CELL_CYCLE	114	18	0.0000000000000000017977499
TCGA-76-6285.5	106	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000021243772
TCGA-06-2558.6	74	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000000000024894464
TCGA-19-1390.13	110	1_KEGG_DNA_REPLICATION	32	15	0.0000000000000000029645981
TCGA-19-1790.18	201	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	32	0.0000000000000000036078933
TCGA-06-2570.8	95	1_KEGG_CELL_CYCLE	114	21	0.0000000000000000037916415
TCGA-06-2558.6	74	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000000048046802
TCGA-76-6191.6	96	1_KEGG_CELL_CYCLE	114	21	0.0000000000000000048073226
TCGA-08-0389.4	56	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000000000049842795
TCGA-08-0360.3	144	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000000000051330764
TCGA-08-0356.2	23	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000000000000000052267569
TCGA-28-2509.6	59	1_KEGG_CELL_CYCLE	114	18	0.0000000000000000053249165
TCGA-28-2502.9	56	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000000000056066517
TCGA-12-0616.1	20	1_KEGG_CELL_CYCLE	114	13	0.0000000000000000069536297
TCGA-08-0356.2	23	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000000000000000070731360
TCGA-06-5408.3	99	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000000071393444
TCGA-19-2624.29	130	1_KEGG_CELL_CYCLE	114	23	0.0000000000000000090521291
TCGA-19-5958.4	35	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000000000092994176
TCGA-06-5859.9	125	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000000098168280
TCGA-28-5218.5	208	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	32	0.0000000000000000106528408
TCGA-02-2486.9	141	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	26	0.0000000000000000107032944
TCGA-12-3653.55	255	1_KEGG_CELL_CYCLE	114	29	0.0000000000000000148810668
TCGA-08-0347.4	16	1_KEGG_CELL_CYCLE	114	12	0.0000000000000000155599920
TCGA-02-0115.1	36	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000000000173409068
TCGA-12-3650.17	101	0_HALLMARK_G2M_CHECKPOINT	174	24	0.0000000000000000243616783
TCGA-06-2559.11	101	0_HALLMARK_G2M_CHECKPOINT	174	24	0.0000000000000000243616783
TCGA-06-0241.8	53	1_KEGG_CELL_CYCLE	114	17	0.0000000000000000270509488
TCGA-19-2623.11	153	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000000000291304907
TCGA-14-1825.8	80	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000000324828928
TCGA-06-0750.12	52	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000000000344708413
TCGA-27-2521.10	94	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000000000397025342
TCGA-06-0141.1	45	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000000000510965906
TCGA-02-0085.1	45	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000000000510965906
TCGA-02-0107.3	71	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000000000516200574
TCGA-02-0086.2	17	1_KEGG_CELL_CYCLE	114	12	0.0000000000000000523760081
TCGA-28-5216.8	162	0_HALLMARK_E2F_TARGETS	169	28	0.0000000000000000551995911
TCGA-32-2491.14	244	1_KEGG_CELL_CYCLE	114	28	0.0000000000000000604248085
TCGA-06-0174.37	141	1_KEGG_CELL_CYCLE	114	23	0.0000000000000000627421427
TCGA-06-0190.8	143	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	27	0.0000000000000000629350353
TCGA-76-6191.6	96	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000000000668492759
TCGA-14-4157.7	101	1_KEGG_DNA_REPLICATION	32	14	0.0000000000000000681756422
TCGA-02-0024.6	206	0_HALLMARK_G2M_CHECKPOINT	174	31	0.0000000000000000763586472
TCGA-08-0356.2	23	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000000000000000778722132
TCGA-14-1825.8	80	1_KEGG_CELL_CYCLE	114	19	0.0000000000000000802394565
TCGA-08-0389.4	56	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000000000913680983
TCGA-06-0129.11	110	1_KEGG_CELL_CYCLE	114	21	0.0000000000000001012646624
TCGA-76-6191.6	96	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000001319591211
TCGA-19-2624.29	130	2_CELL_CYCLE_GO_0007049	265	30	0.0000000000000001975024401
TCGA-41-2575.49	136	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000002040612250
TCGA-06-0139.1	179	0_HALLMARK_COMPLEMENT	176	29	0.0000000000000002335841181
TCGA-27-1830.7	57	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000000002656063819
TCGA-28-2509.6	59	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000000002871797666
TCGA-41-2571.7	72	1_KEGG_CELL_CYCLE	114	18	0.0000000000000003002559023
TCGA-26-5132.7	100	1_KEGG_CELL_CYCLE	114	20	0.0000000000000003129825527
TCGA-14-0787.6	40	1_KEGG_CELL_CYCLE	114	15	0.0000000000000003428635078
TCGA-14-1825.8	80	0_HALLMARK_E2F_TARGETS	169	21	0.0000000000000003933751483
TCGA-02-0014.10	70	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000004557312696
TCGA-32-2491.14	244	0_HALLMARK_E2F_TARGETS	169	32	0.0000000000000005036615183
TCGA-06-2558.6	74	1_KEGG_CELL_CYCLE	114	18	0.0000000000000005164686592
TCGA-06-0130.3	155	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	27	0.0000000000000005718526264
TCGA-02-0074.5	118	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000006151251662
TCGA-06-0122.8	90	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000000000006209604752
TCGA-19-2625.9	146	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000006257030762
TCGA-02-0114.20	132	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000006646888094
TCGA-32-2634.10	118	1_KEGG_DNA_REPLICATION	32	14	0.0000000000000006725431740
TCGA-02-0015.16	115	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000007502433179
TCGA-06-0881.7	203	0_HALLMARK_COMPLEMENT	176	30	0.0000000000000007794892720
TCGA-02-0014.10	70	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000000008241529930
TCGA-06-2570.8	95	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000000010216295632
TCGA-06-0139.1	179	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	20	0.0000000000000010621104059
TCGA-76-4935.7	15	1_KEGG_CELL_CYCLE	114	11	0.0000000000000010691056973
TCGA-28-1753.13	174	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000000010827959635
TCGA-28-5214.11	124	1_KEGG_CELL_CYCLE	114	21	0.0000000000000014007497587
TCGA-27-2521.10	94	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000015224030909
TCGA-02-0060.19	281	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	23	0.0000000000000018774962208
TCGA-32-4210.14	109	1_KEGG_CELL_CYCLE	114	20	0.0000000000000019254633243
TCGA-06-2570.8	95	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000019504947851
TCGA-02-0024.6	206	1_KEGG_CELL_CYCLE	114	25	0.0000000000000020889115197
TCGA-32-1977.11	107	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000000021171602306
TCGA-06-0176.8	95	1_KEGG_CELL_CYCLE	114	19	0.0000000000000026968658452
TCGA-06-0195.8	56	0_HALLMARK_E2F_TARGETS	169	18	0.0000000000000028037325692
TCGA-76-6193.13	271	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	31	0.0000000000000028753931508
TCGA-02-0069.13	16	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000000000000032206705969
TCGA-06-0645.9	136	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	25	0.0000000000000034034458883
TCGA-08-0356.2	23	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0000000000000034601716436
TCGA-02-2485.14	172	0_HALLMARK_E2F_TARGETS	169	27	0.0000000000000037039743017
TCGA-02-0007.17	217	0_HALLMARK_G2M_CHECKPOINT	174	30	0.0000000000000038720223022
TCGA-27-2524.5	75	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000000042432824640
TCGA-06-6391.9	26	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000000000044581426872
TCGA-19-2620.7	47	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000000046382588137
TCGA-76-4925.9	83	1_KEGG_CELL_CYCLE	114	18	0.0000000000000048650802986
TCGA-76-6192.6	43	1_KEGG_FOCAL_ADHESION	195	17	0.0000000000000049361765623
TCGA-28-2501.3	51	1_KEGG_FOCAL_ADHESION	195	18	0.0000000000000054484365640
TCGA-76-6282.11	185	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000000058764097973
TCGA-06-0648.6	17	0_HALLMARK_E2F_TARGETS	169	12	0.0000000000000070118840444
TCGA-08-0245.4	85	1_KEGG_CELL_CYCLE	114	18	0.0000000000000077039118384
TCGA-14-0817.9	85	1_KEGG_CELL_CYCLE	114	18	0.0000000000000077039118384
TCGA-06-5858.19	205	0_HALLMARK_G2M_CHECKPOINT	174	29	0.0000000000000079542663460
TCGA-12-3650.17	101	1_KEGG_CELL_CYCLE	114	19	0.0000000000000092102581144
TCGA-06-2559.11	101	1_KEGG_CELL_CYCLE	114	19	0.0000000000000092102581144
TCGA-06-5411.4	23	1_KEGG_CELL_CYCLE	114	12	0.0000000000000107756881869
TCGA-32-2494.10	173	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	27	0.0000000000000109605047374
TCGA-28-1753.13	174	0_HALLMARK_G2M_CHECKPOINT	174	27	0.0000000000000109708720119
TCGA-06-0881.7	203	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	27	0.0000000000000121917123691
TCGA-06-0881.7	203	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	20	0.0000000000000133365884512
TCGA-06-0129.11	110	2_CELL_CYCLE_PROCESS	163	22	0.0000000000000136140795933
TCGA-02-0071.12	116	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000000145725739325
TCGA-14-0871.20	216	0_HALLMARK_E2F_TARGETS	169	29	0.0000000000000149944451407
TCGA-19-2624.29	130	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000154775694253
TCGA-02-0007.17	217	0_HALLMARK_E2F_TARGETS	169	29	0.0000000000000170547437594
TCGA-02-0114.20	132	0_HALLMARK_G2M_CHECKPOINT	174	24	0.0000000000000195871267641
TCGA-02-0069.12	62	1_KEGG_CELL_CYCLE	114	16	0.0000000000000199130095395
TCGA-28-5216.8	162	2_NON_MEMBRANE_BOUND_ORGANELLE	476	40	0.0000000000000220497914942
TCGA-28-5216.8	162	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	40	0.0000000000000220497914942
TCGA-02-0069.13	16	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000000000230288817368
TCGA-08-0354.5	18	1_KEGG_CELL_CYCLE	114	11	0.0000000000000241846645382
TCGA-06-5858.19	205	1_KEGG_CELL_CYCLE	114	24	0.0000000000000261323877383
TCGA-06-0241.8	53	0_HALLMARK_E2F_TARGETS	169	17	0.0000000000000272439844285
TCGA-06-0155.10	74	1_KEGG_FOCAL_ADHESION	195	20	0.0000000000000277757931643
TCGA-06-0650.2	82	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000000293593516337
TCGA-08-0245.4	85	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000314546619094
TCGA-28-2513.12	134	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000323391165166
TCGA-06-5859.9	125	1_KEGG_CELL_CYCLE	114	20	0.0000000000000328617126128
TCGA-14-0871.20	216	0_HALLMARK_G2M_CHECKPOINT	174	29	0.0000000000000342268377688
TCGA-19-5959.13	92	1_KEGG_CELL_CYCLE	114	18	0.0000000000000350314962891
TCGA-06-0686.5	14	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000000000000376675934528
TCGA-06-2567.9	156	1_KEGG_DNA_REPLICATION	32	14	0.0000000000000382708006379
TCGA-14-0781.7	155	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	18	0.0000000000000387133151126
TCGA-02-0083.21	135	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000387213324891
TCGA-06-0875.7	78	1_KEGG_CELL_CYCLE	114	17	0.0000000000000411114158277
TCGA-76-6192.6	43	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000000000411659677146
TCGA-12-3653.55	255	0_HALLMARK_G2M_CHECKPOINT	174	31	0.0000000000000438381983985
TCGA-19-1390.13	110	2_DNA_METABOLIC_PROCESS	218	24	0.0000000000000458005784007
TCGA-32-4210.14	109	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000464537252941
TCGA-06-0174.37	141	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000483468732047
TCGA-19-5954.17	208	0_HALLMARK_E2F_TARGETS	169	28	0.0000000000000544730030156
TCGA-08-0245.4	85	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000000564465760129
TCGA-06-0143.6	63	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000000578709950491
TCGA-08-0359.5	37	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000000000628581556387
TCGA-19-5955.9	110	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000000000647945779245
TCGA-19-1790.18	201	0_HALLMARK_COMPLEMENT	176	28	0.0000000000000655238140463
TCGA-19-5951.10	138	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000658443605806
TCGA-32-2632.16	229	0_HALLMARK_E2F_TARGETS	169	29	0.0000000000000757970719361
TCGA-28-6450.11	139	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000783510623657
TCGA-76-4934.7	47	0_HALLMARK_E2F_TARGETS	169	16	0.0000000000000842656378571
TCGA-19-5950.7	113	1_KEGG_CELL_CYCLE	114	19	0.0000000000000848548560385
TCGA-06-5408.3	99	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000000000867474629145
TCGA-02-2485.14	172	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000924329614360
TCGA-06-5408.3	99	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000000977879878700
TCGA-02-2485.14	172	1_KEGG_CELL_CYCLE	114	22	0.0000000000000996552846173
TCGA-06-0124.6	55	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000001016255912446
TCGA-06-0875.7	78	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000001032108111775
TCGA-27-1838.17	131	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000001137712484794
TCGA-28-1753.13	174	1_KEGG_CELL_CYCLE	114	22	0.0000000000001282404906272
TCGA-06-5408.3	99	1_KEGG_CELL_CYCLE	114	18	0.0000000000001400899077140
TCGA-19-5954.17	208	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000001408273452433
TCGA-08-0345.2	77	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000001540861268009
TCGA-02-0011.1	288	0_HALLMARK_G2M_CHECKPOINT	174	32	0.0000000000001836617980135
TCGA-06-2567.9	156	1_KEGG_CELL_CYCLE	114	21	0.0000000000001883855136511
TCGA-32-2634.10	118	2_CELL_CYCLE_GO_0007049	265	26	0.0000000000002074923872601
TCGA-41-4097.6	48	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000000002096382992818
TCGA-02-0038.3	199	2_DNA_METABOLIC_PROCESS	218	30	0.0000000000002153307043606
TCGA-02-0011.1	288	1_KEGG_DNA_REPLICATION	32	16	0.0000000000002408123722426
TCGA-32-2632.16	229	1_KEGG_DNA_REPLICATION	32	15	0.0000000000002457795274590
TCGA-87-5896.6	131	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000002510944317778
TCGA-27-2527.6	79	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000002598205713794
TCGA-02-0074.5	118	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000002782662097499
TCGA-02-0079.2	10	1_KEGG_ASTHMA	30	7	0.0000000000003083468337844
TCGA-26-5136.6	160	1_KEGG_CELL_CYCLE	114	21	0.0000000000003201463472565
TCGA-12-0692.3	9	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000000000003531851063507
TCGA-76-6193.13	271	0_HALLMARK_COMPLEMENT	176	31	0.0000000000003578081504414
TCGA-02-0038.3	199	2_DNA_REPLICATION	82	20	0.0000000000003791271322362
TCGA-08-0352.2	59	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000003876394309069
TCGA-06-2565.10	38	1_KEGG_CELL_CYCLE	114	13	0.0000000000004057336979607
TCGA-12-0692.3	9	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000000000004193118008849
TCGA-14-1034.9	9	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0000000000004193118008849
TCGA-19-5954.17	208	1_KEGG_CELL_CYCLE	114	23	0.0000000000004818942050666
TCGA-06-0882.6	21	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0000000000004837584960243
TCGA-26-5133.10	75	1_KEGG_CELL_CYCLE	114	16	0.0000000000005479337044675
TCGA-06-6390.9	82	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000005524394561341
TCGA-02-0102.8	82	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000005524394561341
TCGA-06-2569.5	144	1_KEGG_CELL_CYCLE	114	20	0.0000000000005793103860910
TCGA-14-0817.9	85	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000005877546758550
TCGA-32-4211.14	71	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000006114926299813
TCGA-06-0211.8	62	1_KEGG_CELL_CYCLE	114	15	0.0000000000006377864378577
TCGA-06-1804.6	30	1_KEGG_CELL_CYCLE	114	12	0.0000000000006425732101883
TCGA-28-1753.13	174	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000006563028967501
TCGA-41-2571.7	72	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000007238709440792
TCGA-02-0068.1	72	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000008024266587886
TCGA-06-0882.6	21	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000000000008115563005444
TCGA-06-0139.1	179	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	24	0.0000000000008201124210346
TCGA-06-0128.9	11	1_KEGG_ASTHMA	30	7	0.0000000000008461459173948
TCGA-41-2575.49	136	2_CELL_CYCLE_GO_0007049	265	27	0.0000000000008651553454966
TCGA-76-6282.11	185	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	18	0.0000000000009504008604317
TCGA-12-0692.3	9	1_KEGG_FOCAL_ADHESION	195	9	0.0000000000009559301340624
TCGA-28-2514.9	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000009847895279454
TCGA-06-2569.5	144	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000010026347053577
TCGA-12-3650.17	101	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000011733916886711
TCGA-32-1970.14	94	1_KEGG_CELL_CYCLE	114	17	0.0000000000011796819430174
TCGA-06-0241.8	53	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000012132090219233
TCGA-06-0882.6	21	1_KEGG_ASTHMA	30	8	0.0000000000012478974455167
TCGA-14-0813.10	53	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000000013302945260151
TCGA-02-0099.11	141	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000013596601335690
TCGA-27-2523.12	112	1_KEGG_CELL_CYCLE	114	18	0.0000000000013919878304244
TCGA-02-0079.2	10	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000000000015563357153310
TCGA-06-5856.13	152	1_KEGG_CELL_CYCLE	114	20	0.0000000000017066874935112
TCGA-32-2638.17	159	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000019089399277300
TCGA-02-0075.8	128	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000000019170676606248
TCGA-06-5411.4	23	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000000019935843905972
TCGA-06-0139.1	179	2_IMMUNE_SYSTEM_PROCESS	283	31	0.0000000000020221175156920
TCGA-19-5952.11	193	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	18	0.0000000000020258706041961
TCGA-02-0079.2	10	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0000000000020815553031780
TCGA-41-2572.8	76	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000022765601726671
TCGA-28-5216.8	162	2_CYTOSKELETON	293	30	0.0000000000023213469064854
TCGA-06-0878.10	115	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000024786755013668
TCGA-19-2625.9	146	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000026398305271722
TCGA-06-1804.6	30	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000000000027545412046103
TCGA-26-5134.6	18	1_KEGG_CELL_CYCLE	114	10	0.0000000000029873025140989
TCGA-08-0356.2	23	1_KEGG_ASTHMA	30	8	0.0000000000029943821590913
TCGA-08-0356.2	23	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000000000030418384597709
TCGA-41-2575.49	136	1_KEGG_CELL_CYCLE	114	19	0.0000000000030497288512578
TCGA-06-0195.8	56	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000032451378749621
TCGA-06-0875.7	78	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000033769904471006
TCGA-06-2565.10	38	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000000000033947299374106
TCGA-02-0079.2	10	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000000000033947387714515
TCGA-41-2575.49	136	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000034200414000513
TCGA-19-2619.14	100	1_KEGG_CELL_CYCLE	114	17	0.0000000000035125965126517
TCGA-02-0074.5	118	1_KEGG_CELL_CYCLE	114	18	0.0000000000036289707126058
TCGA-02-0069.13	16	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000000000036722777756452
TCGA-02-0048.9	84	1_KEGG_CELL_CYCLE	114	16	0.0000000000037453971535964
TCGA-02-0079.2	10	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000000000040725504014933
TCGA-19-4068.7	14	0_HALLMARK_E2F_TARGETS	169	10	0.0000000000040848687572959
TCGA-06-0128.9	11	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000000000042680214288603
TCGA-19-5958.4	35	1_KEGG_FOCAL_ADHESION	195	14	0.0000000000042750410467789
TCGA-19-5952.11	193	2_EXTRACELLULAR_REGION_PART	269	31	0.0000000000042787116202314
TCGA-76-4934.7	47	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000000042974199961717
TCGA-06-1804.7	47	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000000042974199961717
TCGA-32-1970.14	94	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000043376569486876
TCGA-06-5412.1	28	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0000000000043783041200383
TCGA-02-0069.13	16	2_EXTRACELLULAR_MATRIX	85	9	0.0000000000045938314702741
TCGA-28-2513.12	134	1_KEGG_FOCAL_ADHESION	195	23	0.0000000000047639184548167
TCGA-27-1836.8	49	0_HALLMARK_E2F_TARGETS	169	15	0.0000000000051591398873323
TCGA-14-0787.6	40	0_HALLMARK_E2F_TARGETS	169	14	0.0000000000052293641538882
TCGA-12-0692.3	9	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000000000052513610197252
TCGA-06-0686.10	26	1_KEGG_CELL_CYCLE	114	11	0.0000000000054175562912582
TCGA-28-5216.8	162	1_KEGG_CELL_CYCLE	114	20	0.0000000000060294200895959
TCGA-76-6285.5	106	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000062855898557770
TCGA-41-5651.5	112	2_CELL_CYCLE_GO_0007049	265	24	0.0000000000063975990147320
TCGA-28-5216.8	162	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	11	0.0000000000066536022930253
TCGA-28-5216.8	162	2_INTERMEDIATE_FILAMENT	20	11	0.0000000000066536022930253
TCGA-02-0038.3	199	2_CELL_CYCLE_GO_0007049	265	31	0.0000000000067648011573020
TCGA-19-2631.15	84	1_KEGG_FOCAL_ADHESION	195	19	0.0000000000068308223584304
TCGA-02-0115.1	36	1_KEGG_FOCAL_ADHESION	195	14	0.0000000000068702119564122
TCGA-14-0790.9	104	1_KEGG_CELL_CYCLE	114	17	0.0000000000069766688849452
TCGA-08-0350.2	46	1_KEGG_CELL_CYCLE	114	13	0.0000000000070387511464209
TCGA-02-2483.10	100	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000000000072205215450030
TCGA-32-1970.14	94	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000000074952082247602
TCGA-19-4068.2	11	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0000000000075777492950117
TCGA-19-2624.29	130	2_CELL_CYCLE_PROCESS	163	21	0.0000000000076103309581670
TCGA-12-0619.11	123	1_KEGG_CELL_CYCLE	114	18	0.0000000000077335635003593
TCGA-06-2563.10	123	1_KEGG_CELL_CYCLE	114	18	0.0000000000077335635003593
TCGA-27-1836.8	49	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000000080036107621107
TCGA-28-2509.6	59	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000081497657933594
TCGA-06-0882.6	21	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000000000081611689662164
TCGA-02-0048.9	84	0_HALLMARK_E2F_TARGETS	169	18	0.0000000000081747159957740
TCGA-02-0043.10	184	2_EXTRACELLULAR_REGION_PART	269	30	0.0000000000081769819039983
TCGA-41-2571.7	72	0_HALLMARK_E2F_TARGETS	169	17	0.0000000000085376186587514
TCGA-06-0128.9	11	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000000000093061100930634
TCGA-06-0686.10	26	0_HALLMARK_E2F_TARGETS	169	12	0.0000000000095204781590004
TCGA-12-0616.1	20	0_HALLMARK_E2F_TARGETS	169	11	0.0000000000106862940185670
TCGA-41-3915.10	109	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000110793339859178
TCGA-02-0079.2	10	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0000000000110961853497039
TCGA-06-0128.9	11	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000000000111631796610375
TCGA-06-2558.6	74	2_CELL_CYCLE_GO_0007049	265	20	0.0000000000114072564804503
TCGA-19-5950.7	113	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000115914782280418
TCGA-19-2629.15	146	1_KEGG_CELL_CYCLE	114	19	0.0000000000117113969622753
TCGA-06-2567.9	156	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000117260077887541
TCGA-02-0085.1	45	1_KEGG_ASTHMA	30	9	0.0000000000121041447747654
TCGA-76-6191.6	96	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000125959196898327
TCGA-14-0871.20	216	1_KEGG_CELL_CYCLE	114	22	0.0000000000132305224925096
TCGA-06-0686.10	26	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000000135735449291056
TCGA-12-0692.6	11	0_HALLMARK_E2F_TARGETS	169	9	0.0000000000136574553464186
TCGA-02-0048.9	84	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000137373075514540
TCGA-12-0692.3	9	2_COLLAGEN	23	6	0.0000000000144620505141940
TCGA-02-0007.17	217	1_KEGG_CELL_CYCLE	114	22	0.0000000000145835202964680
TCGA-12-0616.1	20	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000000000148054948377144
TCGA-02-0021.4	170	1_KEGG_CELL_CYCLE	114	20	0.0000000000155401457613020
TCGA-06-0139.1	179	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	29	0.0000000000157161748939606
TCGA-06-0877.8	61	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000000159879316405430
TCGA-76-4935.7	15	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0000000000162409712073953
TCGA-06-0139.1	179	2_IMMUNE_RESPONSE	206	26	0.0000000000169044606782473
TCGA-02-0079.2	10	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0000000000174331498176603
TCGA-02-0024.6	206	2_CELL_CYCLE_GO_0007049	265	31	0.0000000000181567092872114
TCGA-28-2514.9	62	1_KEGG_CELL_CYCLE	114	14	0.0000000000185696318403148
TCGA-06-0882.6	21	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000000000200985422810000
TCGA-06-0174.37	141	2_CELL_CYCLE_GO_0007049	265	26	0.0000000000201653409499409
TCGA-12-0688.10	93	1_KEGG_CELL_CYCLE	114	16	0.0000000000204321290145724
TCGA-06-0190.8	143	1_KEGG_FOCAL_ADHESION	195	23	0.0000000000206899626077858
TCGA-19-5952.11	193	2_EXTRACELLULAR_REGION	346	34	0.0000000000206968534329354
TCGA-06-0214.9	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000000212064158536128
TCGA-27-2528.10	99	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000229253302044416
TCGA-06-0882.6	21	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000000000247971390720569
TCGA-32-2495.11	67	1_KEGG_FOCAL_ADHESION	195	17	0.0000000000256429488565135
TCGA-26-1439.11	10	1_KEGG_CELL_CYCLE	114	8	0.0000000000261279666081873
TCGA-08-0360.3	144	0_HALLMARK_COMPLEMENT	176	22	0.0000000000280844006930545
TCGA-19-2623.11	153	1_KEGG_CELL_CYCLE	114	19	0.0000000000282426310327376
TCGA-19-2624.29	130	2_MITOTIC_CELL_CYCLE	134	19	0.0000000000283793528146126
TCGA-06-0139.1	179	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000296899035797343
TCGA-06-0128.9	11	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0000000000303985455031127
TCGA-41-4097.6	48	1_KEGG_FOCAL_ADHESION	195	15	0.0000000000311294018040864
TCGA-06-5417.5	79	1_KEGG_CELL_CYCLE	114	15	0.0000000000312194280883446
TCGA-12-1597.6	51	1_KEGG_CELL_CYCLE	114	13	0.0000000000313334421747464
TCGA-19-1390.13	110	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000000328986018245190
TCGA-06-0166.5	35	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000000337908615982771
TCGA-41-3393.5	88	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000362896603091413
TCGA-02-0043.10	184	1_KEGG_ECM_RECEPTOR_INTERACTION	84	18	0.0000000000369554377050119
TCGA-06-5856.13	152	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000378254725611619
TCGA-32-1979.10	116	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000387841339355360
TCGA-12-3653.55	255	1_KEGG_DNA_REPLICATION	32	14	0.0000000000394347675015505
TCGA-06-0154.13	76	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000406860089649213
TCGA-19-5947.4	267	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	19	0.0000000000434919247214473
TCGA-32-2632.16	229	1_KEGG_CELL_CYCLE	114	22	0.0000000000451161416296951
TCGA-02-0071.12	116	1_KEGG_CELL_CYCLE	114	17	0.0000000000461392373268576
TCGA-19-1390.13	110	2_CELL_CYCLE_PROCESS	163	19	0.0000000000465143480815705
TCGA-12-5295.8	66	1_KEGG_CELL_CYCLE	114	14	0.0000000000475032887860827
TCGA-06-0188.11	66	1_KEGG_CELL_CYCLE	114	14	0.0000000000475032887860827
TCGA-06-0128.9	11	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0000000000477456429221004
TCGA-02-0026.1	61	2_CELL_CYCLE_GO_0007049	265	18	0.0000000000488962830143852
TCGA-19-5960.9	134	2_CELL_CYCLE_GO_0007049	265	25	0.0000000000505094951270217
TCGA-08-0357.4	36	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000000520465271219067
TCGA-02-2483.10	100	2_CELL_CYCLE_GO_0007049	265	22	0.0000000000525958672375025
TCGA-02-0074.5	118	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000545674040104487
TCGA-76-6193.13	271	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	19	0.0000000000570750202011512
TCGA-27-2528.10	99	1_KEGG_CELL_CYCLE	114	16	0.0000000000571665212448120
TCGA-14-1825.8	80	2_CELL_CYCLE_GO_0007049	265	20	0.0000000000588915117568037
TCGA-06-0650.2	82	1_KEGG_FOCAL_ADHESION	195	18	0.0000000000654342059776904
TCGA-14-4157.7	101	2_CELL_CYCLE_GO_0007049	265	22	0.0000000000655782886363384
TCGA-08-0353.8	100	1_KEGG_CELL_CYCLE	114	16	0.0000000000673863164318796
TCGA-02-0089.5	91	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000675693780161731
TCGA-28-5218.5	208	1_KEGG_CELL_CYCLE	114	21	0.0000000000692989939711008
TCGA-27-1833.7	17	0_HALLMARK_E2F_TARGETS	169	10	0.0000000000757729105841950
TCGA-06-0178.2	17	0_HALLMARK_E2F_TARGETS	169	10	0.0000000000757729105841950
TCGA-06-1804.6	30	2_REPLICATION_FORK	18	7	0.0000000000803888951470539
TCGA-19-2623.11	153	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000806198370369172
TCGA-06-2564.7	92	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000826750111917358
TCGA-19-5959.13	92	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000826750111917358
TCGA-02-0113.4	9	1_KEGG_ASTHMA	30	6	0.0000000000849041426854587
TCGA-14-1034.9	9	1_KEGG_ASTHMA	30	6	0.0000000000849041426854587
TCGA-02-0054.2	9	1_KEGG_ASTHMA	30	6	0.0000000000849041426854587
TCGA-14-0789.10	106	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000855290008715447
TCGA-19-1390.13	110	2_CELL_CYCLE_PHASE	146	18	0.0000000000878765710205893
TCGA-06-0877.8	61	1_KEGG_FOCAL_ADHESION	195	16	0.0000000000888091599899388
TCGA-02-2486.9	141	0_HALLMARK_ALLOGRAFT_REJECTION	190	22	0.0000000000898725100739123
TCGA-19-5954.17	208	0_HALLMARK_G2M_CHECKPOINT	174	25	0.0000000000927526639266408
TCGA-27-1837.5	85	1_KEGG_CELL_CYCLE	114	15	0.0000000000981147810030304
TCGA-12-0688.10	93	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000001008936490733635
TCGA-76-4934.7	47	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000000001038870854072662
TCGA-26-5136.6	160	0_HALLMARK_E2F_TARGETS	169	22	0.0000000001125999929584314
TCGA-14-1034.7	97	0_HALLMARK_E2F_TARGETS	169	18	0.0000000001182543524943736
TCGA-06-0133.6	57	1_KEGG_ASTHMA	30	9	0.0000000001199536638472075
TCGA-06-0686.5	14	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000000001221899398104946
TCGA-14-0781.7	155	1_KEGG_FOCAL_ADHESION	195	23	0.0000000001242155131318782
TCGA-32-2634.10	118	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000001252829625596160
TCGA-08-0360.3	144	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	15	0.0000000001260889827668063
TCGA-16-1045.10	81	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000001262130492640302
TCGA-27-2523.12	112	0_HALLMARK_E2F_TARGETS	169	19	0.0000000001282494333787100
TCGA-06-0882.6	21	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000000001323074266297165
TCGA-06-0686.5	14	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000000001349752299969147
TCGA-02-0069.13	16	1_KEGG_FOCAL_ADHESION	195	10	0.0000000001354225889662468
TCGA-06-0166.5	35	1_KEGG_FOCAL_ADHESION	195	13	0.0000000001384967101256362
TCGA-76-6193.13	271	0_HALLMARK_COAGULATION	125	24	0.0000000001427912402105928
TCGA-06-0686.5	14	2_EXTRACELLULAR_MATRIX	85	8	0.0000000001489138823480285
TCGA-06-5859.9	125	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000001531527212971391
TCGA-14-0813.10	53	1_KEGG_FOCAL_ADHESION	195	15	0.0000000001625991768956272
TCGA-16-1048.13	97	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000001639547032897004
TCGA-26-5134.6	18	0_HALLMARK_E2F_TARGETS	169	10	0.0000000001678785787054752
TCGA-02-0079.2	10	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0000000001795530117853876
TCGA-02-0079.2	10	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0000000001795530117853876
TCGA-06-2570.8	95	2_CELL_CYCLE_GO_0007049	265	21	0.0000000001866514698747599
TCGA-12-0692.3	9	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0000000001872040310642979
TCGA-06-0141.1	45	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000001875316682332363
TCGA-02-0085.1	45	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000001875316682332363
TCGA-08-0356.2	23	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0000000001881923911388646
TCGA-02-0054.2	9	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0000000002041844600882315
TCGA-08-0353.8	100	0_HALLMARK_E2F_TARGETS	169	18	0.0000000002061981942196187
TCGA-08-0386.4	73	1_KEGG_CELL_CYCLE	114	14	0.0000000002115817400977629
TCGA-16-1048.13	97	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000002182731273143463
TCGA-32-1980.1	24	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000000002199904870749889
TCGA-12-0692.3	9	2_EXTRACELLULAR_MATRIX	85	7	0.0000000002224671702327100
TCGA-26-5134.6	18	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0000000002256176511992762
TCGA-12-0618.5	41	0_HALLMARK_E2F_TARGETS	169	13	0.0000000002327142004533168
TCGA-06-2569.5	144	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000002371088423749463
TCGA-26-1439.10	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000002392757358970715
TCGA-41-5651.5	112	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000002439810032243303
TCGA-02-0069.12	62	0_HALLMARK_E2F_TARGETS	169	15	0.0000000002492635427779728
TCGA-08-0345.2	77	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0000000002612083687858474
TCGA-28-5216.8	162	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000002699947554480213
TCGA-76-6193.13	271	2_DEFENSE_RESPONSE	222	31	0.0000000002751631189654893
TCGA-41-3393.4	12	1_KEGG_CELL_CYCLE	114	8	0.0000000002816993779050884
TCGA-06-0129.11	110	2_MITOTIC_CELL_CYCLE	134	17	0.0000000002905891247811139
TCGA-32-4213.15	198	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000002915934915469779
TCGA-27-2524.5	75	1_KEGG_CELL_CYCLE	114	14	0.0000000003145043743900206
TCGA-06-5411.4	23	2_CELL_CYCLE_GO_0007049	265	12	0.0000000003216191563687725
TCGA-76-4934.7	47	1_KEGG_CELL_CYCLE	114	12	0.0000000003272862506675612
TCGA-02-0113.4	9	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0000000003317871713826499
TCGA-14-1034.9	9	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0000000003317871713826499
TCGA-02-0054.2	9	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0000000003317871713826499
TCGA-08-0386.4	73	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000003428864023881835
TCGA-26-5132.7	100	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000003436903422987836
TCGA-19-2625.9	146	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000003520358205557560
TCGA-41-4097.6	48	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000000003563919665692970
TCGA-06-0881.7	203	2_IMMUNE_RESPONSE	206	26	0.0000000003591731544095386
TCGA-19-5955.9	110	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000000003592550366517631
TCGA-28-5220.7	15	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0000000003606230753325213
TCGA-87-5896.6	131	1_KEGG_CELL_CYCLE	114	17	0.0000000003647077890791953
TCGA-02-0060.19	281	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	26	0.0000000003783589410999188
TCGA-08-0357.4	36	1_KEGG_CELL_CYCLE	114	11	0.0000000003809618606337252
TCGA-02-0069.12	62	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000003841680131435140
TCGA-08-0347.7	25	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000000003865835331875315
TCGA-06-5412.7	153	1_KEGG_LEISHMANIA_INFECTION	70	15	0.0000000003917599395049196
TCGA-02-0060.19	281	0_HALLMARK_COMPLEMENT	176	28	0.0000000004005522482395499
TCGA-02-0021.4	170	0_HALLMARK_E2F_TARGETS	169	22	0.0000000004029789195449384
TCGA-76-6193.13	271	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	27	0.0000000004109491431742512
TCGA-27-1838.17	131	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000004292193822928214
TCGA-06-0155.10	74	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000004305185625499509
TCGA-32-1980.1	24	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000000004435449050715868
TCGA-02-0043.10	184	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	17	0.0000000004459038533538494
TCGA-19-2623.11	153	0_HALLMARK_E2F_TARGETS	169	21	0.0000000004509758413639222
TCGA-06-2559.11	101	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000004549654486416315
TCGA-41-4097.6	48	2_EXTRACELLULAR_MATRIX	85	11	0.0000000004676573559042139
TCGA-76-6193.13	271	0_HALLMARK_INFLAMMATORY_RESPONSE	170	27	0.0000000004762267363006156
TCGA-12-3653.55	255	1_KEGG_FOCAL_ADHESION	195	28	0.0000000004844796509449148
TCGA-06-0128.9	11	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0000000004908877007090522
TCGA-06-0128.9	11	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0000000004908877007090522
TCGA-02-0038.3	199	1_KEGG_MISMATCH_REPAIR	23	11	0.0000000005033048428136233
TCGA-19-4068.6	42	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000005219101229041489
TCGA-06-0169.5	42	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000005219101229041489
TCGA-06-0646.4	63	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000005401400079627918
TCGA-02-0085.1	45	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0000000006230647328592538
TCGA-02-0115.1	36	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000006334801025050585
TCGA-02-0113.4	9	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0000000006410121391510756
TCGA-14-1034.9	9	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0000000006410121391510756
TCGA-02-0054.2	9	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0000000006410121391510756
TCGA-06-0139.1	179	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	17	0.0000000006420367132736530
TCGA-06-0189.3	118	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000006520724924673226
TCGA-26-5134.2	14	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000000006528693151338458
TCGA-12-5301.1	14	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000000006528693151338458
TCGA-02-0043.10	184	2_EXTRACELLULAR_MATRIX	85	17	0.0000000006755587886463256
TCGA-06-5856.13	152	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000007081445758908061
TCGA-02-0047.8	185	2_ENDOPLASMIC_RETICULUM	177	23	0.0000000007197089796310305
TCGA-41-3392.31	136	1_KEGG_FOCAL_ADHESION	195	21	0.0000000007228615015713713
TCGA-02-0021.4	170	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000007400917229736568
TCGA-32-2638.17	159	1_KEGG_ALLOGRAFT_REJECTION	37	12	0.0000000007401078650204763
TCGA-02-0113.4	9	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0000000007476432054169457
TCGA-14-1034.9	9	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0000000007476432054169457
TCGA-02-0054.2	9	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0000000007476432054169457
TCGA-06-0156.4	80	1_KEGG_CELL_CYCLE	114	14	0.0000000008048423459585941
TCGA-28-2501.3	51	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000008430484246341112
TCGA-41-2575.49	136	2_MITOTIC_CELL_CYCLE	134	18	0.0000000008530778308595623
TCGA-02-0079.2	10	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0000000008710663204422830
TCGA-19-5951.10	138	1_KEGG_CELL_CYCLE	114	17	0.0000000008735681536927838
TCGA-02-0038.3	199	2_REPLICATION_FORK	18	10	0.0000000008760257647167888
TCGA-41-3392.31	136	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000008896401077142338
TCGA-06-0221.13	45	0_HALLMARK_E2F_TARGETS	169	13	0.0000000009063245920491369
TCGA-19-1390.13	110	2_CHROMOSOME	102	15	0.0000000009389894496983145
TCGA-08-0375.6	65	1_KEGG_CELL_CYCLE	114	13	0.0000000009390765090556631
TCGA-12-0821.9	81	1_KEGG_CELL_CYCLE	114	14	0.0000000009633584197030362
TCGA-28-1747.5	81	1_KEGG_CELL_CYCLE	114	14	0.0000000009633584197030362
TCGA-27-2518.5	20	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0000000009777268464943316
TCGA-76-6285.5	106	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000009836244228346675
TCGA-19-5952.11	193	0_HALLMARK_ANGIOGENESIS	32	12	0.0000000010012162189162924
TCGA-06-1804.6	30	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	8	0.0000000010361703515736810
TCGA-06-6391.9	26	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000000010448310870670319
TCGA-06-0750.12	52	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000010616361751787904
TCGA-02-2483.10	100	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000011031080769526044
TCGA-19-5952.11	193	0_HALLMARK_COAGULATION	125	20	0.0000000011130169258343192
TCGA-19-1390.13	110	2_NUCLEUS	1110	42	0.0000000011212848972082933
TCGA-14-3476.4	7	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0000000011219322198703281
TCGA-76-4926.9	66	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000011310677418491271
TCGA-02-0043.10	184	2_EXTRACELLULAR_REGION	346	31	0.0000000011322511535198424
TCGA-19-1790.18	201	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	16	0.0000000011625377888520998
TCGA-26-5135.9	71	1_KEGG_FOCAL_ADHESION	195	16	0.0000000011704242257972397
TCGA-41-2571.7	72	2_CELL_CYCLE_GO_0007049	265	18	0.0000000011705978647277719
TCGA-06-2565.10	38	2_CELL_CYCLE_GO_0007049	265	14	0.0000000011868209470384652
TCGA-06-0141.1	45	1_KEGG_ASTHMA	30	8	0.0000000012575900719624268
TCGA-06-0173.35	120	1_KEGG_CELL_CYCLE	114	16	0.0000000012754945071917981
TCGA-19-5955.9	110	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000000012771868338285359
TCGA-14-4157.7	101	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000013072795674095125
TCGA-14-0813.10	53	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000013301660133901528
TCGA-19-5960.9	134	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000013505156895805500
TCGA-02-0069.13	16	2_COLLAGEN	23	6	0.0000000013638849280445497
TCGA-06-0644.16	142	1_KEGG_CELL_CYCLE	114	17	0.0000000014068593698198969
TCGA-06-5413.11	142	1_KEGG_CELL_CYCLE	114	17	0.0000000014068593698198969
TCGA-16-1048.13	97	1_KEGG_FOCAL_ADHESION	195	18	0.0000000014335906122928281
TCGA-06-5859.9	125	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000000015038666595520417
TCGA-02-0107.3	71	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000000015350694356488341
TCGA-06-0156.4	80	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000015672766337009811
TCGA-19-1790.18	201	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	23	0.0000000015700519420862208
TCGA-27-2521.10	94	2_CELL_CYCLE_GO_0007049	265	20	0.0000000015832819860808684
TCGA-02-0069.13	16	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000000016217018352423708
TCGA-06-0139.1	179	0_HALLMARK_ALLOGRAFT_REJECTION	190	23	0.0000000016242423842589700
TCGA-19-4068.7	14	1_KEGG_CELL_CYCLE	114	8	0.0000000016750360719330261
TCGA-19-5955.9	110	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000000017137279793134667
TCGA-19-1390.13	110	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	11	0.0000000017137279793134667
TCGA-02-0026.1	61	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000017217044560174862
TCGA-02-0113.4	9	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0000000017461026151342671
TCGA-14-1034.9	9	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0000000017461026151342671
TCGA-02-0054.2	9	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0000000017461026151342671
TCGA-26-5134.2	14	1_KEGG_FOCAL_ADHESION	195	9	0.0000000017500100232793333
TCGA-32-2634.10	118	1_KEGG_P53_SIGNALING_PATHWAY	66	13	0.0000000018198353932829296
TCGA-02-0015.16	115	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000018400957594871276
TCGA-06-0128.9	11	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0000000018450731763488631
TCGA-32-2634.10	118	2_DNA_REPLICATION	82	14	0.0000000018680288256435095
TCGA-14-3476.4	7	2_COLLAGEN	23	5	0.0000000018994980966271459
TCGA-32-2632.16	229	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	23	0.0000000019049138482627406
TCGA-06-0882.6	21	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0000000019162197772606116
TCGA-06-0882.6	21	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0000000019162197772606116
TCGA-06-0176.8	95	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000020141786078293461
TCGA-06-0124.6	55	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000020584857255328237
TCGA-08-0345.2	77	1_KEGG_ASTHMA	30	9	0.0000000020660990948789921
TCGA-06-0197.1	57	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000021585062766226805
TCGA-06-6391.9	26	1_KEGG_FOCAL_ADHESION	195	11	0.0000000021767559733017219
TCGA-28-5208.28	220	1_KEGG_CELL_CYCLE	114	20	0.0000000021843500444448008
TCGA-06-0192.10	126	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000022117494734763198
TCGA-02-2486.9	141	1_KEGG_LEISHMANIA_INFECTION	70	14	0.0000000022644501609555084
TCGA-06-0128.9	11	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0000000023776728387377385
TCGA-76-6191.6	96	2_CELL_CYCLE_GO_0007049	265	20	0.0000000024090654750160370
TCGA-87-5896.6	131	0_HALLMARK_E2F_TARGETS	169	19	0.0000000024094833873642810
TCGA-14-3476.4	7	1_KEGG_FOCAL_ADHESION	195	7	0.0000000024233530428720127
TCGA-02-0113.4	9	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0000000025604492379861396
TCGA-14-1034.9	9	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0000000025604492379861396
TCGA-02-0054.2	9	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0000000025604492379861396
TCGA-06-0155.10	74	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000000025757439342149968
TCGA-32-5222.9	70	1_KEGG_CELL_CYCLE	114	13	0.0000000025818688534956793
TCGA-27-2523.12	112	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000026276257213907308
TCGA-08-0347.4	16	0_HALLMARK_E2F_TARGETS	169	9	0.0000000026306216048454522
TCGA-02-0038.3	199	2_NUCLEUS	1110	60	0.0000000026758672408007608
TCGA-26-5132.7	100	0_HALLMARK_E2F_TARGETS	169	17	0.0000000027211857010554747
TCGA-19-1390.13	110	0_HALLMARK_MYC_TARGETS_V1	178	18	0.0000000028247109791035423
TCGA-06-0876.9	106	1_KEGG_CELL_CYCLE	114	15	0.0000000028710704051352007
TCGA-02-0015.16	115	1_KEGG_FOCAL_ADHESION	195	19	0.0000000028727182732388736
TCGA-06-0139.1	179	0_HALLMARK_COAGULATION	125	19	0.0000000028740315438313456
TCGA-06-0881.7	203	0_HALLMARK_COAGULATION	125	20	0.0000000028900178010891194
TCGA-06-0881.7	203	2_IMMUNE_SYSTEM_PROCESS	283	29	0.0000000029423507876728397
TCGA-27-1835.6	86	0_HALLMARK_E2F_TARGETS	169	16	0.0000000029699258858806203
TCGA-06-6391.6	30	0_HALLMARK_E2F_TARGETS	169	11	0.0000000029776473863142860
TCGA-32-2638.17	159	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	12	0.0000000029780047725786129
TCGA-76-6191.6	96	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000031286193279419937
TCGA-28-1753.13	174	1_KEGG_ECM_RECEPTOR_INTERACTION	84	16	0.0000000031860673848341509
TCGA-06-0168.4	22	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0000000033141780883320352
TCGA-06-0173.35	120	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000033414397794461081
TCGA-08-0347.4	16	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000000034300447450820743
TCGA-19-2631.15	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000034825998778088542
TCGA-19-4068.2	11	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0000000035031967952767651
TCGA-81-5910.12	128	1_KEGG_CELL_CYCLE	114	16	0.0000000035432640700696215
TCGA-28-5220.7	15	1_KEGG_CELL_CYCLE	114	8	0.0000000035535437311996418
TCGA-32-2634.10	118	2_DNA_METABOLIC_PROCESS	218	20	0.0000000036034436521050924
TCGA-06-1804.6	30	2_DNA_REPLICATION	82	9	0.0000000037155686677539547
TCGA-06-0171.7	57	1_KEGG_CELL_CYCLE	114	12	0.0000000040069055495658613
TCGA-06-2558.6	74	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000000040568835184236983
TCGA-06-6391.6	30	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000000041051610395760116
TCGA-32-2638.17	159	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	12	0.0000000041092370020914104
TCGA-41-3915.10	109	1_KEGG_CELL_CYCLE	114	15	0.0000000043644209824786756
TCGA-06-2561.5	42	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000000044691905677320927
TCGA-08-0356.2	23	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0000000045634085761917547
TCGA-14-1823.12	6	1_KEGG_CELL_CYCLE	114	6	0.0000000045696244811171052
TCGA-14-4157.7	101	2_CHROMOSOME	102	14	0.0000000046859996337364310
TCGA-08-0353.8	100	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000048210759107603310
TCGA-14-3476.4	7	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0000000048408575067236245
TCGA-02-0011.1	288	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	25	0.0000000048589837477467026
TCGA-02-0011.1	288	1_KEGG_CELL_CYCLE	114	22	0.0000000049503606643872753
TCGA-26-5133.10	75	0_HALLMARK_E2F_TARGETS	169	15	0.0000000049959935768610461
TCGA-06-0139.1	179	2_RESPONSE_TO_WOUNDING	163	21	0.0000000049998460012686029
TCGA-06-0881.7	203	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	17	0.0000000050535782055564531
TCGA-06-5859.9	125	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000000053150470920844946
TCGA-27-2521.10	94	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000000053415965106643991
TCGA-19-5947.4	267	0_HALLMARK_COMPLEMENT	176	26	0.0000000053502633010485915
TCGA-76-6282.11	185	0_HALLMARK_COMPLEMENT	176	22	0.0000000053535791578360517
TCGA-76-6193.13	271	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	14	0.0000000054411261220681301
TCGA-02-0086.2	17	0_HALLMARK_E2F_TARGETS	169	9	0.0000000055048263858957396
TCGA-06-0129.11	110	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000055393410808820176
TCGA-28-5218.5	208	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	10	0.0000000055560270556764209
TCGA-28-5218.5	208	2_INTERMEDIATE_FILAMENT	20	10	0.0000000055560270556764209
TCGA-06-0129.11	110	2_NON_MEMBRANE_BOUND_ORGANELLE	476	27	0.0000000056024818493472611
TCGA-06-0129.11	110	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	27	0.0000000056024818493472611
TCGA-02-0089.5	91	1_KEGG_FOCAL_ADHESION	195	17	0.0000000056699194592795500
TCGA-06-2559.11	101	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000000058934920303027492
TCGA-06-0139.1	179	2_DEFENSE_RESPONSE	222	24	0.0000000060378618579171787
TCGA-14-0786.2	10	1_KEGG_CELL_CYCLE	114	7	0.0000000060874775506108218
TCGA-06-0173.35	120	1_KEGG_FOCAL_ADHESION	195	19	0.0000000063174727463503871
TCGA-06-5418.4	24	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000000063864511078409525
TCGA-12-3653.55	255	2_CELL_CYCLE_GO_0007049	265	31	0.0000000064951605590876108
TCGA-06-2559.11	101	2_CELL_CYCLE_GO_0007049	265	20	0.0000000065680328978223240
TCGA-06-0141.1	45	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000065891887499308883
TCGA-02-0085.1	45	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000065891887499308883
TCGA-02-0060.19	281	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	26	0.0000000066616258059293069
TCGA-76-6193.13	271	0_HALLMARK_KRAS_SIGNALING_UP	148	24	0.0000000067274792726821810
TCGA-06-2558.6	74	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000067607353354269157
TCGA-06-0238.4	24	0_HALLMARK_E2F_TARGETS	169	10	0.0000000068591439903476087
TCGA-06-0139.1	179	0_HALLMARK_KRAS_SIGNALING_UP	148	20	0.0000000069160878875241349
TCGA-14-0789.10	106	1_KEGG_FOCAL_ADHESION	195	18	0.0000000070065979158438376
TCGA-06-5859.9	125	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000000071212498141121669
TCGA-27-1833.7	17	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000000071742261156520881
TCGA-02-0086.2	17	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000000071742261156520881
TCGA-06-0648.6	17	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000000071742261156520881
TCGA-28-2502.9	56	1_KEGG_FOCAL_ADHESION	195	14	0.0000000073176544283411149
TCGA-76-6193.13	271	0_HALLMARK_ALLOGRAFT_REJECTION	190	27	0.0000000073283762578591476
TCGA-02-0085.1	45	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000000074542775447540041
TCGA-41-5651.5	112	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000074913111499409821
TCGA-19-5960.9	134	2_NUCLEUS	1110	46	0.0000000075989407709359190
TCGA-06-2561.5	42	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000000077787130295443165
TCGA-02-2486.9	141	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	13	0.0000000078297363719568286
TCGA-32-1982.9	89	1_KEGG_ASTHMA	30	9	0.0000000079461070184979735
TCGA-02-0085.1	45	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000000080950587941825376
TCGA-02-0083.21	135	1_KEGG_CELL_CYCLE	114	16	0.0000000081700189043159777
TCGA-32-1977.11	107	1_KEGG_FOCAL_ADHESION	195	18	0.0000000082732662499750145
TCGA-06-0141.1	45	2_EXTRACELLULAR_MATRIX	85	10	0.0000000084195555211456424
TCGA-02-0085.1	45	2_EXTRACELLULAR_MATRIX	85	10	0.0000000084195555211456424
TCGA-06-5412.7	153	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000084927407876948832
TCGA-06-0882.6	21	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0000000086977530171948948
TCGA-14-4157.7	101	2_REPLICATION_FORK	18	8	0.0000000087175279264615185
TCGA-12-0618.5	41	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000087358980622760297
TCGA-19-5951.10	138	1_KEGG_FOCAL_ADHESION	195	20	0.0000000090895887204633154
TCGA-41-3392.31	136	1_KEGG_CELL_CYCLE	114	16	0.0000000091681220276160259
TCGA-76-6193.13	271	2_EXTRACELLULAR_REGION_PART	269	32	0.0000000094708361015244078
TCGA-06-0743.14	63	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000095236619686730965
TCGA-27-1830.7	57	1_KEGG_FOCAL_ADHESION	195	14	0.0000000095263465360127986
TCGA-06-0173.35	120	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000097813422999754823
TCGA-06-0168.4	22	1_KEGG_FOCAL_ADHESION	195	10	0.0000000098175607438517985
TCGA-28-5215.7	192	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000101419099276955026
TCGA-76-6285.5	106	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000000105946258447607296
TCGA-06-2561.5	42	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000000109192855062538428
TCGA-02-0052.3	116	1_KEGG_CELL_CYCLE	114	15	0.0000000110361850872623944
TCGA-28-2509.6	59	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000000110529375691524015
TCGA-19-2624.29	130	2_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0000000114733329693019757
TCGA-19-2624.29	130	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0000000114733329693019757
TCGA-06-0882.6	21	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0000000116151698634351391
TCGA-32-2638.17	159	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	15	0.0000000116320550738427000
TCGA-06-1804.7	47	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000119271234532418370
TCGA-19-2620.7	47	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000119271234532418370
TCGA-02-0024.6	206	1_KEGG_P53_SIGNALING_PATHWAY	66	15	0.0000000122432708723823645
TCGA-02-0079.2	10	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	7	0.0000000124491567057810923
TCGA-06-0686.1	7	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000000124663337974922757
TCGA-28-5209.15	194	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000125084358967793444
TCGA-08-0345.2	77	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0000000125284591136505651
TCGA-16-1048.13	97	1_KEGG_CELL_CYCLE	114	14	0.0000000125951061109563351
TCGA-14-1034.7	97	1_KEGG_CELL_CYCLE	114	14	0.0000000125951061109563351
TCGA-19-5952.11	193	0_HALLMARK_COMPLEMENT	176	22	0.0000000126508555041799774
TCGA-02-0003.9	227	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	22	0.0000000127055094708955101
TCGA-06-2561.5	42	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000000134452674635816876
TCGA-06-0168.4	22	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000000135700803486005627
TCGA-32-4213.15	198	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	15	0.0000000137785932516217247
TCGA-08-0389.4	56	1_KEGG_DNA_REPLICATION	32	8	0.0000000144252411818519197
TCGA-06-0195.8	56	1_KEGG_DNA_REPLICATION	32	8	0.0000000144252411818519197
TCGA-06-0176.8	95	0_HALLMARK_E2F_TARGETS	169	16	0.0000000147565844701834089
TCGA-06-0132.1	18	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000000148755669460415408
TCGA-06-0129.11	110	2_CELL_CYCLE_PHASE	146	16	0.0000000157360099351194560
TCGA-14-0871.20	216	2_CELL_CYCLE_GO_0007049	265	28	0.0000000162003943015943388
TCGA-27-1836.8	49	1_KEGG_CELL_CYCLE	114	11	0.0000000162091775570419334
TCGA-02-0107.3	71	1_KEGG_FOCAL_ADHESION	195	15	0.0000000171883811614818357
TCGA-19-5955.9	110	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000000174774933599461943
TCGA-19-1390.13	110	2_REPLICATION_FORK	18	8	0.0000000175225169217963785
TCGA-06-0141.1	45	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000000178342536710104984
TCGA-27-2519.7	113	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000000179633524647801765
TCGA-12-3653.55	255	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	23	0.0000000180729453107054607
TCGA-02-0007.17	217	2_CELL_CYCLE_GO_0007049	265	28	0.0000000181428545000276715
TCGA-02-0113.4	9	1_KEGG_LEISHMANIA_INFECTION	70	6	0.0000000185444079746296872
TCGA-02-0113.4	9	1_KEGG_VIRAL_MYOCARDITIS	70	6	0.0000000185444079746296872
TCGA-14-1034.9	9	1_KEGG_LEISHMANIA_INFECTION	70	6	0.0000000185444079746296872
TCGA-14-1034.9	9	1_KEGG_VIRAL_MYOCARDITIS	70	6	0.0000000185444079746296872
TCGA-02-0054.2	9	1_KEGG_LEISHMANIA_INFECTION	70	6	0.0000000185444079746296872
TCGA-02-0054.2	9	1_KEGG_VIRAL_MYOCARDITIS	70	6	0.0000000185444079746296872
TCGA-26-5134.2	14	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0000000187809096036923776
TCGA-06-0188.11	66	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000187911614747834978
TCGA-06-0645.9	136	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000189671454313454605
TCGA-06-0142.3	8	1_KEGG_FOCAL_ADHESION	195	7	0.0000000190490282827709873
TCGA-02-2486.9	141	0_HALLMARK_COMPLEMENT	176	19	0.0000000191583156358686457
TCGA-06-0142.3	8	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0000000192263286593030118
TCGA-02-0102.8	82	0_HALLMARK_E2F_TARGETS	169	15	0.0000000196006085791165770
TCGA-06-5413.11	142	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000196619665660029631
TCGA-02-0060.19	281	0_HALLMARK_APOPTOSIS	150	24	0.0000000197113701402069243
TCGA-02-0085.1	45	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000000197557185420479294
TCGA-14-4157.7	101	2_DNA_METABOLIC_PROCESS	218	18	0.0000000198031906698016094
TCGA-19-5958.4	35	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000000198111483103271949
TCGA-19-2624.29	130	2_CELL_CYCLE_PHASE	146	17	0.0000000198407053843952882
TCGA-02-0114.20	132	2_CELL_CYCLE_GO_0007049	265	22	0.0000000201371058862861355
TCGA-14-1823.12	6	2_CELL_CYCLE_PHASE	146	6	0.0000000207713095361000799
TCGA-02-0060.19	281	0_HALLMARK_COAGULATION	125	22	0.0000000208970547392184040
TCGA-02-0102.8	82	1_KEGG_CELL_CYCLE	114	13	0.0000000215170073523672039
TCGA-06-0166.5	35	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000000221331899976258078
TCGA-19-5958.4	35	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000000221331899976258078
TCGA-02-0038.3	199	2_NON_MEMBRANE_BOUND_ORGANELLE	476	36	0.0000000228831644162804100
TCGA-02-0038.3	199	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	36	0.0000000228831644162804100
TCGA-76-4925.9	83	0_HALLMARK_E2F_TARGETS	169	15	0.0000000235572511618874327
TCGA-27-2528.10	99	1_KEGG_FOCAL_ADHESION	195	17	0.0000000235745271765030868
TCGA-06-0129.11	110	0_HALLMARK_MITOTIC_SPINDLE	175	17	0.0000000238431666872048682
TCGA-19-5955.9	110	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000000239021775753956764
TCGA-06-0745.4	55	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000240812105262452282
TCGA-02-0085.1	45	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000000243189556419133144
TCGA-06-2561.5	42	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0000000245450027370221111
TCGA-19-5958.4	35	2_EXTRACELLULAR_MATRIX	85	9	0.0000000246925310956483973
TCGA-06-0750.13	8	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000000249242175442869326
TCGA-06-5415.3	8	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000000249242175442869326
TCGA-06-0221.4	8	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000000249242175442869326
TCGA-32-2491.14	244	0_HALLMARK_G2M_CHECKPOINT	174	24	0.0000000249366398785091194
TCGA-02-0060.19	281	2_EXTRACELLULAR_REGION_PART	269	32	0.0000000251939330960100718
TCGA-41-2575.49	136	2_CELL_CYCLE_PROCESS	163	18	0.0000000255225034112659883
TCGA-26-5139.10	163	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	9	0.0000000261878219940410162
TCGA-26-5139.10	163	2_INTERMEDIATE_FILAMENT	20	9	0.0000000261878219940410162
TCGA-02-0015.16	115	0_HALLMARK_UV_RESPONSE_DN	122	15	0.0000000264556251688606784
TCGA-08-0356.2	23	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0000000275721937000082429
TCGA-14-0781.7	155	0_HALLMARK_COAGULATION	125	17	0.0000000275820279117518036
TCGA-26-5139.10	163	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000279218545943136727
TCGA-06-0176.8	95	1_KEGG_DNA_REPLICATION	32	9	0.0000000279858719540218229
TCGA-12-0616.4	7	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	5	0.0000000282597221235202872
TCGA-19-2625.9	146	1_KEGG_P53_SIGNALING_PATHWAY	66	13	0.0000000286328451568295689
TCGA-06-2558.6	74	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000288548668038702621
TCGA-32-4210.14	109	2_CELL_CYCLE_GO_0007049	265	20	0.0000000288940672283833648
TCGA-19-2629.15	146	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000292792270099887352
TCGA-06-0221.13	45	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000298396526524097993
TCGA-06-0744.10	36	0_HALLMARK_E2F_TARGETS	169	11	0.0000000298474872743275769
TCGA-81-5910.12	128	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000300351151648772305
TCGA-06-2565.10	38	1_KEGG_ASTHMA	30	7	0.0000000305457979169928518
TCGA-06-0216.6	67	1_KEGG_CELL_CYCLE	114	12	0.0000000307266462712287054
TCGA-06-0750.12	52	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000310986166493724516
TCGA-27-1838.17	131	1_KEGG_FOCAL_ADHESION	195	19	0.0000000313357203490665725
TCGA-28-5218.5	208	2_STRUCTURAL_MOLECULE_ACTIVITY	206	24	0.0000000313649721244689779
TCGA-08-0355.1	45	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000000319316898664720832
TCGA-19-1790.18	201	1_KEGG_FOCAL_ADHESION	195	23	0.0000000324726850460847179
TCGA-06-0878.10	115	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000331216483530455930
TCGA-19-2619.14	100	0_HALLMARK_E2F_TARGETS	169	16	0.0000000333135469614607562
TCGA-06-0128.9	11	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	7	0.0000000338576948528555903
TCGA-06-0881.7	203	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	16	0.0000000341068405265710722
TCGA-19-5955.9	110	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000000344641557619439778
TCGA-19-1390.13	110	2_NON_MEMBRANE_BOUND_ORGANELLE	476	26	0.0000000358926117491733127
TCGA-19-1390.13	110	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	26	0.0000000358926117491733127
TCGA-06-0190.8	143	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000377636324115253078
TCGA-32-1979.4	12	1_KEGG_CELL_CYCLE	114	7	0.0000000393846179001579524
TCGA-32-2634.10	118	1_KEGG_SMALL_CELL_LUNG_CANCER	83	13	0.0000000394355582670863773
TCGA-06-0750.12	52	2_EXTRACELLULAR_MATRIX	85	10	0.0000000396834150286997480
TCGA-76-4931.10	86	1_KEGG_CELL_CYCLE	114	13	0.0000000403306718427233528
TCGA-06-2569.5	144	1_KEGG_DNA_REPLICATION	32	10	0.0000000404495545370887671
TCGA-27-1838.17	131	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000406304452099935364
TCGA-87-5896.6	131	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000406304452099935364
TCGA-14-1823.12	6	2_CELL_CYCLE_PROCESS	163	6	0.0000000406667739779418759
TCGA-32-2634.10	118	2_CHROMOSOME	102	14	0.0000000410441474890611775
TCGA-19-5960.9	134	2_DNA_METABOLIC_PROCESS	218	20	0.0000000410522777683997635
TCGA-41-2575.49	136	2_CELL_CYCLE_PHASE	146	17	0.0000000415385918223573862
TCGA-02-0083.21	135	0_HALLMARK_E2F_TARGETS	169	18	0.0000000415658780645915270
TCGA-06-2561.5	42	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0000000421645110743023988
TCGA-27-1837.5	85	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000000428772873353342057
TCGA-06-0137.9	53	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000430245290069803210
TCGA-41-2575.49	136	1_KEGG_PATHWAYS_IN_CANCER	323	24	0.0000000436054523010831327
TCGA-06-0750.12	52	1_KEGG_FOCAL_ADHESION	195	13	0.0000000438113253878523122
TCGA-32-2632.16	229	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000448205904609074227
TCGA-19-5947.4	267	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	23	0.0000000465522972761447491
TCGA-06-0879.9	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000467504241188143186
TCGA-14-4157.7	101	2_CHROMOSOMAL_PART	78	12	0.0000000468015766445650158
TCGA-08-0347.7	25	1_KEGG_FOCAL_ADHESION	195	10	0.0000000470231004025121897
TCGA-08-0345.2	77	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000000470969944812792299
TCGA-32-2638.17	159	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	17	0.0000000474988830742379708
TCGA-41-2572.8	76	1_KEGG_FOCAL_ADHESION	195	15	0.0000000487651057269380987
TCGA-28-5218.5	208	1_KEGG_ECM_RECEPTOR_INTERACTION	84	16	0.0000000493654319652341525
TCGA-08-0386.4	73	0_HALLMARK_E2F_TARGETS	169	14	0.0000000500028186859303803
TCGA-76-6282.11	185	0_HALLMARK_COAGULATION	125	18	0.0000000510775659284583828
TCGA-02-2486.9	141	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	14	0.0000000510904679450177280
TCGA-41-3915.10	109	1_KEGG_ASTHMA	30	9	0.0000000511896296903985969
TCGA-06-5859.9	125	2_CELL_CYCLE_GO_0007049	265	21	0.0000000514350722649638174
TCGA-14-0817.9	85	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000514372405266221312
TCGA-06-2557.11	177	1_KEGG_CELL_CYCLE	114	17	0.0000000517087542240350242
TCGA-32-2638.17	159	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	12	0.0000000517811121487530690
TCGA-19-2619.14	100	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000520214031351279130
TCGA-02-0038.3	199	2_CHROMOSOME	102	17	0.0000000537525311181497648
TCGA-26-5139.10	163	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	12	0.0000000538949200070213223
TCGA-26-5135.9	71	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000539185458260970706
TCGA-06-0881.7	203	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	12	0.0000000540648937896758237
TCGA-32-1979.10	116	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	12	0.0000000545103544246837347
TCGA-12-3652.19	88	1_KEGG_CELL_CYCLE	114	13	0.0000000545303879846245559
TCGA-27-2519.7	113	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000000555538001733613910
TCGA-27-1837.5	85	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000558636782451116213
TCGA-06-0124.6	55	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000562900480372922983
TCGA-06-0173.35	120	0_HALLMARK_E2F_TARGETS	169	17	0.0000000571026290212128444
TCGA-02-0113.4	9	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	6	0.0000000572706170577482421
TCGA-19-5947.4	267	0_HALLMARK_COAGULATION	125	21	0.0000000593171648156826039
TCGA-12-3650.17	101	2_CELL_CYCLE_GO_0007049	265	19	0.0000000597298862305052096
TCGA-06-0139.1	179	1_KEGG_LEISHMANIA_INFECTION	70	14	0.0000000597445787737205924
TCGA-06-0133.6	57	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000000600476890107025586
TCGA-12-0618.5	41	1_KEGG_CELL_CYCLE	114	10	0.0000000607123319564402400
TCGA-06-0686.10	26	2_CELL_CYCLE_GO_0007049	265	11	0.0000000618510127316962358
TCGA-02-0060.19	281	2_EXTRACELLULAR_REGION	346	36	0.0000000630010467886332194
TCGA-06-0157.7	89	1_KEGG_CELL_CYCLE	114	13	0.0000000632210672574959106
TCGA-06-2557.11	177	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	19	0.0000000643005319407264186
TCGA-06-2561.5	42	1_KEGG_ASTHMA	30	7	0.0000000647416963442307692
TCGA-32-1982.9	89	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000000654856794422953613
TCGA-41-2571.7	72	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000658658651602390350
TCGA-27-1838.17	131	1_KEGG_CELL_CYCLE	114	15	0.0000000659313404862387463
TCGA-28-5215.7	192	2_ECTODERM_DEVELOPMENT	66	14	0.0000000660855366911744095
TCGA-06-0157.7	89	0_HALLMARK_E2F_TARGETS	169	15	0.0000000673490750297299272
TCGA-28-2502.9	56	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000680443743637666410
TCGA-02-0060.19	281	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	31	0.0000000682043792731195053
TCGA-76-4935.7	15	2_CELL_CYCLE_GO_0007049	265	9	0.0000000685633323044143535
TCGA-06-2561.5	42	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000000704684082686174844
TCGA-02-0113.4	9	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	6	0.0000000710900901211554955
TCGA-14-1034.9	9	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	6	0.0000000710900901211554955
TCGA-02-0054.2	9	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	6	0.0000000710900901211554955
TCGA-27-2519.7	113	1_KEGG_ASTHMA	30	9	0.0000000711038617375755097
TCGA-06-0881.7	203	0_HALLMARK_KRAS_SIGNALING_UP	148	20	0.0000000714517930096350001
TCGA-06-5859.9	125	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000000716720946611181671
TCGA-06-0124.6	55	2_EXTRACELLULAR_MATRIX	85	10	0.0000000717872130016081297
TCGA-19-5954.17	208	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	12	0.0000000719420357979439646
TCGA-27-2519.7	113	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000000721907095104364975
TCGA-02-0058.1	110	1_KEGG_CELL_CYCLE	114	14	0.0000000726633316789568909
TCGA-14-1823.12	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0000000737920469271301014
TCGA-08-0386.4	73	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000000742178716023720251
TCGA-32-2634.10	118	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000759229762130119415
TCGA-02-0085.1	45	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0000000761348889467752761
TCGA-02-0009.6	188	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	18	0.0000000767860087967420462
TCGA-28-2502.9	56	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000768958480135527459
TCGA-06-6391.6	30	1_KEGG_CELL_CYCLE	114	9	0.0000000770426778774140504
TCGA-06-0139.1	179	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000000781906073784164085
TCGA-06-2565.3	60	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000791161057979205498
TCGA-76-6193.13	271	1_KEGG_FOCAL_ADHESION	195	26	0.0000000812229868214128618
TCGA-06-0876.9	106	0_HALLMARK_E2F_TARGETS	169	16	0.0000000831994469270444001
TCGA-76-4929.8	91	1_KEGG_CELL_CYCLE	114	13	0.0000000844993743281629849
TCGA-41-2572.8	76	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000848199773890899151
TCGA-06-2563.10	123	0_HALLMARK_E2F_TARGETS	169	17	0.0000000855248941313699190
TCGA-06-0882.6	21	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000000857294226056963150
TCGA-28-2502.9	56	2_EXTRACELLULAR_MATRIX	85	10	0.0000000867607983814453797
TCGA-28-5220.7	15	0_HALLMARK_E2F_TARGETS	169	8	0.0000000868216138246380253
TCGA-76-4935.7	15	0_HALLMARK_E2F_TARGETS	169	8	0.0000000868216138246380253
TCGA-19-2624.29	130	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000874967962925525477
TCGA-27-2527.6	79	1_KEGG_FOCAL_ADHESION	195	15	0.0000000876711261106444581
TCGA-41-2571.7	72	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000000879096653888889860
TCGA-06-0686.5	14	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0000000896815437949753927
TCGA-27-1830.7	57	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000925908592575517262
TCGA-02-0025.5	88	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000939256756134516104
TCGA-06-5412.7	153	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000948076305646764785
TCGA-06-0124.6	55	1_KEGG_FOCAL_ADHESION	195	13	0.0000000948366457780749496
TCGA-76-6193.13	271	2_EXTRACELLULAR_REGION	346	35	0.0000000955363445026233487
TCGA-02-0010.18	184	1_KEGG_CELL_CYCLE	114	17	0.0000000962595334975112500
TCGA-02-2486.9	141	0_HALLMARK_INFLAMMATORY_RESPONSE	170	18	0.0000000965253544125648797
TCGA-06-5859.9	125	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0000000967302231742443336
TCGA-15-0742.13	74	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000973300169274542560
TCGA-06-2564.7	92	1_KEGG_CELL_CYCLE	114	13	0.0000000974227771199188715
TCGA-32-4210.14	109	1_KEGG_DNA_REPLICATION	32	9	0.0000000984514224061798481
TCGA-32-2634.10	118	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0000000985594272818445517
TCGA-06-1804.6	30	1_KEGG_MISMATCH_REPAIR	23	6	0.0000000989636654104851375
TCGA-02-0014.10	70	2_CELL_CYCLE_GO_0007049	265	16	0.0000001008293622264436428
TCGA-32-2638.17	159	1_KEGG_CELL_CYCLE	114	16	0.0000001020257102119889706
TCGA-12-3653.55	255	2_CELL_CYCLE_PROCESS	163	23	0.0000001038024718953932676
TCGA-14-1823.12	6	2_INTERPHASE	62	5	0.0000001041743886408225330
TCGA-14-0781.7	155	0_HALLMARK_COMPLEMENT	176	19	0.0000001041847125546445494
TCGA-06-0189.3	118	1_KEGG_ASTHMA	30	9	0.0000001054156338075831831
TCGA-02-0038.3	199	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000001070359048399386250
TCGA-14-0781.7	155	2_EXTRACELLULAR_REGION_PART	269	23	0.0000001078033212649899982
TCGA-02-0038.3	199	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	12	0.0000001080824539449646898
TCGA-02-0009.6	188	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000001092515914238013842
TCGA-12-3649.15	89	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000001111642009878943936
TCGA-14-0781.7	155	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000001130462514998194143
TCGA-28-5215.7	192	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	9	0.0000001147317382721717637
TCGA-28-5215.7	192	2_INTERMEDIATE_FILAMENT	20	9	0.0000001147317382721717637
TCGA-26-5136.6	160	1_KEGG_DNA_REPLICATION	32	10	0.0000001158106299543742643
TCGA-26-5139.10	163	2_ECTODERM_DEVELOPMENT	66	13	0.0000001162276468562015362
TCGA-27-1837.5	85	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000001172860083836396429
TCGA-06-0125.9	75	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000001177593996957832971
TCGA-06-2569.5	144	2_CELL_CYCLE_GO_0007049	265	22	0.0000001189365088467704103
TCGA-06-0750.13	8	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	7	0.0000001202346051520946794
TCGA-02-0060.19	281	2_RESPONSE_TO_WOUNDING	163	24	0.0000001205457342371334257
TCGA-19-2624.29	130	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000001220697202108255714
TCGA-06-0211.8	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000001231917093837001667
TCGA-32-1977.3	8	1_KEGG_CELL_CYCLE	114	6	0.0000001254530362564219963
TCGA-06-0141.1	45	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000001271339926522644737
TCGA-02-0085.1	45	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000001271339926522644737
TCGA-02-0085.1	45	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000001271339926522644737
TCGA-12-0616.4	7	2_KINESIN_COMPLEX	13	4	0.0000001271729045179478284
TCGA-06-1804.6	30	2_CHROMOSOMAL_PART	78	8	0.0000001277146287613727465
TCGA-19-1390.13	110	2_CHROMOSOMAL_PART	78	12	0.0000001302335531585212829
TCGA-06-0686.5	14	1_KEGG_FOCAL_ADHESION	195	8	0.0000001302672314712207623
TCGA-02-0009.6	188	1_KEGG_ECM_RECEPTOR_INTERACTION	84	15	0.0000001307111227987206008
TCGA-14-3476.4	7	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0000001319497446307968292
TCGA-76-6193.13	271	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	30	0.0000001324154778845882124
TCGA-08-0352.2	59	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000001327965947757257210
TCGA-14-4157.7	101	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000001334049807239234344
TCGA-27-1838.17	131	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000001336639131747198952
TCGA-06-2565.10	38	2_MITOTIC_CELL_CYCLE	134	10	0.0000001338743978317694755
TCGA-02-0015.16	115	1_KEGG_CELL_CYCLE	114	14	0.0000001339315112253723434
TCGA-76-6193.13	271	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	13	0.0000001370248830843350440
TCGA-02-0010.18	184	0_HALLMARK_E2F_TARGETS	169	20	0.0000001375822390288245982
TCGA-76-6193.13	271	1_KEGG_LEISHMANIA_INFECTION	70	16	0.0000001410343275118403966
TCGA-76-6193.13	271	1_KEGG_VIRAL_MYOCARDITIS	70	16	0.0000001410343275118403966
TCGA-06-5859.9	125	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0000001436735678639795463
TCGA-76-6285.5	106	2_CELL_CYCLE_GO_0007049	265	19	0.0000001444527894037942962
TCGA-06-0133.6	57	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000001458810009280764851
TCGA-02-0058.1	110	0_HALLMARK_E2F_TARGETS	169	16	0.0000001480738065557370898
TCGA-27-1837.5	85	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000001481906650705097579
TCGA-26-5139.10	163	1_KEGG_CELL_CYCLE	114	16	0.0000001488433788920873704
TCGA-26-5136.6	160	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000001493369125614183153
TCGA-12-0619.11	123	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000001494128740076295257
TCGA-06-2563.10	123	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000001494128740076295257
TCGA-76-6192.6	43	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000001495064459491247846
TCGA-06-2565.10	38	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000001513926164467367647
TCGA-02-0060.19	281	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	13	0.0000001527635552681581417
TCGA-08-0347.4	16	2_CELL_CYCLE_GO_0007049	265	9	0.0000001528945020938356999
TCGA-06-5417.5	79	0_HALLMARK_E2F_TARGETS	169	14	0.0000001533471349922740967
TCGA-76-6191.6	96	1_KEGG_FOCAL_ADHESION	195	16	0.0000001541325386302308272
TCGA-06-2562.7	57	1_KEGG_FOCAL_ADHESION	195	13	0.0000001543186911619581633
TCGA-28-5214.11	124	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000001555286560942085252
TCGA-28-6450.11	139	1_KEGG_CELL_CYCLE	114	15	0.0000001556855058599502655
TCGA-32-4213.15	198	0_HALLMARK_COMPLEMENT	176	21	0.0000001558581699651707460
TCGA-02-0009.6	188	2_EXTRACELLULAR_MATRIX	85	15	0.0000001559868023630273384
TCGA-02-2486.9	141	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000001570253511291523223
TCGA-14-0787.6	40	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000001575947767557515259
TCGA-19-2629.15	146	0_HALLMARK_E2F_TARGETS	169	18	0.0000001577837696412188314
TCGA-06-5859.9	125	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000001583958473558255828
TCGA-32-4213.15	198	0_HALLMARK_COAGULATION	125	18	0.0000001594046158092923322
TCGA-06-1804.6	30	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0000001603541780732264929
TCGA-02-2486.9	141	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000001659712003617673039
TCGA-28-5216.8	162	2_CYTOSKELETAL_PART	194	20	0.0000001661563718764180470
TCGA-19-1390.13	110	2_INTERPHASE	62	11	0.0000001676914701220006702
TCGA-06-0132.1	18	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0000001692328304988966979
TCGA-19-1390.13	110	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	15	0.0000001699166325689721351
TCGA-32-2615.7	77	1_KEGG_CELL_CYCLE	114	12	0.0000001702893925258110971
TCGA-06-5859.9	125	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000001741865283781577584
TCGA-02-0069.13	16	2_EXTRACELLULAR_REGION_PART	269	9	0.0000001748472155752710450
TCGA-06-0744.3	12	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000001760109665507479255
TCGA-32-1982.9	89	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000001788541043287621550
TCGA-06-0686.5	14	2_COLLAGEN	23	5	0.0000001790810516222564364
TCGA-06-0133.6	57	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000001793734831232289267
TCGA-27-2523.12	112	1_KEGG_FOCAL_ADHESION	195	17	0.0000001815209303440380343
TCGA-41-2575.49	136	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000001816277283107446341
TCGA-08-0345.2	77	0_HALLMARK_COMPLEMENT	176	14	0.0000001844393816958913068
TCGA-81-5910.12	128	1_KEGG_FOCAL_ADHESION	195	18	0.0000001851660530615666284
TCGA-32-2638.17	159	1_KEGG_VIRAL_MYOCARDITIS	70	13	0.0000001858829458671310902
TCGA-76-6192.6	43	2_EXTRACELLULAR_MATRIX	85	9	0.0000001860585427997282664
TCGA-02-0099.11	141	1_KEGG_CELL_CYCLE	114	15	0.0000001912776023494793481
TCGA-41-2573.4	31	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0000001968090014911257196
TCGA-06-0174.37	141	2_MITOTIC_CELL_CYCLE	134	16	0.0000001970001026305089622
TCGA-14-0781.7	155	0_HALLMARK_UV_RESPONSE_DN	122	16	0.0000001973515334761562155
TCGA-06-0650.2	82	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000001986852358916773680
TCGA-06-6390.9	82	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000001986852358916773680
TCGA-02-0028.9	182	1_KEGG_ASTHMA	30	10	0.0000001998478383372800478
TCGA-06-2559.11	101	2_REGULATION_OF_CELL_CYCLE	160	15	0.0000001999163482573758778
TCGA-06-1804.7	47	1_KEGG_FOCAL_ADHESION	195	12	0.0000001999259469567107990
TCGA-19-2620.7	47	1_KEGG_FOCAL_ADHESION	195	12	0.0000001999259469567107990
TCGA-06-0241.8	53	2_CELL_CYCLE_GO_0007049	265	14	0.0000002023970347576905855
TCGA-12-3650.17	101	2_MITOTIC_CELL_CYCLE	134	14	0.0000002038998546297035556
TCGA-19-1790.18	201	0_HALLMARK_COAGULATION	125	18	0.0000002047030508502148524
TCGA-12-5301.7	46	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000002047638266959742268
TCGA-19-5952.11	193	1_KEGG_CELL_CYCLE	114	17	0.0000002057421937028074055
TCGA-32-4210.14	109	2_CHROMOSOME	102	13	0.0000002081877312895843269
TCGA-02-0038.3	199	2_REGULATION_OF_CELL_CYCLE	160	20	0.0000002100883375632067384
TCGA-14-1456.4	41	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000002119504353088806013
TCGA-02-0038.3	199	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	21	0.0000002126379110180282983
TCGA-08-0345.2	77	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0000002154093218623290585
TCGA-02-0075.8	128	1_KEGG_ASTHMA	30	9	0.0000002202580650851747846
TCGA-28-5209.15	194	1_KEGG_CELL_CYCLE	114	17	0.0000002232862490861496647
TCGA-06-2569.5	144	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000002240823979340117350
TCGA-32-1982.9	89	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000002258951965495815734
TCGA-06-0158.4	65	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000002320171379392971489
TCGA-19-5960.9	134	2_CHROMOSOME	102	14	0.0000002335224353419349532
TCGA-28-2513.12	134	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000002344002148137426631
TCGA-06-0155.10	74	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0000002345220244576891923
TCGA-19-2629.15	146	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000002347610222272402726
TCGA-19-5947.4	267	0_HALLMARK_KRAS_SIGNALING_UP	148	22	0.0000002386918641508866513
TCGA-19-1390.13	110	2_DNA_REPLICATION	82	12	0.0000002390179737045696665
TCGA-08-0352.2	59	1_KEGG_FOCAL_ADHESION	195	13	0.0000002460531646051206542
TCGA-14-1829.3	8	2_KINESIN_COMPLEX	13	4	0.0000002541518658034503740
TCGA-14-1825.8	80	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000002584674170747842327
TCGA-32-2632.16	229	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	19	0.0000002588964796123987409
TCGA-19-2631.15	84	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000002598162418274805972
TCGA-06-0129.11	110	2_SPINDLE	35	9	0.0000002616148522361343589
TCGA-06-0197.1	57	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000002630099527134935529
TCGA-06-0176.8	95	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000002690972907957453775
TCGA-06-5858.19	205	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000002697020731527758804
TCGA-19-5947.4	267	2_EXTRACELLULAR_REGION	346	34	0.0000002698742558679327940
TCGA-06-0139.1	179	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000002705458534731093417
TCGA-06-0747.12	80	1_KEGG_CELL_CYCLE	114	12	0.0000002708789938441844293
TCGA-02-0038.3	199	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	19	0.0000002740936373907570501
TCGA-87-5896.6	131	1_KEGG_FOCAL_ADHESION	195	18	0.0000002743170223539513858
TCGA-08-0345.2	77	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0000002766583610240123525
TCGA-06-2570.8	95	2_CELL_CYCLE_PHASE	146	14	0.0000002793659971403653012
TCGA-76-6193.13	271	1_KEGG_ECM_RECEPTOR_INTERACTION	84	17	0.0000002809483127269260600
TCGA-76-6191.6	96	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000002810141956901722097
TCGA-06-0133.6	57	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000002832703735636918481
TCGA-19-5955.9	110	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0000002854619051570978160
TCGA-41-3915.10	109	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000002868975097426835421
TCGA-41-2571.7	72	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000002918860155405311624
TCGA-14-1825.8	80	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000002922988196908593890
TCGA-06-0881.7	203	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000003046996367306609685
TCGA-02-0038.3	199	2_CELL_CYCLE_PHASE	146	19	0.0000003093500580675582884
TCGA-32-2498.13	133	1_KEGG_ASTHMA	30	9	0.0000003112547645477465685
TCGA-06-2565.10	38	2_CELL_CYCLE_PHASE	146	10	0.0000003144324767332327728
TCGA-02-0003.9	227	0_HALLMARK_COMPLEMENT	176	22	0.0000003166148301261686001
TCGA-27-1833.7	17	2_CELL_CYCLE_GO_0007049	265	9	0.0000003169790682492048000
TCGA-02-0086.2	17	2_CELL_CYCLE_GO_0007049	265	9	0.0000003169790682492048000
TCGA-06-0648.6	17	2_CELL_CYCLE_GO_0007049	265	9	0.0000003169790682492048000
TCGA-19-5955.9	110	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0000003197477523136701565
TCGA-06-0881.7	203	1_KEGG_LEISHMANIA_INFECTION	70	14	0.0000003236293127391821339
TCGA-06-0174.37	141	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000003243210653213882094
TCGA-28-5215.7	192	2_CYTOSKELETON	293	26	0.0000003250302653390434672
TCGA-06-2565.10	38	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000003268032561637031928
TCGA-19-5952.11	193	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	20	0.0000003280411134021596285
TCGA-32-2634.10	118	1_KEGG_MISMATCH_REPAIR	23	8	0.0000003302690424978703205
TCGA-28-2513.12	134	1_KEGG_ASTHMA	30	9	0.0000003329906924992298254
TCGA-32-4719.15	123	1_KEGG_CELL_CYCLE	114	14	0.0000003351627822083324897
TCGA-32-1986.8	87	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000003357105838792875156
TCGA-02-0071.12	116	0_HALLMARK_E2F_TARGETS	169	16	0.0000003359540398187954374
TCGA-19-1790.18	201	1_KEGG_ECM_RECEPTOR_INTERACTION	84	15	0.0000003381070529038172433
TCGA-06-0129.11	110	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000003409124890192902516
TCGA-06-0238.4	24	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000003453512262491554884
TCGA-19-5950.7	113	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000003482676563482920616
TCGA-06-1804.7	47	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000003511674552132763514
TCGA-32-1977.11	107	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	12	0.0000003513269052600077806
TCGA-14-0787.7	14	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000003556919683056902957
TCGA-06-0645.9	136	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	12	0.0000003591356134859704823
TCGA-06-0139.1	179	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000003605685030089560777
TCGA-02-0023.3	24	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000003635472879252209192
TCGA-02-0069.8	7	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	6	0.0000003754449669765610604
TCGA-76-4925.9	83	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000003756616853199226911
TCGA-28-5218.5	208	2_CYTOSKELETON	293	27	0.0000003810788568047451460
TCGA-06-2565.10	38	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000003910353429463127563
TCGA-19-5954.17	208	0_HALLMARK_COMPLEMENT	176	21	0.0000003947701447579558657
TCGA-19-5954.17	208	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000003957893636469985906
TCGA-06-0178.2	17	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0000004019472768881724785
TCGA-76-6193.13	271	1_KEGG_ALLOGRAFT_REJECTION	37	12	0.0000004022563718724383453
TCGA-27-2519.7	113	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0000004085334255056347323
TCGA-27-2519.7	113	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0000004120527064836109825
TCGA-32-1991.11	82	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000004126438701992474847
TCGA-76-6193.13	271	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	17	0.0000004157085957041903635
TCGA-06-2565.10	38	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0000004168640650372584554
TCGA-06-5412.7	153	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	17	0.0000004274408062730058460
TCGA-14-3476.17	53	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000004278780756328495979
TCGA-06-0750.12	52	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000004313999294828915962
TCGA-41-3393.5	88	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000004350949400497563433
TCGA-06-0174.37	141	2_CELL_CYCLE_PROCESS	163	17	0.0000004355163928686620522
TCGA-06-1804.7	47	2_EXTRACELLULAR_MATRIX	85	9	0.0000004366876860272544481
TCGA-32-1986.8	87	2_EXTRACELLULAR_MATRIX	85	11	0.0000004371719835270121835
TCGA-41-3393.5	88	1_KEGG_FOCAL_ADHESION	195	15	0.0000004384848978436755424
TCGA-27-2519.7	113	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0000004397559828328921538
TCGA-14-4157.7	101	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000004459359708925211847
TCGA-02-2486.9	141	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0000004459977676382976085
TCGA-08-0389.4	56	2_CELL_CYCLE_GO_0007049	265	14	0.0000004532341718671887104
TCGA-06-2569.5	144	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000004539051262988415031
TCGA-19-5950.7	113	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000004574255750771268789
TCGA-14-0817.9	85	1_KEGG_DNA_REPLICATION	32	8	0.0000004575487850681242170
TCGA-28-5218.5	208	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000004590599785241142445
TCGA-19-1790.18	201	0_HALLMARK_KRAS_SIGNALING_UP	148	19	0.0000004668887482064502835
TCGA-06-0744.10	36	1_KEGG_CELL_CYCLE	114	9	0.0000004772578477855216780
TCGA-28-2514.9	62	1_KEGG_FOCAL_ADHESION	195	13	0.0000004784296140138582061
TCGA-06-0214.9	62	1_KEGG_FOCAL_ADHESION	195	13	0.0000004784296140138582061
TCGA-08-0356.2	23	0_HALLMARK_ALLOGRAFT_REJECTION	190	9	0.0000004822318819147567700
TCGA-06-0644.16	142	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000004874860750290005908
TCGA-06-0879.9	84	1_KEGG_CELL_CYCLE	114	12	0.0000004880113369493627489
TCGA-19-2631.15	84	1_KEGG_CELL_CYCLE	114	12	0.0000004880113369493627489
TCGA-32-2495.11	67	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000004949644237284131134
TCGA-02-0026.1	61	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000004960299350432837587
TCGA-02-2486.9	141	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000005077316586942958472
TCGA-02-0003.9	227	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	9	0.0000005139076573972074168
TCGA-02-0003.9	227	2_INTERMEDIATE_FILAMENT	20	9	0.0000005139076573972074168
TCGA-02-2486.9	141	1_KEGG_ASTHMA	30	9	0.0000005264426866621999790
TCGA-06-0141.1	45	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000005338493280076158619
TCGA-19-4068.2	11	1_KEGG_ALLOGRAFT_REJECTION	37	5	0.0000005339307708701927384
TCGA-14-1823.15	87	2_CELL_CELL_SIGNALING	353	19	0.0000005382651301504765987
TCGA-06-0195.8	56	1_KEGG_ASTHMA	30	7	0.0000005401264690139036315
TCGA-19-5951.10	138	0_HALLMARK_E2F_TARGETS	169	17	0.0000005473457231538124854
TCGA-19-5954.17	208	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	15	0.0000005481240103846301986
TCGA-02-0011.1	288	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	15	0.0000005494197801476362033
TCGA-14-0781.7	155	2_EXTRACELLULAR_REGION	346	25	0.0000005524878576311193797
TCGA-32-1986.8	87	0_HALLMARK_ANGIOGENESIS	32	8	0.0000005530419892342817923
TCGA-06-5856.13	152	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000005544370782644205733
TCGA-08-0345.2	77	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0000005558040215525268064
TCGA-06-0133.6	57	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0000005577526663906158191
TCGA-02-0084.1	25	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000005590610647485889514
TCGA-08-0354.5	18	0_HALLMARK_E2F_TARGETS	169	8	0.0000005639617189809095359
TCGA-02-0052.3	116	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000005669832248469126230
TCGA-27-2519.7	113	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0000005730642548287485735
TCGA-06-2569.5	144	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000005811755726776956539
TCGA-02-2485.14	172	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000005838967050111624575
TCGA-06-0154.13	76	1_KEGG_FOCAL_ADHESION	195	14	0.0000006034756262219647886
TCGA-06-0882.6	21	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0000006052098277315163000
TCGA-02-0060.19	281	1_KEGG_ALLOGRAFT_REJECTION	37	12	0.0000006114310703204546199
TCGA-06-5859.9	125	2_CELL_PROLIFERATION_GO_0008283	436	25	0.0000006186547389549774818
TCGA-27-1837.5	85	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000006296172884321135453
TCGA-06-0184.11	108	1_KEGG_MELANOMA	71	11	0.0000006339709946000573148
TCGA-28-2513.12	134	0_HALLMARK_ANGIOGENESIS	32	9	0.0000006373603821307109418
TCGA-32-1979.4	12	0_HALLMARK_E2F_TARGETS	169	7	0.0000006425303343705631676
TCGA-41-3393.4	12	0_HALLMARK_E2F_TARGETS	169	7	0.0000006425303343705631676
TCGA-27-1835.6	86	1_KEGG_CELL_CYCLE	114	12	0.0000006472320753558314629
TCGA-12-3650.17	101	2_CELL_CYCLE_PHASE	146	14	0.0000006477909952047827239
TCGA-28-5218.5	208	2_EXTRACELLULAR_MATRIX	85	15	0.0000006527980261290882000
TCGA-02-2486.9	141	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000006534999079338883959
TCGA-02-2486.9	141	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000006579924208881490068
TCGA-28-1753.13	174	1_KEGG_FOCAL_ADHESION	195	20	0.0000006702765473058854200
TCGA-02-0113.4	9	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	6	0.0000006859617668116556467
TCGA-14-1034.9	9	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	6	0.0000006859617668116556467
TCGA-02-0054.2	9	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	6	0.0000006859617668116556467
TCGA-08-0360.3	144	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	21	0.0000006933721246673613737
TCGA-06-0127.3	5	1_KEGG_ASTHMA	30	4	0.0000006963963464443090104
TCGA-02-0038.3	199	2_INTRACELLULAR_ORGANELLE_PART	912	49	0.0000007014141581133581819
TCGA-02-0099.11	141	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0000007019886328939603348
TCGA-06-5859.9	125	0_HALLMARK_ALLOGRAFT_REJECTION	190	17	0.0000007111212310422945749
TCGA-32-2494.10	173	0_HALLMARK_COMPLEMENT	176	19	0.0000007123337548801645208
TCGA-06-2557.11	177	1_KEGG_LEISHMANIA_INFECTION	70	13	0.0000007130053797064124775
TCGA-12-3650.17	101	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000007146604037368702255
TCGA-19-2629.15	146	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000007167754737977997193
TCGA-19-2629.15	146	1_KEGG_ASTHMA	30	9	0.0000007196350881312263409
TCGA-06-0174.37	141	2_CELL_CYCLE_PHASE	146	16	0.0000007230094275202690234
TCGA-08-0345.2	77	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000007238211167714576012
TCGA-06-0130.3	155	1_KEGG_CELL_CYCLE	114	15	0.0000007396876802608929006
TCGA-27-1835.6	86	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000007401200263546509226
TCGA-19-5947.4	267	2_EXTRACELLULAR_REGION_PART	269	29	0.0000007620318487323479504
TCGA-08-0350.2	46	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000007767067798118412036
TCGA-14-1823.12	6	2_CELL_CYCLE_GO_0007049	265	6	0.0000007784984083532479818
TCGA-06-0139.1	179	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	14	0.0000007790121165899119520
TCGA-06-0881.7	203	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	13	0.0000007887506005237789411
TCGA-41-3393.4	12	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0000007890444898066865527
TCGA-02-0107.3	71	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000007935884817782300987
TCGA-27-1835.6	86	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000007986880745514355103
TCGA-41-4097.6	48	2_EXTRACELLULAR_REGION_PART	269	13	0.0000008103756325101919970
TCGA-02-2486.9	141	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0000008112258026574440614
TCGA-76-6193.13	271	2_IMMUNE_SYSTEM_PROCESS	283	30	0.0000008128850279795699740
TCGA-12-0692.3	9	2_EXTRACELLULAR_REGION_PART	269	7	0.0000008137904804117657219
TCGA-02-0038.3	199	2_ORGANELLE_PART	916	49	0.0000008162034530878172478
TCGA-12-0619.11	123	0_HALLMARK_E2F_TARGETS	169	16	0.0000008212686059230318304
TCGA-32-4719.15	123	0_HALLMARK_E2F_TARGETS	169	16	0.0000008212686059230318304
TCGA-06-0645.9	136	0_HALLMARK_COMPLEMENT	176	17	0.0000008217557062261378475
TCGA-02-0014.10	70	2_DNA_METABOLIC_PROCESS	218	14	0.0000008332566333015846518
TCGA-06-5858.19	205	2_CELL_CYCLE_GO_0007049	265	25	0.0000008386940191848160463
TCGA-19-1390.13	110	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	36	0.0000008477485723386465904
TCGA-28-1753.13	174	2_CELL_CYCLE_GO_0007049	265	23	0.0000008582220476855914640
TCGA-06-2557.11	177	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000008676342939849376961
TCGA-27-1837.5	85	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0000008731551085505317711
TCGA-02-0115.1	36	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0000008795775327579365554
TCGA-19-5958.4	35	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000008820038096284692604
TCGA-27-2519.7	113	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0000008854964137852405632
TCGA-32-4211.14	71	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000008955194078322671851
TCGA-06-0879.9	84	1_KEGG_MELANOMA	71	10	0.0000008955194078322671851
TCGA-06-2561.5	42	1_KEGG_FOCAL_ADHESION	195	11	0.0000009039106940864425463
TCGA-06-0881.7	203	0_HALLMARK_INFLAMMATORY_RESPONSE	170	20	0.0000009054333208202007449
TCGA-16-0846.2	27	0_HALLMARK_E2F_TARGETS	169	9	0.0000009101739830146378402
TCGA-06-0178.2	17	1_KEGG_CELL_CYCLE	114	7	0.0000009201206864576569407
TCGA-06-0133.6	57	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000009282009494861080938
TCGA-19-2629.15	146	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000009284505298392474361
TCGA-28-5214.11	124	0_HALLMARK_E2F_TARGETS	169	16	0.0000009284792713909712071
TCGA-28-5218.5	208	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	12	0.0000009290416568401004439
TCGA-06-0173.35	120	1_KEGG_PATHWAYS_IN_CANCER	323	21	0.0000009330982192404122056
TCGA-06-0881.7	203	2_EXTRACELLULAR_REGION_PART	269	25	0.0000009336237844826888521
TCGA-06-2565.10	38	2_CELL_CYCLE_PROCESS	163	10	0.0000009338656549199235154
TCGA-02-0026.1	61	2_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0000009409408034928678866
TCGA-02-0026.1	61	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0000009409408034928678866
TCGA-27-1837.5	85	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0000009469914700111400419
TCGA-28-5216.8	162	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	11	0.0000009499780830403708822
TCGA-32-1980.1	24	1_KEGG_FOCAL_ADHESION	195	9	0.0000009558125704149860966
TCGA-02-0023.3	24	1_KEGG_FOCAL_ADHESION	195	9	0.0000009558125704149860966
TCGA-32-2638.17	159	1_KEGG_FOCAL_ADHESION	195	19	0.0000009656272304415352025
TCGA-08-0360.3	144	0_HALLMARK_COAGULATION	125	15	0.0000009762474324079960495
TCGA-19-2629.15	146	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000009811844748574347555
TCGA-28-2509.6	59	2_DNA_METABOLIC_PROCESS	218	13	0.0000009854583026176658146
TCGA-27-2524.5	75	0_HALLMARK_E2F_TARGETS	169	13	0.0000009877225755116804570
TCGA-14-2554.5	59	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000009925002531243423105
TCGA-76-6192.6	43	2_COLLAGEN	23	6	0.0000009958540106227829876
TCGA-08-0359.5	37	0_HALLMARK_E2F_TARGETS	169	10	0.0000009969043548655745561
TCGA-02-0009.6	188	2_EXTRACELLULAR_REGION_PART	269	24	0.0000009999728483481222114
TCGA-02-0028.9	182	1_KEGG_LEISHMANIA_INFECTION	70	13	0.0000010081581175161847844
TCGA-02-0003.9	227	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000010087263507024144081
TCGA-02-0107.3	71	2_EXTRACELLULAR_MATRIX	85	10	0.0000010089383541896231402
TCGA-12-3652.19	88	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000010159405184989327964
TCGA-02-0068.1	72	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000010325295356101849088
TCGA-19-4068.2	11	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	5	0.0000010392214913276961557
TCGA-14-0787.7	14	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	8	0.0000010462628946281275680
TCGA-06-2565.10	38	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0000010489128575792129625
TCGA-02-0115.1	36	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000010534976747090008652
TCGA-02-0114.20	132	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000010552204129764295194
TCGA-19-5954.17	208	0_HALLMARK_APOPTOSIS	150	19	0.0000010615728628189222017
TCGA-19-4068.7	14	1_KEGG_DNA_REPLICATION	32	5	0.0000010640815036472880025
TCGA-06-0644.16	142	0_HALLMARK_ANGIOGENESIS	32	9	0.0000010719959163397401232
TCGA-02-0001.5	117	2_AXON	10	6	0.0000010807094562798009022
TCGA-27-1832.11	88	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000010961157222280808168
TCGA-06-0649.13	88	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000010961157222280808168
TCGA-41-3915.10	109	1_KEGG_FOCAL_ADHESION	195	16	0.0000010977438417453203756
TCGA-76-6191.6	96	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000010987150777016620989
TCGA-06-0645.9	136	2_EXTRACELLULAR_REGION	346	23	0.0000010988668634981150308
TCGA-32-2632.16	229	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000011076250153471613190
TCGA-02-0038.3	199	2_CHROMOSOMAL_PART	78	14	0.0000011338949402522094837
TCGA-06-1804.6	30	2_CHROMOSOME	102	8	0.0000011361820945409458121
TCGA-06-5412.7	153	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000011375845643545155140
TCGA-26-5135.9	71	1_KEGG_CELL_CYCLE	114	11	0.0000011415057795232794816
TCGA-06-0141.1	45	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000011493970711298408581
TCGA-14-1825.8	80	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000011543253526777152578
TCGA-08-0357.4	36	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000011613079815243155608
TCGA-19-2624.29	130	2_SPINDLE	35	9	0.0000011799259726783085416
TCGA-06-1804.6	30	2_DNA_METABOLIC_PROCESS	218	10	0.0000011810153653217589562
TCGA-06-5859.9	125	2_CHROMOSOME	102	13	0.0000011834852901075384352
TCGA-06-0157.7	89	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000011864686084430016614
TCGA-06-2558.6	74	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0000012088045929352062243
TCGA-06-2570.8	95	2_CELL_CYCLE_PROCESS	163	14	0.0000012188431358101005810
TCGA-14-0781.7	155	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	13	0.0000012500307400926753719
TCGA-19-1390.13	110	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0000012614858239741046618
TCGA-19-5959.13	92	0_HALLMARK_E2F_TARGETS	169	14	0.0000012697608465652616745
TCGA-02-0115.1	36	2_EXTRACELLULAR_MATRIX	85	8	0.0000012785675471055378061
TCGA-32-1982.9	89	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000012799733395260197240
TCGA-27-2521.10	94	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000013154147516039649583
TCGA-02-0026.1	61	2_CHROMOSOME	102	10	0.0000013260494568135045553
TCGA-06-0141.1	45	2_COLLAGEN	23	6	0.0000013263805229460669645
TCGA-02-0085.1	45	2_COLLAGEN	23	6	0.0000013263805229460669645
TCGA-06-2565.10	38	0_HALLMARK_E2F_TARGETS	169	10	0.0000013322416856913081052
TCGA-06-5858.19	205	1_KEGG_DNA_REPLICATION	32	10	0.0000013361537896242876247
TCGA-06-0122.8	90	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0000013393540358824593176
TCGA-06-0129.11	110	2_MICROTUBULE_CYTOSKELETON	117	13	0.0000013403714229584014753
TCGA-06-5413.11	142	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000013611942550903301391
TCGA-06-0141.1	45	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000013744126942272494257
TCGA-32-4719.15	123	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000013801678243786047729
TCGA-32-1982.9	89	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0000013862792824316149416
TCGA-06-0881.7	203	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000013885996773659795633
TCGA-26-5136.6	160	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000013893548334380002528
TCGA-32-2615.7	77	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	13	0.0000013898517086477908628
TCGA-02-0003.9	227	0_HALLMARK_ALLOGRAFT_REJECTION	190	22	0.0000014076496675070342844
TCGA-27-2524.5	75	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000014186497733958634798
TCGA-26-5133.10	75	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000014186497733958634798
TCGA-06-0187.10	55	2_SYNAPTIC_TRANSMISSION	152	11	0.0000014304562828048959416
TCGA-32-1982.9	89	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0000014385790088172137442
TCGA-08-0359.5	37	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000014710645287492775690
TCGA-26-1439.10	84	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000014710645287492775690
TCGA-06-5412.7	153	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000014725289093205031100
TCGA-19-2624.29	130	2_CELL_PROLIFERATION_GO_0008283	436	25	0.0000014794946900367842997
TCGA-06-0187.10	55	2_CELL_CELL_SIGNALING	353	15	0.0000014815738402259637250
TCGA-06-0745.4	55	2_CELL_CELL_SIGNALING	353	15	0.0000014815738402259637250
TCGA-08-0360.3	144	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000014866262838234778424
TCGA-02-0033.5	144	0_HALLMARK_APOPTOSIS	150	16	0.0000014866262838234778424
TCGA-76-6193.13	271	2_IMMUNE_RESPONSE	206	25	0.0000014934630354662334357
TCGA-81-5910.12	128	0_HALLMARK_E2F_TARGETS	169	16	0.0000014992021679597600130
TCGA-14-4157.7	101	2_DNA_REPLICATION	82	11	0.0000015107762190978704503
TCGA-02-2483.10	100	2_DNA_METABOLIC_PROCESS	218	16	0.0000015266998889867026946
TCGA-02-2483.10	100	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0000015491914503338013210
TCGA-02-0009.6	188	2_EXTRACELLULAR_REGION	346	27	0.0000015664227435469210918
TCGA-06-2557.11	177	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000015695931890381725346
TCGA-76-4934.7	47	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000015700678979746354144
TCGA-02-0028.9	182	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	14	0.0000015737550645268563128
TCGA-06-0192.10	126	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000015796722092863786390
TCGA-32-1977.11	107	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0000015993682375562537010
TCGA-32-2491.14	244	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000016027634174617937806
TCGA-28-5216.8	162	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000016040995749422720222
TCGA-14-3476.4	7	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	5	0.0000016216650616897428125
TCGA-76-6191.6	96	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000016233878986790946150
TCGA-06-0877.8	61	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000016274968706322791354
TCGA-06-2565.10	38	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0000016351176213206200685
TCGA-02-0069.13	16	2_EXTRACELLULAR_REGION	346	9	0.0000016474677718494577731
TCGA-02-0046.8	148	0_HALLMARK_E2F_TARGETS	169	17	0.0000016562017028370965632
TCGA-32-1977.11	107	1_KEGG_ASTHMA	30	8	0.0000016712316797722945910
TCGA-06-0127.3	5	1_KEGG_ALLOGRAFT_REJECTION	37	4	0.0000016772911432171114553
TCGA-14-0781.7	155	2_EXTRACELLULAR_MATRIX	85	13	0.0000016974048688071024599
TCGA-02-0028.9	182	0_HALLMARK_COMPLEMENT	176	19	0.0000017026414082158935349
TCGA-06-0686.5	14	2_EXTRACELLULAR_REGION_PART	269	8	0.0000017044861734596893061
TCGA-28-5215.7	192	1_KEGG_CELL_CYCLE	114	16	0.0000017252267641487778546
TCGA-02-0026.1	61	2_NUCLEUS	1110	26	0.0000017294065579693295528
TCGA-32-1977.11	107	2_EXTRACELLULAR_REGION_PART	269	18	0.0000017308833454049118806
TCGA-32-1991.11	82	1_KEGG_FOCAL_ADHESION	195	14	0.0000017321299045592070842
TCGA-06-6390.9	82	1_KEGG_FOCAL_ADHESION	195	14	0.0000017321299045592070842
TCGA-06-1804.7	47	2_COLLAGEN	23	6	0.0000017431521203606226387
TCGA-02-0003.9	227	1_KEGG_ASTHMA	30	10	0.0000017536399552638190198
TCGA-02-0085.1	45	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0000017635874678299731757
TCGA-02-0085.1	45	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0000017635874678299731757
TCGA-02-0075.8	128	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000017658963890091949999
TCGA-19-2619.14	100	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000017671829757034273698
TCGA-06-0154.13	76	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000017860753989450353459
TCGA-19-5952.11	193	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	14	0.0000017868654733259359504
TCGA-19-5954.17	208	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000017992854303408754453
TCGA-06-0184.11	108	1_KEGG_ASTHMA	30	8	0.0000018011655822715516581
TCGA-15-0742.13	74	1_KEGG_CELL_CYCLE	114	11	0.0000018079369762062690038
TCGA-32-2634.10	118	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000018149054009206980063
TCGA-27-1837.5	85	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0000018187919419355272929
TCGA-08-0246.6	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000018249767166812435319
TCGA-02-0043.10	184	1_KEGG_FOCAL_ADHESION	195	20	0.0000018251848804862067680
TCGA-02-0048.9	84	2_CELL_CYCLE_GO_0007049	265	16	0.0000018256446342601952429
TCGA-19-5947.4	267	1_KEGG_FOCAL_ADHESION	195	24	0.0000018308312293157444497
TCGA-14-3476.4	7	2_EXTRACELLULAR_MATRIX	85	5	0.0000018314199366585135393
TCGA-12-1597.6	51	0_HALLMARK_E2F_TARGETS	169	11	0.0000018763523949956752045
TCGA-32-2634.10	118	2_REPLICATION_FORK	18	7	0.0000019022603436915623943
TCGA-19-2624.29	130	2_CHROMOSOME	102	13	0.0000019343760788947119038
TCGA-06-0881.7	203	2_EXTRACELLULAR_REGION	346	28	0.0000019461690240898511068
TCGA-41-4097.6	48	2_COLLAGEN	23	6	0.0000019890918157180558743
TCGA-12-0692.6	11	1_KEGG_CELL_CYCLE	114	6	0.0000020097070625419020311
TCGA-02-2470.4	11	1_KEGG_CELL_CYCLE	114	6	0.0000020097070625419020311
TCGA-06-5858.19	205	1_KEGG_P53_SIGNALING_PATHWAY	66	13	0.0000020312395564347939233
TCGA-08-0345.2	77	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000020379892119161675086
TCGA-06-0139.1	179	2_EXTRACELLULAR_REGION_PART	269	23	0.0000020384522784343211702
TCGA-06-0195.8	56	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0000020423297893936529244
TCGA-19-5955.9	110	1_KEGG_ASTHMA	30	8	0.0000020875531419609426666
TCGA-02-0038.3	199	2_CELL_CYCLE_PROCESS	163	19	0.0000020941947246118056750
TCGA-76-6193.13	271	2_RESPONSE_TO_WOUNDING	163	22	0.0000021207098629199068625
TCGA-08-0345.2	77	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000021418404730365076914
TCGA-06-0877.7	4	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000021610089566548805824
TCGA-08-0348.3	4	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000021610089566548805824
TCGA-08-0245.4	85	2_CELL_CYCLE_GO_0007049	265	16	0.0000021930944898035945940
TCGA-19-5952.11	193	0_HALLMARK_APOPTOSIS	150	18	0.0000022166213629261058780
TCGA-28-5209.15	194	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000022541464456409044817
TCGA-06-0168.4	22	2_COLLAGEN	23	5	0.0000023258191702817372510
TCGA-02-0007.17	217	1_KEGG_DNA_REPLICATION	32	10	0.0000023287262392991396749
TCGA-06-0152.10	19	1_KEGG_CELL_CYCLE	114	7	0.0000023369336804905237785
TCGA-06-0645.9	136	2_EXTRACELLULAR_REGION_PART	269	20	0.0000023494568447256550937
TCGA-12-5299.5	6	1_KEGG_CELL_CYCLE	114	5	0.0000023524342982457799793
TCGA-06-5412.7	153	0_HALLMARK_ALLOGRAFT_REJECTION	190	18	0.0000023789063880861213189
TCGA-26-1439.11	10	2_CELL_CYCLE_GO_0007049	265	7	0.0000023831509431784003139
TCGA-28-5209.15	194	0_HALLMARK_APOPTOSIS	150	18	0.0000024105878576381670599
TCGA-76-6282.11	185	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000024185583371876597014
TCGA-41-2572.8	76	1_KEGG_CELL_CYCLE	114	11	0.0000024278275089267066815
TCGA-08-0347.7	25	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0000024312941994943035927
TCGA-02-0114.20	132	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000024579758528259186184
TCGA-19-5952.11	193	2_EXTRACELLULAR_MATRIX	85	14	0.0000024768572205117368469
TCGA-12-0692.7	23	2_SYNAPTIC_TRANSMISSION	152	8	0.0000025202357047115182116
TCGA-06-0139.1	179	2_EXTRACELLULAR_REGION	346	26	0.0000025317321004607895437
TCGA-12-1597.6	51	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000025602934068390093010
TCGA-06-0127.3	5	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	4	0.0000025709979211826923100
TCGA-02-0113.3	46	1_KEGG_FOCAL_ADHESION	195	11	0.0000026212786132284096625
TCGA-41-5651.5	112	2_CELL_CYCLE_PHASE	146	14	0.0000026243247802175715416
TCGA-76-6192.6	43	2_EXTRACELLULAR_REGION_PART	269	12	0.0000026246010525057432967
TCGA-27-2527.6	79	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000026383816050508411315
TCGA-06-0195.8	56	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000026458284086521089254
TCGA-28-1747.5	81	0_HALLMARK_E2F_TARGETS	169	13	0.0000026688426443434475843
TCGA-19-5954.17	208	1_KEGG_FOCAL_ADHESION	195	21	0.0000026710549197616822898
TCGA-14-0790.9	104	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000027046193740613019848
TCGA-26-5134.6	18	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000027067471089554684697
TCGA-02-2486.9	141	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	10	0.0000027103711150634421965
TCGA-06-0241.8	53	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0000027391350482196113291
TCGA-06-0139.1	179	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	16	0.0000027683878540180056176
TCGA-06-5417.5	79	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000027743339644643309889
TCGA-12-3650.17	101	2_CELL_CYCLE_PROCESS	163	14	0.0000027975685020101847196
TCGA-02-0115.1	36	0_HALLMARK_ANGIOGENESIS	32	6	0.0000028172481071041787197
TCGA-19-2619.14	100	1_KEGG_FOCAL_ADHESION	195	15	0.0000028179585816437665896
TCGA-28-5215.7	192	2_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000028265896162841983913
TCGA-28-5215.7	192	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000028265896162841983913
TCGA-02-0014.10	70	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000028323555158952548194
TCGA-06-0877.7	4	2_INTERPHASE	62	4	0.0000028413699800239502455
TCGA-08-0348.3	4	2_INTERPHASE	62	4	0.0000028413699800239502455
TCGA-06-0127.3	5	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	4	0.0000028413878104298747838
TCGA-32-4211.14	71	1_KEGG_FOCAL_ADHESION	195	13	0.0000028436485626589513469
TCGA-02-0046.8	148	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000028496632869994836546
TCGA-19-4068.2	11	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	5	0.0000028560483030091884476
TCGA-14-0787.6	40	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000028677991210919729335
TCGA-28-5215.7	192	2_EPIDERMIS_DEVELOPMENT	59	12	0.0000028880041795156411980
TCGA-19-5954.17	208	0_HALLMARK_COAGULATION	125	17	0.0000029021267704700774946
TCGA-76-6191.6	96	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0000029317858103104977320
TCGA-06-5417.5	79	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000029773007641537407983
TCGA-06-6391.9	26	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0000030333936191031447690
TCGA-14-0787.6	40	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0000030797549805695130761
TCGA-19-1390.13	110	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	15	0.0000030971937807860703541
TCGA-19-5958.4	35	2_EXTRACELLULAR_REGION_PART	269	11	0.0000031266338494304737101
TCGA-19-2619.10	8	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0000031369134873509891645
TCGA-12-0692.7	23	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000031369134873509891645
TCGA-06-5412.1	28	0_HALLMARK_COAGULATION	125	8	0.0000031532766226430666246
TCGA-27-2523.12	112	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000031593900801513904059
TCGA-19-5960.9	134	2_CELL_CYCLE_PHASE	146	15	0.0000031798142920936905211
TCGA-02-0060.19	281	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	12	0.0000031950614442329628807
TCGA-02-2485.14	172	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000031984757158459208509
TCGA-06-0129.11	110	2_CHROMOSOME	102	12	0.0000032127486091291456336
TCGA-06-0187.10	55	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0000032208681394138667442
TCGA-02-0038.3	199	2_DNA_DEPENDENT_DNA_REPLICATION	46	11	0.0000032514185890993039168
TCGA-06-5856.13	152	1_KEGG_FOCAL_ADHESION	195	18	0.0000032547348329006053264
TCGA-19-4068.7	14	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0000033142595771393275830
TCGA-14-0789.10	106	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000033230943604024705372
TCGA-76-6285.5	106	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000033230943604024705372
TCGA-02-0038.3	199	2_CELL_PROLIFERATION_GO_0008283	436	31	0.0000033332797195116885141
TCGA-28-5216.8	162	2_STRUCTURAL_MOLECULE_ACTIVITY	206	19	0.0000033835679582720730313
TCGA-06-0650.2	82	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000034015572100648473248
TCGA-02-0102.8	82	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000034015572100648473248
TCGA-02-0068.1	72	1_KEGG_FOCAL_ADHESION	195	13	0.0000034080627368264305229
TCGA-02-0003.9	227	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000034249058380963574336
TCGA-06-0139.1	179	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000034599858139786161343
TCGA-06-0174.37	141	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0000034720074489916433682
TCGA-06-0126.7	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	5	0.0000034818092934545919922
TCGA-26-1439.10	84	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000035375225431243788953
TCGA-26-5139.10	163	2_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0000035463808930644254116
TCGA-26-5139.10	163	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0000035463808930644254116
TCGA-19-5950.7	113	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000035848733257596994927
TCGA-06-6391.9	26	2_EXTRACELLULAR_MATRIX	85	7	0.0000035933791602617636511
TCGA-02-0083.21	135	1_KEGG_FOCAL_ADHESION	195	17	0.0000036003483515566647816
TCGA-06-0141.1	45	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0000036723598813486364666
TCGA-02-0043.10	184	0_HALLMARK_COAGULATION	125	16	0.0000036834403147214616708
TCGA-14-0813.10	53	2_COLLAGEN	23	6	0.0000036924815856742481983
TCGA-08-0358.9	43	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0000037332145461431025459
TCGA-32-1980.1	24	2_COLLAGEN	23	5	0.0000037420276684258901930
TCGA-08-0390.3	6	0_HALLMARK_COAGULATION	125	5	0.0000037545391988748485607
TCGA-32-2632.16	229	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000037577288369122693393
TCGA-19-5950.7	113	2_REGULATION_OF_PHOSPHORYLATION	45	9	0.0000037926799385754064067
TCGA-06-2557.11	177	0_HALLMARK_E2F_TARGETS	169	18	0.0000038186854793424671885
TCGA-14-1034.7	97	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000038254494456925649930
TCGA-41-3392.31	136	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000038324044486582021726
TCGA-02-0102.8	82	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000038343777471147805222
TCGA-32-1980.1	24	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0000038583423804394677677
TCGA-06-2565.3	60	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000038723461668558523981
TCGA-27-1830.7	57	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0000038862488097421148695
TCGA-19-4068.7	14	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0000038863864254231996403
TCGA-32-1986.8	87	1_KEGG_FOCAL_ADHESION	195	14	0.0000038926641843605655220
TCGA-76-6192.6	43	2_EXTRACELLULAR_REGION	346	13	0.0000038951474494358109973
TCGA-32-4208.28	140	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000039326520716758000970
TCGA-19-1790.18	201	2_EXTRACELLULAR_REGION_PART	269	24	0.0000039610567695434108706
TCGA-41-5651.5	112	2_CHROMOSOME	102	12	0.0000039634148233515204907
TCGA-02-0114.20	132	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000039749054847984486584
TCGA-06-2557.11	177	1_KEGG_ASTHMA	30	9	0.0000039980274162025738758
TCGA-41-5651.5	112	0_HALLMARK_MYC_TARGETS_V1	178	15	0.0000040016704653316202393
TCGA-06-0686.1	7	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	6	0.0000040232038795346167719
TCGA-06-0650.2	82	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000040370397272058267425
TCGA-08-0359.5	37	1_KEGG_FOCAL_ADHESION	195	10	0.0000040395047187260711325
TCGA-76-6192.6	43	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000040905366676525238741
TCGA-12-0821.9	81	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000041005788542736694839
TCGA-06-0221.13	45	1_KEGG_CELL_CYCLE	114	9	0.0000041035432972316300657
TCGA-02-0099.11	141	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000041894712219925218425
TCGA-76-6285.5	106	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000041949215895773526113
TCGA-06-0137.9	53	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000042177808423361715445
TCGA-06-0241.8	53	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000042177808423361715445
TCGA-06-0241.8	53	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000042821647475682426129
TCGA-06-0650.2	82	2_EXTRACELLULAR_MATRIX	85	10	0.0000043154094260874454613
TCGA-14-0817.9	85	2_DNA_REPLICATION	82	10	0.0000043154094260874454613
TCGA-02-0102.8	82	2_EXTRACELLULAR_MATRIX	85	10	0.0000043154094260874454613
TCGA-19-5954.17	208	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	13	0.0000043312653911086259026
TCGA-26-1439.10	84	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000043386054641353801909
TCGA-19-4068.6	42	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000043386054641353801909
TCGA-06-2561.5	42	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000043386054641353801909
TCGA-76-6193.13	271	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	16	0.0000043460564378379773576
TCGA-19-1390.13	110	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0000043460751023504229143
TCGA-06-0139.1	179	1_KEGG_ASTHMA	30	9	0.0000044159064688050231836
TCGA-02-0014.10	70	1_KEGG_DNA_REPLICATION	32	7	0.0000044274734484536951926
TCGA-02-0099.11	141	2_EXTRACELLULAR_REGION_PART	269	20	0.0000044958453272581637872
TCGA-06-0877.8	61	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000045100405112792160581
TCGA-19-5951.10	138	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000045353414916858996077
TCGA-02-0003.9	227	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000045430115821754267063
TCGA-06-0241.8	53	1_KEGG_BLADDER_CANCER	42	7	0.0000045485422488530058993
TCGA-02-0007.17	217	2_NON_MEMBRANE_BOUND_ORGANELLE	476	34	0.0000045795853916932805901
TCGA-02-0007.17	217	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	34	0.0000045795853916932805901
TCGA-12-0692.7	23	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0000046135716711015503684
TCGA-41-5651.5	112	2_DNA_REPLICATION	82	11	0.0000046210069366795754407
TCGA-02-0043.10	184	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000046334630747870311125
TCGA-02-0003.9	227	0_HALLMARK_APOPTOSIS	150	19	0.0000046550727771342644050
TCGA-02-0085.1	45	2_EXTRACELLULAR_REGION_PART	269	12	0.0000046772798418450688073
TCGA-32-2634.10	118	2_CHROMOSOMAL_PART	78	11	0.0000046810906051470801457
TCGA-06-2557.11	177	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000047348362403317134856
TCGA-06-0645.9	136	0_HALLMARK_KRAS_SIGNALING_UP	148	15	0.0000047363743709491504683
TCGA-19-2625.9	146	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000047453730633874478335
TCGA-12-0692.3	9	2_EXTRACELLULAR_REGION	346	7	0.0000047540165522644483863
TCGA-02-0021.4	170	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	12	0.0000047785621904994213583
TCGA-14-1825.8	80	2_CELL_CYCLE_PHASE	146	12	0.0000048688840748685100184
TCGA-26-1439.10	84	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000048783026542909135119
TCGA-76-6192.6	43	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0000048841395034381517232
TCGA-27-2518.5	20	1_KEGG_FOCAL_ADHESION	195	8	0.0000049125553747945366963
TCGA-02-0080.3	20	1_KEGG_FOCAL_ADHESION	195	8	0.0000049125553747945366963
TCGA-28-6450.11	139	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000049286799842950132649
TCGA-06-0127.3	5	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	4	0.0000049369724625534553182
TCGA-27-1837.5	85	0_HALLMARK_E2F_TARGETS	169	13	0.0000049371153251355719935
TCGA-08-0358.9	43	2_CELL_CELL_SIGNALING	353	13	0.0000049699242973591589037
TCGA-32-2632.16	229	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000049835067744093295439
TCGA-27-2528.10	99	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000050345661406730977329
TCGA-06-0139.1	179	0_HALLMARK_INFLAMMATORY_RESPONSE	170	18	0.0000050387608687492377741
TCGA-32-2491.14	244	1_KEGG_ECM_RECEPTOR_INTERACTION	84	15	0.0000050511796299859189563
TCGA-08-0360.3	144	2_RESPONSE_TO_WOUNDING	163	16	0.0000050856287468879242527
TCGA-02-2486.9	141	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0000050970738729605234612
TCGA-02-0083.21	135	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000051011021432198795910
TCGA-28-6450.11	139	0_HALLMARK_E2F_TARGETS	169	16	0.0000051268556038840516577
TCGA-06-0214.9	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000052381265110891832624
TCGA-27-1833.7	17	2_CELL_CYCLE_PHASE	146	7	0.0000052616263369696057909
TCGA-32-2634.10	118	2_CELL_CYCLE_PHASE	146	14	0.0000052653022281598684104
TCGA-02-0064.3	26	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000052906979753562400091
TCGA-06-5415.7	7	2_CELL_CYCLE_GO_0007049	265	6	0.0000053213606518873983865
TCGA-14-1823.12	6	2_MITOTIC_CELL_CYCLE	134	5	0.0000053403643149918210295
TCGA-06-0644.16	142	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000053633538205975418874
TCGA-32-2632.16	229	0_HALLMARK_APOPTOSIS	150	19	0.0000053906232139075237328
TCGA-06-0195.8	56	2_CELL_CYCLE_GO_0007049	265	13	0.0000053974308304625642801
TCGA-06-0140.2	25	2_SYNAPTIC_TRANSMISSION	152	8	0.0000054097879558416287686
TCGA-06-0126.8	15	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	7	0.0000054173295508437816506
TCGA-06-0881.7	203	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	19	0.0000054210786812786015517
TCGA-06-0644.16	142	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000054697682785963629064
TCGA-27-1837.5	85	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000054892344323307717288
TCGA-02-0011.1	288	0_HALLMARK_COMPLEMENT	176	23	0.0000055056608011306303432
TCGA-06-0646.4	63	1_KEGG_CELL_CYCLE	114	10	0.0000055456050487450573753
TCGA-12-0616.1	20	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000055900703141882240107
TCGA-08-0380.4	6	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	4	0.0000056071852293288257764
TCGA-02-0107.3	71	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000056454963416275461205
TCGA-32-2494.10	173	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000056592755009754776901
TCGA-06-0195.8	56	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000056733157379310808268
TCGA-28-6450.11	139	1_KEGG_FOCAL_ADHESION	195	17	0.0000056785870742247877767
TCGA-06-0644.16	142	0_HALLMARK_UV_RESPONSE_DN	122	14	0.0000056860129046390284142
TCGA-32-2634.10	118	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000056866352093117284895
TCGA-32-2634.10	118	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000056866352093117284895
TCGA-41-3392.31	136	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000056896912395576966672
TCGA-28-5218.5	208	2_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0000057132321026937093713
TCGA-28-5218.5	208	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0000057132321026937093713
TCGA-06-0141.1	45	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0000057135655170246748958
TCGA-06-2561.5	42	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0000057594234144670860371
TCGA-08-0353.8	100	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000057613163173249354009
TCGA-06-0125.9	75	1_KEGG_FOCAL_ADHESION	195	13	0.0000057637432313523836937
TCGA-19-1790.18	201	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	14	0.0000057774464487510080859
TCGA-28-5215.7	192	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	11	0.0000057987374006986414516
TCGA-06-0645.9	136	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	12	0.0000057991921516935441229
TCGA-27-1830.7	57	2_COLLAGEN	23	6	0.0000058005522324711022956
TCGA-06-5859.9	125	1_KEGG_ASTHMA	30	8	0.0000058079968288915606776
TCGA-02-0009.6	188	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000058166314923173195313
TCGA-12-0692.7	23	2_CELL_CELL_SIGNALING	353	10	0.0000058537098981476298740
TCGA-06-5411.4	23	0_HALLMARK_E2F_TARGETS	169	8	0.0000058551085094232516851
TCGA-19-5954.17	208	2_CELL_CYCLE_GO_0007049	265	24	0.0000058736089804783236777
TCGA-32-1979.10	116	0_HALLMARK_COAGULATION	125	13	0.0000059584442585746549159
TCGA-06-5859.9	125	2_DNA_METABOLIC_PROCESS	218	17	0.0000059611900464159612439
TCGA-27-2523.12	112	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000060098009008944641690
TCGA-06-0143.6	63	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000060673973363177747853
TCGA-32-4210.14	109	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000060900079674899212364
TCGA-06-2557.11	177	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000061146466247808860399
TCGA-06-0122.8	90	1_KEGG_FOCAL_ADHESION	195	14	0.0000061616251429034660394
TCGA-32-2494.10	173	0_HALLMARK_ANGIOGENESIS	32	9	0.0000062030902180611666220
TCGA-26-5132.7	100	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000062085280254114143356
TCGA-02-0058.1	110	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000062550279039115839891
TCGA-19-1390.13	110	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000062550279039115839891
TCGA-32-2632.16	229	2_REPLICATION_FORK	18	8	0.0000063277321661197742696
TCGA-02-0099.11	141	0_HALLMARK_E2F_TARGETS	169	16	0.0000063304881072767984544
TCGA-02-2486.9	141	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	16	0.0000063304881072767984544
TCGA-06-0127.3	5	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	4	0.0000063389593645694790718
TCGA-06-2569.5	144	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000064228171378983059235
TCGA-02-0028.9	182	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	17	0.0000064269394709742103515
TCGA-32-2638.17	159	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000064441639166128597161
TCGA-19-2629.15	146	2_CELL_CYCLE_GO_0007049	265	20	0.0000064511661849638950162
TCGA-19-2625.9	146	2_CELL_CYCLE_GO_0007049	265	20	0.0000064511661849638950162
TCGA-28-2502.9	56	2_EXTRACELLULAR_REGION_PART	269	13	0.0000064747387571990746714
TCGA-06-0645.9	136	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0000064922532399747612481
TCGA-08-0389.4	56	2_DNA_METABOLIC_PROCESS	218	12	0.0000064957168424346602709
TCGA-06-0881.7	203	0_HALLMARK_ALLOGRAFT_REJECTION	190	20	0.0000065261673430077208070
TCGA-06-6391.9	26	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0000065459784504887685614
TCGA-08-0360.3	144	0_HALLMARK_ALLOGRAFT_REJECTION	190	17	0.0000066032503458487445155
TCGA-26-5139.10	163	2_EPIDERMIS_DEVELOPMENT	59	11	0.0000066513244309807540989
TCGA-14-0790.9	104	0_HALLMARK_E2F_TARGETS	169	14	0.0000066547517144343239524
TCGA-06-2557.11	177	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000067116602959561571671
TCGA-06-0195.8	56	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000067770399231100284749
TCGA-76-4929.8	91	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000068641433790871672895
TCGA-32-2634.10	118	2_DNA_DEPENDENT_DNA_REPLICATION	46	9	0.0000068683448157492942338
TCGA-02-0010.18	184	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000069163253612232704207
TCGA-32-1986.8	87	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000069182399804004931343
TCGA-27-2519.7	113	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0000069664731147552584208
TCGA-06-0644.16	142	0_HALLMARK_E2F_TARGETS	169	16	0.0000070248976270287637964
TCGA-06-5413.11	142	0_HALLMARK_E2F_TARGETS	169	16	0.0000070248976270287637964
TCGA-06-0744.10	36	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000070441029489266728168
TCGA-06-0174.37	141	1_KEGG_FOCAL_ADHESION	195	17	0.0000070887099092220935673
TCGA-02-0024.6	206	2_MICROTUBULE_CYTOSKELETON	117	16	0.0000071337750847212841627
TCGA-19-2629.15	146	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0000071607920811518133760
TCGA-28-5216.8	162	2_CELL_CYCLE_GO_0007049	265	21	0.0000071900659811535638316
TCGA-08-0345.2	77	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0000072377463150948504803
TCGA-06-0644.16	142	2_EXTRACELLULAR_MATRIX	85	12	0.0000072423895716808822152
TCGA-27-2524.5	75	0_HALLMARK_ANGIOGENESIS	32	7	0.0000072457923199582440602
TCGA-19-1390.13	110	2_MITOTIC_CELL_CYCLE	134	13	0.0000072672269906955753356
TCGA-76-6282.11	185	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000072731272317207886947
TCGA-02-0085.1	45	2_EXTRACELLULAR_REGION	346	13	0.0000072746499947963791792
TCGA-06-2557.11	177	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0000074844804798409327211
TCGA-08-0345.2	77	0_HALLMARK_COAGULATION	125	11	0.0000075258097998367326902
TCGA-41-2575.49	136	2_MITOSIS	71	11	0.0000075891822897224468200
TCGA-02-2485.14	172	1_KEGG_MELANOMA	71	12	0.0000076873233723120305730
TCGA-06-2569.5	144	2_REPLICATION_FORK	18	7	0.0000077169151129132424898
TCGA-06-0127.2	23	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0000077189238658789165117
TCGA-06-0173.35	120	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000077359572885573444934
TCGA-06-0649.13	88	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000077494124214700981309
TCGA-32-4209.2	56	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000078522155208938598331
TCGA-06-1804.7	47	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000078538963328114949646
TCGA-12-3653.55	255	1_KEGG_MELANOMA	71	14	0.0000078613130916270209747
TCGA-06-0155.10	74	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000079004399417815256759
TCGA-19-1390.13	110	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0000079317857017156527684
TCGA-14-0787.7	14	2_RECEPTOR_ACTIVITY	499	9	0.0000079529187501797685074
TCGA-06-1804.7	47	2_EXTRACELLULAR_REGION_PART	269	12	0.0000080767044004641189717
TCGA-06-5414.13	102	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000080897931753069642606
TCGA-32-4208.28	140	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	12	0.0000080898520693592426841
TCGA-06-5415.7	7	1_KEGG_CELL_CYCLE	114	5	0.0000081543356433654216837
TCGA-32-2491.14	244	2_NON_MEMBRANE_BOUND_ORGANELLE	476	36	0.0000081628281571109363051
TCGA-32-2491.14	244	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	36	0.0000081628281571109363051
TCGA-76-6282.11	185	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	17	0.0000082544148687640739564
TCGA-02-0054.2	9	0_HALLMARK_ALLOGRAFT_REJECTION	190	6	0.0000082561039389499289449
TCGA-27-1831.9	85	1_KEGG_CELL_CYCLE	114	11	0.0000082605628450929109952
TCGA-19-5959.13	92	1_KEGG_FOCAL_ADHESION	195	14	0.0000082838501579421462104
TCGA-06-2569.5	144	2_EXTRACELLULAR_MATRIX	85	12	0.0000085009463235436001296
TCGA-06-0139.1	179	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000085840370535624459106
TCGA-06-5412.7	153	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000086376134495753090952
TCGA-08-0359.5	37	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000086402137367285031222
TCGA-19-2629.15	146	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0000086617034117118975193
TCGA-32-1982.9	89	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000086679555369683724506
TCGA-32-1982.9	89	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000086679555369683724506
TCGA-76-6192.6	43	0_HALLMARK_ANGIOGENESIS	32	6	0.0000086729287322823508553
TCGA-32-2615.7	77	0_HALLMARK_ANGIOGENESIS	32	7	0.0000087381673112795498241
TCGA-02-0071.12	116	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000087482284246493228905
TCGA-26-5135.9	71	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000087690384711683746160
TCGA-76-4931.10	86	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000087730502431006435486
TCGA-32-4208.28	140	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0000088330292081933979868
TCGA-41-2575.49	136	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000088489160249462109689
TCGA-06-2557.11	177	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000089950012115648647892
TCGA-41-5651.5	112	2_MITOTIC_CELL_CYCLE	134	13	0.0000090909723083981383053
TCGA-14-0786.4	62	2_CELL_CELL_SIGNALING	353	15	0.0000091256342075529732022
TCGA-14-0871.20	216	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000091324453301936638278
TCGA-14-1034.7	97	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000091394957698087255838
TCGA-26-5139.10	163	2_CYTOSKELETON	293	22	0.0000091482755322992515619
TCGA-41-4097.6	48	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000091572675806452435510
TCGA-06-0210.6	103	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000092129578163908701339
TCGA-19-5947.4	267	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	27	0.0000092795210502453360699
TCGA-06-0188.11	66	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000092865154168219819065
TCGA-12-0616.4	7	2_MICROTUBULE_CYTOSKELETON	117	5	0.0000093017448703004795922
TCGA-76-6282.11	185	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000093853281603488677070
TCGA-06-2558.6	74	2_CHROMOSOME	102	10	0.0000094085767800266451738
TCGA-28-1753.13	174	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0000094653136933204091064
TCGA-32-4208.28	140	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000094801408910536937122
TCGA-06-0122.8	90	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000096817549301175164839
TCGA-02-0099.11	141	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000096827838787799843919
TCGA-06-0138.2	30	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000096852722412992599569
TCGA-06-0197.1	57	2_APOPTOSIS_GO	389	15	0.0000096980742700359857689
TCGA-06-5411.4	23	1_KEGG_GLIOMA	62	6	0.0000097506594212092533025
TCGA-06-0219.2	4	1_KEGG_ECM_RECEPTOR_INTERACTION	84	4	0.0000098278665540048263646
TCGA-02-0033.1	4	1_KEGG_ECM_RECEPTOR_INTERACTION	84	4	0.0000098278665540048263646
TCGA-06-0140.2	25	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0000098806409220924018734
TCGA-26-1439.10	84	1_KEGG_ASTHMA	30	7	0.0000099346640551005060591
TCGA-26-1439.11	10	0_HALLMARK_E2F_TARGETS	169	6	0.0000100280394380069233051
TCGA-14-0786.2	10	0_HALLMARK_E2F_TARGETS	169	6	0.0000100280394380069233051
TCGA-06-0197.1	57	2_PROGRAMMED_CELL_DEATH	390	15	0.0000100425789437509156216
TCGA-08-0350.2	46	0_HALLMARK_E2F_TARGETS	169	10	0.0000101550015011403749730
TCGA-06-0139.1	179	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000102201280638623392944
TCGA-41-2575.49	136	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0000102472830902086474929
TCGA-06-2570.8	95	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000102698074811478926380
TCGA-02-0085.1	45	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0000102851961661538221087
TCGA-06-0197.1	57	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	15	0.0000103982540475450613570
TCGA-14-0790.9	104	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000104762118899445018702
TCGA-06-0189.3	118	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000104975520509850014862
TCGA-02-0074.5	118	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000104975520509850014862
TCGA-06-0174.37	141	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000105231562690575770349
TCGA-32-4208.28	140	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000105325755590924431936
TCGA-06-0877.7	4	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000105761694503922046214
TCGA-08-0348.3	4	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000105761694503922046214
TCGA-28-2509.6	59	2_CELL_CYCLE_GO_0007049	265	13	0.0000107215856862534389648
TCGA-19-2624.29	130	2_MICROTUBULE_CYTOSKELETON	117	13	0.0000107547263949362250420
TCGA-06-0143.6	63	2_COLLAGEN	23	6	0.0000107603567747189484717
TCGA-19-1390.12	10	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	6	0.0000107649834830737094069
TCGA-02-0089.5	91	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000107992911517690837571
TCGA-06-0744.3	12	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	7	0.0000108549442273673908623
TCGA-08-0345.2	77	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000108963921300287080806
TCGA-12-0619.11	123	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000109303052847844569986
TCGA-06-2563.10	123	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000109303052847844569986
TCGA-06-5418.5	13	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0000110363441885344450697
TCGA-06-0184.11	108	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000111202818244348440504
TCGA-41-5651.5	112	2_CELL_CYCLE_PROCESS	163	14	0.0000111236904421173637850
TCGA-08-0375.6	65	1_KEGG_FOCAL_ADHESION	195	12	0.0000111360288297793804790
TCGA-76-4934.7	47	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000111512061757893679126
TCGA-27-2519.7	113	0_HALLMARK_ALLOGRAFT_REJECTION	190	15	0.0000111575283639025788049
TCGA-28-5215.7	192	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000112158536619060872255
TCGA-02-0099.11	141	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000112160876432101186222
TCGA-06-5859.9	125	2_CELL_CYCLE_PHASE	146	14	0.0000112714102529162242224
TCGA-19-2623.11	153	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000112877871898443763978
TCGA-19-5955.9	110	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0000113143148801595429031
TCGA-06-0645.9	136	1_KEGG_ASTHMA	30	8	0.0000113566779384444020343
TCGA-27-1833.7	17	2_CELL_CYCLE_PROCESS	163	7	0.0000113694930248595388046
TCGA-02-0043.10	184	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	8	0.0000114734273768737029582
TCGA-06-2557.11	177	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0000116546391841178426389
TCGA-02-2483.10	100	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000116616487878868997419
TCGA-76-4929.8	91	0_HALLMARK_E2F_TARGETS	169	13	0.0000116755912871952206779
TCGA-19-5947.4	267	1_KEGG_LEISHMANIA_INFECTION	70	14	0.0000116927041233947009503
TCGA-26-1439.10	84	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0000117928801598154800332
TCGA-41-3915.10	109	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000119681271453873103937
TCGA-02-0001.5	117	2_ENZYME_REGULATOR_ACTIVITY	277	18	0.0000121942497027387975416
TCGA-28-5208.28	220	2_TRANSMISSION_OF_NERVE_IMPULSE	164	19	0.0000124873256168274355979
TCGA-06-0686.5	14	2_EXTRACELLULAR_REGION	346	8	0.0000125027070548342013773
TCGA-19-2629.15	146	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0000125141132589215140251
TCGA-06-0876.9	106	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000125225321821292919774
TCGA-76-4935.7	15	2_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0000125236115635470896402
TCGA-76-4935.7	15	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0000125236115635470896402
TCGA-02-0026.1	61	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000125427434588309715994
TCGA-06-0133.6	57	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0000126014477351506060625
TCGA-06-0133.6	57	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0000126014477351506060625
TCGA-06-0176.8	95	1_KEGG_FOCAL_ADHESION	195	14	0.0000127292867407897659037
TCGA-41-2573.4	31	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0000127407442468885981617
TCGA-32-1979.10	116	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	11	0.0000127900581406572475234
TCGA-14-0781.7	155	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000128015541802678459887
TCGA-19-2623.11	153	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000128404895885767015928
TCGA-12-3653.55	255	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	13	0.0000128516873843401854762
TCGA-06-0881.7	203	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000130450343517577762431
TCGA-06-0145.4	7	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	4	0.0000130457525722702738166
TCGA-06-0137.9	53	1_KEGG_FOCAL_ADHESION	195	11	0.0000132029968044276265941
TCGA-32-4208.28	140	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000132378505581213852565
TCGA-14-1034.7	97	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000133220807235623057394
TCGA-06-0188.11	66	1_KEGG_FOCAL_ADHESION	195	12	0.0000133672760450439425187
TCGA-06-0881.7	203	1_KEGG_ASTHMA	30	9	0.0000133743025248470238958
TCGA-12-0688.10	93	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000133826886584808283547
TCGA-19-2631.1	6	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0000134541669570486571359
TCGA-41-3915.10	109	2_CELL_CYCLE_GO_0007049	265	17	0.0000134610613907802482980
TCGA-06-2567.9	156	2_REPLICATION_FORK	18	7	0.0000135027057065662132172
TCGA-06-0157.7	89	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000135046233060459980156
TCGA-27-1837.5	85	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0000135459204362427268150
TCGA-12-3649.15	89	1_KEGG_CELL_CYCLE	114	11	0.0000135813185653992585055
TCGA-06-2570.8	95	2_MITOTIC_CELL_CYCLE	134	12	0.0000136854694842739824795
TCGA-06-0877.7	4	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000137479277349670474912
TCGA-08-0348.3	4	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000137479277349670474912
TCGA-41-3393.5	88	1_KEGG_ASTHMA	30	7	0.0000138054750970141954051
TCGA-06-0649.13	88	1_KEGG_ASTHMA	30	7	0.0000138054750970141954051
TCGA-02-0099.11	141	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000140955681583869366064
TCGA-32-4208.28	140	1_KEGG_ASTHMA	30	8	0.0000142883090099584643922
TCGA-06-5411.4	23	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000143223212414943169342
TCGA-76-6191.6	96	2_DNA_REPLICATION	82	10	0.0000144064649003589515891
TCGA-06-2567.9	156	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000145094481333152270746
TCGA-19-5947.4	267	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000145420585970674303003
TCGA-19-4068.2	11	1_KEGG_VIRAL_MYOCARDITIS	70	5	0.0000145672113079965415545
TCGA-19-5960.9	134	2_CELL_CYCLE_PROCESS	163	15	0.0000146647341604642678656
TCGA-06-0744.4	11	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0000147170090595288041669
TCGA-12-3653.55	255	2_REPLICATION_FORK	18	8	0.0000147763334618686445964
TCGA-87-5896.6	131	1_KEGG_DNA_REPLICATION	32	8	0.0000148106005755786778637
TCGA-76-6282.11	185	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000148497873469711352888
TCGA-06-1804.6	30	2_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0000148551417193129419440
TCGA-06-1804.6	30	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0000148551417193129419440
TCGA-27-2521.10	94	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000148688179650067429103
TCGA-02-0075.8	128	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0000148903988774072659713
TCGA-06-5858.19	205	2_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000149683549103243499168
TCGA-06-5858.19	205	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000149683549103243499168
TCGA-32-1979.4	12	2_CELL_CYCLE_GO_0007049	265	7	0.0000149863502458863319194
TCGA-28-2501.3	51	2_STRUCTURAL_MOLECULE_ACTIVITY	206	11	0.0000152111697176153011371
TCGA-19-2629.15	146	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0000152978749474719493556
TCGA-06-0189.3	118	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	11	0.0000153386054499645212385
TCGA-28-2514.9	62	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000155488449611236397474
TCGA-27-2523.12	112	1_KEGG_MELANOMA	71	10	0.0000155534865700295186976
TCGA-06-0881.7	203	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	23	0.0000155754197501470168115
TCGA-06-0140.2	25	2_CELL_CELL_SIGNALING	353	10	0.0000156408562311362475574
TCGA-02-0028.9	182	2_AXON	10	6	0.0000156695345217941245548
TCGA-06-5415.3	8	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	6	0.0000157321117026843484098
TCGA-06-0221.4	8	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	6	0.0000157321117026843484098
TCGA-06-0744.10	36	1_KEGG_BLADDER_CANCER	42	6	0.0000158693464658523795616
TCGA-19-5950.7	113	1_KEGG_FOCAL_ADHESION	195	15	0.0000159146188626409533029
TCGA-08-0357.4	36	0_HALLMARK_E2F_TARGETS	169	9	0.0000159232674243116751603
TCGA-06-5413.11	142	1_KEGG_ASTHMA	30	8	0.0000159850552530360876826
TCGA-06-2565.10	38	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0000160276388718845918169
TCGA-12-5299.5	6	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0000160646048090857115561
TCGA-19-2625.9	146	1_KEGG_MELANOMA	71	11	0.0000160785562454272291098
TCGA-26-5136.6	160	2_REPLICATION_FORK	18	7	0.0000161101117394870308657
TCGA-12-3650.17	101	2_CHROMOSOME	102	11	0.0000161182250368258070199
TCGA-06-2559.11	101	2_CHROMOSOME	102	11	0.0000161182250368258070199
TCGA-06-5415.7	7	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0000161436537986494570293
TCGA-32-4211.14	71	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000161900904575125055541
TCGA-12-0619.11	123	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000163137804491124217062
TCGA-14-1034.7	97	2_CELL_CYCLE_GO_0007049	265	16	0.0000163438511306788205539
TCGA-28-5215.7	192	2_TISSUE_DEVELOPMENT	115	15	0.0000164569474683428939351
TCGA-06-0176.8	95	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000164993004470758274234
TCGA-08-0380.5	47	2_CELL_CELL_SIGNALING	353	13	0.0000166884238773504051080
TCGA-02-0010.18	184	2_AXON	10	6	0.0000167344512698869262704
TCGA-19-5954.17	208	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000168285465490981568084
TCGA-28-5218.5	208	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000168285465490981568084
TCGA-02-0024.6	206	2_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000169045932748299447567
TCGA-02-0024.6	206	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000169045932748299447567
TCGA-19-2623.11	153	2_EXTRACELLULAR_MATRIX	85	12	0.0000169649569756253666307
TCGA-14-1825.8	80	2_CELL_CYCLE_PROCESS	163	12	0.0000171132994181023015889
TCGA-06-5411.3	19	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	6	0.0000172300523339083312289
TCGA-41-4097.6	48	0_HALLMARK_ANGIOGENESIS	32	6	0.0000172522859225261103152
TCGA-06-0184.11	108	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000172632903185168232782
TCGA-02-0003.9	227	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	14	0.0000173057056608048252496
TCGA-41-4097.6	48	2_EXTRACELLULAR_REGION	346	13	0.0000174004822129067131405
TCGA-19-2629.15	146	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000175002426820883991089
TCGA-02-2483.10	100	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000175892440117574725181
TCGA-06-2565.10	38	2_MITOSIS	71	7	0.0000177294232756024469654
TCGA-08-0354.7	47	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0000177873107019476067812
TCGA-02-0024.6	206	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000179231252288004613892
TCGA-14-0789.10	106	2_CELL_CELL_SIGNALING	353	19	0.0000179731942901439053562
TCGA-06-0195.8	56	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0000179971864759703503505
TCGA-06-0645.9	136	2_RESPONSE_TO_WOUNDING	163	15	0.0000179993254483535098016
TCGA-26-5135.9	71	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000180254389834722444702
TCGA-06-0650.2	82	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000180847621122237063151
TCGA-02-0102.8	82	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000180847621122237063151
TCGA-02-0026.1	61	2_DNA_METABOLIC_PROCESS	218	12	0.0000183070439179860888399
TCGA-02-0068.1	72	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000183722330538363200800
TCGA-32-1979.4	12	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0000183795761374016599634
TCGA-06-2567.9	156	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000184163664035224496800
TCGA-06-2563.10	123	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000186433835470053140893
TCGA-14-0813.10	53	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000187826428533347303523
TCGA-06-0152.11	56	2_CELL_CELL_SIGNALING	353	14	0.0000188420636590739264701
TCGA-06-5859.9	125	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000189497862360620729773
TCGA-06-5859.9	125	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000189497862360620729773
TCGA-02-0038.3	199	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	10	0.0000189643849286789854477
TCGA-76-4929.8	91	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000190288837294583742014
TCGA-14-4157.7	101	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000190408369580790115549
TCGA-19-5959.13	92	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000190671282016464717108
TCGA-06-0881.7	203	2_RESPONSE_TO_WOUNDING	163	18	0.0000191189829282912354886
TCGA-06-2565.10	38	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0000195821501107180958689
TCGA-76-6282.11	185	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0000199119053810696454096
TCGA-41-3392.31	136	0_HALLMARK_ANGIOGENESIS	32	8	0.0000199207656864934324400
TCGA-08-0354.5	18	2_CELL_CYCLE_GO_0007049	265	8	0.0000199925612588358763452
TCGA-32-4211.14	71	2_EXTRACELLULAR_MATRIX	85	9	0.0000200405509000956031328
TCGA-28-5214.11	124	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000201687710642964852337
TCGA-12-3653.55	255	2_CELL_CYCLE_PHASE	146	19	0.0000202251036117634835118
TCGA-06-0878.10	115	1_KEGG_FOCAL_ADHESION	195	15	0.0000203260852176080232642
TCGA-76-4927.8	93	1_KEGG_ASTHMA	30	7	0.0000203821812268258187361
TCGA-19-5947.4	267	2_EXTRACELLULAR_MATRIX	85	15	0.0000204345507014421247090
TCGA-06-0648.6	17	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0000209936157806948983250
TCGA-26-1439.10	84	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000210502563530014859434
TCGA-76-6193.13	271	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	15	0.0000211041619654636271742
TCGA-32-1982.9	89	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0000211193922772986015764
TCGA-32-1982.6	8	1_KEGG_CELL_CYCLE	114	5	0.0000215358066552167030266
TCGA-14-0787.7	14	2_PLASMA_MEMBRANE	1096	11	0.0000215695650837669491496
TCGA-76-4927.8	93	1_KEGG_CELL_CYCLE	114	11	0.0000217761713110223436587
TCGA-06-5859.9	125	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000218036582626169658111
TCGA-26-1439.10	84	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000219411813835201747959
TCGA-32-2494.10	173	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000219496430654383418025
TCGA-27-2528.10	99	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000219640978011983313653
TCGA-06-0130.3	155	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	11	0.0000220717872770686364186
TCGA-32-2634.10	118	2_CELL_CYCLE_PROCESS	163	14	0.0000220917952123652956318
TCGA-06-2565.10	38	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0000223453618799138323617
TCGA-14-0813.5	5	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	5	0.0000223862403344606072529
TCGA-06-5411.4	23	1_KEGG_MELANOMA	71	6	0.0000224016982718205271048
TCGA-02-0107.3	71	2_COLLAGEN	23	6	0.0000224016982718205271048
TCGA-06-0189.3	118	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000224811520270881504493
TCGA-06-5412.7	153	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0000225344159566936781040
TCGA-06-0148.6	69	1_KEGG_FOCAL_ADHESION	195	12	0.0000226745463791758204480
TCGA-02-0068.1	72	2_EXTRACELLULAR_MATRIX	85	9	0.0000227373169734555525591
TCGA-41-3915.10	109	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0000229127364822058349485
TCGA-28-2514.9	62	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000229282548642992627650
TCGA-76-4926.9	66	2_CELL_CELL_SIGNALING	353	15	0.0000229643567338759993089
TCGA-08-0386.4	73	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000231621550839131351205
TCGA-06-0127.3	5	1_KEGG_LEISHMANIA_INFECTION	70	4	0.0000232203607622899701080
TCGA-06-0127.3	5	1_KEGG_VIRAL_MYOCARDITIS	70	4	0.0000232203607622899701080
TCGA-28-2514.9	62	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0000233449047873461692267
TCGA-19-5952.11	193	0_HALLMARK_HYPOXIA	154	17	0.0000234735298785789554680
TCGA-32-1979.10	116	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000235163117851873792823
TCGA-14-1825.8	80	2_MITOTIC_CELL_CYCLE	134	11	0.0000238063828092273261088
TCGA-76-6282.11	185	2_EXTRACELLULAR_REGION	346	25	0.0000238757785304009040859
TCGA-41-3393.5	88	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0000240365918790445940063
TCGA-76-6193.13	271	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	12	0.0000240859037358523114087
TCGA-02-0024.6	206	2_CELL_CYCLE_PROCESS	163	18	0.0000240931852476232082419
TCGA-19-2619.14	100	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000242324207290699551634
TCGA-14-0786.4	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000243437186424922862645
TCGA-06-0157.7	89	1_KEGG_DNA_REPLICATION	32	7	0.0000243464143340124938028
TCGA-14-0787.7	14	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	4	0.0000243697473341584177947
TCGA-06-0124.6	55	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000245256294636712534002
TCGA-27-2528.10	99	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000247181555994125079197
TCGA-32-1979.4	12	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	5	0.0000248291807738108161890
TCGA-81-5910.12	128	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000248550346592462084293
TCGA-06-2557.11	177	0_HALLMARK_ALLOGRAFT_REJECTION	190	18	0.0000248892569964086088439
TCGA-19-1390.13	110	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000249078524161759280763
TCGA-02-2483.10	100	2_INTERPHASE	62	9	0.0000249517386729046650661
TCGA-02-0010.18	184	1_KEGG_PATHWAYS_IN_CANCER	323	24	0.0000249843446071832296846
TCGA-06-0190.8	143	1_KEGG_CELL_CYCLE	114	13	0.0000250335188449002260546
TCGA-06-0881.7	203	0_HALLMARK_ANGIOGENESIS	32	9	0.0000252609896051935863492
TCGA-19-2624.29	130	0_HALLMARK_MITOTIC_SPINDLE	175	15	0.0000254767821239504652163
TCGA-02-0034.4	88	2_AXON	10	5	0.0000256617461205582547397
TCGA-06-0241.8	53	2_REGULATION_OF_CELL_CYCLE	160	10	0.0000257938750317481929044
TCGA-12-5299.6	38	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000260163653507219892204
TCGA-14-1829.3	8	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	4	0.0000260163653507219892204
TCGA-32-2494.10	173	1_KEGG_FOCAL_ADHESION	195	18	0.0000261059496238096935274
TCGA-06-5415.7	7	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0000262858069668899944947
TCGA-06-0122.8	90	0_HALLMARK_ANGIOGENESIS	32	7	0.0000263382736920893481699
TCGA-06-0184.11	108	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000264996078322308757408
TCGA-32-1982.9	89	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0000265847520461610140714
TCGA-27-2521.10	94	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000266965443597020630334
TCGA-14-4157.7	101	2_INTERPHASE	62	9	0.0000272537024634114765211
TCGA-06-2559.11	101	1_KEGG_GLIOMA	62	9	0.0000272537024634114765211
TCGA-06-0646.4	63	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000273391405880206633317
TCGA-06-5856.13	152	1_KEGG_ASTHMA	30	8	0.0000273462147954512843314
TCGA-06-0138.2	30	2_SYNAPTIC_TRANSMISSION	152	8	0.0000273462147954512843314
TCGA-14-0813.10	53	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000273538972106616248457
TCGA-41-3393.4	12	2_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0000274157701222360536679
TCGA-41-3393.4	12	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0000274157701222360536679
TCGA-19-5954.17	208	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000276483866437784192474
TCGA-28-5218.5	208	2_ECTODERM_DEVELOPMENT	66	12	0.0000276483866437784192474
TCGA-27-2528.10	99	2_EXTRACELLULAR_MATRIX	85	10	0.0000277733833234450646613
TCGA-06-2570.8	95	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000279102034757556931885
TCGA-28-2502.9	56	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000279148368377380457091
TCGA-06-0195.8	56	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0000279148368377380457091
TCGA-27-1837.5	85	1_KEGG_FOCAL_ADHESION	195	13	0.0000280747016147077002981
TCGA-06-0211.8	62	1_KEGG_MELANOMA	71	8	0.0000280758482272784801984
TCGA-06-0166.5	35	2_COLLAGEN	23	5	0.0000280844371239482517731
TCGA-19-5958.4	35	2_COLLAGEN	23	5	0.0000280844371239482517731
TCGA-06-0750.12	52	2_EXTRACELLULAR_REGION_PART	269	12	0.0000280962126705582743733
TCGA-08-0245.4	85	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000281426320436552799382
TCGA-02-0028.9	182	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0000282182248443157529224
TCGA-02-0060.19	281	0_HALLMARK_ANGIOGENESIS	32	10	0.0000282199539183953432406
TCGA-06-0750.12	52	0_HALLMARK_ANGIOGENESIS	32	6	0.0000283518935256280974714
TCGA-08-0375.6	65	0_HALLMARK_E2F_TARGETS	169	11	0.0000284031584587181544358
TCGA-41-3915.10	109	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000285092301188488023156
TCGA-41-2571.7	72	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000285807300153317785086
TCGA-06-2559.11	101	1_KEGG_FOCAL_ADHESION	195	14	0.0000286616227265451671438
TCGA-41-5651.5	112	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000287322973969167840393
TCGA-06-5412.7	153	1_KEGG_ASTHMA	30	8	0.0000287946021071175238147
TCGA-06-0155.10	74	2_COLLAGEN	23	6	0.0000288416519421330035252
TCGA-08-0354.5	18	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0000288757349325422463737
TCGA-27-2528.10	99	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0000288928255789906660034
TCGA-06-1804.6	30	2_NUCLEAR_REPLICATION_FORK	10	4	0.0000289279715567004873540
TCGA-19-1790.18	201	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	17	0.0000289751281669422552185
TCGA-27-1834.10	39	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000289798166042582141968
TCGA-32-1986.8	87	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000290523119749571278496
TCGA-02-0074.5	118	1_KEGG_FOCAL_ADHESION	195	15	0.0000290572986029977999804
TCGA-41-3392.31	136	0_HALLMARK_E2F_TARGETS	169	15	0.0000294813816743062597262
TCGA-26-5133.10	75	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000295374313807081985330
TCGA-32-2634.10	118	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	10	0.0000297050981252557110609
TCGA-12-0821.9	81	0_HALLMARK_E2F_TARGETS	169	12	0.0000297608242847511049239
TCGA-02-0089.5	91	0_HALLMARK_APOPTOSIS	150	12	0.0000299377234698626158162
TCGA-32-4210.14	109	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0000300182529331470149150
TCGA-32-4210.14	109	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0000300182529331470149150
TCGA-28-5218.5	208	2_COLLAGEN	23	8	0.0000300978667908969150190
TCGA-32-2494.10	173	1_KEGG_CELL_CYCLE	114	14	0.0000302681161845450836894
TCGA-06-0173.35	120	1_KEGG_MELANOMA	71	10	0.0000304227398080615705036
TCGA-06-0126.7	5	2_EXTRACELLULAR_REGION_PART	269	5	0.0000304910843021999965305
TCGA-19-2619.14	100	2_EXTRACELLULAR_MATRIX	85	10	0.0000306357280336073657884
TCGA-19-1790.18	201	2_EXTRACELLULAR_REGION	346	26	0.0000307059718439595265944
TCGA-27-1833.2	41	2_CELL_CELL_SIGNALING	353	12	0.0000308321614785311137871
TCGA-32-1979.4	12	2_REGULATION_OF_CELL_CYCLE	160	6	0.0000308369992448347178494
TCGA-19-5960.9	134	2_DNA_REPLICATION	82	11	0.0000310592123242197653437
TCGA-32-4719.15	123	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000312174257536811195564
TCGA-27-2519.7	113	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000312610382022237103775
TCGA-08-0353.8	100	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0000312953292150508548220
TCGA-41-2571.7	72	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0000314131229523927999066
TCGA-19-1390.13	110	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	9	0.0000315845055961958180528
TCGA-32-4719.15	123	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000316211694109516308756
TCGA-06-2562.7	57	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000316929658620893989164
TCGA-27-1830.7	57	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000316929658620893989164
TCGA-27-1838.17	131	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000317167213112838473508
TCGA-87-5896.6	131	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000317167213112838473508
TCGA-06-0141.1	45	1_KEGG_FOCAL_ADHESION	195	10	0.0000320479690304862309337
TCGA-02-0085.1	45	1_KEGG_FOCAL_ADHESION	195	10	0.0000320479690304862309337
TCGA-02-0114.20	132	1_KEGG_PATHWAYS_IN_CANCER	323	20	0.0000320805639782723993770
TCGA-06-0219.6	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000321192726401386168997
TCGA-08-0244.4	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000321192726401386168997
TCGA-12-5299.5	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000321192726401386168997
TCGA-14-1829.11	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000321192726401386168997
TCGA-14-2554.9	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000321192726401386168997
TCGA-06-0184.11	108	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000324268493978309923186
TCGA-27-1835.6	86	1_KEGG_FOCAL_ADHESION	195	13	0.0000324820296141422186248
TCGA-02-0115.1	36	2_COLLAGEN	23	5	0.0000325623081685260548049
TCGA-06-2565.10	38	2_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0000329121964997441962281
TCGA-06-2565.10	38	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0000329121964997441962281
TCGA-41-3915.10	109	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0000330772437911600112985
TCGA-14-0813.10	53	2_EXTRACELLULAR_MATRIX	85	8	0.0000330912797743217369653
TCGA-06-2561.5	42	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0000334690865792562435542
TCGA-12-5295.8	66	0_HALLMARK_E2F_TARGETS	169	11	0.0000335612186026464480730
TCGA-14-1034.7	97	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000335779855016678211344
TCGA-06-0152.10	19	2_CELL_CYCLE_GO_0007049	265	8	0.0000336987779400110292112
TCGA-06-5411.4	23	2_MITOTIC_CELL_CYCLE	134	7	0.0000338257655512209424683
TCGA-14-4157.7	101	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0000338684414390854623229
TCGA-12-3650.17	101	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0000338684414390854623229
TCGA-02-0054.3	93	2_AXON	10	5	0.0000339678092860909902661
TCGA-06-6391.9	26	0_HALLMARK_ANGIOGENESIS	32	5	0.0000339756882720064853519
TCGA-06-0877.7	4	1_KEGG_CELL_CYCLE	114	4	0.0000339881320918470231519
TCGA-16-0861.5	4	1_KEGG_CELL_CYCLE	114	4	0.0000339881320918470231519
TCGA-06-2561.7	4	1_KEGG_CELL_CYCLE	114	4	0.0000339881320918470231519
TCGA-08-0348.3	4	1_KEGG_CELL_CYCLE	114	4	0.0000339881320918470231519
TCGA-08-0358.9	43	2_SYNAPTIC_TRANSMISSION	152	9	0.0000340332067670048621670
TCGA-06-6389.4	39	0_HALLMARK_E2F_TARGETS	169	9	0.0000342304396992077037093
TCGA-28-5218.6	8	1_KEGG_AXON_GUIDANCE	125	5	0.0000343043458932707539459
TCGA-06-0154.2	5	2_KINESIN_COMPLEX	13	3	0.0000343425263974143568581
TCGA-02-0060.19	281	1_KEGG_ECM_RECEPTOR_INTERACTION	84	15	0.0000343713800643082316878
TCGA-14-0813.10	53	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0000344442726662133561909
TCGA-06-2558.6	74	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000347009045955434333882
TCGA-06-0130.3	155	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0000347234637977747822549
TCGA-76-4929.8	91	2_SYNAPTIC_TRANSMISSION	152	12	0.0000347626318375521376164
TCGA-41-3915.10	109	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000348826704383860169479
TCGA-02-0089.5	91	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0000353313735374513341529
TCGA-27-1833.2	41	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000356566154822464867328
TCGA-32-4211.14	71	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0000356991924705184031363
TCGA-02-0107.3	71	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0000356991924705184031363
TCGA-06-0192.10	126	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000357123283055712931471
TCGA-06-0645.9	136	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0000358286156215219096398
TCGA-06-0210.6	103	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000363710065827575133564
TCGA-14-4157.7	101	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500981099
TCGA-14-4157.7	101	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500981099
TCGA-12-3650.17	101	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500981099
TCGA-12-3650.17	101	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500981099
TCGA-06-2559.11	101	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500981099
TCGA-06-2559.11	101	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500981099
TCGA-32-2615.7	77	2_COLLAGEN	23	6	0.0000367417327357153777087
TCGA-06-5859.9	125	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000368421430392171868383
TCGA-06-0145.19	81	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000369946866383000360777
TCGA-06-0210.6	103	1_KEGG_FOCAL_ADHESION	195	14	0.0000370816035643790174064
TCGA-06-0139.1	179	2_INFLAMMATORY_RESPONSE	112	14	0.0000371714576101692473014
TCGA-06-0174.37	141	1_KEGG_GLIOMA	62	10	0.0000373018652269800900733
TCGA-14-0871.20	216	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000377337168207728706668
TCGA-27-1838.17	131	2_CELL_CYCLE_GO_0007049	265	18	0.0000379455054362123707823
TCGA-02-0046.8	148	1_KEGG_CELL_CYCLE	114	13	0.0000379519482853631870715
TCGA-06-0213.9	74	2_SYNAPTIC_TRANSMISSION	152	11	0.0000384540918582652719812
TCGA-08-0375.6	65	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000384912927399604272178
TCGA-32-4213.15	198	1_KEGG_FOCAL_ADHESION	195	19	0.0000387697143985528549321
TCGA-02-0001.5	117	2_NEURON_PROJECTION	16	6	0.0000387832531836604903078
TCGA-08-0389.4	56	2_DNA_REPLICATION	82	8	0.0000389571688532891252568
TCGA-06-0195.8	56	2_DNA_REPLICATION	82	8	0.0000389571688532891252568
TCGA-32-2638.17	159	1_KEGG_ASTHMA	30	8	0.0000389580199746635946062
TCGA-06-5414.13	102	1_KEGG_ASTHMA	30	7	0.0000389712361848288865989
TCGA-06-0939.7	58	2_SYNAPTIC_TRANSMISSION	152	10	0.0000392835875090650146085
TCGA-02-0028.9	182	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000395947596201484946100
TCGA-19-5952.11	193	0_HALLMARK_UV_RESPONSE_DN	122	15	0.0000400365934019124338210
TCGA-06-0129.11	110	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	5	0.0000400666024833400583418
TCGA-02-0048.9	84	2_MITOTIC_CELL_CYCLE	134	11	0.0000402204553003617209638
TCGA-27-2528.10	99	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000402284818039793103345
TCGA-06-5408.3	99	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000402284818039793103345
TCGA-06-0174.37	141	2_CELL_PROLIFERATION_GO_0008283	436	24	0.0000403297070160974006599
TCGA-06-0745.4	55	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000407659041047705349636
TCGA-08-0375.6	65	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000408555291550606039172
TCGA-41-2571.7	72	1_KEGG_BLADDER_CANCER	42	7	0.0000408612673645173806337
TCGA-16-0846.2	27	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000410906015691244513237
TCGA-12-0821.9	81	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000412917615412728133137
TCGA-76-6191.6	96	1_KEGG_DNA_REPLICATION	32	7	0.0000414342680757787013035
TCGA-02-0014.10	70	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000415503671530844721251
TCGA-28-5214.11	124	1_KEGG_MELANOMA	71	10	0.0000417693130866214742871
TCGA-02-0003.9	227	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000417815694967670308961
TCGA-14-0790.9	104	1_KEGG_FOCAL_ADHESION	195	14	0.0000420819501591299091939
TCGA-06-0881.7	203	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000421635309362218565587
TCGA-06-0219.6	6	2_INTERPHASE	62	4	0.0000422027988152758623628
TCGA-08-0244.4	6	2_INTERPHASE	62	4	0.0000422027988152758623628
TCGA-12-5299.5	6	2_INTERPHASE	62	4	0.0000422027988152758623628
TCGA-14-1829.11	6	2_INTERPHASE	62	4	0.0000422027988152758623628
TCGA-14-2554.9	6	2_INTERPHASE	62	4	0.0000422027988152758623628
TCGA-06-0192.10	126	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0000423435850964800253489
TCGA-76-6285.5	106	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0000427368842558296696717
TCGA-76-6285.5	106	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000427368842558296696717
TCGA-02-0075.8	128	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000427444108002026480026
TCGA-06-0168.4	22	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0000431338361411160502667
TCGA-06-0197.1	57	2_REGULATION_OF_APOPTOSIS	309	13	0.0000431605283975804038536
TCGA-28-5204.3	4	2_ION_CHANNEL_ACTIVITY	121	4	0.0000432711648252336004571
TCGA-08-0358.9	43	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000434224654082676620164
TCGA-19-5958.4	35	2_EXTRACELLULAR_REGION	346	11	0.0000434429561302217512081
TCGA-02-0083.21	135	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000434762117116488174700
TCGA-32-4210.14	109	2_DNA_METABOLIC_PROCESS	218	15	0.0000436123637002696709912
TCGA-28-5207.12	188	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0000437635055319693413154
TCGA-08-0353.8	100	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000439660297003461919595
TCGA-02-0027.3	81	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000440297627206825121604
TCGA-02-0026.1	61	2_CELL_CYCLE_PHASE	146	10	0.0000442983271869796393721
TCGA-76-4927.8	93	2_SYNAPTIC_TRANSMISSION	152	12	0.0000446500741261120489092
TCGA-28-2502.9	56	0_HALLMARK_ANGIOGENESIS	32	6	0.0000447902864565153513562
TCGA-06-0197.1	57	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	13	0.0000448502569273404792750
TCGA-06-5412.7	153	2_IMMUNE_SYSTEM_PROCESS	283	20	0.0000449122861348035337268
TCGA-08-0389.4	56	2_REGULATION_OF_CELL_CYCLE	160	10	0.0000450923549926338006959
TCGA-32-2634.10	118	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	13	0.0000451306801673480385340
TCGA-06-5415.7	7	2_REGULATION_OF_CELL_CYCLE	160	5	0.0000451963692773974033516
TCGA-02-0028.9	182	0_HALLMARK_APOPTOSIS	150	16	0.0000453570397100813599051
TCGA-19-4068.2	11	1_KEGG_ASTHMA	30	4	0.0000453581235851108154045
TCGA-06-0188.11	66	2_CELL_CYCLE_GO_0007049	265	13	0.0000454537236389150389520
TCGA-28-1753.13	174	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000454591209713526450166
TCGA-06-0188.11	66	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000454591209713526450166
TCGA-32-2632.16	229	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000457516359635555766605
TCGA-06-2557.11	177	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0000458988155549145562351
TCGA-02-0074.5	118	2_CELL_CYCLE_GO_0007049	265	17	0.0000459480207176642254730
TCGA-06-0875.7	78	2_CELL_CYCLE_GO_0007049	265	14	0.0000460030306840629021198
TCGA-02-0052.3	116	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0000466136268675800842900
TCGA-06-5859.9	125	2_CELL_CYCLE_PROCESS	163	14	0.0000467334057395963343149
TCGA-32-1977.11	107	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000468101653516278374580
TCGA-06-5411.3	19	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0000468362608114481323218
TCGA-41-2575.49	136	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000473010255702326445383
TCGA-02-0060.19	281	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	15	0.0000479202371947711912217
TCGA-02-0060.19	281	0_HALLMARK_INFLAMMATORY_RESPONSE	170	21	0.0000485060863612085010053
TCGA-28-5218.5	208	2_TISSUE_DEVELOPMENT	115	15	0.0000486254556572596546783
TCGA-06-0127.3	5	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	4	0.0000488063258558699494686
TCGA-06-0686.6	3	1_KEGG_ASTHMA	30	3	0.0000488294966402187397957
TCGA-19-5958.2	3	1_KEGG_ASTHMA	30	3	0.0000488294966402187397957
TCGA-28-5215.7	192	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	16	0.0000488498522487722721818
TCGA-28-5208.28	220	2_AXON	10	6	0.0000489066708471230801396
TCGA-28-5204.3	4	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	125	4	0.0000493627835511306145913
TCGA-27-1830.7	57	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000495714794889067129641
TCGA-06-2558.6	74	1_KEGG_BLADDER_CANCER	42	7	0.0000495927174794517615776
TCGA-06-0138.2	30	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0000496622670941343326094
TCGA-02-0099.11	141	1_KEGG_FOCAL_ADHESION	195	16	0.0000497173489915476749337
TCGA-28-5220.7	15	1_KEGG_GLIOMA	62	5	0.0000498264069603652619842
TCGA-06-0168.4	22	2_EXTRACELLULAR_MATRIX	85	6	0.0000498340285341400209451
TCGA-02-0011.1	288	2_CELL_DEVELOPMENT	511	40	0.0000499297689113142065210
TCGA-76-4934.7	47	1_KEGG_FOCAL_ADHESION	195	10	0.0000501844587099218390736
TCGA-02-0060.19	281	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	18	0.0000505337227158413678386
TCGA-06-0122.8	90	2_EXTRACELLULAR_REGION_PART	269	15	0.0000506512516454080637444
TCGA-76-6285.5	106	1_KEGG_ASTHMA	30	7	0.0000509890936563905746337
TCGA-08-0345.2	77	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0000513880506007643114035
TCGA-06-5408.3	99	0_HALLMARK_ANGIOGENESIS	32	7	0.0000513905465641681659622
TCGA-06-5415.7	7	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	4	0.0000515551033627357799629
TCGA-14-0813.5	5	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0000519283653287860909472
TCGA-06-2565.3	60	1_KEGG_FOCAL_ADHESION	195	11	0.0000523316256677772286910
TCGA-02-0026.1	61	2_CHROMOSOMAL_PART	78	8	0.0000523432059051807604955
TCGA-12-0616.7	45	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000523890585525554257438
TCGA-08-0355.1	45	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000523890585525554257438
TCGA-19-5954.17	208	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000524498192634690146266
TCGA-32-2495.11	67	1_KEGG_MELANOMA	71	8	0.0000525710709325765665522
TCGA-32-1977.11	107	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000526389053466568010236
TCGA-06-0197.1	57	2_CELL_DEVELOPMENT	511	16	0.0000527400698468931074985
TCGA-06-0219.6	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732783812
TCGA-08-0244.4	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732783812
TCGA-12-5299.5	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732783812
TCGA-14-1823.12	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732783812
TCGA-14-1829.11	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732783812
TCGA-14-2554.9	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732783812
TCGA-02-0115.1	36	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0000531587696227093004409
TCGA-02-0043.10	184	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	40	0.0000532519242444637745421
TCGA-06-0189.3	118	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000533701632582743502897
TCGA-19-5951.10	138	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000534190912063695625333
TCGA-06-0650.2	82	2_COLLAGEN	23	6	0.0000538443061415290125040
TCGA-02-0102.8	82	2_COLLAGEN	23	6	0.0000538443061415290125040
TCGA-06-0876.9	106	1_KEGG_FOCAL_ADHESION	195	14	0.0000539578806539421773213
TCGA-76-6285.5	106	1_KEGG_FOCAL_ADHESION	195	14	0.0000539578806539421773213
TCGA-76-6285.5	106	2_EXTRACELLULAR_MATRIX	85	10	0.0000539672457019201135095
TCGA-14-0871.20	216	2_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000544149229220312365260
TCGA-14-0871.20	216	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000544149229220312365260
TCGA-15-1444.3	107	1_KEGG_ASTHMA	30	7	0.0000544413439947505882217
TCGA-06-2562.7	57	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000545360661889141053464
TCGA-06-0133.6	57	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0000545360661889141053464
TCGA-76-4925.9	83	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000547682929998206624003
TCGA-12-0616.1	20	2_CELL_CYCLE_GO_0007049	265	8	0.0000548087840258199281585
TCGA-06-0644.16	142	1_KEGG_FOCAL_ADHESION	195	16	0.0000550263990841480098853
TCGA-28-2513.12	134	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000550594073720056244271
TCGA-02-2483.10	100	1_KEGG_DNA_REPLICATION	32	7	0.0000551299508736093231680
TCGA-19-5954.17	208	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000553053693871649867052
TCGA-06-0141.1	45	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0000553172217423915916394
TCGA-06-0141.1	45	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0000553172217423915916394
TCGA-06-0124.6	55	2_EXTRACELLULAR_REGION_PART	269	12	0.0000553472582467935350246
TCGA-06-0127.3	5	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	4	0.0000562891443176195775525
TCGA-02-0060.19	281	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	15	0.0000563750351003033890653
TCGA-32-2634.10	118	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0000565797228168159717300
TCGA-02-0074.5	118	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0000565797228168159717300
TCGA-02-2483.10	100	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	15	0.0000565916855167968116955
TCGA-19-5951.10	138	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000566214756866077173459
TCGA-06-0190.8	143	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0000572214948276356398429
TCGA-02-2483.10	100	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000572226789679186739410
TCGA-28-2501.3	51	2_CYTOSKELETON	293	12	0.0000574708924714665178829
TCGA-06-0184.11	108	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000575953890697764302751
TCGA-32-2498.13	133	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000577757876002020994452
TCGA-06-2565.10	38	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0000581590996107976274999
TCGA-76-4925.9	83	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000583883928147178776400
TCGA-06-0176.8	95	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000584966162544855284395
TCGA-16-1045.10	81	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000587658489897829934448
TCGA-06-6390.9	82	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000589270959699463793189
TCGA-06-0141.1	45	2_EXTRACELLULAR_REGION_PART	269	11	0.0000590560958017290020539
TCGA-12-3650.17	101	1_KEGG_DNA_REPLICATION	32	7	0.0000590974016853543785343
TCGA-32-1977.11	107	2_EXTRACELLULAR_MATRIX	85	10	0.0000590994698018041872412
TCGA-02-2485.14	172	2_CHROMOSOME	102	13	0.0000592963848476808053729
TCGA-28-2509.6	59	2_DNA_REPLICATION	82	8	0.0000595516422408865368017
TCGA-14-0789.11	3	2_CALCIUM_CHANNEL_ACTIVITY	32	3	0.0000596537692944526504570
TCGA-26-1439.7	3	2_CALCIUM_CHANNEL_ACTIVITY	32	3	0.0000596537692944526504570
TCGA-14-1825.5	3	2_CALCIUM_CHANNEL_ACTIVITY	32	3	0.0000596537692944526504570
TCGA-27-1830.7	57	2_EXTRACELLULAR_MATRIX	85	8	0.0000599236385290823327858
TCGA-14-1825.8	80	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000601370114520732954467
TCGA-02-0099.11	141	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000602339382743447864150
TCGA-27-2524.5	75	1_KEGG_FOCAL_ADHESION	195	12	0.0000603021635121397950254
TCGA-28-6450.11	139	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000606795700425122707246
TCGA-02-0003.9	227	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000610013331941538142059
TCGA-06-0645.9	136	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	18	0.0000612430714722349327445
TCGA-28-2513.12	134	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000612750452632828529736
TCGA-08-0345.2	77	0_HALLMARK_ALLOGRAFT_REJECTION	190	12	0.0000613008027991295950101
TCGA-06-5411.4	23	2_CELL_CYCLE_PHASE	146	7	0.0000613693592240778805534
TCGA-28-2509.6	59	1_KEGG_DNA_REPLICATION	32	6	0.0000617168586453749925787
TCGA-32-1980.1	24	2_BLOOD_COAGULATION	39	5	0.0000623304906715201870095
TCGA-32-1980.1	24	2_COAGULATION	39	5	0.0000623304906715201870095
TCGA-19-1790.18	201	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	22	0.0000625729796072867916349
TCGA-08-0354.7	47	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000626734017819563390917
TCGA-08-0380.5	47	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000626734017819563390917
TCGA-28-5219.9	47	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000626734017819563390917
TCGA-28-1753.13	174	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0000628841607793531452058
TCGA-41-3915.10	109	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000629596224563955681732
TCGA-02-2486.9	141	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000629606394399150331043
TCGA-76-6191.6	96	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000635551493470800152449
TCGA-06-0132.1	18	1_KEGG_FOCAL_ADHESION	195	7	0.0000635740403992074963341
TCGA-06-0877.7	4	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0000638920249990072901475
TCGA-08-0348.3	4	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0000638920249990072901475
TCGA-02-0099.11	141	2_EXTRACELLULAR_REGION	346	21	0.0000639008478701867470816
TCGA-06-5412.1	28	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	9	0.0000643077795445472059650
TCGA-06-0143.6	63	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000647141133621330393510
TCGA-08-0350.2	46	2_CELL_CYCLE_GO_0007049	265	11	0.0000648705320176515932507
TCGA-32-4208.28	140	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000649925071037936257466
TCGA-02-2483.10	100	2_CELL_CYCLE_PHASE	146	12	0.0000651826392336738472079
TCGA-06-0189.3	118	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000652458814920670190050
TCGA-32-2634.10	118	1_KEGG_BLADDER_CANCER	42	8	0.0000652458814920670190050
TCGA-32-2634.10	118	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000652458814920670190050
TCGA-06-0877.7	4	2_MITOTIC_CELL_CYCLE	134	4	0.0000654040538362039538178
TCGA-08-0348.3	4	2_MITOTIC_CELL_CYCLE	134	4	0.0000654040538362039538178
TCGA-19-2623.11	153	2_NON_MEMBRANE_BOUND_ORGANELLE	476	26	0.0000655651550339064618025
TCGA-19-2623.11	153	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	26	0.0000655651550339064618025
TCGA-08-0352.2	59	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000655865638375807696739
TCGA-19-2624.29	130	2_MITOSIS	71	10	0.0000658106960683533826493
TCGA-02-0075.8	128	1_KEGG_CELL_CYCLE	114	12	0.0000658209376199239524921
TCGA-32-2491.14	244	1_KEGG_ASTHMA	30	9	0.0000664241026239897772252
TCGA-19-2629.15	146	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0000665978235782922604359
TCGA-12-0692.3	9	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0000675692107931674294059
TCGA-02-0054.3	93	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	8	0.0000676816233053267364431
TCGA-32-2634.10	118	0_HALLMARK_MYC_TARGETS_V1	178	14	0.0000681063407635317056557
TCGA-06-5858.19	205	1_KEGG_FOCAL_ADHESION	195	19	0.0000682280538892367260147
TCGA-02-0099.11	141	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000684349657544669866607
TCGA-06-0219.6	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362956014
TCGA-08-0380.4	6	2_KINESIN_COMPLEX	13	3	0.0000686305085328362956014
TCGA-14-0817.3	6	2_KINESIN_COMPLEX	13	3	0.0000686305085328362956014
TCGA-08-0244.4	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362956014
TCGA-12-5299.5	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362956014
TCGA-14-1823.12	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362956014
TCGA-14-1829.11	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362956014
TCGA-14-2554.9	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362956014
TCGA-08-0360.3	144	2_DEFENSE_RESPONSE	222	17	0.0000686416531310127562638
TCGA-19-5955.9	110	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000687603065056990484872
TCGA-06-0219.6	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0000692716744472813840102
TCGA-08-0244.4	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0000692716744472813840102
TCGA-12-5299.5	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0000692716744472813840102
TCGA-14-1829.11	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0000692716744472813840102
TCGA-14-2554.9	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0000692716744472813840102
TCGA-06-0174.37	141	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000695740220746922887179
TCGA-76-6282.11	185	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0000699584095940649470201
TCGA-06-2569.5	144	2_CHROMOSOME	102	12	0.0000699690056917034769630
TCGA-32-2632.16	229	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000702795455617926100597
TCGA-02-0080.3	20	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0000709360238991845653070
TCGA-06-0192.10	126	1_KEGG_FOCAL_ADHESION	195	15	0.0000715176169854189454442
TCGA-06-0133.6	57	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0000720885550506303269874
TCGA-26-5133.10	75	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000722468245534739738614
TCGA-27-1833.7	17	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0000722799935177201915417
TCGA-06-0648.6	17	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0000722799935177201915417
TCGA-06-5411.4	23	1_KEGG_BLADDER_CANCER	42	5	0.0000727770424549086593661
TCGA-06-6390.9	82	2_EXTRACELLULAR_MATRIX	85	9	0.0000727882920852944632125
TCGA-06-6391.6	30	1_KEGG_DNA_REPLICATION	32	5	0.0000729056774724421395584
TCGA-14-4157.7	101	2_CELL_CYCLE_PHASE	146	12	0.0000730006239677824574161
TCGA-06-0876.9	106	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000734492791289091624457
TCGA-32-4719.15	123	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000739699165120897823931
TCGA-06-0877.7	4	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0000739743565080539064623
TCGA-08-0348.3	4	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0000739743565080539064623
TCGA-08-0356.2	23	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	7	0.0000740002361282178727862
TCGA-26-5135.9	71	0_HALLMARK_E2F_TARGETS	169	11	0.0000740601720752905457856
TCGA-12-0618.5	41	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000743045194797219734880
TCGA-06-2565.10	38	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0000743840926535172349736
TCGA-06-5415.7	7	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000746022171870706028978
TCGA-06-2564.7	92	1_KEGG_FOCAL_ADHESION	195	13	0.0000747660839072024298226
TCGA-06-2565.3	60	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000751422807554619898293
TCGA-19-2624.29	130	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000755422964014754828388
TCGA-02-0026.1	61	1_KEGG_DNA_REPLICATION	32	6	0.0000756957043535024431870
TCGA-02-0114.20	132	1_KEGG_MELANOMA	71	10	0.0000761816261978862498214
TCGA-28-2513.12	134	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0000764926906038933929850
TCGA-28-5204.5	5	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0000765863038705428519947
TCGA-02-0014.12	5	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0000765863038705428519947
TCGA-27-2523.12	112	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0000766700998310768864737
TCGA-32-1980.1	24	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0000767270658872099123099
TCGA-08-0245.4	85	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000768094117324901593099
TCGA-27-1831.9	85	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000768094117324901593099
TCGA-06-0195.8	56	2_DNA_METABOLIC_PROCESS	218	11	0.0000775762749304553046780
TCGA-02-0099.11	141	2_EXTRACELLULAR_MATRIX	85	11	0.0000776149999439466339131
TCGA-06-0148.6	69	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000780754499805859825297
TCGA-28-1753.13	174	2_CELL_CYCLE_PROCESS	163	16	0.0000784293776164293000635
TCGA-06-0145.19	81	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000785920213284398101522
TCGA-06-0141.1	45	2_EXTRACELLULAR_REGION	346	12	0.0000786239496837178378219
TCGA-06-0644.16	142	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000787176509095925680537
TCGA-28-1753.13	174	1_KEGG_ASTHMA	30	8	0.0000788779747119831202515
TCGA-08-0352.2	59	2_EXTRACELLULAR_MATRIX	85	8	0.0000792532710163570426999
TCGA-06-5412.7	153	2_MEMBRANE	1443	50	0.0000793669556247340472538
TCGA-06-0129.11	110	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	5	0.0000793912081054874317274
TCGA-02-0058.1	110	2_AXON	10	5	0.0000793912081054874317274
TCGA-06-0190.8	143	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000796008309122063327382
TCGA-06-0211.7	10	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0000805968417693215903857
TCGA-32-2632.16	229	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000807394738334605736397
TCGA-32-2494.10	173	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0000809611951099929673305
TCGA-32-2494.10	173	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0000809611951099929673305
TCGA-27-2528.10	99	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000810594630207564856164
TCGA-26-1439.10	84	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000811551715818010723945
TCGA-19-5960.9	134	2_MITOTIC_CELL_CYCLE	134	13	0.0000812114225738025613619
TCGA-06-0939.7	58	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0000812203890847975549768
TCGA-06-0189.3	118	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0000813907183538091407587
TCGA-06-0137.9	53	2_CELL_CELL_SIGNALING	353	13	0.0000814355571781840114872
TCGA-76-4929.8	91	2_TRANSMISSION_OF_NERVE_IMPULSE	164	12	0.0000814531691466079691083
TCGA-15-0742.13	74	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0000818748130537060085600
TCGA-06-0192.10	126	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	14	0.0000820312237087770493218
TCGA-32-4213.15	198	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000822870971080854414405
TCGA-06-5411.3	19	0_HALLMARK_ALLOGRAFT_REJECTION	190	7	0.0000826911726054323459279
TCGA-27-2526.7	71	1_KEGG_MELANOMA	71	8	0.0000837337811571148700170
TCGA-02-0038.3	199	0_HALLMARK_DNA_REPAIR	125	15	0.0000841725409753911040520
TCGA-02-0003.9	227	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	16	0.0000842181222429849393220
TCGA-06-0213.9	74	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0000846736308391375809817
TCGA-02-0033.1	4	2_COLLAGEN	23	3	0.0000850637445751083377419
TCGA-12-0688.10	93	1_KEGG_FOCAL_ADHESION	195	13	0.0000853592916901684862791
TCGA-02-0099.11	141	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000858262669305613417562
TCGA-14-1825.8	80	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000858489059335427507919
TCGA-06-0877.8	61	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000858736509899881350280
TCGA-14-0790.9	104	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000862343321018926319390
TCGA-08-0347.4	16	2_MITOTIC_CELL_CYCLE	134	6	0.0000876337797135359573971
TCGA-12-1597.6	51	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000876898272882109519871
TCGA-19-2619.14	100	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000877499840261000815713
TCGA-76-6192.6	43	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	17	0.0000877887421722213783393
TCGA-06-2557.11	177	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	11	0.0000877922758403458606278
TCGA-06-0176.8	95	2_CELL_CYCLE_GO_0007049	265	15	0.0000881099431343416403814
TCGA-32-1980.1	24	2_EXTRACELLULAR_MATRIX	85	6	0.0000886131617947083819690
TCGA-41-3915.10	109	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	10	0.0000886417602945935659015
TCGA-06-0747.12	80	2_SYNAPTIC_TRANSMISSION	152	11	0.0000887421319704125152392
TCGA-06-0143.6	63	1_KEGG_FOCAL_ADHESION	195	11	0.0000890905664349825391875
TCGA-12-1597.6	51	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000899806493462107287104
TCGA-27-1837.5	85	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000901156115073881429801
TCGA-02-0083.21	135	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000903427759712926298219
TCGA-02-0083.21	135	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000903427759712926298219
TCGA-32-4719.15	123	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000903866565672918929409
TCGA-02-0021.4	170	2_CELL_CYCLE_GO_0007049	265	20	0.0000904165586358932912110
TCGA-32-1977.11	107	2_EXTRACELLULAR_REGION	346	18	0.0000904881831404230114633
TCGA-06-2565.3	60	2_EXTRACELLULAR_MATRIX	85	8	0.0000907830386136313638576
TCGA-06-0881.7	203	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	10	0.0000912081685574321295897
TCGA-06-0644.16	142	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000912644921512131059591
TCGA-08-0352.2	59	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0000915245906466558115403
TCGA-06-0143.6	63	0_HALLMARK_ANGIOGENESIS	32	6	0.0000921898704962878263059
TCGA-02-0038.3	199	2_INTERPHASE	62	11	0.0000922875475777916551724
TCGA-06-5415.7	7	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000923432016349153141988
TCGA-12-3650.17	101	2_MITOSIS	71	9	0.0000924223339681393477301
TCGA-06-0877.7	4	2_CELL_CYCLE_PHASE	146	4	0.0000925171804447448347872
TCGA-08-0348.3	4	2_CELL_CYCLE_PHASE	146	4	0.0000925171804447448347872
TCGA-76-4935.7	15	2_CELL_CYCLE_PHASE	146	6	0.0000926636917950863212880
TCGA-19-2624.29	130	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000929225707116601161613
TCGA-19-2624.29	130	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	5	0.0000930405037300324348802
TCGA-06-0686.6	3	1_KEGG_ALLOGRAFT_REJECTION	37	3	0.0000934495539148811319883
TCGA-19-5958.2	3	1_KEGG_ALLOGRAFT_REJECTION	37	3	0.0000934495539148811319883
TCGA-06-0145.19	81	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000936640124313405060064
TCGA-06-0881.7	203	2_DEFENSE_RESPONSE	222	20	0.0000937076349395454013787
TCGA-41-3915.10	109	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000938065738065533004679
TCGA-32-4210.14	109	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000938065738065533004679
TCGA-32-4213.15	198	2_EXTRACELLULAR_REGION	346	25	0.0000947653919670227276638
TCGA-19-5952.11	193	0_HALLMARK_E2F_TARGETS	169	17	0.0000948226980511822814708
TCGA-76-4928.15	78	1_KEGG_FOCAL_ADHESION	195	12	0.0000949705877632535887777
TCGA-19-2619.14	100	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0000958943844962549714079
TCGA-02-0009.6	188	1_KEGG_FOCAL_ADHESION	195	18	0.0000959089181242296146728
TCGA-26-1439.11	10	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0000959786041261883194741
TCGA-06-5413.11	142	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000964902476159285813753
TCGA-28-5215.7	192	0_HALLMARK_APOPTOSIS	150	16	0.0000966475753668715495230
TCGA-02-0007.17	217	2_CYTOSKELETON	293	24	0.0000967240017428987034799
TCGA-19-2624.29	130	2_M_PHASE	94	11	0.0000968231821826178053582
TCGA-06-6391.7	5	2_CYTOKINESIS	18	3	0.0000979064201585514587173
TCGA-06-5415.7	7	1_KEGG_GLIOMA	62	4	0.0000979894953653834646125
TCGA-06-5415.7	7	2_INTERPHASE	62	4	0.0000979894953653834646125
TCGA-12-0616.7	45	2_CELL_CELL_SIGNALING	353	12	0.0000980676177546857248766
TCGA-08-0355.1	45	2_CELL_CELL_SIGNALING	353	12	0.0000980676177546857248766
TCGA-02-0048.9	84	2_CELL_CYCLE_PHASE	146	11	0.0000982444258564001956851
TCGA-06-0875.7	78	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000987676969239956978634
TCGA-08-0347.4	16	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0000992022045737016777353
TCGA-28-5220.7	15	1_KEGG_MELANOMA	71	5	0.0000994560770351951084836
TCGA-02-0075.8	128	0_HALLMARK_E2F_TARGETS	169	14	0.0001003586272181376608768
TCGA-06-5414.13	102	1_KEGG_MELANOMA	71	9	0.0001007653685259813665506
TCGA-02-0075.8	128	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0001010916752379695677513
TCGA-32-2498.13	133	1_KEGG_CELL_CYCLE	114	12	0.0001011933403459824810586
TCGA-02-0027.3	81	2_SYNAPTIC_TRANSMISSION	152	11	0.0001012815869032297186108
TCGA-27-1833.7	17	2_INTERPHASE	62	5	0.0001016428608859326637335
TCGA-06-0648.6	17	2_INTERPHASE	62	5	0.0001016428608859326637335
TCGA-76-6191.6	96	2_REGULATION_OF_CELL_PROLIFERATION	265	15	0.0001018348002413287290866
TCGA-19-5947.4	267	0_HALLMARK_INFLAMMATORY_RESPONSE	170	20	0.0001024595607778329181721
TCGA-06-5859.9	125	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0001025627348173026120006
TCGA-06-0137.9	53	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001026823286498538222427
TCGA-06-2569.5	144	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0001030507990540228567197
TCGA-06-0877.8	61	2_EXTRACELLULAR_MATRIX	85	8	0.0001037285490723704767680
TCGA-19-1390.12	10	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	5	0.0001037617325452496640703
TCGA-02-0011.1	288	2_REGULATION_OF_APOPTOSIS	309	29	0.0001039862947180882893003
TCGA-02-0028.9	182	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0001043454795706315156589
TCGA-76-4927.8	93	2_TRANSMISSION_OF_NERVE_IMPULSE	164	12	0.0001043737366028669164876
TCGA-12-3650.17	101	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0001046988396247122921285
TCGA-41-3915.10	109	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0001053139480133158384497
TCGA-14-0817.9	85	2_DNA_METABOLIC_PROCESS	218	13	0.0001059405462216945760208
TCGA-14-0787.3	4	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	4	0.0001060032525913648382421
TCGA-06-0645.9	136	2_INFLAMMATORY_RESPONSE	112	12	0.0001063857335791892070242
TCGA-32-2634.10	118	2_INTERPHASE	62	9	0.0001070143998527989584717
TCGA-19-4068.7	14	2_CHROMOSOMAL_PART	78	5	0.0001075352990694099903322
TCGA-28-2514.9	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001076530734267602714945
TCGA-02-2486.9	141	2_IMMUNE_RESPONSE	206	16	0.0001077376946563530986682
TCGA-06-0650.2	82	2_EXTRACELLULAR_REGION_PART	269	14	0.0001078003510542830599124
TCGA-02-0102.8	82	2_EXTRACELLULAR_REGION_PART	269	14	0.0001078003510542830599124
TCGA-02-0099.11	141	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0001079433036893786098569
TCGA-02-0033.5	144	0_HALLMARK_P53_PATHWAY	151	14	0.0001081938023316033898723
TCGA-06-0126.7	5	2_EXTRACELLULAR_REGION	346	5	0.0001082482503095086729923
TCGA-02-0014.10	70	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0001086020160679652919256
TCGA-06-5417.5	79	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001092952609790031953327
TCGA-06-0879.9	84	2_CELL_CELL_SIGNALING	353	16	0.0001093328615961609428121
TCGA-08-0349.1	31	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0001094292998779374355900
TCGA-41-3393.5	88	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0001101013595769643088921
TCGA-02-2485.14	172	2_CELL_CYCLE_GO_0007049	265	20	0.0001101744770403781527963
TCGA-02-0046.8	148	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0001104536773093979333798
TCGA-08-0390.1	54	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001108592018406266948693
TCGA-76-4925.9	83	1_KEGG_BLADDER_CANCER	42	7	0.0001111115147929868986762
TCGA-06-0143.6	63	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0001113470980118594279729
TCGA-08-0389.4	56	2_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0001115689642456572916712
TCGA-08-0389.4	56	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0001115689642456572916712
TCGA-02-0011.1	288	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	29	0.0001116151412654954979461
TCGA-06-5418.4	24	2_SYNAPTIC_TRANSMISSION	152	7	0.0001129586498813683090141
TCGA-19-5955.9	110	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0001131440951131286221142
TCGA-28-5220.7	15	2_CELL_CYCLE_GO_0007049	265	7	0.0001132515113744702114776
TCGA-06-5859.9	125	2_CHROMOSOMAL_PART	78	10	0.0001137713555763358370303
TCGA-12-3652.19	88	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0001142553901528656722358
TCGA-15-0742.13	74	0_HALLMARK_E2F_TARGETS	169	11	0.0001154205536580054855533
TCGA-06-0876.9	106	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0001162844929985747301085
TCGA-15-0742.13	74	1_KEGG_MELANOMA	71	8	0.0001165171142859554510212
TCGA-06-0155.10	74	1_KEGG_MELANOMA	71	8	0.0001165171142859554510212
TCGA-32-1980.1	24	2_HEMOSTASIS	44	5	0.0001165855587009587569086
TCGA-19-1390.13	110	2_DNA_REPAIR	113	11	0.0001170655811042422720855
TCGA-06-0192.10	126	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0001183824820631934057269
TCGA-14-0813.10	53	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0001184934736261114530346
TCGA-06-0143.3	3	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0001188264598042314637051
TCGA-06-0213.9	74	2_CELL_CELL_SIGNALING	353	15	0.0001188458005420380193167
TCGA-06-0155.10	74	2_CELL_CELL_SIGNALING	353	15	0.0001188458005420380193167
TCGA-41-5651.5	112	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0001189269869855042366423
TCGA-14-0871.20	216	2_CHROMOSOME	102	14	0.0001189723422934332473441
TCGA-12-0616.4	7	2_CYTOSKELETAL_PART	194	5	0.0001190438780082450122028
TCGA-06-0187.10	55	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001195133810207321694739
TCGA-06-0745.4	55	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001195133810207321694739
TCGA-06-0145.4	7	2_KINESIN_COMPLEX	13	3	0.0001200080102540832476367
TCGA-06-5415.7	7	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0001200080102540832476367
TCGA-08-0355.2	7	2_KINESIN_COMPLEX	13	3	0.0001200080102540832476367
TCGA-06-0189.3	118	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0001201010776646347814412
TCGA-06-0169.5	42	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0001208181429137841132694
TCGA-06-2561.5	42	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0001208181429137841132694
TCGA-41-5651.5	112	1_KEGG_DNA_REPLICATION	32	7	0.0001213246147078230608015
TCGA-06-0138.2	30	2_CELL_CELL_SIGNALING	353	10	0.0001216040827744352382199
TCGA-02-0026.1	61	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0001217248619359907502472
TCGA-06-0881.7	203	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0001222156743424602435948
TCGA-76-4926.9	66	0_HALLMARK_ANGIOGENESIS	32	6	0.0001224060307783025750364
TCGA-06-0646.4	63	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001224291717671687558695
TCGA-02-0075.8	128	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0001234693616108818834017
TCGA-08-0360.3	144	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	11	0.0001234902767124435930043
TCGA-02-0047.8	185	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0001242174180749923298548
TCGA-76-6282.11	185	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0001242174180749923298548
TCGA-76-6285.5	106	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0001243421552597053164960
TCGA-08-0389.4	56	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0001244245466925788612487
TCGA-06-0195.8	56	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0001244245466925788612487
TCGA-32-2491.14	244	1_KEGG_DNA_REPLICATION	32	9	0.0001244700827891430600439
TCGA-06-0877.7	4	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0001248520416170792522552
TCGA-08-0348.3	4	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0001248520416170792522552
TCGA-02-0007.17	217	2_INTRACELLULAR_ORGANELLE_PART	912	47	0.0001248666769155603413141
TCGA-06-0171.7	57	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0001264181337718707184067
TCGA-02-0026.1	61	2_CELL_CYCLE_PROCESS	163	10	0.0001266655691963512471009
TCGA-12-3653.55	255	2_INTERPHASE	62	12	0.0001270464333654541344652
TCGA-76-6282.11	185	1_KEGG_ASTHMA	30	8	0.0001271121276324184130955
TCGA-06-0192.10	126	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0001273069750217896694156
TCGA-06-2565.10	38	2_M_PHASE	94	7	0.0001276912370925882729555
TCGA-06-0686.6	3	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	3	0.0001282074961045579343608
TCGA-19-5958.2	3	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	3	0.0001282074961045579343608
TCGA-06-0152.11	56	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001286629417773311784452
TCGA-02-0026.1	61	2_REPLICATION_FORK	18	5	0.0001288844993414404104751
TCGA-41-3393.4	12	2_SPINDLE	35	4	0.0001292659359758315516277
TCGA-76-4934.7	47	2_COLLAGEN	23	5	0.0001301919896787317760135
TCGA-76-6193.13	271	0_HALLMARK_HYPOXIA	154	19	0.0001301987003652388017686
TCGA-15-1444.3	107	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0001302547059656648906385
TCGA-02-0027.3	81	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0001302989533119800749303
TCGA-02-0028.9	182	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0001306183841883261061503
TCGA-28-2502.9	56	2_EXTRACELLULAR_REGION	346	13	0.0001306903370348518338313
TCGA-28-2513.12	134	2_EXTRACELLULAR_REGION	346	20	0.0001309321225762034184882
TCGA-06-0176.8	95	2_COLLAGEN	23	6	0.0001309730455263748193431
TCGA-02-0033.5	144	2_CELL_CELL_SIGNALING	353	21	0.0001311860824972632666701
TCGA-06-5411.4	23	2_CELL_CYCLE_PROCESS	163	7	0.0001313496809005255570261
TCGA-19-2631.1	6	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	5	0.0001313778107439524816830
TCGA-19-2620.8	6	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	5	0.0001313778107439524816830
TCGA-06-2558.6	74	2_MITOTIC_CELL_CYCLE	134	10	0.0001320270116380086464561
TCGA-28-5220.7	15	2_PHOSPHORYLATION	271	7	0.0001321014295083803333046
TCGA-41-2575.49	136	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0001322074288375246710250
TCGA-06-1804.7	47	2_EXTRACELLULAR_REGION	346	12	0.0001336984796107559966220
TCGA-27-1833.7	17	2_MITOTIC_CELL_CYCLE	134	6	0.0001338627491442765879166
TCGA-02-0086.2	17	2_MITOTIC_CELL_CYCLE	134	6	0.0001338627491442765879166
TCGA-06-0648.6	17	2_MITOTIC_CELL_CYCLE	134	6	0.0001338627491442765879166
TCGA-26-5139.10	163	2_TISSUE_DEVELOPMENT	115	13	0.0001338750865837774620473
TCGA-06-0143.6	63	2_EXTRACELLULAR_MATRIX	85	8	0.0001344476981841807665917
TCGA-27-2523.12	112	2_CELL_CYCLE_GO_0007049	265	16	0.0001344684023695876548630
TCGA-28-5208.28	220	2_SYNAPTIC_TRANSMISSION	152	17	0.0001347071465617143669075
TCGA-19-5947.4	267	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0001347428294988483037532
TCGA-32-2634.10	118	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0001349123649097059120597
TCGA-06-6389.1	18	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0001349364060043436129837
TCGA-15-1444.3	107	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0001349691069158948943628
TCGA-41-3393.5	88	2_EXTRACELLULAR_MATRIX	85	9	0.0001358441663708604568456
TCGA-02-0107.3	71	2_EXTRACELLULAR_REGION_PART	269	13	0.0001358762700506160089452
TCGA-32-2498.13	133	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0001363828925842885952946
TCGA-06-6391.7	5	2_CELL_DIVISION	20	3	0.0001367375361253355347223
TCGA-02-0046.8	148	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0001373959098740100198341
TCGA-06-0686.6	3	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	3	0.0001380696111895146844031
TCGA-19-5958.2	3	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	3	0.0001380696111895146844031
TCGA-06-0133.6	57	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001383262848823495932190
TCGA-06-0171.7	57	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001383262848823495932190
TCGA-12-0692.7	23	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	8	0.0001385231651930798251002
TCGA-76-6285.5	106	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0001387766109552435774954
TCGA-19-2624.29	130	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0001393618041000123332004
TCGA-76-6191.6	96	2_COLLAGEN	23	6	0.0001394878286703471730740
TCGA-32-2638.17	159	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0001395561408635526102432
TCGA-02-0086.2	17	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0001397804655694664087168
TCGA-06-0648.6	17	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0001397804655694664087168
TCGA-02-0011.1	288	2_APOPTOSIS_GO	389	33	0.0001401724359429399626147
TCGA-02-2485.14	172	0_HALLMARK_APOPTOSIS	150	15	0.0001409904298755146508093
TCGA-06-0173.35	120	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0001410276158533678176471
TCGA-06-0645.9	136	0_HALLMARK_ALLOGRAFT_REJECTION	190	15	0.0001422065733656977209835
TCGA-76-4926.9	66	2_SYNAPTIC_TRANSMISSION	152	10	0.0001422878616573112586612
TCGA-02-0007.17	217	2_ORGANELLE_PART	916	47	0.0001426845407474733198969
TCGA-14-0817.9	85	2_CELL_CYCLE_GO_0007049	265	14	0.0001432288953443474005880
TCGA-32-4719.15	123	1_KEGG_ASTHMA	30	7	0.0001432785024531521567148
TCGA-02-0003.9	227	0_HALLMARK_KRAS_SIGNALING_UP	148	17	0.0001433305010866888233503
TCGA-06-0125.9	75	2_CELL_CELL_SIGNALING	353	15	0.0001435829046923306072554
TCGA-19-5952.11	193	1_KEGG_FOCAL_ADHESION	195	18	0.0001437375433159364401543
TCGA-28-5207.12	188	1_KEGG_ASTHMA	30	8	0.0001440186841062905665194
TCGA-06-0877.7	4	2_CELL_CYCLE_PROCESS	163	4	0.0001443615308488250170618
TCGA-08-0348.3	4	2_CELL_CYCLE_PROCESS	163	4	0.0001443615308488250170618
TCGA-28-2513.12	134	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0001445883328374595168473
TCGA-81-5910.12	128	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0001449212949266675100682
TCGA-02-2485.14	172	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0001450742658334511453293
TCGA-08-0357.4	36	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0001453254438753693710690
TCGA-06-0744.10	36	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0001453254438753693710690
TCGA-02-0003.9	227	1_KEGG_LEISHMANIA_INFECTION	70	12	0.0001454551385724825993996
TCGA-12-0688.10	93	0_HALLMARK_E2F_TARGETS	169	12	0.0001455891975148371729476
TCGA-06-0184.11	108	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0001463797965296478788971
TCGA-08-0347.4	16	2_CELL_CYCLE_PHASE	146	6	0.0001463806519212457917575
TCGA-02-0027.3	81	1_KEGG_FOCAL_ADHESION	195	12	0.0001465059231391486267888
TCGA-32-1980.1	24	2_WOUND_HEALING	46	5	0.0001466598402374378880102
TCGA-06-0650.2	82	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0001467951230531938753166
TCGA-06-6390.9	82	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0001467951230531938753166
TCGA-76-4926.9	66	1_KEGG_FOCAL_ADHESION	195	11	0.0001472275573486772658801
TCGA-28-5218.5	208	2_CORNIFIED_ENVELOPE	12	6	0.0001481833769429472609687
TCGA-06-0939.7	58	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001485221357135819725964
TCGA-02-0011.1	288	2_PROGRAMMED_CELL_DEATH	390	33	0.0001490013378191833582753
TCGA-32-1977.11	107	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0001493810517794451776102
TCGA-28-5216.8	162	2_REGULATION_OF_CELL_CYCLE	160	15	0.0001503525463539325001706
TCGA-06-0145.17	11	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0001503636853511089368097
TCGA-32-4211.14	71	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0001505417534171421989776
TCGA-06-0189.3	118	2_EXTRACELLULAR_MATRIX	85	10	0.0001513096809828805972258
TCGA-28-5218.5	208	0_HALLMARK_COAGULATION	125	15	0.0001514822995166956089846
TCGA-14-0871.20	216	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0001527518980129223666233
TCGA-41-2575.49	136	2_M_PHASE	94	11	0.0001544912268392120008320
TCGA-28-5209.15	194	1_KEGG_FOCAL_ADHESION	195	18	0.0001556004876146123037592
TCGA-06-0168.4	22	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0001556731344736114438024
TCGA-12-3653.55	255	2_DNA_METABOLIC_PROCESS	218	22	0.0001557877333892681832959
TCGA-26-1439.11	10	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0001560776360463167337141
TCGA-32-1977.3	8	0_HALLMARK_E2F_TARGETS	169	5	0.0001564413977421306013813
TCGA-02-0007.17	217	2_CYTOSKELETAL_PART	194	19	0.0001566273186501890291034
TCGA-76-4929.8	91	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0001570191518026568659218
TCGA-06-0122.8	90	0_HALLMARK_COMPLEMENT	176	12	0.0001571398055049112675498
TCGA-08-0375.6	65	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001572811292034301548694
TCGA-06-0158.4	65	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001572811292034301548694
TCGA-02-0011.1	288	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	33	0.0001583486480318499109964
TCGA-41-3915.10	109	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0001586228556345858073991
TCGA-41-3915.10	109	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0001586228556345858073991
TCGA-19-1390.13	110	2_BIOPOLYMER_METABOLIC_PROCESS	1367	38	0.0001591357707748435545113
TCGA-14-2554.5	59	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001592695436762300083711
TCGA-32-2494.10	173	2_REGULATION_OF_PHOSPHORYLATION	45	9	0.0001597382530492459532055
TCGA-28-5215.7	192	0_HALLMARK_COMPLEMENT	176	17	0.0001599667272615997847679
TCGA-28-5220.7	15	2_REGULATION_OF_CELL_CYCLE	160	6	0.0001601355928977711865976
TCGA-32-2632.16	229	1_KEGG_LEISHMANIA_INFECTION	70	12	0.0001601687988085591233308
TCGA-32-2632.16	229	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0001601687988085591233308
TCGA-06-1804.6	30	0_HALLMARK_DNA_REPAIR	125	7	0.0001601690088008339129394
TCGA-06-0130.3	155	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0001604036462583494223547
TCGA-06-0184.11	108	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0001606755702612180371994
TCGA-06-5415.7	7	1_KEGG_PANCREATIC_CANCER	70	4	0.0001607305003550419189324
TCGA-06-5415.7	7	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0001607305003550419189324
TCGA-76-6282.11	185	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0001613446721013780298451
TCGA-02-0071.12	116	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0001614367482631001260267
TCGA-06-0645.9	136	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0001622819504470324788580
TCGA-19-5959.13	92	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0001627295473131049594918
TCGA-32-2632.16	229	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0001635239607998589166180
TCGA-06-5856.13	152	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0001639775644094401295045
TCGA-06-5858.19	205	2_CELL_CYCLE_PHASE	146	16	0.0001648474872696266684425
TCGA-19-2624.29	130	2_CHROMOSOMAL_PART	78	10	0.0001653340083120949084803
TCGA-06-0219.6	6	2_CELL_CYCLE_GO_0007049	265	5	0.0001657542880369776774896
TCGA-08-0244.4	6	2_CELL_CYCLE_GO_0007049	265	5	0.0001657542880369776774896
TCGA-12-5299.5	6	2_CELL_CYCLE_GO_0007049	265	5	0.0001657542880369776774896
TCGA-14-1823.12	6	2_REGULATION_OF_CELL_PROLIFERATION	265	5	0.0001657542880369776774896
TCGA-14-1829.11	6	2_CELL_CYCLE_GO_0007049	265	5	0.0001657542880369776774896
TCGA-14-2554.9	6	2_CELL_CYCLE_GO_0007049	265	5	0.0001657542880369776774896
TCGA-06-0125.6	8	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	5	0.0001659478049853058460004
TCGA-02-0068.1	72	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0001660727455681342674097
TCGA-32-2498.13	133	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0001664938961884410639162
TCGA-06-0649.13	88	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0001666856377948005012331
TCGA-19-5954.17	208	2_CELL_CYCLE_PROCESS	163	17	0.0001667297893881537025271
TCGA-27-1836.8	49	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0001675450438196108182871
TCGA-27-2528.10	99	2_COLLAGEN	23	6	0.0001678162073185403670508
TCGA-28-5204.5	5	1_KEGG_CELL_CYCLE	114	4	0.0001683571388454677304758
TCGA-06-0881.7	203	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0001684536741216904301606
TCGA-19-5954.17	208	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0001686502767532419119929
TCGA-06-0192.10	126	1_KEGG_ASTHMA	30	7	0.0001692266676668777538629
TCGA-06-5415.7	7	1_KEGG_MELANOMA	71	4	0.0001702828433269841805400
TCGA-06-2567.9	156	2_CHROMOSOME	102	12	0.0001705495511315090651112
TCGA-06-2565.3	60	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001705878816249717692347
TCGA-06-0143.3	3	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0001706626988483258612096
TCGA-06-0130.3	155	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0001712178230146338311479
TCGA-06-5418.4	24	2_CELL_CELL_SIGNALING	353	9	0.0001723399024326596642824
TCGA-06-0145.17	11	1_KEGG_CELL_CYCLE	114	5	0.0001725962475219382067943
TCGA-06-6390.6	11	1_KEGG_CELL_CYCLE	114	5	0.0001725962475219382067943
TCGA-32-4210.14	109	2_CELL_CYCLE_PHASE	146	12	0.0001726564292175207190362
TCGA-41-3915.10	109	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0001726972749902726624906
TCGA-41-3915.10	109	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0001726972749902726624906
TCGA-28-5207.12	188	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0001727062069482532486245
TCGA-19-2629.15	146	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0001730913868802252031289
TCGA-06-2567.9	156	2_DNA_METABOLIC_PROCESS	218	17	0.0001731338705733151081025
TCGA-14-0787.6	40	2_CELL_CYCLE_GO_0007049	265	10	0.0001734421385505525113873
TCGA-02-0001.5	117	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0001739354427558654255914
TCGA-06-5412.7	153	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0001741213176008080479058
TCGA-06-0174.37	141	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0001751405358012798972166
TCGA-28-5204.3	4	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	4	0.0001751636632978574115247
TCGA-08-0389.4	56	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0001753712355880748580052
TCGA-06-2558.6	74	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0001758591090733464628020
TCGA-06-2558.6	74	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0001758591090733464628020
TCGA-32-2615.7	77	0_HALLMARK_E2F_TARGETS	169	11	0.0001761516336511815888563
TCGA-28-2513.12	134	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0001764942620660634245433
TCGA-19-5960.9	134	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0001764942620660634245433
TCGA-06-5859.9	125	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	9	0.0001766057284096354590332
TCGA-06-5859.9	125	2_INTERPHASE	62	9	0.0001766057284096354590332
TCGA-27-1833.7	17	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0001768887721086989889361
TCGA-06-0648.6	17	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0001768887721086989889361
TCGA-76-4926.9	66	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001776941793808655995369
TCGA-02-0048.9	84	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001776941793808655995369
TCGA-12-3653.55	255	2_MITOTIC_CELL_CYCLE	134	17	0.0001780345781310479276894
TCGA-19-2619.14	100	2_COLLAGEN	23	6	0.0001782508263243233340503
TCGA-26-5132.7	100	2_CELL_CYCLE_GO_0007049	265	15	0.0001783538996126849828124
TCGA-76-4935.7	15	2_CELL_CYCLE_PROCESS	163	6	0.0001788887105573047121843
TCGA-12-0688.10	93	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0001788914941649814285482
TCGA-02-0011.1	288	0_HALLMARK_KRAS_SIGNALING_UP	148	19	0.0001792298809719273676357
TCGA-02-0113.3	46	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0001795212275341136253046
TCGA-02-0060.19	281	0_HALLMARK_UV_RESPONSE_DN	122	17	0.0001795459050760582107257
TCGA-02-2483.10	100	2_CHROMOSOME	102	10	0.0001798086644299665549755
TCGA-06-5415.7	7	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	4	0.0001802534222691193127250
TCGA-06-2564.7	92	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0001808135319063446718336
TCGA-19-5959.13	92	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0001808135319063446718336
TCGA-32-1977.3	8	0_HALLMARK_G2M_CHECKPOINT	174	5	0.0001810643781262149772712
TCGA-06-5859.9	125	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0001811934754248395093839
TCGA-02-0011.1	288	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	22	0.0001830559500863525020185
TCGA-06-0645.9	136	2_DEFENSE_RESPONSE	222	16	0.0001831643450923479911254
TCGA-76-6193.13	271	2_INFLAMMATORY_RESPONSE	112	16	0.0001833377105666913662284
TCGA-19-2624.29	130	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	5	0.0001840302128549712364775
TCGA-32-1982.9	89	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0001840568611408042413047
TCGA-06-5418.5	13	1_KEGG_FOCAL_ADHESION	195	6	0.0001840634548371187226897
TCGA-06-5414.13	102	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0001852701314094224805187
TCGA-27-2521.10	94	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0001856086942564629492514
TCGA-06-0142.3	8	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	5	0.0001863397519882088368935
TCGA-02-0074.5	118	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0001872695185247289309267
TCGA-06-0645.9	136	2_IMMUNE_SYSTEM_PROCESS	283	18	0.0001876923643115396671006
TCGA-02-0114.20	132	2_CELL_CYCLE_PHASE	146	13	0.0001886956231287300472799
TCGA-06-5412.7	153	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0001887818057292483023800
TCGA-41-2571.7	72	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0001890619180239389018894
TCGA-15-1444.3	107	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0001892048695116746025602
TCGA-02-0060.19	281	1_KEGG_VIRAL_MYOCARDITIS	70	13	0.0001898791770362411924535
TCGA-06-5418.4	24	2_TRANSMISSION_OF_NERVE_IMPULSE	164	7	0.0001906044776713583391650
TCGA-02-0107.3	71	0_HALLMARK_ANGIOGENESIS	32	6	0.0001906741201272002853538
TCGA-06-0214.9	62	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0001937106576597224843941
TCGA-41-3393.4	12	1_KEGG_OOCYTE_MEIOSIS	105	5	0.0001938294366745466372134
TCGA-06-0747.12	80	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0001940351378608814916348
TCGA-06-0139.1	179	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	16	0.0001942152822442439234155
TCGA-06-0130.3	155	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0001947471401381560681884
TCGA-06-0129.11	110	2_MITOSIS	71	9	0.0001947874978762620856634
TCGA-28-2509.5	4	1_KEGG_ASTHMA	30	3	0.0001948992264520510995281
TCGA-06-0126.3	4	1_KEGG_ASTHMA	30	3	0.0001948992264520510995281
TCGA-08-0246.6	62	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001950164526820988145691
TCGA-32-2634.10	118	2_NUCLEUS	1110	35	0.0001950550928128758965997
TCGA-08-0245.4	85	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001950827048844313823042
TCGA-14-0817.9	85	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001950827048844313823042
TCGA-06-0189.3	118	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0001959804372368834763339
TCGA-06-0129.11	110	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0001964048630961299243911
TCGA-27-2521.10	94	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0001964346886468276286598
TCGA-06-0241.8	53	1_KEGG_MELANOMA	71	7	0.0001980611041728537469186
TCGA-28-2501.3	51	2_COLLAGEN	23	5	0.0001981085529833945702450
TCGA-06-0141.1	45	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0001989090549965582947235
TCGA-02-0048.9	84	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0001989090549965582947235
TCGA-08-0355.1	45	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0001989090549965582947235
TCGA-32-4719.15	123	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0002003557070029904558280
TCGA-06-0645.9	136	1_KEGG_FOCAL_ADHESION	195	15	0.0002005091343065173244316
TCGA-41-2575.49	136	1_KEGG_FOCAL_ADHESION	195	15	0.0002005091343065173244316
TCGA-19-5959.13	92	2_EXTRACELLULAR_MATRIX	85	9	0.0002006239294040812904535
TCGA-12-0688.10	93	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0002008079371763274857503
TCGA-08-0360.3	144	2_INFLAMMATORY_RESPONSE	112	12	0.0002008430374803186276196
TCGA-02-0075.8	128	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0002022668044680900887363
TCGA-28-2501.3	51	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	10	0.0002023886021525426591895
TCGA-06-5418.4	24	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	8	0.0002030062468982163500445
TCGA-06-0878.10	115	1_KEGG_CELL_CYCLE	114	11	0.0002036284679865120060462
TCGA-06-0129.11	110	2_M_PHASE	94	10	0.0002043743156004110175360
TCGA-19-1390.13	110	2_M_PHASE	94	10	0.0002043743156004110175360
TCGA-12-1597.6	51	2_CELL_CYCLE_GO_0007049	265	11	0.0002044794188579715597115
TCGA-12-5299.6	38	2_SYNAPTIC_TRANSMISSION	152	8	0.0002048953608638637974553
TCGA-06-0130.3	155	2_EXTRACELLULAR_MATRIX	85	11	0.0002061253972163874228704
TCGA-76-6193.13	271	2_CELLULAR_DEFENSE_RESPONSE	50	11	0.0002064850181748913735078
TCGA-02-0026.1	61	2_INTERPHASE	62	7	0.0002068040115138066663107
TCGA-06-0686.6	3	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	3	0.0002080184664749895216349
TCGA-19-5958.2	3	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	3	0.0002080184664749895216349
TCGA-06-0646.4	63	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002081670435519371363618
TCGA-06-0743.14	63	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002081670435519371363618
TCGA-76-6193.13	271	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	99	15	0.0002085588085682332738433
TCGA-02-0064.3	26	2_SYNAPTIC_TRANSMISSION	152	7	0.0002089686890271401354096
TCGA-28-2514.9	62	0_HALLMARK_E2F_TARGETS	169	10	0.0002093326638367415252259
TCGA-06-0211.8	62	0_HALLMARK_E2F_TARGETS	169	10	0.0002093326638367415252259
TCGA-08-0357.4	36	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0002093456271257260463848
TCGA-06-0744.10	36	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0002093456271257260463848
TCGA-06-0881.7	203	0_HALLMARK_APOPTOSIS	150	16	0.0002103739670849067301250
TCGA-02-0089.5	91	1_KEGG_BLADDER_CANCER	42	7	0.0002110316344623626178684
TCGA-08-0360.3	144	2_EXTRACELLULAR_REGION_PART	269	18	0.0002114955953289261237401
TCGA-19-2624.19	5	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	3	0.0002123216354215716581040
TCGA-12-3650.17	101	2_CHROMOSOMAL_PART	78	9	0.0002127770332133370142537
TCGA-76-4934.4	20	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0002129619242056561339779
TCGA-06-0145.19	81	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0002130965016529693214272
TCGA-06-0174.37	141	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0002132853485689930207042
TCGA-06-0174.37	141	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0002132853485689930207042
TCGA-06-0184.11	108	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0002141519527928169915488
TCGA-28-2513.12	134	2_AXON	10	5	0.0002142606997407539722554
TCGA-32-2634.10	118	1_KEGG_FOCAL_ADHESION	195	14	0.0002143676498539738312782
TCGA-02-0038.3	199	2_MITOTIC_CELL_CYCLE	134	15	0.0002149420907712107006986
TCGA-06-0176.8	95	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0002154581127887233982492
TCGA-32-4213.15	198	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0002155230574503542778295
TCGA-27-1837.5	85	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0002159943356688088622174
TCGA-27-2519.7	113	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0002169789112046757273249
TCGA-87-5896.6	131	2_NON_MEMBRANE_BOUND_ORGANELLE	476	23	0.0002178724240554491520770
TCGA-87-5896.6	131	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	23	0.0002178724240554491520770
TCGA-06-0216.6	67	2_CELL_CELL_SIGNALING	353	14	0.0002185529758891702591453
TCGA-76-6285.5	106	2_DNA_METABOLIC_PROCESS	218	14	0.0002188037416374619180490
TCGA-06-0750.12	52	2_COLLAGEN	23	5	0.0002188350437254720697120
TCGA-08-0389.4	56	2_CHROMOSOME	102	8	0.0002188738748723423398028
TCGA-06-0195.8	56	2_CHROMOSOME	102	8	0.0002188738748723423398028
TCGA-08-0359.5	37	0_HALLMARK_ANGIOGENESIS	32	5	0.0002193084626669682222089
TCGA-06-0129.11	110	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0002204714593694399448354
TCGA-12-0688.10	93	2_EXTRACELLULAR_MATRIX	85	9	0.0002205073267989434511373
TCGA-27-2524.5	75	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0002210309337326538754644
TCGA-02-0027.3	81	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0002211933783360149499784
TCGA-02-2483.10	100	2_CELL_CYCLE_PROCESS	163	12	0.0002215606629714709206475
TCGA-26-1439.10	84	1_KEGG_FOCAL_ADHESION	195	12	0.0002217361789717220378268
TCGA-02-0038.3	199	2_NUCLEAR_PART	466	29	0.0002227626807729372556723
TCGA-02-0086.2	17	2_CELL_CYCLE_PHASE	146	6	0.0002233546658764804903729
TCGA-06-0648.6	17	2_CELL_CYCLE_PHASE	146	6	0.0002233546658764804903729
TCGA-32-1979.4	12	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0002248579053701090348441
TCGA-02-0003.9	227	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0002263265109282665201330
TCGA-06-5413.11	142	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0002269957108374782257191
TCGA-06-0122.8	90	2_EXTRACELLULAR_REGION	346	16	0.0002275820518143942098894
TCGA-28-1753.13	174	0_HALLMARK_COMPLEMENT	176	16	0.0002304783966759529336907
TCGA-02-0048.9	84	2_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0002315119854663925979318
TCGA-02-0048.9	84	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0002315119854663925979318
TCGA-02-0043.10	184	2_SYSTEM_DEVELOPMENT	694	35	0.0002329631208066671723897
TCGA-14-3476.17	53	2_SYNAPTIC_TRANSMISSION	152	9	0.0002332053319723867825051
TCGA-32-1986.8	87	2_EXTRACELLULAR_REGION_PART	269	14	0.0002334472755212119003416
TCGA-02-0014.10	70	2_DNA_REPLICATION	82	8	0.0002347535339969909740608
TCGA-06-0197.1	57	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	16	0.0002354090308231112705674
TCGA-76-6191.6	96	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0002360664657521178619835
TCGA-76-6191.6	96	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0002360664657521178619835
TCGA-32-2638.17	159	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0002362628664290842086821
TCGA-08-0375.6	65	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002364441398093618837244
TCGA-06-0158.4	65	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002364441398093618837244
TCGA-28-5204.3	4	2_CALCIUM_CHANNEL_ACTIVITY	32	3	0.0002380655930138500259857
TCGA-06-0686.1	7	2_RECEPTOR_ACTIVITY	499	6	0.0002383692346187669269548
TCGA-02-0043.10	184	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0002387918761678675314258
TCGA-06-5411.4	23	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	5	0.0002412457272816744306091
TCGA-06-0137.9	53	2_COLLAGEN	23	5	0.0002412457272816744306091
TCGA-14-0789.10	106	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0002417727616277015958730
TCGA-76-6285.5	106	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0002417727616277015958730
TCGA-41-5651.5	112	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0002420664586492267075259
TCGA-41-5651.5	112	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0002420664586492267075259
TCGA-02-0034.4	88	2_SYNAPTIC_TRANSMISSION	152	11	0.0002427774337826904148176
TCGA-06-0646.4	63	0_HALLMARK_E2F_TARGETS	169	10	0.0002450267291503145303255
TCGA-28-5214.11	124	1_KEGG_DNA_REPLICATION	32	7	0.0002451279961424922639902
TCGA-19-1790.18	201	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0002451628714736949063088
TCGA-06-2558.6	74	2_CHROMOSOMAL_PART	78	8	0.0002458100660136370001901
TCGA-02-0083.21	135	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0002458432120046962800208
TCGA-19-2624.29	130	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0002458560163096333030762
TCGA-06-0750.13	8	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	7	0.0002459428602136226886705
TCGA-14-0789.10	106	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0002460035564240914906196
TCGA-76-6193.13	271	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	12	0.0002473457436517473295723
TCGA-02-0026.1	61	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0002476424692227652008675
TCGA-14-4157.7	101	2_CELL_CYCLE_PROCESS	163	12	0.0002477199729697173585796
TCGA-06-0195.8	56	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0002477531412726847646032
TCGA-02-2483.10	100	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0002485520832281277060077
TCGA-02-0009.6	188	0_HALLMARK_ANGIOGENESIS	32	8	0.0002501419308105630153263
TCGA-06-0686.6	3	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	3	0.0002504616422491228074076
TCGA-19-5958.2	3	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	3	0.0002504616422491228074076
TCGA-76-4926.9	66	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002516129280860250941841
TCGA-12-5295.8	66	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002516129280860250941841
TCGA-06-0127.3	5	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	4	0.0002522718229588345804741
TCGA-08-0347.4	16	2_REGULATION_OF_CELL_CYCLE	160	6	0.0002526416717586655756242
TCGA-76-6285.5	106	2_COLLAGEN	23	6	0.0002527220663351096435756
TCGA-02-0011.1	288	1_KEGG_LEISHMANIA_INFECTION	70	13	0.0002529304055407907334506
TCGA-08-0360.3	144	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0002529998898647401709035
TCGA-41-2573.4	31	1_KEGG_FOCAL_ADHESION	195	8	0.0002531485611764437704263
TCGA-06-0148.6	69	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0002531715438125145024861
TCGA-06-0141.1	45	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0002539041501188215080830
TCGA-41-4097.6	48	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0002540813218984048723649
TCGA-27-1834.10	39	2_SYNAPTIC_TRANSMISSION	152	8	0.0002542851091548813504198
TCGA-76-6282.11	185	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0002554588483147694701232
TCGA-19-5947.4	267	2_RESPONSE_TO_WOUNDING	163	19	0.0002570912926831382867322
TCGA-02-0024.6	206	0_HALLMARK_APOPTOSIS	150	16	0.0002577395768482540526836
TCGA-32-1977.11	107	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0002579741105485037892288
TCGA-15-1444.3	107	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0002579741105485037892288
TCGA-16-1048.13	97	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0002583704122636359436227
TCGA-06-0174.37	141	2_MICROTUBULE_CYTOSKELETON	117	12	0.0002589694097363045709355
TCGA-28-5216.8	162	2_ECTODERM_DEVELOPMENT	66	10	0.0002597148594214211008747
TCGA-32-1986.8	87	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0002600355337223106909871
TCGA-27-2521.10	94	2_INTERPHASE	62	8	0.0002611872604992544560053
TCGA-32-4213.15	198	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0002620740720586012717681
TCGA-32-4213.15	198	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0002620740720586012717681
TCGA-06-0174.37	141	1_KEGG_BLADDER_CANCER	42	8	0.0002621231436789601791648
TCGA-26-5134.3	21	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0002626470627561734889899
TCGA-76-4935.8	21	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0002626470627561734889899
TCGA-27-2521.10	94	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0002642783837324523955707
TCGA-06-0750.13	8	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	7	0.0002647462634411639056595
TCGA-06-0195.8	56	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0002650693259508397708023
TCGA-06-0195.8	56	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0002650693259508397708023
TCGA-06-0176.8	95	2_EXTRACELLULAR_MATRIX	85	9	0.0002654790393847721876285
TCGA-27-2524.5	75	1_KEGG_DNA_REPLICATION	32	6	0.0002655502400227436276235
TCGA-32-2615.7	77	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0002656160766749218228588
TCGA-32-1977.11	107	2_COLLAGEN	23	6	0.0002673195929371621716239
TCGA-06-0216.6	67	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002674972644651567549139
TCGA-14-1829.14	67	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002674972644651567549139
TCGA-32-2495.11	67	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002674972644651567549139
TCGA-12-3653.55	255	1_KEGG_PATHWAYS_IN_CANCER	323	27	0.0002675140296877533412252
TCGA-14-4157.7	101	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0002686581267921574634611
TCGA-32-4213.15	198	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0002693744827176389319487
TCGA-32-1977.11	107	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0002711252082698468882441
TCGA-15-1444.3	107	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0002711252082698468882441
TCGA-06-0241.8	53	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0002711840631606273876314
TCGA-06-2558.6	74	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0002711954104149839070784
TCGA-08-0354.7	47	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0002717505597807310106957
TCGA-32-1979.4	12	1_KEGG_BLADDER_CANCER	42	4	0.0002750210108871977950432
TCGA-32-1980.1	24	2_REGULATION_OF_BODY_FLUID_LEVELS	52	5	0.0002752773029427804944887
TCGA-06-0197.1	57	1_KEGG_BLADDER_CANCER	42	6	0.0002759946033959377077738
TCGA-06-0645.9	136	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0002766604868391945248017
TCGA-06-5413.11	142	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0002768766654723836431566
TCGA-12-3653.55	255	2_NUCLEUS	1110	59	0.0002793042832235212631110
TCGA-16-1045.10	81	1_KEGG_ASTHMA	30	6	0.0002802816620898605933475
TCGA-02-0071.12	116	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0002806703021240038284541
TCGA-08-0347.4	16	2_CELL_CYCLE_PROCESS	163	6	0.0002821503822919852323518
TCGA-28-5218.5	208	0_HALLMARK_E2F_TARGETS	169	17	0.0002832312543323415362367
TCGA-02-0038.3	199	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	47	0.0002834172105708921036993
TCGA-26-1439.10	84	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0002837931571137858603911
TCGA-28-5218.5	208	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0002842265305044098773826
TCGA-06-0176.8	95	1_KEGG_BLADDER_CANCER	42	7	0.0002843717766071773888140
TCGA-19-4068.2	11	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	5	0.0002852970622843756308244
TCGA-76-4928.15	78	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0002882508734935296636562
TCGA-19-5952.11	193	1_KEGG_MELANOMA	71	11	0.0002889162879229043869554
TCGA-76-4931.10	86	1_KEGG_FOCAL_ADHESION	195	12	0.0002894231984958264619276
TCGA-02-0026.1	61	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0002904854769496138040992
TCGA-06-5856.13	152	1_KEGG_MELANOMA	71	10	0.0002907110562353791213819
TCGA-76-6191.6	96	2_EXTRACELLULAR_MATRIX	85	9	0.0002908162836414397646630
TCGA-76-4926.9	66	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0002914628944363231114606
TCGA-06-0124.6	55	2_COLLAGEN	23	5	0.0002915185258238049042026
TCGA-02-0075.8	128	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0002922785728216425863747
TCGA-02-0075.8	128	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0002922785728216425863747
TCGA-08-0358.9	43	1_KEGG_FOCAL_ADHESION	195	9	0.0002936484372692298627956
TCGA-28-5208.28	220	2_CELL_CELL_SIGNALING	353	26	0.0002944870755752613958670
TCGA-28-5213.9	143	2_AXON	10	5	0.0002967841465132662779822
TCGA-06-2558.6	74	2_CELL_CYCLE_PHASE	146	10	0.0002973733661652643153403
TCGA-02-0033.1	4	1_KEGG_FOCAL_ADHESION	195	4	0.0002975074737158271676561
TCGA-02-0016.4	4	1_KEGG_FOCAL_ADHESION	195	4	0.0002975074737158271676561
TCGA-06-2567.9	156	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0002985427235952237265057
TCGA-41-3915.10	109	2_COLLAGEN	23	6	0.0002986028680806571871179
TCGA-06-0881.7	203	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0003004917373751708579988
TCGA-06-0148.6	69	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003015006585980916004909
TCGA-02-0043.10	184	2_COLLAGEN	23	7	0.0003017853982516836364516
TCGA-02-2483.10	100	2_DNA_REPLICATION	82	9	0.0003027799535770058056601
TCGA-28-1753.13	174	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0003029767662707166320582
TCGA-14-0790.9	104	2_CELL_CYCLE_GO_0007049	265	15	0.0003037618728497849568577
TCGA-02-0048.9	84	2_CELL_CYCLE_PROCESS	163	11	0.0003044412263628137687264
TCGA-06-2565.10	38	2_REGULATION_OF_CELL_CYCLE	160	8	0.0003047634517516081766215
TCGA-06-2559.11	101	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0003052412885639516917057
TCGA-76-6191.6	96	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0003057395193450498428224
TCGA-06-5859.9	125	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0003068494032728554736338
TCGA-02-0033.5	144	2_AXON	10	5	0.0003073226946849441816589
TCGA-19-5958.4	35	1_KEGG_PANCREATIC_CANCER	70	6	0.0003079865020620581620922
TCGA-02-0026.1	61	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0003080460022208656063747
TCGA-76-6282.11	185	0_HALLMARK_KRAS_SIGNALING_UP	148	15	0.0003088928521096930912906
TCGA-06-2558.6	74	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0003091735113648103484146
TCGA-28-2513.12	134	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	13	0.0003101272458300955315452
TCGA-06-0877.7	4	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0003140659813711730555426
TCGA-08-0348.3	4	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0003140659813711730555426
TCGA-19-5954.17	208	1_KEGG_ASTHMA	30	8	0.0003146274613130459175091
TCGA-19-1390.13	110	1_KEGG_MISMATCH_REPAIR	23	6	0.0003153395358269347266596
TCGA-06-0189.3	118	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0003155766380510724011116
TCGA-26-1439.10	84	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0003158787106807992169609
TCGA-26-1439.11	10	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0003159268233975435179184
TCGA-28-5204.3	4	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	4	0.0003163917133322919033982
TCGA-02-0038.3	199	0_HALLMARK_MYC_TARGETS_V1	178	17	0.0003177702646316341397216
TCGA-16-1048.13	97	2_EXTRACELLULAR_MATRIX	85	9	0.0003182322892863111043864
TCGA-06-0219.6	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437826028
TCGA-08-0244.4	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437826028
TCGA-12-5299.5	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437826028
TCGA-14-1823.12	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437826028
TCGA-14-1829.11	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437826028
TCGA-14-2554.9	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437826028
TCGA-19-4068.2	11	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	4	0.0003186225524812704898957
TCGA-06-0145.17	11	2_CELL_CYCLE_GO_0007049	265	6	0.0003193576976994510411949
TCGA-28-2502.9	56	2_COLLAGEN	23	5	0.0003195891642548654657668
TCGA-02-0014.10	70	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003196645499842647761106
TCGA-27-2521.10	94	2_CELL_CYCLE_PHASE	146	11	0.0003200374067368724393355
TCGA-02-0071.12	116	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0003201864439145646400002
TCGA-06-0189.3	118	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0003205567842135642565513
TCGA-06-0189.3	118	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0003205567842135642565513
TCGA-06-5415.7	7	1_KEGG_SMALL_CELL_LUNG_CANCER	83	4	0.0003210638311410397936069
TCGA-06-0148.6	69	2_CELL_CELL_SIGNALING	353	14	0.0003225878688744217314723
TCGA-32-1986.12	17	1_KEGG_ASTHMA	30	4	0.0003228292685771626344821
TCGA-41-2571.7	72	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0003228465895186709722769
TCGA-06-0745.4	55	2_SYNAPTIC_TRANSMISSION	152	9	0.0003255572058427578510317
TCGA-32-1980.1	24	2_EXTRACELLULAR_REGION_PART	269	8	0.0003256851418187678122787
TCGA-06-0178.2	17	2_CELL_CYCLE_GO_0007049	265	7	0.0003261393864812887877745
TCGA-41-4097.6	48	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0003264120269005010236546
TCGA-28-5214.11	124	1_KEGG_PATHWAYS_IN_CANCER	323	18	0.0003268646786930788487348
TCGA-32-4213.15	198	2_EXTRACELLULAR_REGION_PART	269	21	0.0003269912927214812235245
TCGA-02-2486.9	141	2_IMMUNE_SYSTEM_PROCESS	283	18	0.0003280692497800997129744
TCGA-14-0787.6	40	1_KEGG_DNA_REPLICATION	32	5	0.0003286944318526843441565
TCGA-26-1439.11	10	2_CELL_CYCLE_PHASE	146	5	0.0003292916978446608572764
TCGA-08-0354.5	18	2_CELL_CYCLE_PHASE	146	6	0.0003307824270028672606486
TCGA-06-2570.8	95	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0003315896478560012941052
TCGA-06-2570.8	95	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0003315896478560012941052
TCGA-02-0089.5	91	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0003333554737734674205604
TCGA-41-3393.4	12	2_MICROTUBULE_CYTOSKELETON	117	5	0.0003338243251135973740061
TCGA-14-1034.7	97	1_KEGG_GLIOMA	62	8	0.0003339400079161761419715
TCGA-12-0616.1	20	2_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0003349153166938438120660
TCGA-12-0616.1	20	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0003349153166938438120660
TCGA-28-2513.12	134	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0003357464229957970200217
TCGA-02-0060.19	281	0_HALLMARK_ALLOGRAFT_REJECTION	190	21	0.0003376208469893718236779
TCGA-19-2624.29	130	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0003383485950309168257752
TCGA-06-0185.13	71	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003386336555915159924300
TCGA-02-0107.3	71	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003386336555915159924300
TCGA-27-2526.7	71	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003386336555915159924300
TCGA-19-2624.29	130	1_KEGG_DNA_REPLICATION	32	7	0.0003392144681850870076810
TCGA-06-5412.7	153	2_IMMUNE_RESPONSE	206	16	0.0003396939655032276219639
TCGA-19-2623.11	153	2_STRUCTURAL_MOLECULE_ACTIVITY	206	16	0.0003396939655032276219639
TCGA-02-0043.10	184	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	39	0.0003398475554469323730092
TCGA-28-5204.3	4	2_LIGAND_GATED_CHANNEL_ACTIVITY	36	3	0.0003425901586604368238148
TCGA-06-5408.3	99	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0003425976267976255074631
TCGA-14-1034.7	97	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0003432024073929372271624
TCGA-19-2625.9	146	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0003432594164447453884484
TCGA-06-0130.3	155	2_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0003433725905272269358220
TCGA-06-0130.3	155	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0003433725905272269358220
TCGA-02-0114.20	132	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0003482644674082947789349
TCGA-27-1831.9	85	1_KEGG_MELANOMA	71	8	0.0003484506219375225729087
TCGA-02-0009.6	188	2_COLLAGEN	23	7	0.0003495809839269672426344
TCGA-06-2562.7	57	2_COLLAGEN	23	5	0.0003497611461800636872485
TCGA-06-0197.1	57	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	10	0.0003498124254883372354248
TCGA-06-2557.11	177	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0003506709997842795368747
TCGA-02-0064.3	26	2_TRANSMISSION_OF_NERVE_IMPULSE	164	7	0.0003518208471002867558132
TCGA-06-0747.12	80	2_CELL_CELL_SIGNALING	353	15	0.0003524721931701770070815
TCGA-02-0046.8	148	2_AXON	10	5	0.0003524908335851261722768
TCGA-19-5947.4	267	0_HALLMARK_APOPTOSIS	150	18	0.0003542388777026689999916
TCGA-06-0156.4	80	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0003547759953418520612219
TCGA-06-5413.11	142	1_KEGG_FOCAL_ADHESION	195	15	0.0003560198123702940889608
TCGA-02-0085.1	45	0_HALLMARK_ALLOGRAFT_REJECTION	190	9	0.0003568426369426314602451
TCGA-27-1838.17	131	0_HALLMARK_ANGIOGENESIS	32	7	0.0003575275897436725781875
TCGA-26-5139.10	163	2_CYTOSKELETAL_PART	194	16	0.0003581253798659175748183
TCGA-41-2571.7	72	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003584311847567845624347
TCGA-02-0068.1	72	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003584311847567845624347
TCGA-02-0024.6	206	2_CYTOSKELETAL_PART	194	18	0.0003584795576864897967591
TCGA-06-2565.10	38	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0003608914466162709954594
TCGA-12-0619.11	123	1_KEGG_FOCAL_ADHESION	195	14	0.0003621959554121452289598
TCGA-27-2527.6	79	0_HALLMARK_ANGIOGENESIS	32	6	0.0003631145356468040859797
TCGA-32-1979.4	12	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0003653471827327128287032
TCGA-41-2575.49	136	1_KEGG_GLIOMA	62	9	0.0003655257448981491389187
TCGA-32-1979.10	116	0_HALLMARK_COMPLEMENT	176	13	0.0003658845200310733474305
TCGA-02-0099.11	141	1_KEGG_ASTHMA	30	7	0.0003667445899024224394668
TCGA-14-4157.7	101	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0003669787219460607765112
TCGA-02-0107.3	71	2_EXTRACELLULAR_REGION	346	14	0.0003672294263878198039043
TCGA-76-6191.6	96	0_HALLMARK_MYC_TARGETS_V1	178	12	0.0003679727354216809570922
TCGA-12-5299.6	38	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0003687298592025452519290
TCGA-06-0219.6	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076490871
TCGA-08-0244.4	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076490871
TCGA-12-5299.5	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076490871
TCGA-14-1823.12	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076490871
TCGA-14-1829.11	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076490871
TCGA-14-2554.9	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076490871
TCGA-02-0075.8	128	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0003687704247989938679056
TCGA-32-2615.7	77	2_EXTRACELLULAR_REGION_PART	269	13	0.0003688542991650602402738
TCGA-06-0645.9	136	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	13	0.0003692561911279386606399
TCGA-02-0060.19	281	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0003702051012208447725547
TCGA-02-0115.4	3	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0003711041744650904624335
TCGA-06-0750.9	3	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0003711041744650904624335
TCGA-27-1834.9	3	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0003711041744650904624335
TCGA-06-0882.9	3	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0003711041744650904624335
TCGA-06-0882.5	3	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	58	3	0.0003711041744650904624335
TCGA-06-0744.10	36	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0003711217535779454601216
TCGA-41-2571.7	72	1_KEGG_FOCAL_ADHESION	195	11	0.0003718797655913877388441
TCGA-27-2523.12	112	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0003719782572538455809284
TCGA-28-2509.5	4	1_KEGG_ALLOGRAFT_REJECTION	37	3	0.0003727890198417063466647
TCGA-06-0126.3	4	1_KEGG_ALLOGRAFT_REJECTION	37	3	0.0003727890198417063466647
TCGA-08-0353.8	100	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0003737840473268338016902
TCGA-19-5959.13	92	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0003739858251524433535411
TCGA-27-1837.5	85	1_KEGG_ASTHMA	30	6	0.0003744177815768404550371
TCGA-02-0079.2	10	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	5	0.0003769703371939811965136
TCGA-06-0145.19	81	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0003778272969479998938391
TCGA-32-4209.2	56	2_AXON	10	4	0.0003825972923970864521086
TCGA-06-5858.19	205	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0003827618443131989081629
TCGA-28-5207.12	188	0_HALLMARK_E2F_TARGETS	169	16	0.0003832015958746078001379
TCGA-06-5856.13	152	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0003843034336820431952006
TCGA-28-2513.12	134	2_EXTRACELLULAR_REGION_PART	269	17	0.0003846154814505734083861
TCGA-02-0086.2	17	2_REGULATION_OF_CELL_CYCLE	160	6	0.0003849990469876109233129
TCGA-06-0178.2	17	2_REGULATION_OF_CELL_CYCLE	160	6	0.0003849990469876109233129
TCGA-02-0064.3	26	2_CELL_CELL_SIGNALING	353	9	0.0003853734398567196218176
TCGA-06-0139.1	179	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0003859849823385528102583
TCGA-12-0692.7	23	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0003873444537525719982320
TCGA-02-2470.4	11	2_MITOTIC_CELL_CYCLE	134	5	0.0003883448536117864468599
TCGA-32-4213.15	198	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	12	0.0003893689225374041785674
TCGA-32-5222.9	70	2_CELL_CELL_SIGNALING	353	14	0.0003897670308655914518138
TCGA-19-5951.10	138	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0003904803667952529860376
TCGA-06-5414.13	102	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0003905303228530833956414
TCGA-06-0881.7	203	2_EXTRACELLULAR_MATRIX	85	12	0.0003931192950087789494615
TCGA-02-0003.9	227	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	10	0.0003934161041989056909439
TCGA-76-6191.6	96	2_CELL_CYCLE_PHASE	146	11	0.0003981398052142337681478
TCGA-08-0359.5	37	1_KEGG_CELL_CYCLE	114	7	0.0003991770229764805442627
TCGA-12-5295.8	66	2_CELL_CYCLE_GO_0007049	265	12	0.0003994895024679959182924
TCGA-06-0197.1	57	0_HALLMARK_APOPTOSIS	150	9	0.0004001935679771150152460
TCGA-19-2623.11	153	2_CYTOSKELETON	293	19	0.0004002097081230952661281
TCGA-06-0213.9	74	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0004006059304299646860875
TCGA-06-0128.8	74	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0004006059304299646860875
TCGA-06-0155.10	74	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0004008083713430766787007
TCGA-28-5214.11	124	1_KEGG_FOCAL_ADHESION	195	14	0.0004009772621404696568356
TCGA-14-0787.7	14	2_MEMBRANE	1443	11	0.0004010469427791974925644
TCGA-32-1979.10	116	0_HALLMARK_KRAS_SIGNALING_UP	148	12	0.0004010803296184090125515
TCGA-28-2513.12	134	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0004012218269043012165362
TCGA-19-1390.12	10	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	5	0.0004027817448057558662525
TCGA-02-0060.19	281	2_EXTRACELLULAR_SPACE	192	21	0.0004036643282666455044908
TCGA-26-5132.7	100	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0004038388159324143031684
TCGA-06-5858.19	205	2_DNA_METABOLIC_PROCESS	218	19	0.0004038631727653816641706
TCGA-06-0190.8	143	1_KEGG_ASTHMA	30	7	0.0004038751098027822008900
TCGA-27-2524.5	75	2_DNA_REPLICATION	82	8	0.0004051157207653602104411
TCGA-06-0190.8	143	0_HALLMARK_E2F_TARGETS	169	14	0.0004065552960432695559466
TCGA-14-0781.7	155	2_STRUCTURAL_MOLECULE_ACTIVITY	206	16	0.0004067910245311665289221
TCGA-06-0649.13	88	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0004087265783982968578476
TCGA-02-0001.5	117	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	8	0.0004091236431385158653883
TCGA-28-6450.11	139	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0004094805507725195951700
TCGA-26-1439.11	10	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0004104764824658850650568
TCGA-06-0645.9	136	2_IMMUNE_RESPONSE	206	15	0.0004115945929116673982634
TCGA-32-4210.14	109	2_CHROMOSOMAL_PART	78	9	0.0004119997932218299324658
TCGA-06-5412.7	153	2_AXON	10	5	0.0004162033768181583001135
TCGA-19-4068.7	14	2_CHROMOSOME	102	5	0.0004162100396457748098869
TCGA-26-5136.6	160	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0004166527155417902562005
TCGA-08-0352.2	59	2_COLLAGEN	23	5	0.0004168673276805995244094
TCGA-06-0145.19	81	2_CELL_CELL_SIGNALING	353	15	0.0004181015287250709820503
TCGA-19-1790.18	201	0_HALLMARK_ANGIOGENESIS	32	8	0.0004186541238274681564664
TCGA-28-5208.28	220	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0004217131288755325796251
TCGA-06-0648.6	17	1_KEGG_DNA_REPLICATION	32	4	0.0004226731583098804873565
TCGA-08-0360.3	144	1_KEGG_ASTHMA	30	7	0.0004235988444869779787592
TCGA-16-0861.4	6	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	3	0.0004239689059652274700715
TCGA-06-0166.5	35	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0004240065417184888524327
TCGA-19-2631.15	84	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	12	0.0004253327178389396568021
TCGA-02-0034.4	88	2_NEURON_PROJECTION	16	5	0.0004256270745522072176600
TCGA-32-1982.9	89	1_KEGG_FOCAL_ADHESION	195	12	0.0004256598253677479413819
TCGA-06-0157.7	89	1_KEGG_FOCAL_ADHESION	195	12	0.0004256598253677479413819
TCGA-76-6285.5	106	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0004258942326551097079870
TCGA-12-3653.55	255	2_DNA_REPLICATION	82	13	0.0004265758757457721248030
TCGA-06-2569.5	144	1_KEGG_FOCAL_ADHESION	195	15	0.0004282128772914401489309
TCGA-02-0086.2	17	2_CELL_CYCLE_PROCESS	163	6	0.0004298490491653002461281
TCGA-06-0648.6	17	2_CELL_CYCLE_PROCESS	163	6	0.0004298490491653002461281
TCGA-02-0054.3	93	2_SYNAPTIC_TRANSMISSION	152	11	0.0004316340720311864298867
TCGA-06-2559.11	101	1_KEGG_BLADDER_CANCER	42	7	0.0004340521427381157986911
TCGA-02-2470.4	11	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0004340888522924933709719
TCGA-06-2569.5	144	2_CHROMOSOMAL_PART	78	10	0.0004342462239973607016075
TCGA-02-0024.6	206	2_DNA_METABOLIC_PROCESS	218	19	0.0004359138655833771219816
TCGA-32-1982.9	89	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	10	0.0004384489226490176534690
TCGA-41-5651.5	112	2_DNA_METABOLIC_PROCESS	218	14	0.0004400653176822385431212
TCGA-06-2558.6	74	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0004402428939333502804637
TCGA-08-0360.3	144	2_EXTRACELLULAR_REGION	346	20	0.0004404561138698522807129
TCGA-26-1439.11	10	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0004415012873614721964320
TCGA-14-4157.7	101	2_NUCLEUS	1110	31	0.0004416141158213812982665
TCGA-32-4719.15	123	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0004421907917644935068387
TCGA-08-0360.3	144	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	14	0.0004434148323882072372654
TCGA-06-5859.9	125	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	14	0.0004434595208854156893861
TCGA-06-5414.13	102	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0004436362343690616123933
TCGA-14-0781.7	155	2_AXON	10	5	0.0004441121508768593791755
TCGA-06-0130.3	155	2_AXON	10	5	0.0004441121508768593791755
TCGA-27-2524.5	75	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0004454971215992565365845
TCGA-26-5133.10	75	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0004454971215992565365845
TCGA-06-0129.11	110	2_CHROMOSOMAL_PART	78	9	0.0004457531415442485571085
TCGA-41-2572.8	76	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0004463807709857270486671
TCGA-14-1823.12	6	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0004466223214596150379446
TCGA-06-0216.6	67	0_HALLMARK_E2F_TARGETS	169	10	0.0004470507392907497093947
TCGA-14-3476.17	53	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0004471686563420743977526
TCGA-02-0071.12	116	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0004473624966693897828628
TCGA-28-2501.3	51	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0004474597838720144847569
TCGA-06-0750.12	52	2_EXTRACELLULAR_REGION	346	12	0.0004475974827185995666423
TCGA-28-2513.12	134	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0004500057960399167760607
TCGA-02-0071.12	116	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0004510090935928468425936
TCGA-02-0071.12	116	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0004510090935928468425936
TCGA-32-4719.15	123	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0004510788558028514297869
TCGA-06-0122.8	90	0_HALLMARK_COAGULATION	125	10	0.0004525337168489311522913
TCGA-14-0789.10	106	2_TRANSMISSION_OF_NERVE_IMPULSE	164	12	0.0004538331220973426021262
TCGA-02-0115.4	3	2_INTERPHASE	62	3	0.0004548599908694180406557
TCGA-06-0750.9	3	2_INTERPHASE	62	3	0.0004548599908694180406557
TCGA-27-1834.9	3	2_INTERPHASE	62	3	0.0004548599908694180406557
TCGA-06-0882.9	3	2_INTERPHASE	62	3	0.0004548599908694180406557
TCGA-19-5947.4	267	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	19	0.0004567721761299123415384
TCGA-27-1834.10	39	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0004570920366256151184774
TCGA-02-0102.8	82	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0004592599277390203198548
TCGA-41-2575.49	136	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0004611286055357744569257
TCGA-06-0645.9	136	0_HALLMARK_ANGIOGENESIS	32	7	0.0004621210279909653559707
TCGA-28-2501.3	51	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0004622331702521069994073
TCGA-76-6191.6	96	2_DNA_METABOLIC_PROCESS	218	13	0.0004626954495077637485520
TCGA-06-5418.4	24	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0004640649389694819003209
TCGA-06-5414.13	102	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0004645174166576328863426
TCGA-06-5414.13	102	1_KEGG_BLADDER_CANCER	42	7	0.0004645174166576328863426
TCGA-12-0692.7	23	2_NEUROLOGICAL_SYSTEM_PROCESS	296	8	0.0004645789739213073668740
TCGA-28-1753.13	174	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0004661220425656094779737
TCGA-14-1823.15	87	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0004670807637926542663781
TCGA-06-5858.19	205	2_CHROMOSOME	102	13	0.0004677247386843749353200
TCGA-06-5856.13	152	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0004683086289130005785801
TCGA-27-2526.7	71	2_CELL_CELL_SIGNALING	353	14	0.0004692854842197683980579
TCGA-76-6282.11	185	2_EXTRACELLULAR_REGION_PART	269	20	0.0004726806691451516766189
TCGA-06-0877.7	4	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0004739093609704170284060
TCGA-16-0861.5	4	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0004739093609704170284060
TCGA-08-0348.3	4	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0004739093609704170284060
TCGA-19-5955.9	110	0_HALLMARK_ALLOGRAFT_REJECTION	190	13	0.0004749948460422718978652
TCGA-12-3653.55	255	2_REGULATION_OF_CELL_CYCLE	160	18	0.0004760269664363306471241
TCGA-26-5135.9	71	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0004763904947780492446681
TCGA-06-0152.10	19	2_CELL_CYCLE_PHASE	146	6	0.0004773202377179817370786
TCGA-06-0189.3	118	2_COLLAGEN	23	6	0.0004791405468021565287710
TCGA-02-0074.5	118	2_COLLAGEN	23	6	0.0004791405468021565287710
TCGA-76-4927.8	93	2_CELL_CELL_SIGNALING	353	16	0.0004795614355758046846306
TCGA-02-2483.10	100	2_REGULATION_OF_MOLECULAR_FUNCTION	286	15	0.0004814632638067533601176
TCGA-06-0155.10	74	2_EXTRACELLULAR_MATRIX	85	8	0.0004829591602194174132512
TCGA-06-0154.13	76	1_KEGG_CELL_CYCLE	114	9	0.0004830227451429602446471
TCGA-06-0877.8	61	2_CELL_CELL_SIGNALING	353	13	0.0004846072531929773979237
TCGA-28-5207.12	188	2_CYTOSKELETAL_PART	194	17	0.0004851853835841015046004
TCGA-02-0043.10	184	2_PROTEOLYSIS	154	15	0.0004856786273251865559790
TCGA-26-1439.10	84	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0004861432931891145579895
TCGA-27-2524.5	75	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0004892823521485406427015
TCGA-06-0130.3	155	2_CYTOSKELETON	293	19	0.0004919321385515886511930
TCGA-19-5947.4	267	2_CYTOKINE_BINDING	44	10	0.0004930569989694415277207
TCGA-32-2491.14	244	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0004931242538083115568154
TCGA-06-0877.8	61	2_COLLAGEN	23	5	0.0004937919708206452715574
TCGA-32-2498.13	133	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0004958654785513779512593
TCGA-76-4928.15	78	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0004959527186586228705151
TCGA-06-0875.7	78	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0004959527186586228705151
TCGA-15-0742.13	74	1_KEGG_FOCAL_ADHESION	195	11	0.0004961352786253582242831
TCGA-06-2558.6	74	1_KEGG_FOCAL_ADHESION	195	11	0.0004961352786253582242831
TCGA-14-0787.6	40	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0004963272110929936370080
TCGA-08-0380.5	47	2_SIGNAL_TRANSDUCTION	1442	22	0.0004963490439597311332937
TCGA-02-0047.8	185	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0004968317411072800237476
TCGA-41-4097.6	48	2_ORGAN_DEVELOPMENT	460	13	0.0004976797188728961096604
TCGA-06-0192.10	126	2_SIGNAL_TRANSDUCTION	1442	42	0.0004983644217033258516994
TCGA-32-2494.10	173	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0004990526891885216191624
TCGA-06-0157.7	89	1_KEGG_MELANOMA	71	8	0.0004993270876346669233728
TCGA-06-0219.6	6	1_KEGG_CELL_CYCLE	114	4	0.0005003665479399304347533
TCGA-08-0244.4	6	1_KEGG_CELL_CYCLE	114	4	0.0005003665479399304347533
TCGA-14-1829.11	6	1_KEGG_CELL_CYCLE	114	4	0.0005003665479399304347533
TCGA-14-2554.9	6	1_KEGG_CELL_CYCLE	114	4	0.0005003665479399304347533
TCGA-19-5947.4	267	0_HALLMARK_UV_RESPONSE_DN	122	16	0.0005011339154897024531637
TCGA-02-0038.3	199	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	10	0.0005016138942601740865340
TCGA-76-6191.6	96	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0005016748696522403249548
TCGA-28-2513.12	134	2_EXTRACELLULAR_MATRIX	85	10	0.0005039203133178386199292
TCGA-76-4934.4	20	2_CELL_CELL_SIGNALING	353	8	0.0005040030600792114005848
TCGA-06-2563.10	123	2_CELL_CYCLE_GO_0007049	265	16	0.0005071554065646211809787
TCGA-14-0789.10	106	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0005088750232033968819156
TCGA-76-6285.5	106	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0005088750232033968819156
TCGA-32-2634.10	118	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	13	0.0005106477449596139939550
TCGA-06-0877.7	4	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0005112825355504712135368
TCGA-28-2509.5	4	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	3	0.0005112825355504712135368
TCGA-06-0126.3	4	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	3	0.0005112825355504712135368
TCGA-08-0348.3	4	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0005112825355504712135368
TCGA-19-2625.9	146	1_KEGG_FOCAL_ADHESION	195	15	0.0005133960510774488589236
TCGA-06-0238.4	24	1_KEGG_CELL_CYCLE	114	6	0.0005151911967451350705255
TCGA-32-4210.14	109	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0005159478730929278151793
TCGA-06-0184.11	108	1_KEGG_FOCAL_ADHESION	195	13	0.0005164683527581918681335
TCGA-06-0645.9	136	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0005170966783444962263858
TCGA-32-1979.4	12	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0005181257584781613851135
TCGA-08-0360.3	144	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0005182109719955743740855
TCGA-26-5136.6	160	2_AXON	10	5	0.0005204234525557468928753
TCGA-41-5651.5	112	2_CHROMOSOMAL_PART	78	9	0.0005205351353485852339623
TCGA-26-5134.6	18	2_CELL_CYCLE_GO_0007049	265	7	0.0005209600934414821988422
TCGA-28-1753.13	174	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0005210572608241139432733
TCGA-27-2527.6	79	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005222255444123493706501
TCGA-32-2491.14	244	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0005231145496168154718220
TCGA-06-5411.3	19	1_KEGG_ASTHMA	30	4	0.0005234373192492676159573
TCGA-27-1838.17	131	2_DNA_METABOLIC_PROCESS	218	15	0.0005235327232167836077406
TCGA-28-2513.12	134	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0005253513930479186124986
TCGA-02-0034.4	88	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0005258839883075238112384
TCGA-28-2501.3	51	2_EXTRACELLULAR_MATRIX	85	7	0.0005276067070465610730004
TCGA-19-5951.10	138	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0005287532816053760326147
TCGA-27-2523.12	112	2_NUCLEUS	1110	33	0.0005312468856957134688904
TCGA-19-2623.11	153	2_EXTRACELLULAR_REGION_PART	269	18	0.0005354206267175640144781
TCGA-06-0881.7	203	0_HALLMARK_UV_RESPONSE_DN	122	14	0.0005364349866028596518913
TCGA-27-2524.5	75	2_EXTRACELLULAR_MATRIX	85	8	0.0005367062916168862047109
TCGA-02-0001.5	117	2_CALCIUM_ION_BINDING	75	9	0.0005377418742363589783048
TCGA-14-4157.7	101	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0005381958830642495378999
TCGA-02-0068.1	72	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0005385877285045346770168
TCGA-16-1048.13	97	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0005387836746826434475982
TCGA-28-5213.9	143	2_CELL_CELL_SIGNALING	353	20	0.0005414419537139689457203
TCGA-02-0028.9	182	2_NEURON_PROJECTION	16	6	0.0005425756241955355385631
TCGA-32-1977.11	107	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0005427733245685754416565
TCGA-15-1444.3	107	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0005427733245685754416565
TCGA-32-4208.28	140	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0005428702944732254108764
TCGA-19-5954.17	208	0_HALLMARK_ANGIOGENESIS	32	8	0.0005443941049267591409874
TCGA-06-5412.7	153	2_INTEGRAL_TO_MEMBRANE	956	37	0.0005467844896054667664168
TCGA-32-2615.7	77	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0005478158044634792289002
TCGA-06-0747.12	80	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005495237957023178408320
TCGA-06-0156.4	80	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005495237957023178408320
TCGA-16-0861.5	4	1_KEGG_BLADDER_CANCER	42	3	0.0005505681065357978477490
TCGA-28-2509.5	4	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	3	0.0005505681065357978477490
TCGA-06-0126.3	4	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	3	0.0005505681065357978477490
TCGA-06-0140.2	25	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0005515687181915280602740
TCGA-08-0347.7	25	2_COLLAGEN	23	4	0.0005515687181915280602740
TCGA-32-2495.11	67	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0005553910298133515714702
TCGA-08-0380.4	6	2_MICROTUBULE_CYTOSKELETON	117	4	0.0005556326453842319731610
TCGA-06-5415.7	7	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0005566614758104053602150
TCGA-14-0789.10	106	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0005569611004305986476370
TCGA-28-5204.3	4	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	4	0.0005585404911803761593761
TCGA-19-5960.9	134	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0005597708877893743661947
TCGA-02-0054.3	93	2_NEURON_PROJECTION	16	5	0.0005618949217442722283630
TCGA-08-0389.4	56	2_CHROMOSOMAL_PART	78	7	0.0005632539108368170982510
TCGA-06-0195.8	56	2_CHROMOSOMAL_PART	78	7	0.0005632539108368170982510
TCGA-02-2486.9	141	0_HALLMARK_APOPTOSIS	150	13	0.0005636671961695302818587
TCGA-02-2470.4	11	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0005639568863392011499255
TCGA-28-5214.11	124	2_CELL_CYCLE_GO_0007049	265	16	0.0005678278090031191847886
TCGA-12-3653.55	255	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0005703229616772592614968
TCGA-12-3653.55	255	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0005703229616772592614968
TCGA-26-1439.11	10	2_CELL_CYCLE_PROCESS	163	5	0.0005709813461061227389190
TCGA-26-5133.10	75	1_KEGG_FOCAL_ADHESION	195	11	0.0005710440952853513760235
TCGA-28-5207.12	188	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0005724025128240661569254
TCGA-06-2567.9	156	2_CELL_CYCLE_GO_0007049	265	18	0.0005751200763277537243712
TCGA-19-1390.13	110	2_INTRACELLULAR_ORGANELLE_PART	912	29	0.0005754700566813327139784
TCGA-28-2509.6	59	0_HALLMARK_P53_PATHWAY	151	9	0.0005757791163747560817324
TCGA-02-0027.3	81	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005778735051391627186579
TCGA-06-0145.19	81	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005778735051391627186579
TCGA-28-1747.5	81	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005778735051391627186579
TCGA-32-4210.14	109	2_CELL_CYCLE_PROCESS	163	12	0.0005781099165323098356892
TCGA-12-0618.5	41	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0005782476431106864985660
TCGA-32-1979.4	12	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0005783713772550545025725
TCGA-02-0010.18	184	2_NEURON_PROJECTION	16	6	0.0005788109416480915559236
TCGA-06-2565.10	38	2_MICROTUBULE_CYTOSKELETON	117	7	0.0005788943269294447155002
TCGA-26-1439.11	10	2_INTERPHASE	62	4	0.0005793176245407901606838
TCGA-06-0743.14	63	2_COLLAGEN	23	5	0.0005815527158580189584156
TCGA-19-1790.18	201	2_RESPONSE_TO_WOUNDING	163	16	0.0005820707188504843079477
TCGA-28-2509.6	59	2_NUCLEUS	1110	22	0.0005830213381156702009273
TCGA-06-5859.9	125	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	9	0.0005866590050157525788183
TCGA-14-1825.8	80	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0005871975457016390641252
TCGA-14-1825.8	80	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0005871975457016390641252
TCGA-06-0241.8	53	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0005873936791897898775441
TCGA-06-5858.19	205	2_REGULATION_OF_CELL_CYCLE	160	16	0.0005898851081923274465232
TCGA-06-0881.7	203	2_COLLAGEN	23	7	0.0005899099368842563792525
TCGA-06-5412.1	28	2_RESPONSE_TO_WOUNDING	163	7	0.0005899420812838203700967
TCGA-08-0246.6	62	2_CELL_CELL_SIGNALING	353	13	0.0005927559811349370063813
TCGA-06-0195.8	56	2_REGULATION_OF_CELL_CYCLE	160	9	0.0005927613505724148735415
TCGA-02-0089.5	91	1_KEGG_MELANOMA	71	8	0.0005937477572913719102432
TCGA-06-0145.17	11	2_CELL_CYCLE_PHASE	146	5	0.0005961997410012625760525
TCGA-02-2470.4	11	2_CELL_CYCLE_PHASE	146	5	0.0005961997410012625760525
TCGA-02-0075.8	128	1_KEGG_FOCAL_ADHESION	195	14	0.0005963192803669587014476
TCGA-02-0083.21	135	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0005964796870188197831439
TCGA-32-1986.8	87	2_STRUCTURAL_MOLECULE_ACTIVITY	206	12	0.0005981423267139825486471
TCGA-41-4097.6	48	1_KEGG_ASTHMA	30	5	0.0005983743323003917801220
TCGA-12-0692.3	9	2_SYSTEM_DEVELOPMENT	694	7	0.0005984040312316294503089
TCGA-06-0214.9	62	1_KEGG_MELANOMA	71	7	0.0005989785699522876330492
TCGA-02-0075.8	128	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0006014758063917494601211
TCGA-32-2615.7	77	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0006015439689299934868105
TCGA-19-2629.15	146	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0006028215136803488204825
TCGA-02-0001.5	117	2_CELL_PROJECTION	76	9	0.0006037010174053140595940
TCGA-06-0129.11	110	2_CYTOSKELETAL_PART	194	13	0.0006044580900299881221979
TCGA-14-0789.10	106	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0006050580878979283086169
TCGA-76-6285.5	106	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0006050580878979283086169
TCGA-76-6285.5	106	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0006050580878979283086169
TCGA-32-4208.28	140	2_SYNAPTIC_TRANSMISSION	152	13	0.0006051837350293551125169
TCGA-32-1991.11	82	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0006073010161858994953796
TCGA-06-2567.9	156	2_REGULATION_OF_CELL_CYCLE	160	14	0.0006082266028683126855153
TCGA-02-0074.5	118	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0006086022386779315566235
TCGA-02-0074.5	118	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0006086022386779315566235
TCGA-19-5952.11	193	2_EXTRACELLULAR_SPACE	192	17	0.0006094574003119783249527
TCGA-14-3476.4	7	2_EXTRACELLULAR_REGION_PART	269	5	0.0006108333290806675260065
TCGA-32-2494.10	173	0_HALLMARK_ALLOGRAFT_REJECTION	190	16	0.0006112004000053478580332
TCGA-76-6193.13	271	0_HALLMARK_UV_RESPONSE_DN	122	16	0.0006131135242512010270072
TCGA-28-5220.7	15	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0006144092625768130542033
TCGA-06-0686.10	26	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0006151931185406047308470
TCGA-19-2629.15	146	2_CELL_CYCLE_PHASE	146	13	0.0006176549176070582954784
TCGA-76-6285.5	106	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0006180288638326661638037
TCGA-06-0216.6	67	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0006187726872155895193814
TCGA-06-0219.6	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950309705
TCGA-08-0244.4	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950309705
TCGA-12-5299.5	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950309705
TCGA-14-1823.12	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950309705
TCGA-14-1829.11	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950309705
TCGA-14-2554.9	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950309705
TCGA-14-1034.9	9	0_HALLMARK_ALLOGRAFT_REJECTION	190	5	0.0006225392565853752040866
TCGA-06-0745.4	55	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0006228192618121462234212
TCGA-19-1390.13	110	2_ORGANELLE_PART	916	29	0.0006313262263801193820492
TCGA-06-0173.35	120	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0006324926529548868976705
TCGA-28-5208.28	220	0_HALLMARK_E2F_TARGETS	169	17	0.0006338112221615191822083
TCGA-06-5415.7	7	2_PHOSPHORYLATION	271	5	0.0006338279667849076653638
TCGA-02-0075.8	128	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0006345735653788227900035
TCGA-06-5859.9	125	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0006350063779364254531318
TCGA-08-0359.5	37	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0006354364637808020306597
TCGA-08-0354.5	18	2_CELL_CYCLE_PROCESS	163	6	0.0006356055651050071921351
TCGA-32-4210.14	109	2_DNA_REPLICATION	82	9	0.0006371864187765824026274
TCGA-28-5207.12	188	1_KEGG_CELL_CYCLE	114	13	0.0006405068721530938818595
TCGA-19-5955.9	110	1_KEGG_FOCAL_ADHESION	195	13	0.0006414030044179665603424
TCGA-26-5136.6	160	2_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0006418029706908328540019
TCGA-26-5136.6	160	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0006418029706908328540019
TCGA-06-5415.7	7	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0006443504297464966576112
TCGA-32-1977.11	107	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0006453036272799692442750
TCGA-15-1444.3	107	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0006453036272799692442750
TCGA-19-5947.4	267	0_HALLMARK_ALLOGRAFT_REJECTION	190	20	0.0006475139052759164640105
TCGA-06-6391.9	26	2_COLLAGEN	23	4	0.0006508043336348971058536
TCGA-02-0064.3	26	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0006508043336348971058536
TCGA-06-0130.3	155	2_EXTRACELLULAR_REGION_PART	269	18	0.0006517233413739598017755
TCGA-02-0024.6	206	2_CYTOSKELETON	293	22	0.0006517981839699286831027
TCGA-19-5952.11	193	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	20	0.0006553051964084075651021
TCGA-32-2632.16	229	1_KEGG_ASTHMA	30	8	0.0006580739787054714967293
TCGA-06-0686.6	3	1_KEGG_LEISHMANIA_INFECTION	70	3	0.0006583563167684111129552
TCGA-06-0686.6	3	1_KEGG_VIRAL_MYOCARDITIS	70	3	0.0006583563167684111129552
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	3	0.0006583563167684111129552
TCGA-19-5958.2	3	1_KEGG_LEISHMANIA_INFECTION	70	3	0.0006583563167684111129552
TCGA-19-5958.2	3	1_KEGG_VIRAL_MYOCARDITIS	70	3	0.0006583563167684111129552
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	3	0.0006583563167684111129552
TCGA-32-2615.7	77	2_EXTRACELLULAR_MATRIX	85	8	0.0006597246169106031014190
TCGA-08-0354.7	47	1_KEGG_FOCAL_ADHESION	195	9	0.0006607160640612000238395
TCGA-19-5951.10	138	2_EXTRACELLULAR_MATRIX	85	10	0.0006635825330853793507443
TCGA-19-2619.14	100	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0006642809363266830198491
TCGA-02-2483.10	100	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0006642809363266830198491
TCGA-28-1753.13	174	2_EXTRACELLULAR_MATRIX	85	11	0.0006671023408056876366490
TCGA-06-0879.9	84	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0006694963678198753622567
TCGA-02-0048.9	84	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0006694963678198753622567
TCGA-27-2527.6	79	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0006696428565793884979743
TCGA-41-3393.5	88	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0006703064332389662566269
TCGA-06-0188.11	66	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0006709508351805413889010
TCGA-06-2559.11	101	2_CELL_CYCLE_PHASE	146	11	0.0006717443629713267666537
TCGA-06-2563.10	123	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0006718979574548017159180
TCGA-32-4208.28	140	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0006780934065368571846827
TCGA-06-0877.7	4	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0006803740881349948279450
TCGA-16-0861.5	4	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0006803740881349948279450
TCGA-08-0348.3	4	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0006803740881349948279450
TCGA-14-0813.5	5	2_RECEPTOR_ACTIVITY	499	5	0.0006814283145147419229470
TCGA-08-0360.3	144	0_HALLMARK_ANGIOGENESIS	32	7	0.0006827259124300195805915
TCGA-06-2558.6	74	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0006844172474317023954771
TCGA-06-0128.8	74	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0006844172474317023954771
TCGA-14-0789.10	106	2_EXTRACELLULAR_MATRIX	85	9	0.0006848256344007025604725
TCGA-02-0114.20	132	2_CELL_CYCLE_PROCESS	163	13	0.0006852573294863057405679
TCGA-02-2470.4	11	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0006906161010644819948576
TCGA-41-3393.5	88	0_HALLMARK_ANGIOGENESIS	32	6	0.0006930025827758942366663
TCGA-19-2619.14	100	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0006947448435143118534649
TCGA-06-5859.9	125	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	24	0.0006953280412942850971514
TCGA-02-0115.1	36	2_EXTRACELLULAR_REGION	346	10	0.0006996590581027629885888
TCGA-16-0846.2	27	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0007004620450252337614250
TCGA-06-2569.5	144	2_DNA_REPLICATION	82	10	0.0007009361983359939894667
TCGA-08-0245.4	85	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0007023184444920507578380
TCGA-14-0817.9	85	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0007023184444920507578380
TCGA-27-1831.9	85	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0007023184444920507578380
TCGA-19-5950.7	113	2_REGULATION_OF_CELL_CYCLE	160	12	0.0007026120437377337320933
TCGA-06-0174.37	141	1_KEGG_OOCYTE_MEIOSIS	105	11	0.0007029415183215088729074
TCGA-76-4927.8	93	1_KEGG_MELANOMA	71	8	0.0007030712093643392245068
TCGA-06-0211.8	62	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0007033319630882367296670
TCGA-02-0014.10	70	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0007074210733570617058025
TCGA-41-3915.10	109	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0007078713883663153433323
TCGA-41-3915.10	109	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0007078713883663153433323
TCGA-06-5412.7	153	2_INTRINSIC_TO_MEMBRANE	966	37	0.0007095817543250001763894
TCGA-32-1979.4	12	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	4	0.0007141355253398267268275
TCGA-06-0241.8	53	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0007141355253398267268275
TCGA-12-3653.55	255	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0007164026724528968492756
TCGA-32-2615.7	77	0_HALLMARK_HYPOXIA	154	10	0.0007182980052059504978007
TCGA-02-0007.17	217	2_MICROTUBULE_CYTOSKELETON	117	14	0.0007192264207227343220108
TCGA-76-4928.15	78	2_SYNAPTIC_TRANSMISSION	152	10	0.0007195506161193001171822
TCGA-06-6389.4	39	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0007198241272003297894569
TCGA-08-0360.3	144	0_HALLMARK_APOPTOSIS	150	13	0.0007202349769427630584231
TCGA-41-2575.49	136	1_KEGG_PROSTATE_CANCER	87	10	0.0007223536446837673218740
TCGA-28-5218.5	208	0_HALLMARK_UV_RESPONSE_DN	122	14	0.0007224893460273178972392
TCGA-19-2624.29	130	1_KEGG_FOCAL_ADHESION	195	14	0.0007230211848446276836841
TCGA-06-0174.37	141	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0007246322188103031117570
TCGA-06-2570.8	95	1_KEGG_ASTHMA	30	6	0.0007279281787117371140677
TCGA-16-0846.2	27	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0007282810072836907967428
TCGA-26-1442.5	27	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0007282810072836907967428
TCGA-32-4210.14	109	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0007325869312996104772834
TCGA-32-2494.10	173	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	15	0.0007326559482281025078090
TCGA-32-4208.28	140	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0007358378922688135585772
TCGA-06-0188.11	66	2_COLLAGEN	23	5	0.0007358961663151663808516
TCGA-06-0190.8	143	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0007372598806882211175048
TCGA-06-0190.8	143	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0007372598806882211175048
TCGA-14-1825.8	80	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0007387924261622284957327
TCGA-02-0085.1	45	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	8	0.0007418058147024872255038
TCGA-26-1439.11	10	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0007469354618890496890979
TCGA-19-2625.9	146	1_KEGG_DNA_REPLICATION	32	7	0.0007499683124920788167278
TCGA-28-5220.7	15	1_KEGG_BLADDER_CANCER	42	4	0.0007510941684010607848065
TCGA-32-1979.4	12	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0007513452682456848302772
TCGA-19-2619.14	100	2_DNA_METABOLIC_PROCESS	218	13	0.0007513917879833734462733
TCGA-32-2615.7	77	1_KEGG_FOCAL_ADHESION	195	11	0.0007514402485198084938670
TCGA-06-6389.4	39	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0007520840074804876693171
TCGA-19-5954.17	208	2_EXTRACELLULAR_REGION_PART	269	21	0.0007525031552825546792701
TCGA-28-5218.5	208	2_EXTRACELLULAR_REGION_PART	269	21	0.0007525031552825546792701
TCGA-19-2620.7	47	0_HALLMARK_ANGIOGENESIS	32	5	0.0007535482331700815933698
TCGA-28-5204.3	4	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	4	0.0007584034370872165141050
TCGA-06-5858.19	205	2_CELL_CYCLE_PROCESS	163	16	0.0007609831544223909054192
TCGA-19-5955.9	110	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0007654987640257993140175
TCGA-02-0028.9	182	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0007676555682897272421539
TCGA-76-4925.9	83	2_CELL_CYCLE_GO_0007049	265	13	0.0007681211487699625764525
TCGA-06-0125.9	75	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0007693785926841427902020
TCGA-27-2524.5	75	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0007693785926841427902020
TCGA-02-2483.10	100	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0007704238230701442730064
TCGA-02-2483.10	100	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0007704238230701442730064
TCGA-32-1986.8	87	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0007715493050047330129623
TCGA-14-1823.15	87	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0007715493050047330129623
TCGA-32-1986.12	17	1_KEGG_ALLOGRAFT_REJECTION	37	4	0.0007720213403900005964126
TCGA-06-5413.11	142	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0007739488722697479648055
TCGA-06-5413.11	142	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0007739488722697479648055
TCGA-28-5213.9	143	2_SYNAPTIC_TRANSMISSION	152	13	0.0007744604178814245946938
TCGA-28-5216.8	162	2_INTRACELLULAR_ORGANELLE_PART	912	37	0.0007745115243805887270123
TCGA-28-1753.13	174	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0007792414668844373226708
TCGA-06-0129.11	110	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0007798260206403198136274
TCGA-19-1390.13	110	1_KEGG_BLADDER_CANCER	42	7	0.0007798260206403198136274
TCGA-06-2564.7	92	2_CELL_CYCLE_PROCESS	163	11	0.0007823088052818586704204
TCGA-26-5134.3	21	2_CELL_CELL_SIGNALING	353	8	0.0007878175425707637175368
TCGA-26-1439.11	10	0_HALLMARK_G2M_CHECKPOINT	174	5	0.0007906961369646460253274
TCGA-14-0786.4	62	1_KEGG_FOCAL_ADHESION	195	10	0.0007963239289211221372256
TCGA-02-0010.18	184	2_REGULATION_OF_CELL_CYCLE	160	15	0.0007996556959137585043201
TCGA-27-2527.6	79	2_EXTRACELLULAR_MATRIX	85	8	0.0008061349644537120062021
TCGA-32-2498.13	133	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0008076272348231275204078
TCGA-02-0025.5	88	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0008080141747520242856764
TCGA-02-0034.4	88	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0008080141747520242856764
TCGA-27-1832.11	88	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0008080141747520242856764
TCGA-41-3393.5	88	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0008080141747520242856764
TCGA-02-0058.1	110	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0008089218527391955427044
TCGA-02-0058.1	110	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0008089218527391955427044
TCGA-06-5414.13	102	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0008097841229857404314260
TCGA-06-0156.4	80	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0008110218301730202656447
TCGA-08-0358.9	43	2_SYSTEM_PROCESS	451	12	0.0008116461384044540905078
TCGA-26-5139.10	163	2_STRUCTURAL_MOLECULE_ACTIVITY	206	16	0.0008128749389792447235109
TCGA-08-0347.4	16	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0008167152132616828114769
TCGA-06-0877.8	61	2_SYNAPTIC_TRANSMISSION	152	9	0.0008178797980837611671448
TCGA-06-0152.10	19	2_REGULATION_OF_CELL_CYCLE	160	6	0.0008206575114335296679963
TCGA-12-0616.7	45	2_SYNAPTIC_TRANSMISSION	152	8	0.0008210307300281298979738
TCGA-08-0355.1	45	2_SYNAPTIC_TRANSMISSION	152	8	0.0008210307300281298979738
TCGA-28-2509.5	4	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	3	0.0008291006003653896049357
TCGA-06-0126.3	4	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	3	0.0008291006003653896049357
TCGA-28-5207.12	188	2_CELL_CELL_SIGNALING	353	23	0.0008306250172023242920802
TCGA-06-2558.6	74	2_CELL_CYCLE_PROCESS	163	10	0.0008323115515016743732116
TCGA-06-2567.9	156	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	8	0.0008349984115122490715630
TCGA-28-5207.12	188	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0008431874837898734129787
TCGA-06-2559.11	101	2_DNA_METABOLIC_PROCESS	218	13	0.0008450248388622636072295
TCGA-02-0089.5	91	0_HALLMARK_ANGIOGENESIS	32	6	0.0008463361220031771423034
TCGA-41-2575.46	4	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	4	0.0008490588502755491619872
TCGA-32-2634.10	118	2_INTRACELLULAR_ORGANELLE_PART	912	30	0.0008511868968955984583735
TCGA-32-1986.8	87	2_EXTRACELLULAR_REGION	346	15	0.0008535874376825488933640
TCGA-76-4934.4	20	2_SYNAPTIC_TRANSMISSION	152	6	0.0008542309069648240833772
TCGA-41-3915.10	109	0_HALLMARK_E2F_TARGETS	169	12	0.0008550084528020966906717
TCGA-28-2513.12	134	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0008554093191057198300453
TCGA-06-0166.5	35	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0008566657206775058971959
TCGA-19-5958.4	35	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0008566657206775058971959
TCGA-06-0124.6	55	2_EXTRACELLULAR_REGION	346	12	0.0008617058250209723739219
TCGA-02-0074.5	118	2_CHROMOSOME	102	10	0.0008622092960778301789712
TCGA-08-0390.1	54	2_CELL_CELL_SIGNALING	353	12	0.0008630919010335351849311
TCGA-06-0154.13	76	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0008633379874490520414915
TCGA-28-5216.8	162	2_ORGANELLE_PART	916	37	0.0008634351266438678807261
TCGA-12-3653.55	255	2_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0008675450907602465970905
TCGA-12-3653.55	255	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0008675450907602465970905
TCGA-19-5960.9	134	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	35	0.0008676323287849155426951
TCGA-41-3915.10	109	2_EXTRACELLULAR_MATRIX	85	9	0.0008698830138506233452741
TCGA-06-0750.13	8	2_PLASMA_MEMBRANE_PART	901	7	0.0008708172909573509527792
TCGA-08-0360.3	144	2_IMMUNE_RESPONSE	206	15	0.0008712981709848660822129
TCGA-02-0115.1	36	2_EXTRACELLULAR_REGION_PART	269	9	0.0008721662906622581080268
TCGA-02-0114.20	132	1_KEGG_FOCAL_ADHESION	195	14	0.0008734209055111532248039
TCGA-12-5299.5	6	2_NEGATIVE_REGULATION_OF_GROWTH	29	3	0.0008734985787320463396927
TCGA-27-1838.17	131	1_KEGG_MELANOMA	71	9	0.0008752339938667689405241
TCGA-28-2502.9	56	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0008775030839227612820125
TCGA-06-5411.3	19	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0008777932210932066527109
TCGA-32-2498.13	133	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0008797131155208268030524
TCGA-32-2498.13	133	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0008797131155208268030524
TCGA-41-5651.5	112	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0008820274727267239395917
TCGA-27-2523.12	112	1_KEGG_BLADDER_CANCER	42	7	0.0008820274727267239395917
TCGA-06-0877.7	4	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0008831019970021057249876
TCGA-08-0348.3	4	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0008831019970021057249876
TCGA-06-0122.8	90	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0008847853105281470531898
TCGA-08-0357.4	36	1_KEGG_FOCAL_ADHESION	195	8	0.0008887921560397484075505
TCGA-27-2528.10	99	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0008890288266745503603303
TCGA-76-4935.8	21	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0008893853738369877567904
TCGA-32-4213.15	198	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0008901960646396984326925
TCGA-28-1753.13	174	0_HALLMARK_KRAS_SIGNALING_UP	148	14	0.0008905255226929675513303
TCGA-41-2575.49	136	2_SPINDLE	35	7	0.0008906216988649235831096
TCGA-28-5218.5	208	2_EPIDERMIS_DEVELOPMENT	59	10	0.0008930490896780819438244
TCGA-41-5651.5	112	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0008930702381718960908633
TCGA-27-2523.12	112	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0008930702381718960908633
TCGA-02-0027.3	81	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0008934608418094574285723
TCGA-06-0145.19	81	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0008934608418094574285723
TCGA-06-0145.19	81	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0008934608418094574285723
TCGA-28-2502.9	56	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0008939139314271117402189
TCGA-06-0644.16	142	2_EXTRACELLULAR_REGION_PART	269	17	0.0008939299485273942283761
TCGA-32-5222.9	70	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0008947941846716594462008
TCGA-28-1753.13	174	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0008947941846716606388232
TCGA-06-0241.8	53	0_HALLMARK_MYC_TARGETS_V1	178	9	0.0008966857338186491133483
TCGA-02-0007.17	217	2_CHROMOSOME	102	13	0.0009003255875985354721516
TCGA-02-0011.1	288	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	42	0.0009007797586360869910790
TCGA-06-5856.13	152	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0009030623559650917614797
TCGA-06-5856.13	152	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0009030623559650917614797
TCGA-06-2564.7	92	0_HALLMARK_ANGIOGENESIS	32	6	0.0009032382261964647714864
TCGA-02-2470.4	11	2_INTERPHASE	62	4	0.0009058867052790717504934
TCGA-02-0026.1	61	2_INTRACELLULAR_ORGANELLE_PART	912	20	0.0009068695140456881033028
TCGA-02-0003.9	227	2_CYTOSKELETON	293	23	0.0009068970504478991549735
TCGA-06-2564.7	92	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0009099777468628408513829
TCGA-19-5954.17	208	2_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0009107000129066645252932
TCGA-19-5954.17	208	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0009107000129066645252932
TCGA-06-0750.13	8	2_RECEPTOR_ACTIVITY	499	6	0.0009108423384729353667125
TCGA-06-5415.3	8	2_RECEPTOR_ACTIVITY	499	6	0.0009108423384729353667125
TCGA-06-0221.4	8	2_RECEPTOR_ACTIVITY	499	6	0.0009108423384729353667125
TCGA-27-1838.17	131	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0009120358851267733671375
TCGA-27-1838.17	131	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0009120358851267733671375
TCGA-06-0152.10	19	2_CELL_CYCLE_PROCESS	163	6	0.0009157560105049688484874
TCGA-06-2567.9	156	2_CHROMOSOMAL_PART	78	10	0.0009158685735253677346127
TCGA-02-0011.1	288	2_REPLICATION_FORK	18	7	0.0009166811823674756408431
TCGA-19-5950.7	113	2_CELL_CYCLE_GO_0007049	265	15	0.0009191909371742424663884
TCGA-12-3653.55	255	2_CHROMOSOME	102	14	0.0009201441023837561138804
TCGA-06-0190.8	143	2_EXTRACELLULAR_MATRIX	85	10	0.0009243645309074720664566
TCGA-02-0089.5	91	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0009251495021211495655214
TCGA-26-5135.9	71	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0009262193124537846777161
TCGA-02-0028.9	182	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0009269339310649422772684
TCGA-02-0028.9	182	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	11	0.0009269339310649422772684
TCGA-02-0054.3	93	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0009295163565648273829717
TCGA-87-5896.6	131	2_CYTOSKELETON	293	17	0.0009296620347400321848069
TCGA-14-1823.12	6	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	4	0.0009310917031484804064906
TCGA-06-0158.4	65	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0009350052492047842330608
TCGA-32-2634.10	118	2_ORGANELLE_PART	916	30	0.0009350577320067875305640
TCGA-12-0616.4	7	2_CYTOSKELETON	293	5	0.0009353020786578065568981
TCGA-19-1790.18	201	0_HALLMARK_ALLOGRAFT_REJECTION	190	17	0.0009362595343601752984758
TCGA-28-2513.12	134	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0009375449861148221850776
TCGA-32-4209.2	56	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0009396102309835021931458
TCGA-19-5955.9	110	2_EXTRACELLULAR_MATRIX	85	9	0.0009405201725871740721721
TCGA-28-2509.6	59	2_REGULATION_OF_CELL_CYCLE	160	9	0.0009414299354169444527737
TCGA-76-4931.10	86	2_CELL_CELL_SIGNALING	353	15	0.0009433620216629386937696
TCGA-06-5412.7	153	1_KEGG_FOCAL_ADHESION	195	15	0.0009458466554554754556622
TCGA-06-6391.7	5	0_HALLMARK_MITOTIC_SPINDLE	175	4	0.0009475408028079456345880
TCGA-27-2521.10	94	2_NUCLEUS	1110	29	0.0009485735422150890980286
TCGA-02-0026.1	61	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0009510810241502491799853
TCGA-02-0014.10	70	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0009556196777216318521964
TCGA-41-3392.31	136	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0009582753005235716001545
TCGA-76-6193.13	271	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	16	0.0009589167907814462711927
TCGA-06-0219.6	6	2_MITOTIC_CELL_CYCLE	134	4	0.0009595763597279654763539
TCGA-08-0244.4	6	2_MITOTIC_CELL_CYCLE	134	4	0.0009595763597279654763539
TCGA-12-5299.5	6	2_MITOTIC_CELL_CYCLE	134	4	0.0009595763597279654763539
TCGA-14-1829.11	6	2_MITOTIC_CELL_CYCLE	134	4	0.0009595763597279654763539
TCGA-14-2554.9	6	2_MITOTIC_CELL_CYCLE	134	4	0.0009595763597279654763539
TCGA-14-1825.8	80	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0009596197875249088803801
TCGA-06-2565.10	38	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	7	0.0009601984221571655594291
TCGA-28-5218.5	208	2_EXTRACELLULAR_REGION	346	24	0.0009614905465506670950021
TCGA-12-0688.10	93	1_KEGG_DNA_REPLICATION	32	6	0.0009632433494136462574439
TCGA-32-2632.16	229	2_DNA_REPLICATION	82	12	0.0009648548400933578501545
TCGA-19-5959.13	92	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0009668719022703319140519
TCGA-32-2615.7	77	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0009670852614719992320844
TCGA-06-0140.2	25	2_NEUROLOGICAL_SYSTEM_PROCESS	296	8	0.0009702005369041673396233
TCGA-02-0034.5	6	1_KEGG_ASTHMA	30	3	0.0009703223555124101170483
TCGA-76-6193.13	271	2_EXTRACELLULAR_SPACE	192	20	0.0009730191791430715681638
TCGA-02-0026.1	61	2_ORGANELLE_PART	916	20	0.0009730282328061094819852
TCGA-27-2521.10	94	2_CELL_CYCLE_PROCESS	163	11	0.0009754294168918349518943
TCGA-06-5414.13	102	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0009755530337659792591842
TCGA-02-2483.10	100	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0009771548758053972150855
TCGA-02-0011.1	288	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0009780274156130387957359
TCGA-06-2562.7	57	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0009794385683992046665730
TCGA-12-0688.10	93	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0009800237824497582024563
TCGA-08-0350.2	46	2_SYNAPTIC_TRANSMISSION	152	8	0.0009804453384375409405460
TCGA-12-5301.7	46	2_SYNAPTIC_TRANSMISSION	152	8	0.0009804453384375409405460
TCGA-06-1804.6	30	2_NUCLEAR_CHROMOSOME_PART	22	4	0.0009813473044121925371874
TCGA-32-1991.11	82	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0009829659898799318531321
TCGA-76-4925.9	83	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0009841215242798878604091
TCGA-06-0166.5	35	2_EXTRACELLULAR_MATRIX	85	6	0.0009873969907307164096955
TCGA-28-5204.3	4	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	4	0.0009923706157720759216123
TCGA-06-5412.1	28	0_HALLMARK_COMPLEMENT	176	7	0.0009936101458271999475880
TCGA-76-4935.7	15	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0009970171893207457110980
TCGA-28-2509.5	4	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	3	0.0009980279902263710246207
TCGA-02-0033.1	4	2_EXTRACELLULAR_MATRIX_PART	51	3	0.0009980279902263710246207
TCGA-06-0126.3	4	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	3	0.0009980279902263710246207
TCGA-08-0347.4	16	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0009982368892663098965123
TCGA-19-2623.11	153	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0010008473200733244198174
TCGA-28-5220.7	15	2_DNA_METABOLIC_PROCESS	218	6	0.0010015778762815375890066
TCGA-76-6192.6	43	2_ORGAN_DEVELOPMENT	460	12	0.0010030246868339147588156
TCGA-06-0686.10	26	2_MICROTUBULE_CYTOSKELETON	117	6	0.0010078061830481655804237
TCGA-27-2528.10	99	2_CELL_CYCLE_GO_0007049	265	14	0.0010082348597869050799147
TCGA-06-0154.2	5	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	3	0.0010089636545425389665964
TCGA-32-4211.7	5	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	3	0.0010089636545425389665964
TCGA-76-4927.8	93	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0010099822364786693092847
TCGA-02-0054.3	93	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0010099822364786693092847
TCGA-08-0358.9	43	2_NEUROLOGICAL_SYSTEM_PROCESS	296	10	0.0010140346220492968670052
TCGA-06-0192.10	126	2_RECEPTOR_ACTIVITY	499	22	0.0010167544189828832488370
TCGA-28-2513.12	134	2_COLLAGEN	23	6	0.0010180796740117089346084
TCGA-06-0686.5	14	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0010193741354483968307443
TCGA-08-0357.4	36	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0010208251064964563459975
TCGA-06-0877.7	4	2_CELL_CYCLE_GO_0007049	265	4	0.0010230805817773877628568
TCGA-06-0877.7	4	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0010230805817773877628568
TCGA-16-0861.5	4	2_CELL_CYCLE_GO_0007049	265	4	0.0010230805817773877628568
TCGA-06-2561.7	4	2_CELL_CYCLE_GO_0007049	265	4	0.0010230805817773877628568
TCGA-08-0348.3	4	2_CELL_CYCLE_GO_0007049	265	4	0.0010230805817773877628568
TCGA-08-0348.3	4	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0010230805817773877628568
TCGA-06-0221.13	45	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0010248608762027247923165
TCGA-06-0241.8	53	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0010272503934409720274812
TCGA-06-0216.6	67	1_KEGG_MELANOMA	71	7	0.0010281449406311501601485
TCGA-06-2557.11	177	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0010306167581751483550145
TCGA-32-1979.4	12	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0010311889428938280591913
TCGA-06-0145.17	11	2_CELL_CYCLE_PROCESS	163	5	0.0010322263615828474511010
TCGA-02-2470.4	11	2_CELL_CYCLE_PROCESS	163	5	0.0010322263615828474511010
TCGA-06-2569.5	144	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0010327529718608856670881
TCGA-19-1790.18	201	0_HALLMARK_INFLAMMATORY_RESPONSE	170	16	0.0010336244416907064934408
TCGA-06-0686.1	7	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0010346620888498818738310
TCGA-26-5135.9	71	1_KEGG_BLADDER_CANCER	42	6	0.0010404145083967703509786
TCGA-02-0024.6	206	2_CELL_CYCLE_PHASE	146	15	0.0010423249445846007130850
TCGA-32-2615.7	77	2_EXTRACELLULAR_REGION	346	14	0.0010496754612116683796214
TCGA-14-0787.6	40	0_HALLMARK_MYC_TARGETS_V1	178	8	0.0010534396395299823381148
TCGA-32-2491.14	244	1_KEGG_FOCAL_ADHESION	195	19	0.0010627948394970343232863
TCGA-06-0197.1	57	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0010635206140546273317210
TCGA-06-0171.7	57	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0010635206140546273317210
TCGA-32-4211.14	71	2_COLLAGEN	23	5	0.0010635904428012129055436
TCGA-02-0086.2	17	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0010647568016528467880338
TCGA-06-0178.2	17	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0010647568016528467880338
TCGA-19-5952.11	193	2_GLYCOSAMINOGLYCAN_BINDING	26	7	0.0010652084008663869566652
TCGA-32-2494.10	173	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0010679419282234540317100
TCGA-41-2571.7	72	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0010733074089878526062580
TCGA-12-5299.5	6	2_REGULATION_OF_CELL_GROWTH	31	3	0.0010740290711921758517317
TCGA-27-1833.7	17	2_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0010755041580235542245797
TCGA-27-1833.7	17	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0010755041580235542245797
TCGA-12-3650.17	101	2_M_PHASE	94	9	0.0010778678047485416077039
TCGA-06-5413.11	142	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	10	0.0010792845556737357733817
TCGA-26-1439.10	84	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0010800308794765198748544
TCGA-28-1753.13	174	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0010833559966495918871349
TCGA-06-5415.7	7	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0010864810746585619200683
TCGA-19-1390.13	110	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	7	0.0010866815714191005535355
TCGA-02-0011.1	288	0_HALLMARK_APOPTOSIS	150	18	0.0010878935691532238324436
TCGA-14-0787.6	40	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0010911170305584097072610
TCGA-06-0882.6	21	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	6	0.0010914888988743298367523
TCGA-02-0001.5	117	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	8	0.0010989224575612438917355
TCGA-06-0130.3	155	0_HALLMARK_E2F_TARGETS	169	14	0.0010992556730292969442014
TCGA-16-0846.2	27	1_KEGG_CELL_CYCLE	114	6	0.0011001066612534454464828
TCGA-06-2570.8	95	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0011004871289035773017362
TCGA-06-0176.8	95	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0011004871289035773017362
TCGA-06-0171.7	57	0_HALLMARK_E2F_TARGETS	169	9	0.0011027172984627328471141
TCGA-02-0038.3	199	2_DNA_REPAIR	113	13	0.0011100259431391871350892
TCGA-08-0357.4	36	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0011131300528396839526202
TCGA-06-0744.10	36	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0011131300528396839526202
TCGA-02-0016.2	29	2_CELL_CELL_SIGNALING	353	9	0.0011181588101579753840448
TCGA-06-0878.10	115	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0011189075557934580629899
TCGA-02-0015.16	115	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0011189075557934580629899
TCGA-08-0352.2	59	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0011191844993782874839727
TCGA-06-0216.6	67	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0011216775815798601858425
TCGA-08-0386.4	73	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0011224015862438970446424
TCGA-16-0861.5	4	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	3	0.0011225006697692836710178
TCGA-02-0054.3	93	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0011234607499772473592631
TCGA-26-5135.9	71	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0011243039183009969836369
TCGA-32-4719.15	123	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0011264318563253608845159
TCGA-41-2571.7	72	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0011312829848541643140702
TCGA-19-2624.24	3	2_PHOTORECEPTOR_CELL_MAINTENANCE	5	2	0.0011358270105119685263600
TCGA-19-5947.4	267	1_KEGG_CELL_CYCLE	114	15	0.0011360037951628765284795
TCGA-02-0046.8	148	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0011364793101485172466258
TCGA-06-0174.37	141	2_SPINDLE	35	7	0.0011382284144542840695347
TCGA-02-0068.1	72	2_COLLAGEN	23	5	0.0011411419419444155092663
TCGA-06-5411.4	23	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	5	0.0011411419419444157261068
TCGA-08-0352.2	59	2_EXTRACELLULAR_REGION_PART	269	11	0.0011429521811988103269231
TCGA-12-1597.6	51	1_KEGG_DNA_REPLICATION	32	5	0.0011430074500473749385399
TCGA-28-2501.3	51	0_HALLMARK_ANGIOGENESIS	32	5	0.0011430074500473749385399
TCGA-19-2619.14	100	2_CELL_CYCLE_GO_0007049	265	14	0.0011433317602802114346799
TCGA-32-1979.10	116	2_RESPONSE_TO_WOUNDING	163	12	0.0011433923838150303418232
TCGA-02-0046.8	148	2_CYTOSKELETON	293	18	0.0011448002589891047558329
TCGA-06-0686.6	3	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	3	0.0011459777728703756174977
TCGA-19-5958.2	3	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	3	0.0011459777728703756174977
TCGA-76-4928.15	78	1_KEGG_GLIOMA	62	7	0.0011480635681170390377526
TCGA-19-5955.9	110	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0011492143253537818580606
TCGA-06-2562.7	57	2_EXTRACELLULAR_MATRIX	85	7	0.0011535870092939846075220
TCGA-06-0176.8	95	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0011554886180929607990969
TCGA-14-4157.7	101	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0011560102089095420762471
TCGA-32-1980.1	24	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	5	0.0011568078883567335917587
TCGA-06-0875.7	78	2_REGULATION_OF_CELL_CYCLE	160	10	0.0011576351548468922104257
TCGA-19-2629.15	146	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0011606477749938578277605
TCGA-12-5295.8	66	2_CELL_CYCLE_PHASE	146	9	0.0011606477749938578277605
TCGA-02-0060.19	281	2_DEFENSE_RESPONSE	222	22	0.0011609824300662493958697
TCGA-32-4213.15	198	1_KEGG_CELL_CYCLE	114	13	0.0011612662477369546393940
TCGA-28-5207.12	188	2_AXON	10	5	0.0011620427671538888746150
TCGA-27-2518.5	20	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0011622442278423953353206
TCGA-02-0080.3	20	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0011622442278423953353206
TCGA-06-0241.8	53	2_MITOTIC_CELL_CYCLE	134	8	0.0011626512137363777775467
TCGA-08-0354.7	47	2_SYNAPTIC_TRANSMISSION	152	8	0.0011655930169295243298971
TCGA-08-0380.5	47	2_SYNAPTIC_TRANSMISSION	152	8	0.0011655930169295243298971
TCGA-28-5219.9	47	2_SYNAPTIC_TRANSMISSION	152	8	0.0011655930169295243298971
TCGA-06-0744.3	12	2_RECEPTOR_ACTIVITY	499	7	0.0011677207994614576674897
TCGA-02-0060.19	281	2_PLASMA_MEMBRANE	1096	61	0.0011689823857693021867676
TCGA-41-3915.10	109	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0011700575492548351448641
TCGA-08-0357.4	36	2_EXTRACELLULAR_MATRIX	85	6	0.0011763941029712947795166
TCGA-06-0210.6	103	1_KEGG_ASTHMA	30	6	0.0011767717579729678779865
TCGA-32-1986.12	17	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	4	0.0011785643785563704958458
TCGA-26-5134.3	21	2_SYNAPTIC_TRANSMISSION	152	6	0.0011801154482213600110940
TCGA-02-0028.9	182	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0011804879461976025036007
TCGA-06-0142.3	8	2_COLLAGEN	23	3	0.0011833456061492654727563
TCGA-06-0138.2	30	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0011853305412804207227828
TCGA-76-4925.9	83	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0011907767744320811240111
TCGA-28-5220.7	15	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0011936134589285963495536
TCGA-02-0052.3	116	1_KEGG_FOCAL_ADHESION	195	13	0.0011943407589977269797621
TCGA-02-0071.12	116	1_KEGG_FOCAL_ADHESION	195	13	0.0011943407589977269797621
TCGA-06-0195.8	56	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0011957315565933341466875
TCGA-32-4208.28	140	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0011961023287971668960933
TCGA-16-1048.13	97	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0011969080548340051747130
TCGA-41-2571.7	72	2_MITOTIC_CELL_CYCLE	134	9	0.0011980034959041558489945
TCGA-02-0048.9	84	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0012008731784658387663212
TCGA-06-5414.13	102	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0012023665382461829354704
TCGA-41-3392.31	136	1_KEGG_MELANOMA	71	9	0.0012027909236451688346908
TCGA-41-2575.49	136	1_KEGG_MELANOMA	71	9	0.0012027909236451688346908
TCGA-02-0071.12	116	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0012044450399005537325620
TCGA-27-2527.6	79	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0012073799298862894577994
TCGA-76-6191.6	96	2_CELL_CYCLE_PROCESS	163	11	0.0012094614144287961846058
TCGA-28-5214.11	124	2_CELL_CELL_SIGNALING	353	18	0.0012144211799530375307798
TCGA-81-5910.12	128	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0012157417594950909508350
TCGA-06-2567.9	156	1_KEGG_FOCAL_ADHESION	195	15	0.0012158084738608460409481
TCGA-28-5209.15	194	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0012184722618604941837828
TCGA-76-4935.7	15	2_MICROTUBULE_CYTOSKELETON	117	5	0.0012286467845243603108640
TCGA-02-0011.1	288	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	40	0.0012318550294818314885803
TCGA-26-5132.7	100	1_KEGG_MELANOMA	71	8	0.0012321925670537388266407
TCGA-06-0145.17	11	0_HALLMARK_E2F_TARGETS	169	5	0.0012354831732585649407830
TCGA-06-6390.6	11	0_HALLMARK_E2F_TARGETS	169	5	0.0012354831732585649407830
TCGA-16-1048.13	97	0_HALLMARK_ANGIOGENESIS	32	6	0.0012369538662062487099219
TCGA-06-2565.3	60	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0012384570801532441674392
TCGA-28-5214.11	124	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0012446254517948849953324
TCGA-14-0813.5	5	2_CELL_SURFACE_RECEPTOR_LINKED_SIGNAL_TRANSDUCTION_GO_0007166	563	5	0.0012486894122644203938832
TCGA-06-5411.3	19	1_KEGG_ALLOGRAFT_REJECTION	37	4	0.0012502751617508144760249
TCGA-41-5651.5	112	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0012511371273755528526345
TCGA-32-2491.14	244	2_REGULATION_OF_CELL_CYCLE	160	17	0.0012523503741048921944490
TCGA-06-0158.4	65	1_KEGG_FOCAL_ADHESION	195	10	0.0012564589694477031143333
TCGA-19-5952.11	193	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0012596161223036169644202
TCGA-06-0148.6	69	1_KEGG_MELANOMA	71	7	0.0012604476264270439607451
TCGA-06-5858.19	205	2_INTERPHASE	62	10	0.0012627294345785699397622
TCGA-02-0099.11	141	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0012628858513154257552091
TCGA-32-2632.16	229	0_HALLMARK_ALLOGRAFT_REJECTION	190	18	0.0012687462114903155611934
TCGA-16-1045.10	81	1_KEGG_FOCAL_ADHESION	195	11	0.0012688816820138986134897
TCGA-32-2491.14	244	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0012688911789921614430704
TCGA-02-0003.9	227	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0012704446815790504908550
TCGA-02-0007.17	217	2_REGULATION_OF_CELL_CYCLE	160	16	0.0012730079233573960133946
TCGA-06-0241.8	53	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0012747323925743645010172
TCGA-06-0686.6	3	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	3	0.0012747986444249222257735
TCGA-19-5958.2	3	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	3	0.0012747986444249222257735
TCGA-19-5947.4	267	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	13	0.0012770025460612276571593
TCGA-06-0649.13	88	2_CELL_CELL_SIGNALING	353	15	0.0012837266022596306291187
TCGA-06-2570.8	95	2_CHROMOSOME	102	9	0.0012838172952895528233785
TCGA-06-0145.4	7	2_MICROTUBULE_CYTOSKELETON	117	4	0.0012840738460695732842815
TCGA-06-5414.13	102	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0012845512164678014616764
TCGA-28-2502.9	56	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0012855257643381932507881
TCGA-06-6391.9	26	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0012906399913480282991979
TCGA-06-5412.7	153	2_PATTERN_BINDING	33	7	0.0012908972383417250968246
TCGA-02-0011.1	288	2_DNA_METABOLIC_PROCESS	218	22	0.0012916487961742203604415
TCGA-02-0058.1	110	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0012925355897841787813224
TCGA-02-0071.12	116	2_CELL_CYCLE_GO_0007049	265	15	0.0012965391140149498064998
TCGA-26-1439.10	84	2_EXTRACELLULAR_MATRIX	85	8	0.0012989481666078204948750
TCGA-27-2528.10	99	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0012994937279898733338557
TCGA-02-0086.2	17	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0013011870712731177061883
TCGA-32-1986.12	17	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	4	0.0013011870712731177061883
TCGA-02-0058.1	110	2_NEURON_PROJECTION	16	5	0.0013014552732945820334026
TCGA-16-1048.13	97	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0013073189730449677557061
TCGA-02-0038.3	199	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	7	0.0013101244284506744289254
TCGA-02-0024.6	206	2_INTRACELLULAR_ORGANELLE_PART	912	43	0.0013125362370673516413527
TCGA-06-0750.13	8	2_INTEGRAL_TO_MEMBRANE	956	7	0.0013128747986550178862564
TCGA-28-2501.3	51	2_CYTOSKELETAL_PART	194	9	0.0013155535038398820466693
TCGA-02-0060.19	281	2_IMMUNE_RESPONSE	206	21	0.0013167082664191456266300
TCGA-28-1753.13	174	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0013174230780912030668028
TCGA-19-5952.11	193	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0013231740285662091718977
TCGA-08-0347.4	16	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0013247421965711493954676
TCGA-06-0877.7	4	2_PROTEIN_KINASE_BINDING	56	3	0.0013279380428747897344849
TCGA-08-0348.3	4	2_PROTEIN_KINASE_BINDING	56	3	0.0013279380428747897344849
TCGA-06-2559.11	101	1_KEGG_MELANOMA	71	8	0.0013302373182868304415244
TCGA-06-0645.9	136	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0013312583863341225561688
TCGA-06-5413.11	142	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0013328333951460893079533
TCGA-32-2632.16	229	1_KEGG_MISMATCH_REPAIR	23	7	0.0013346411898764710089738
TCGA-02-0052.3	116	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0013352314420819449275468
TCGA-76-4934.4	20	2_TRANSMISSION_OF_NERVE_IMPULSE	164	6	0.0013368838983801947534885
TCGA-02-0001.5	117	2_TRANSMISSION_OF_NERVE_IMPULSE	164	12	0.0013403767613881607465021
TCGA-14-4157.7	101	0_HALLMARK_DNA_REPAIR	125	10	0.0013446119980023672757508
TCGA-27-1836.8	49	2_CELL_CYCLE_GO_0007049	265	10	0.0013455869001770292322367
TCGA-28-5220.7	15	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	8	0.0013501946951230486219236
TCGA-02-0060.19	281	2_SIGNAL_TRANSDUCTION	1442	74	0.0013503878511759734391134
TCGA-28-2514.9	62	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0013521594282141966535116
TCGA-06-0214.9	62	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0013521594282141966535116
TCGA-06-0211.8	62	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0013521594282141966535116
TCGA-32-1979.4	12	1_KEGG_GLIOMA	62	4	0.0013521594282142157354698
TCGA-32-1979.4	12	2_INTERPHASE	62	4	0.0013521594282142157354698
TCGA-27-2524.5	75	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0013523649948850818662549
TCGA-08-0353.8	100	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0013531773863713107090151
TCGA-02-0028.9	182	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0013544930824833706275306
TCGA-06-0219.6	6	2_CELL_CYCLE_PHASE	146	4	0.0013545792962007230895993
TCGA-08-0244.4	6	2_CELL_CYCLE_PHASE	146	4	0.0013545792962007230895993
TCGA-12-5299.5	6	2_CELL_CYCLE_PHASE	146	4	0.0013545792962007230895993
TCGA-14-1829.11	6	2_CELL_CYCLE_PHASE	146	4	0.0013545792962007230895993
TCGA-14-2554.9	6	2_CELL_CYCLE_PHASE	146	4	0.0013545792962007230895993
TCGA-32-4208.28	140	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0013587975780850597689459
TCGA-19-5960.9	134	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0013622684660317344994968
TCGA-19-5960.9	134	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0013622684660317344994968
TCGA-06-0132.2	2	2_INTERLEUKIN_1_SECRETION	9	2	0.0013632810598856977876009
TCGA-06-0139.1	179	2_CELL_CELL_SIGNALING	353	22	0.0013665111649100972375515
TCGA-06-0878.10	115	2_EXTRACELLULAR_MATRIX	85	9	0.0013734206675169648593365
TCGA-02-0015.16	115	2_EXTRACELLULAR_MATRIX	85	9	0.0013734206675169648593365
TCGA-02-0099.11	141	2_COLLAGEN	23	6	0.0013747237908198163200413
TCGA-06-2561.5	42	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0013760744316053728861921
TCGA-32-2634.10	118	2_MITOTIC_CELL_CYCLE	134	11	0.0013765899350040974782189
TCGA-06-5412.7	153	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0013795104492221488701881
TCGA-06-5856.13	152	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0013798092354450920953707
TCGA-06-5408.3	99	1_KEGG_FOCAL_ADHESION	195	12	0.0013840867912649880769327
TCGA-06-0879.9	84	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0013854372887423728900186
TCGA-32-1977.11	107	0_HALLMARK_KRAS_SIGNALING_UP	148	11	0.0013864129472532776138349
TCGA-28-5209.15	194	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0013874945483492908543388
TCGA-14-0789.10	106	1_KEGG_ASTHMA	30	6	0.0013947775378613178065557
TCGA-27-2524.5	75	2_COLLAGEN	23	5	0.0014009477216679129714383
TCGA-19-1790.18	201	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0014025378065021052581551
TCGA-28-5220.7	15	2_NUCLEUS	1110	10	0.0014026533598553521300228
TCGA-06-0187.10	55	2_NEUROLOGICAL_SYSTEM_PROCESS	296	11	0.0014028416175980943508828
TCGA-06-2563.10	123	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0014052826208146801476723
TCGA-06-0190.8	143	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0014060678850311121926286
TCGA-12-3650.17	101	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0014084976824505130756082
TCGA-06-0171.7	57	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0014097444179849716056757
TCGA-06-0750.13	8	2_INTRINSIC_TO_MEMBRANE	966	7	0.0014109629407907556090940
TCGA-06-0173.35	120	1_KEGG_BLADDER_CANCER	42	7	0.0014110007161067276634792
TCGA-32-2632.16	229	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	9	0.0014123487120628241877490
TCGA-27-1835.6	86	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0014219246171669433932011
TCGA-76-4931.10	86	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0014219246171669433932011
TCGA-06-5411.4	23	2_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0014223076860437288120725
TCGA-06-5411.4	23	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0014223076860437288120725
TCGA-76-4929.8	91	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0014238744502379646356821
TCGA-12-0692.6	11	0_HALLMARK_G2M_CHECKPOINT	174	5	0.0014280273412612264245791
TCGA-06-0644.16	142	2_COLLAGEN	23	6	0.0014331403082000714315630
TCGA-06-0644.16	142	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	6	0.0014331403082000714315630
TCGA-02-0083.21	135	2_CYTOSKELETON	293	17	0.0014332026815463828721409
TCGA-02-0048.9	84	2_MICROTUBULE_CYTOSKELETON	117	9	0.0014361366675302575986878
TCGA-02-0102.8	82	1_KEGG_FOCAL_ADHESION	195	11	0.0014393551038876289862450
TCGA-02-0099.11	141	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0014429647086067036183127
TCGA-27-2519.7	113	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0014448038376371865384312
TCGA-02-0026.1	61	2_DNA_REPLICATION	82	7	0.0014459275771509124113717
TCGA-06-5412.7	153	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0014504170573424669983542
TCGA-32-4208.28	140	2_TRANSMISSION_OF_NERVE_IMPULSE	164	13	0.0014532052992587759111115
TCGA-76-4928.15	78	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0014535540729102456800059
TCGA-28-2514.9	62	2_REGULATION_OF_CELL_CYCLE	160	9	0.0014553788196204038921100
TCGA-28-5209.15	194	2_CELL_CELL_SIGNALING	353	23	0.0014573483661117286273173
TCGA-02-0014.10	70	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0014580963118312447249214
TCGA-19-5955.9	110	0_HALLMARK_COMPLEMENT	176	12	0.0014606595615439250772372
TCGA-02-0079.1	5	1_KEGG_FOCAL_ADHESION	195	4	0.0014634696314001027859369
TCGA-19-5947.4	267	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0014639483619711068061731
TCGA-12-5299.6	38	2_CELL_CELL_SIGNALING	353	10	0.0014643292400901221535225
TCGA-06-5414.13	102	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0014654870582330660651327
TCGA-12-0616.7	45	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0014658336609732092615382
TCGA-08-0355.1	45	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0014658336609732092615382
TCGA-06-0645.9	136	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	13	0.0014674738789552661637205
TCGA-08-0347.4	16	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0014680123672726988915543
TCGA-76-4928.15	78	2_AXON	10	4	0.0014692778954676678510732
TCGA-06-2567.9	156	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0014693174871956077905816
TCGA-06-2567.9	156	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0014693174871956077905816
TCGA-06-2567.9	156	2_DNA_REPLICATION	82	10	0.0014715091848468736697442
TCGA-32-2494.10	173	1_KEGG_ASTHMA	30	7	0.0014741517661708972760509
TCGA-02-0024.6	206	2_ORGANELLE_PART	916	43	0.0014777008494376649323787
TCGA-16-0861.5	4	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0014779336709904154247008
TCGA-06-2561.7	4	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0014779336709904154247008
TCGA-02-0071.12	116	2_EXTRACELLULAR_MATRIX	85	9	0.0014781330598388959553235
TCGA-19-2619.14	100	0_HALLMARK_ANGIOGENESIS	32	6	0.0014815811119559881437607
TCGA-19-2619.14	100	1_KEGG_DNA_REPLICATION	32	6	0.0014815811119559881437607
TCGA-19-4068.2	11	1_KEGG_LEISHMANIA_INFECTION	70	4	0.0014818733605298460825200
TCGA-28-5219.9	47	2_CELL_CELL_SIGNALING	353	11	0.0014896821402619804010359
TCGA-28-5208.28	220	2_CELL_CYCLE_GO_0007049	265	21	0.0014926540146777502772457
TCGA-06-0190.8	143	2_COLLAGEN	23	6	0.0014935782065595485084558
TCGA-02-0060.19	281	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	13	0.0014967589400074754468761
TCGA-06-0154.13	76	2_COLLAGEN	23	5	0.0014972164819327228937884
TCGA-32-2638.17	159	0_HALLMARK_E2F_TARGETS	169	14	0.0014993588314743547598717
TCGA-19-1390.12	10	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	5	0.0015031379725826917760634
TCGA-06-2564.7	92	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0015033929739612377114721
TCGA-32-4208.28	140	1_KEGG_CELL_CYCLE	114	11	0.0015080857897645794096775
TCGA-28-5216.8	162	1_KEGG_DNA_REPLICATION	32	7	0.0015180142869781602411872
TCGA-32-2634.10	118	1_KEGG_GLIOMA	62	8	0.0015182606136078427138542
TCGA-06-5415.7	7	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0015193427062773169275434
TCGA-14-3476.4	7	0_HALLMARK_UV_RESPONSE_DN	122	4	0.0015193575655872123067458
TCGA-26-5132.7	100	2_REGULATION_OF_CELL_CYCLE	160	11	0.0015215377898400107761073
TCGA-06-0210.6	103	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0015241782547620232740604
TCGA-14-1829.14	67	2_CELL_CELL_SIGNALING	353	13	0.0015282534615079054925169
TCGA-32-2495.11	67	2_CELL_CELL_SIGNALING	353	13	0.0015282534615079054925169
TCGA-28-5208.28	220	2_REGULATION_OF_CELL_CYCLE	160	16	0.0015299186184571762162770
TCGA-06-5413.11	142	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0015316096930361685658772
TCGA-02-0015.16	115	0_HALLMARK_E2F_TARGETS	169	12	0.0015334087563571060629924
TCGA-28-5215.7	192	2_STRUCTURAL_MOLECULE_ACTIVITY	206	17	0.0015354092251515514318955
TCGA-06-0140.2	25	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0015355909234347684105132
TCGA-06-5412.7	153	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0015444083481316271937861
TCGA-19-2623.11	153	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0015444083481316271937861
TCGA-08-0353.8	100	1_KEGG_FOCAL_ADHESION	195	12	0.0015447270716902063679432
TCGA-02-0084.1	25	1_KEGG_VIRAL_MYOCARDITIS	70	5	0.0015457186601497837578206
TCGA-02-0025.5	88	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0015478903372416706867715
TCGA-28-5220.7	15	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0015502186277641697657176
TCGA-06-0877.8	61	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0015539348045305726754572
TCGA-06-2569.5	144	2_COLLAGEN	23	6	0.0015560914646603599999219
TCGA-32-4213.15	198	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0015614092737321070072931
TCGA-06-0219.6	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317322426
TCGA-08-0244.4	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317322426
TCGA-12-5299.5	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317322426
TCGA-14-1823.12	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317322426
TCGA-14-1829.11	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317322426
TCGA-14-2554.9	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317322426
TCGA-76-6285.5	106	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0015626613957100022201524
TCGA-02-0052.3	116	2_EXTRACELLULAR_REGION_PART	269	15	0.0015677477856923251967741
TCGA-06-0645.9	136	0_HALLMARK_INFLAMMATORY_RESPONSE	170	13	0.0015696689492532974689182
TCGA-06-2559.11	101	1_KEGG_DNA_REPLICATION	32	6	0.0015714221883940588699036
TCGA-06-2561.5	42	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0015784640404959285678310
TCGA-32-2491.14	244	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0015789396442921095880391
TCGA-28-2501.3	51	2_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0015838639199133922302182
TCGA-28-2501.3	51	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0015838639199133922302182
TCGA-06-5414.13	102	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	10	0.0015871348357157967230019
TCGA-76-6191.6	96	2_MITOTIC_CELL_CYCLE	134	10	0.0015918215417059721709242
TCGA-32-2634.10	118	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0015968073163739350799756
TCGA-06-0128.8	74	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0016028709748166277554438
TCGA-32-2632.16	229	1_KEGG_MELANOMA	71	11	0.0016054987035885783658307
TCGA-06-2562.7	57	2_CELL_CELL_SIGNALING	353	12	0.0016084039029729004476044
TCGA-12-0692.3	9	2_ORGAN_DEVELOPMENT	460	6	0.0016156783542202791427445
TCGA-19-1790.18	201	2_AXON	10	5	0.0016195774485421063175472
TCGA-12-5295.8	66	2_SYNAPTIC_TRANSMISSION	152	9	0.0016301895668562620036329
TCGA-06-0174.37	141	1_KEGG_MELANOMA	71	9	0.0016316828301561009471193
TCGA-06-0174.37	141	2_MITOSIS	71	9	0.0016316828301561009471193
TCGA-06-0211.8	62	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0016321245081841689959085
TCGA-02-0007.17	217	2_CELL_CYCLE_PROCESS	163	16	0.0016363123263827242422075
TCGA-12-5299.6	38	2_SYSTEM_PROCESS	451	11	0.0016368663589268518405301
TCGA-06-0158.4	65	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0016377300686408952697798
TCGA-32-1979.10	116	2_EXTRACELLULAR_REGION	346	17	0.0016392571577340305649662
TCGA-14-0789.10	106	2_SYNAPTIC_TRANSMISSION	152	11	0.0016454695452238410000034
TCGA-14-0817.9	85	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	7	0.0016488913999795598748499
TCGA-41-2575.49	136	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0016501041782925798123705
TCGA-06-0192.10	126	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0016546985144643728150166
TCGA-06-2557.11	177	0_HALLMARK_COMPLEMENT	176	15	0.0016574157491004123162609
TCGA-32-1977.11	107	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	8	0.0016576441309449688448624
TCGA-28-5208.28	220	2_NEURON_PROJECTION	16	6	0.0016582957568735375367130
TCGA-28-2514.9	62	2_CELL_CYCLE_GO_0007049	265	11	0.0016598638826863822397922
TCGA-32-2632.16	229	2_CHROMOSOME	102	13	0.0016614169135937657210272
TCGA-32-1977.11	107	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0016656746355150206170825
TCGA-15-1444.3	107	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0016656746355150206170825
TCGA-06-2563.10	123	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0016682618136639501115609
TCGA-19-2625.9	146	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	16	0.0016705590262497981880740
TCGA-19-5954.17	208	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0016711515295322928575245
TCGA-06-0124.6	55	0_HALLMARK_ANGIOGENESIS	32	5	0.0016766066812392342675470
TCGA-12-5299.5	6	2_ENZYME_BINDING	154	4	0.0016781161832271579512771
TCGA-14-1829.14	67	1_KEGG_FOCAL_ADHESION	195	10	0.0016793658572101554434658
TCGA-76-6285.5	106	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0016848347403671853819013
TCGA-12-3649.15	89	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0016887563355280970842087
TCGA-41-2571.7	72	1_KEGG_MELANOMA	71	7	0.0016905614296585380618154
TCGA-28-5216.8	162	2_CORNIFIED_ENVELOPE	12	5	0.0016924375708221638201639
TCGA-27-2524.5	75	2_CELL_CYCLE_GO_0007049	265	12	0.0016934326488621911140781
TCGA-26-5133.10	75	2_CELL_CYCLE_GO_0007049	265	12	0.0016934326488621911140781
TCGA-02-0079.1	5	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	3	0.0016952632202979081924021
TCGA-76-4935.4	5	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	3	0.0016952632202979081924021
TCGA-06-0197.1	57	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	15	0.0016968451848713306945315
TCGA-02-0025.5	88	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0016979436787158516848628
TCGA-27-1832.11	88	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0016979436787158516848628
TCGA-26-5139.10	163	1_KEGG_GLIOMA	62	9	0.0017014009302915387294997
TCGA-06-0876.9	106	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0017107946531146258229567
TCGA-41-3393.5	88	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0017127864966736767917549
TCGA-06-0649.13	88	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0017127864966736767917549
TCGA-02-0043.10	184	1_KEGG_MELANOMA	71	10	0.0017139214477112025072914
TCGA-02-0010.18	184	1_KEGG_MELANOMA	71	10	0.0017139214477112025072914
TCGA-02-0009.6	188	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	38	0.0017154720966429861522817
TCGA-19-2624.19	5	2_TRANSPORT	600	5	0.0017184894503128515883678
TCGA-06-0881.7	203	0_HALLMARK_HYPOXIA	154	15	0.0017196418406998919149037
TCGA-06-0141.1	45	2_ORGAN_DEVELOPMENT	460	12	0.0017204434226621341270241
TCGA-27-1836.8	49	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0017215431439845684837009
TCGA-12-3650.17	101	1_KEGG_FOCAL_ADHESION	195	12	0.0017216883360232444668408
TCGA-19-2623.11	153	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0017226132158338358386224
TCGA-02-0060.19	281	2_INFLAMMATORY_RESPONSE	112	15	0.0017228802036764285718351
TCGA-87-5896.6	131	0_HALLMARK_MYC_TARGETS_V1	178	13	0.0017229759997295218936636
TCGA-06-0152.10	19	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0017234782779342509937553
TCGA-02-2486.9	141	2_DEFENSE_RESPONSE	222	15	0.0017238623139824904486467
TCGA-41-2571.7	72	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0017251858299332002450593
TCGA-06-2570.8	95	2_CHROMOSOMAL_PART	78	8	0.0017252527271257452837899
TCGA-14-0789.10	106	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0017255838064215755014996
TCGA-06-5412.7	153	2_EXTRACELLULAR_MATRIX	85	10	0.0017262736139309804456882
TCGA-27-1833.7	17	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0017263427110997446936591
TCGA-06-0648.6	17	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0017263427110997446936591
TCGA-06-0744.4	11	2_CELL_CELL_SIGNALING	353	6	0.0017372260128938816266947
TCGA-06-0882.1	11	2_CELL_CELL_SIGNALING	353	6	0.0017372260128938816266947
TCGA-06-0130.3	155	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0017403736010319929752160
TCGA-08-0350.2	46	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0017484624550484671127309
TCGA-12-5301.7	46	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0017484624550484671127309
TCGA-28-2514.9	62	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0017587061570338599451879
TCGA-06-0214.9	62	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0017587061570338599451879
TCGA-02-0046.8	148	2_CELL_PROLIFERATION_GO_0008283	436	22	0.0017715949956898546010370
TCGA-19-2629.15	146	2_REGULATION_OF_CELL_CYCLE	160	13	0.0017735820421413623412116
TCGA-06-0184.11	108	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0017743284622301700847319
TCGA-27-2519.7	113	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0017788987340863159341414
TCGA-27-1833.7	17	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0017813118842152813377927
TCGA-02-0086.2	17	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0017813118842152813377927
TCGA-06-0648.6	17	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0017813118842152813377927
TCGA-41-4097.6	48	1_KEGG_ALLOGRAFT_REJECTION	37	5	0.0017822639730838724537315
TCGA-06-0139.1	179	2_ENDOPEPTIDASE_ACTIVITY	91	11	0.0017822878259777989815721
TCGA-06-6391.6	30	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0017864796127672480721693
TCGA-28-5215.7	192	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0017948173050089382286193
TCGA-06-0130.3	155	2_CONTRACTILE_FIBER	22	6	0.0017960442738493976981562
TCGA-16-0861.5	4	1_KEGG_GLIOMA	62	3	0.0018109158535375548346874
TCGA-16-0861.5	4	2_INTERPHASE	62	3	0.0018109158535375548346874
TCGA-06-2561.7	4	2_INTERPHASE	62	3	0.0018109158535375548346874
TCGA-02-0028.9	182	2_CELL_CELL_SIGNALING	353	22	0.0018189914362739178707584
TCGA-26-5133.10	75	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0018201657895760647940669
TCGA-06-0166.5	35	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0018202751144312501706268
TCGA-12-0692.3	9	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	7	0.0018228273189724846642390
TCGA-76-4928.15	78	1_KEGG_BLADDER_CANCER	42	6	0.0018235660039633279187743
TCGA-06-0875.7	78	1_KEGG_BLADDER_CANCER	42	6	0.0018235660039633279187743
TCGA-28-5207.12	188	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0018237714224299259643119
TCGA-76-6191.6	96	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0018249148738154607075207
TCGA-02-0071.12	116	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0018283744987381935539345
TCGA-02-0024.6	206	2_AXON	10	5	0.0018294327690825794990870
TCGA-32-2491.14	244	0_HALLMARK_ANGIOGENESIS	32	8	0.0018342814348722591855784
TCGA-12-3653.55	255	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0018356252239008653132091
TCGA-06-0122.8	90	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0018404222598113388707081
TCGA-06-5414.13	102	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0018412214443327167608805
TCGA-06-0174.37	141	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0018413712291505998207980
TCGA-06-0879.9	84	1_KEGG_FOCAL_ADHESION	195	11	0.0018418488120600191512710
TCGA-19-1790.18	201	2_DEFENSE_RESPONSE	222	18	0.0018423310731685666949420
TCGA-26-5134.3	21	2_TRANSMISSION_OF_NERVE_IMPULSE	164	6	0.0018448737084967466431235
TCGA-06-0155.10	74	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0018461666566375277680895
TCGA-32-2634.10	118	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0018475011663616380981623
TCGA-06-0216.6	67	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0018515601554402196481097
TCGA-19-5952.11	193	2_POLYSACCHARIDE_BINDING	28	7	0.0018520842708183936874133
TCGA-06-0157.7	89	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0018522910442701626728551
TCGA-28-5213.9	143	2_TRANSMISSION_OF_NERVE_IMPULSE	164	13	0.0018530816275286769376218
TCGA-02-0034.5	6	1_KEGG_ALLOGRAFT_REJECTION	37	3	0.0018538954181749113005184
TCGA-32-1977.11	107	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0018541183275936586657279
TCGA-15-1444.3	107	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0018541183275936586657279
TCGA-32-1980.1	24	0_HALLMARK_ANGIOGENESIS	32	4	0.0018560071119806955623061
TCGA-06-0216.6	67	2_SYNAPTIC_TRANSMISSION	152	9	0.0018575517841043550498759
TCGA-14-1829.14	67	2_SYNAPTIC_TRANSMISSION	152	9	0.0018575517841043550498759
TCGA-02-0014.12	5	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	4	0.0018597795567781695656034
TCGA-02-0025.5	88	2_EXTRACELLULAR_MATRIX	85	8	0.0018602397319463076768437
TCGA-02-0009.6	188	0_HALLMARK_COAGULATION	125	13	0.0018696496962284268276294
TCGA-19-5952.11	193	2_RESPONSE_TO_WOUNDING	163	15	0.0018724595420709950078370
TCGA-08-0386.4	73	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0018730180656737400492207
TCGA-06-2558.6	74	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0018730943696064713578642
TCGA-19-2624.29	130	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	6	0.0018764487364096558725396
TCGA-02-0060.19	281	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	10	0.0018772339897989644315335
TCGA-26-1439.11	10	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0019003819210952099024586
TCGA-06-0877.7	4	2_KINASE_BINDING	63	3	0.0019013099459527262047320
TCGA-08-0348.3	4	2_KINASE_BINDING	63	3	0.0019013099459527262047320
TCGA-02-0014.10	70	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0019027861445964689736388
TCGA-06-0241.8	53	1_KEGG_GLIOMA	62	6	0.0019032480217043650470854
TCGA-06-0241.8	53	2_INTERPHASE	62	6	0.0019032480217043650470854
TCGA-27-1834.10	39	2_CELL_CELL_SIGNALING	353	10	0.0019045891640286447682451
TCGA-14-0871.20	216	2_CELL_CYCLE_PHASE	146	15	0.0019063292281997800455690
TCGA-08-0347.4	16	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0019064457565608683084490
TCGA-06-5411.3	19	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	4	0.0019073705288265812955728
TCGA-02-0048.9	84	2_INTERPHASE	62	7	0.0019088018919071092667494
TCGA-14-0786.4	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0019088018919071092667494
TCGA-06-0211.8	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0019088018919071092667494
TCGA-41-3915.10	109	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0019139347063393855833541
TCGA-32-4210.14	109	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0019139347063393855833541
TCGA-14-0787.6	40	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0019155979948841436039109
TCGA-06-5412.7	153	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	10	0.0019265690219577671395135
TCGA-06-0876.9	106	1_KEGG_MELANOMA	71	8	0.0019267912594983355439177
TCGA-14-1825.8	80	2_M_PHASE	94	8	0.0019346059132841555983084
TCGA-02-0014.10	70	2_CELL_CYCLE_PHASE	146	9	0.0019350470237014371494011
TCGA-06-0156.4	80	2_COLLAGEN	23	5	0.0019358338013393584526450
TCGA-14-0813.5	5	2_NEUROTRANSMITTER_RECEPTOR_ACTIVITY	47	3	0.0019365704753599177496276
TCGA-28-2514.9	62	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0019435322692046151822620
TCGA-06-0214.9	62	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0019435322692046151822620
TCGA-06-0211.8	62	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0019435322692046151822620
TCGA-14-0789.11	3	2_CATION_CHANNEL_ACTIVITY	100	3	0.0019447609868713557068620
TCGA-26-1439.7	3	2_CATION_CHANNEL_ACTIVITY	100	3	0.0019447609868713557068620
TCGA-14-1825.5	3	2_CATION_CHANNEL_ACTIVITY	100	3	0.0019447609868713557068620
TCGA-28-5220.7	15	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	4	0.0019448811671261122951959
TCGA-28-5207.12	188	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0019493632659208584307492
TCGA-06-6391.6	30	2_NON_MEMBRANE_BOUND_ORGANELLE	476	10	0.0019560384048766285385035
TCGA-06-6391.6	30	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	10	0.0019560384048766285385035
TCGA-14-0787.6	40	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0019561107873577393903575
TCGA-14-0787.6	40	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0019561107873577393903575
TCGA-06-0219.6	6	2_REGULATION_OF_CELL_CYCLE	160	4	0.0019562130326867895220577
TCGA-08-0244.4	6	2_REGULATION_OF_CELL_CYCLE	160	4	0.0019562130326867895220577
TCGA-12-5299.5	6	2_REGULATION_OF_CELL_CYCLE	160	4	0.0019562130326867895220577
TCGA-14-1829.11	6	2_REGULATION_OF_CELL_CYCLE	160	4	0.0019562130326867895220577
TCGA-14-2554.9	6	2_REGULATION_OF_CELL_CYCLE	160	4	0.0019562130326867895220577
TCGA-08-0360.3	144	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0019594637404616900566712
TCGA-06-0939.7	58	2_CELL_CELL_SIGNALING	353	12	0.0019607337433368539694745
TCGA-06-0192.10	126	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0019638055534813040822750
TCGA-32-2638.17	159	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0019648655978928633580871
TCGA-06-5417.5	79	1_KEGG_BLADDER_CANCER	42	6	0.0019669884572090876734274
TCGA-41-5651.5	112	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0019677209709366063478120
TCGA-32-1970.14	94	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0019797869932379379490084
TCGA-02-0060.19	281	2_EXTRACELLULAR_MATRIX	85	13	0.0019821660518169552898937
TCGA-06-0129.11	110	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0019854803994793410702735
TCGA-02-0058.1	110	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0019854803994793410702735
TCGA-12-5299.5	6	2_CELL_PROLIFERATION_GO_0008283	436	5	0.0019970758490022062769942
TCGA-14-1823.12	6	2_CELL_PROLIFERATION_GO_0008283	436	5	0.0019970758490022062769942
TCGA-02-0038.3	199	2_NUCLEAR_CHROMOSOME	39	8	0.0019981079062629781249727
TCGA-76-4929.8	91	2_CELL_CELL_SIGNALING	353	15	0.0020031841190634815975946
TCGA-27-1830.7	57	0_HALLMARK_ANGIOGENESIS	32	5	0.0020083816956740618148158
TCGA-06-0197.1	57	0_HALLMARK_ANGIOGENESIS	32	5	0.0020083816956740618148158
TCGA-19-5958.4	35	1_KEGG_ENDOMETRIAL_CANCER	52	5	0.0020085863019499408839430
TCGA-14-0817.3	6	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	3	0.0020123201238557999158407
TCGA-14-1823.15	87	2_SYNAPTIC_TRANSMISSION	152	10	0.0020215958869392830314637
TCGA-06-2559.11	101	2_CELL_CYCLE_PROCESS	163	11	0.0020237917923515476997798
TCGA-06-0878.10	115	2_ENZYME_REGULATOR_ACTIVITY	277	15	0.0020278116743212477347813
TCGA-12-3649.15	89	2_EXTRACELLULAR_MATRIX	85	8	0.0020291493450646301381635
TCGA-06-0213.9	74	1_KEGG_MELANOMA	71	7	0.0020408026723403708581339
TCGA-06-5859.9	125	2_DNA_REPLICATION	82	9	0.0020430650060432038565839
TCGA-32-4208.28	140	0_HALLMARK_E2F_TARGETS	169	13	0.0020459976705617458070385
TCGA-16-1045.10	81	2_COLLAGEN	23	5	0.0020599030013037701071499
TCGA-02-0043.10	184	0_HALLMARK_APOPTOSIS	150	14	0.0020645109536729364975438
TCGA-14-0817.9	85	2_INTERPHASE	62	7	0.0020694940414083245333599
TCGA-28-2514.9	62	2_EXTRACELLULAR_MATRIX	85	7	0.0020694940414083245333599
TCGA-06-0214.9	62	2_EXTRACELLULAR_MATRIX	85	7	0.0020694940414083245333599
TCGA-02-0083.21	135	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0020721447071338199713564
TCGA-19-5960.9	134	2_BIOPOLYMER_METABOLIC_PROCESS	1367	41	0.0020742208509487145874639
TCGA-08-0354.7	47	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0020762883627409873393832
TCGA-08-0380.5	47	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0020762883627409873393832
TCGA-28-5219.9	47	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0020762883627409873393832
TCGA-27-1831.9	85	1_KEGG_FOCAL_ADHESION	195	11	0.0020779441710672818394157
TCGA-06-0148.6	69	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0020855059492871272884551
TCGA-76-6192.6	43	2_SYSTEM_DEVELOPMENT	694	14	0.0020857221103889600488657
TCGA-76-6191.6	96	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0020872981829064885840597
TCGA-14-0789.10	106	0_HALLMARK_ANGIOGENESIS	32	6	0.0020902696702111440291150
TCGA-06-0174.37	141	2_M_PHASE	94	10	0.0020903040706929162245720
TCGA-02-0015.16	115	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0020922640242567488826075
TCGA-02-0058.1	110	0_HALLMARK_APOPTOSIS	150	11	0.0020942323795293516473792
TCGA-06-5412.7	153	2_PLASMA_MEMBRANE	1096	39	0.0020987902197949375761310
TCGA-02-0024.6	206	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	8	0.0021004311381653574530848
TCGA-02-0021.4	170	1_KEGG_DNA_REPLICATION	32	7	0.0021008872136140162995011
TCGA-28-5216.8	162	2_CHROMOSOME	102	11	0.0021028293547669398531885
TCGA-19-5960.9	134	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0021043979338757809981197
TCGA-14-0787.6	40	1_KEGG_FOCAL_ADHESION	195	8	0.0021044875698721689227799
TCGA-08-0357.4	36	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0021052938797228464874733
TCGA-06-5411.3	19	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	4	0.0021054642128010702013807
TCGA-06-0219.6	6	2_CELL_CYCLE_PROCESS	163	4	0.0021074980335091557034910
TCGA-08-0244.4	6	2_CELL_CYCLE_PROCESS	163	4	0.0021074980335091557034910
TCGA-12-5299.5	6	2_CELL_CYCLE_PROCESS	163	4	0.0021074980335091557034910
TCGA-14-1829.11	6	2_CELL_CYCLE_PROCESS	163	4	0.0021074980335091557034910
TCGA-14-2554.9	6	2_CELL_CYCLE_PROCESS	163	4	0.0021074980335091557034910
TCGA-19-5947.4	267	1_KEGG_ASTHMA	30	8	0.0021115820332593430649903
TCGA-27-2519.7	113	2_IMMUNE_SYSTEM_PROCESS	283	15	0.0021147824368416279217087
TCGA-14-1825.8	80	1_KEGG_BLADDER_CANCER	42	6	0.0021195132856908255498951
TCGA-27-2524.5	75	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0021264062851716132758473
TCGA-06-5410.3	3	1_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	103	3	0.0021269816035198322104471
TCGA-06-0743.14	63	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0021320984819243157977475
TCGA-32-2634.10	118	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0021322325935242336311659
TCGA-08-0354.5	18	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0021360458242483159121972
TCGA-06-5859.9	125	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	24	0.0021375323097543759420791
TCGA-14-3476.4	7	2_EXTRACELLULAR_REGION	346	5	0.0021385097857585153545423
TCGA-32-2491.14	244	2_CELL_CYCLE_GO_0007049	265	22	0.0021475422406195131437567
TCGA-02-0033.5	144	2_CATION_BINDING	165	13	0.0021501115401554465357548
TCGA-12-0616.1	20	0_HALLMARK_MYC_TARGETS_V1	178	6	0.0021623569561063041982729
TCGA-32-1979.10	116	2_CELL_CELL_SIGNALING	353	17	0.0021631591091825978605268
TCGA-26-5133.10	75	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0021654815975596527176383
TCGA-76-6193.13	271	0_HALLMARK_APOPTOSIS	150	17	0.0021662489868987996194383
TCGA-28-5220.7	15	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	8	0.0021718242172192605242420
TCGA-06-2564.7	92	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0021788785439280193567679
TCGA-32-1986.12	17	1_KEGG_CELL_CYCLE	114	5	0.0021816944557566135196036
TCGA-06-6390.9	82	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	9	0.0021848741829744401307667
TCGA-14-0789.11	3	2_GATED_CHANNEL_ACTIVITY	104	3	0.0021901592749114765119878
TCGA-26-1439.7	3	2_GATED_CHANNEL_ACTIVITY	104	3	0.0021901592749114765119878
TCGA-14-1825.5	3	2_GATED_CHANNEL_ACTIVITY	104	3	0.0021901592749114765119878
TCGA-06-6390.9	82	2_COLLAGEN	23	5	0.0021901665529375120844424
TCGA-16-0861.5	4	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0021904036089462008106421
TCGA-19-2629.15	146	2_CELL_CYCLE_PROCESS	163	13	0.0021908936002376271437453
TCGA-41-2571.7	72	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0021915279786463861232126
TCGA-32-4719.15	123	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0021916678269423648522940
TCGA-02-0010.18	184	2_CELL_CELL_SIGNALING	353	22	0.0021928326013016404515132
TCGA-06-0188.11	66	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0021930780803088791193478
TCGA-26-1439.11	10	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0021992180620423284857778
TCGA-14-0813.5	5	2_NEUROTRANSMITTER_BINDING	49	3	0.0021996919564487862029656
TCGA-08-0347.7	25	0_HALLMARK_ANGIOGENESIS	32	4	0.0022042927574090062300960
TCGA-12-0692.3	9	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	7	0.0022057432538879757737138
TCGA-32-5222.9	70	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0022103954504090151875206
TCGA-32-1979.4	12	1_KEGG_PANCREATIC_CANCER	70	4	0.0022103954504090464125432
TCGA-06-0122.8	90	2_EXTRACELLULAR_MATRIX	85	8	0.0022109697573686514296409
TCGA-08-0354.5	18	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0022118804523953692654781
TCGA-19-5958.4	35	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	5	0.0022119387353426818096369
TCGA-32-2615.7	77	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0022141240424965093896992
TCGA-06-5415.7	7	2_MITOTIC_CELL_CYCLE	134	4	0.0022143734492268856740849
TCGA-08-0360.3	144	2_IMMUNE_SYSTEM_PROCESS	283	17	0.0022163231651718402585860
TCGA-32-1980.1	24	2_EXTRACELLULAR_REGION	346	8	0.0022183859436542769164036
TCGA-02-0052.3	116	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	11	0.0022185830246333713977602
TCGA-06-0143.6	63	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0022187871096360622241717
TCGA-32-2632.16	229	2_NON_MEMBRANE_BOUND_ORGANELLE	476	30	0.0022304496260847090499668
TCGA-32-2632.16	229	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	30	0.0022304496260847090499668
TCGA-06-0241.8	53	2_CELL_CYCLE_PHASE	146	8	0.0022331992540042646180898
TCGA-19-5960.9	134	0_HALLMARK_MYC_TARGETS_V1	178	13	0.0022333715561146604521026
TCGA-14-0813.10	53	1_KEGG_PATHWAYS_IN_CANCER	323	11	0.0022410884215622217836839
TCGA-06-0686.10	26	2_MITOTIC_CELL_CYCLE	134	6	0.0022421563579509873505302
TCGA-19-5960.9	134	2_CONDENSED_CHROMOSOME	26	6	0.0022421563579509873505302
TCGA-19-5960.9	134	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	6	0.0022421563579509873505302
TCGA-32-1986.12	17	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	4	0.0022470639160506733489342
TCGA-41-4097.6	48	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	16	0.0022489378140988368522113
TCGA-06-0130.3	155	2_STRUCTURAL_MOLECULE_ACTIVITY	206	15	0.0022493980563671857678121
TCGA-02-2485.14	172	2_CHROMOSOMAL_PART	78	10	0.0022494352180124524247240
TCGA-06-0649.13	88	2_SYNAPTIC_TRANSMISSION	152	10	0.0022496495347796132205365
TCGA-14-0787.6	40	2_EXTRACELLULAR_MATRIX	85	6	0.0022525760856813106282337
TCGA-19-2625.9	146	2_NUCLEUS	1110	38	0.0022546251028590096228410
TCGA-02-2483.10	100	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0022658933074371449128970
TCGA-16-0861.5	4	1_KEGG_PATHWAYS_IN_CANCER	323	4	0.0022673387264994715115107
TCGA-06-0174.35	4	2_PHOTORECEPTOR_CELL_MAINTENANCE	5	2	0.0022711730186414200334533
TCGA-27-1838.17	131	2_CHROMOSOME	102	10	0.0022724101592659280181297
TCGA-02-2485.14	172	1_KEGG_DNA_REPLICATION	32	7	0.0022728260181662158535831
TCGA-06-0143.6	63	2_EXTRACELLULAR_REGION_PART	269	11	0.0022731728915952186149962
TCGA-02-0011.1	288	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0022745673625067792771037
TCGA-32-1986.8	87	0_HALLMARK_HYPOXIA	154	10	0.0022788476421145816355751
TCGA-12-3653.55	255	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0022817361619188285259963
TCGA-12-3653.55	255	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0022817361619188285259963
TCGA-06-0140.2	25	2_TRANSPORT	600	10	0.0022894116412385981211564
TCGA-02-0052.3	116	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0022967345142960045832614
TCGA-28-1753.13	174	2_REGULATION_OF_CELL_CYCLE	160	14	0.0022993546904796898985857
TCGA-06-0129.11	110	2_CYTOSKELETON	293	15	0.0023071592406170913884533
TCGA-02-0058.1	110	2_CYTOSKELETON	293	15	0.0023071592406170913884533
TCGA-28-2509.6	59	0_HALLMARK_MYC_TARGETS_V1	178	9	0.0023072391832396860027188
TCGA-06-0192.10	126	0_HALLMARK_ALLOGRAFT_REJECTION	190	13	0.0023092511222082231538144
TCGA-27-1833.7	17	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0023131308416843156076925
TCGA-02-0086.2	17	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0023131308416843156076925
TCGA-06-0648.6	17	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0023131308416843156076925
TCGA-06-0650.2	82	2_EXTRACELLULAR_REGION	346	14	0.0023269281280341351861307
TCGA-02-0102.8	82	2_EXTRACELLULAR_REGION	346	14	0.0023269281280341351861307
TCGA-41-3392.31	136	0_HALLMARK_COMPLEMENT	176	13	0.0023275807256489268980137
TCGA-02-0048.9	84	2_REGULATION_OF_CELL_CYCLE	160	10	0.0023282316296128553918809
TCGA-02-2483.10	100	2_MITOTIC_CELL_CYCLE	134	10	0.0023283246421340344188555
TCGA-12-3653.55	255	0_HALLMARK_MYC_TARGETS_V1	178	18	0.0023296791346407138070806
TCGA-32-1979.4	12	1_KEGG_MELANOMA	71	4	0.0023407657100924560492072
TCGA-06-0185.13	71	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0023407657100924560492072
TCGA-32-1970.14	94	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0023421205302027068781423
TCGA-28-5214.11	124	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0023462562255761299466472
TCGA-08-0386.4	73	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0023482989818496436545958
TCGA-28-2509.6	59	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	15	0.0023487026933580613247132
TCGA-06-5415.7	7	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	4	0.0023499320036133100608744
TCGA-32-1982.9	89	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	10	0.0023533427690887198137359
TCGA-06-0158.4	65	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0023533989335642810369897
TCGA-06-0219.6	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826152977936
TCGA-08-0244.4	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826152977936
TCGA-12-5299.5	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826152977936
TCGA-14-1823.12	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826152977936
TCGA-14-1829.11	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826152977936
TCGA-14-2554.9	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826152977936
TCGA-19-5947.4	267	2_IMMUNE_RESPONSE	206	20	0.0023615420824218136264250
TCGA-76-6193.13	271	1_KEGG_ASTHMA	30	8	0.0023620561297304698208932
TCGA-27-2528.10	99	0_HALLMARK_E2F_TARGETS	169	11	0.0023660458153231841808839
TCGA-02-0007.17	217	2_AXON	10	5	0.0023671203423117691093391
TCGA-02-0009.6	188	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0023674002209729590878728
TCGA-32-1979.10	116	1_KEGG_ASTHMA	30	6	0.0023734493087281503809205
TCGA-06-0878.10	115	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0023735381255087983562446
TCGA-02-0015.16	115	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0023735381255087983562446
TCGA-76-4927.8	93	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0023752969266459451370965
TCGA-28-5207.12	188	2_CYTOSKELETON	293	20	0.0023791442181430185430491
TCGA-08-0352.2	59	2_CELL_CELL_SIGNALING	353	12	0.0023797342601298743409999
TCGA-14-2554.5	59	2_CELL_CELL_SIGNALING	353	12	0.0023797342601298743409999
TCGA-76-6191.6	96	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0023820452102482777244352
TCGA-19-2624.24	3	2_MICROVILLUS	7	2	0.0023848999669261110138929
TCGA-19-5960.9	134	2_CHROMOSOMAL_PART	78	9	0.0023890782432533477948333
TCGA-12-3652.19	88	2_AXON	10	4	0.0023897006907099035792619
TCGA-08-0352.2	59	0_HALLMARK_ANGIOGENESIS	32	5	0.0023899138532588043437599
TCGA-14-0789.10	106	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0023902922059452721449679
TCGA-14-0789.10	106	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0023902922059452721449679
TCGA-76-6285.5	106	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0023902922059452721449679
TCGA-32-4210.14	109	2_REPLICATION_FORK	18	5	0.0023947215857795917624828
TCGA-06-0148.6	69	2_SYNAPTIC_TRANSMISSION	152	9	0.0023955699630529335777962
TCGA-12-0616.7	45	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0023968253381514655932227
TCGA-14-0781.7	155	2_COLLAGEN	23	6	0.0023971793794809680665236
TCGA-06-0130.3	155	2_COLLAGEN	23	6	0.0023971793794809680665236
TCGA-32-2494.10	173	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	18	0.0023994474287684980015611
TCGA-27-1836.8	49	2_REGULATION_OF_CELL_CYCLE	160	8	0.0023996092779646547958616
TCGA-02-0047.8	185	2_CELL_CELL_SIGNALING	353	22	0.0024049897197118705674534
TCGA-19-5947.4	267	2_IMMUNE_SYSTEM_PROCESS	283	24	0.0024070576367121181322883
TCGA-28-5220.7	15	2_MITOTIC_CELL_CYCLE	134	5	0.0024114458128336713725604
TCGA-76-4935.7	15	2_MITOTIC_CELL_CYCLE	134	5	0.0024114458128336713725604
TCGA-06-0156.4	80	0_HALLMARK_E2F_TARGETS	169	10	0.0024298468599952640668838
TCGA-28-5220.7	15	2_PROTEIN_KINASE_BINDING	56	4	0.0024326321048459549449550
TCGA-27-2518.4	6	0_HALLMARK_E2F_TARGETS	169	4	0.0024360818622308458465675
TCGA-12-5299.5	6	0_HALLMARK_E2F_TARGETS	169	4	0.0024360818622308458465675
TCGA-76-6193.13	271	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0024409074079038131296904
TCGA-02-0086.2	17	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0024441034690318775603191
TCGA-06-0648.6	17	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0024441034690318775603191
TCGA-41-2575.49	136	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	6	0.0024457729964249175398650
TCGA-02-0001.5	117	2_CELL_CELL_SIGNALING	353	17	0.0024459936204714988715325
TCGA-06-0154.13	76	1_KEGG_MELANOMA	71	7	0.0024499215698894926708518
TCGA-06-5859.9	125	2_MITOTIC_CELL_CYCLE	134	11	0.0024524083367559552579240
TCGA-02-0038.3	199	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0024529180152981135826229
TCGA-02-0102.8	82	1_KEGG_BLADDER_CANCER	42	6	0.0024536476831451799543449
TCGA-32-2638.17	159	2_EXTRACELLULAR_MATRIX	85	10	0.0024559239214361049813418
TCGA-28-1753.13	174	1_KEGG_DNA_REPLICATION	32	7	0.0024564246935876526099773
TCGA-02-0052.3	116	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0024574674759988137870415
TCGA-02-0071.12	116	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0024574674759988137870415
TCGA-26-5133.10	75	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0024628951267255919273247
TCGA-32-2498.13	133	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0024644956987553579691452
TCGA-41-2571.7	72	2_CELL_CYCLE_PHASE	146	9	0.0024669638446546127141801
TCGA-02-0058.1	110	2_CELL_DEVELOPMENT	511	20	0.0024687657657963945484481
TCGA-26-1439.10	84	2_COLLAGEN	23	5	0.0024701721768679452823081
TCGA-06-0127.2	23	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0024701721768679452823081
TCGA-32-1979.4	12	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	4	0.0024767714663093539848027
TCGA-19-2624.29	130	2_INTRACELLULAR_ORGANELLE_PART	912	31	0.0024805529398265854963690
TCGA-19-1790.18	201	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	11	0.0024838876037801024647400
TCGA-06-0126.7	5	2_EXTRACELLULAR_MATRIX_PART	51	3	0.0024855615365190686025243
TCGA-06-2567.9	156	1_KEGG_MISMATCH_REPAIR	23	6	0.0024891848118968446477994
TCGA-06-5415.7	7	2_REGULATION_OF_KINASE_ACTIVITY	138	4	0.0024915835543350187651634
TCGA-12-0620.1	2	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0024993486097923873524851
TCGA-06-0133.2	2	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0024993486097923873524851
TCGA-02-0023.1	2	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0024993486097923873524851
TCGA-02-0010.16	2	2_PHAGOCYTOSIS	12	2	0.0024993486097923873524851
TCGA-06-0127.4	2	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0024993486097923873524851
TCGA-08-0355.3	2	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0024993486097923873524851
TCGA-06-5858.19	205	2_NUCLEAR_CHROMOSOME	39	8	0.0025001033842613597582560
TCGA-06-0188.11	66	2_REGULATION_OF_CELL_CYCLE	160	9	0.0025062663202104476165011
TCGA-06-0192.10	126	2_PLASMA_MEMBRANE	1096	34	0.0025066232873601455855006
TCGA-06-2558.6	74	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0025137866345944573365223
TCGA-19-5947.4	267	2_RECEPTOR_ACTIVITY	499	34	0.0025148550916672331341506
TCGA-02-0010.18	184	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0025230202748930926140436
TCGA-12-0618.5	41	2_CELL_CYCLE_GO_0007049	265	9	0.0025293993934849849300472
TCGA-02-0027.3	81	2_CELL_CELL_SIGNALING	353	14	0.0025313383943433840662929
TCGA-06-0152.10	19	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0025347406286156228330531
TCGA-06-0176.8	95	2_DNA_REPLICATION	82	8	0.0025377463690128372261756
TCGA-06-0219.6	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739426451
TCGA-02-0034.5	6	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	3	0.0025410108637575739426451
TCGA-08-0244.4	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739426451
TCGA-12-5299.5	6	2_REGULATION_OF_GROWTH	41	3	0.0025410108637575739426451
TCGA-12-5299.5	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739426451
TCGA-14-1823.12	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739426451
TCGA-14-1829.11	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739426451
TCGA-14-2554.9	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739426451
TCGA-02-0001.5	117	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0025435881093880370953930
TCGA-14-1829.3	8	2_MICROTUBULE_CYTOSKELETON	117	4	0.0025435881093880730909051
TCGA-32-1977.11	107	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0025471559867367770876867
TCGA-15-1444.3	107	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0025471559867367770876867
TCGA-14-4157.7	101	2_MITOTIC_CELL_CYCLE	134	10	0.0025533566303361891758339
TCGA-02-2483.10	100	2_CHROMOSOMAL_PART	78	8	0.0025553073543913120205251
TCGA-06-0129.11	110	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	8	0.0025559493304398912295883
TCGA-32-1982.9	89	0_HALLMARK_ALLOGRAFT_REJECTION	190	11	0.0025646699135832844336502
TCGA-08-0246.6	62	2_SIGNAL_TRANSDUCTION	1442	25	0.0025682455564509211812241
TCGA-14-1456.4	41	1_KEGG_FOCAL_ADHESION	195	8	0.0025688339555269210090493
TCGA-27-2521.10	94	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0025690361476229488235656
TCGA-06-2559.11	101	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0025799694299850932030505
TCGA-27-2521.10	94	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0025881066519811788545491
TCGA-06-2564.7	92	2_CELL_CYCLE_GO_0007049	265	13	0.0025885633270670603892083
TCGA-19-5959.13	92	2_CELL_CYCLE_GO_0007049	265	13	0.0025885633270670603892083
TCGA-32-2491.14	244	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0025916459289346436764556
TCGA-41-5651.5	112	2_M_PHASE	94	9	0.0025929755436235948917734
TCGA-28-5220.7	15	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	5	0.0025951482227137044958565
TCGA-76-4927.8	93	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0025953610474492849746753
TCGA-06-0176.8	95	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0026059678640368531821192
TCGA-02-2470.4	11	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0026092905579022545627110
TCGA-41-3392.31	136	0_HALLMARK_APOPTOSIS	150	12	0.0026094112733929921213449
TCGA-28-5216.8	162	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	126	12	0.0026131290622161467904205
TCGA-06-2564.7	92	2_EXTRACELLULAR_MATRIX	85	8	0.0026165858258491675285284
TCGA-06-0877.7	4	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	3	0.0026194147197289795701847
TCGA-16-0861.5	4	1_KEGG_PANCREATIC_CANCER	70	3	0.0026194147197289795701847
TCGA-28-2509.5	4	1_KEGG_LEISHMANIA_INFECTION	70	3	0.0026194147197289795701847
TCGA-28-2509.5	4	1_KEGG_VIRAL_MYOCARDITIS	70	3	0.0026194147197289795701847
TCGA-06-0126.3	4	1_KEGG_LEISHMANIA_INFECTION	70	3	0.0026194147197289795701847
TCGA-06-0126.3	4	1_KEGG_VIRAL_MYOCARDITIS	70	3	0.0026194147197289795701847
TCGA-08-0348.3	4	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	3	0.0026194147197289795701847
TCGA-02-0060.19	281	2_BLOOD_COAGULATION	39	9	0.0026203487618864803286589
TCGA-02-0060.19	281	2_COAGULATION	39	9	0.0026203487618864803286589
TCGA-27-1831.9	85	2_COLLAGEN	23	5	0.0026203742226190117337037
TCGA-12-0616.1	20	1_KEGG_BLADDER_CANCER	42	4	0.0026233644873580905070021
TCGA-32-2634.10	118	1_KEGG_ASTHMA	30	6	0.0026242351890139545972369
TCGA-02-0074.5	118	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0026319371856342106859306
TCGA-19-4068.6	42	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0026361829689906415667700
TCGA-32-4213.12	5	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	3	0.0026373183680241797481603
TCGA-06-5415.7	7	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	4	0.0026395052204698185062404
TCGA-41-2575.49	136	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0026505562160257529341623
TCGA-08-0389.4	56	2_INTERPHASE	62	6	0.0026509265291395152537579
TCGA-76-4928.15	78	1_KEGG_PANCREATIC_CANCER	70	7	0.0026546147482438761655565
TCGA-06-0216.6	67	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0026602184476162559108314
TCGA-02-0054.3	93	2_CELL_CELL_SIGNALING	353	15	0.0026660412622793315702563
TCGA-02-2485.14	172	1_KEGG_GLIOMA	62	9	0.0026677127427262520634188
TCGA-28-5207.12	188	0_HALLMARK_APOPTOSIS	150	14	0.0026713813818817085631030
TCGA-06-0745.4	55	1_KEGG_FOCAL_ADHESION	195	9	0.0026734022758272820916026
TCGA-06-0750.13	8	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0026876100268588584522866
TCGA-06-5415.3	8	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0026876100268588584522866
TCGA-06-0221.4	8	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0026876100268588584522866
TCGA-02-0114.20	132	1_KEGG_BLADDER_CANCER	42	7	0.0026879395303217664021933
TCGA-02-0114.20	132	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0026879395303217664021933
TCGA-02-0038.3	199	2_DNA_BINDING	496	28	0.0026942322929494333383360
TCGA-06-0184.11	108	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	10	0.0026972532433933073953147
TCGA-06-0184.11	108	0_HALLMARK_ALLOGRAFT_REJECTION	190	12	0.0027006773529178532133876
TCGA-06-0188.11	66	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0027074790395044813322289
TCGA-08-0359.5	37	2_APOPTOSIS_GO	389	10	0.0027081110784026255627888
TCGA-12-0618.5	41	2_CELL_PROLIFERATION_GO_0008283	436	11	0.0027097740275991029877678
TCGA-32-5222.9	70	2_SYNAPTIC_TRANSMISSION	152	9	0.0027116538232445580938745
TCGA-19-2624.29	130	2_ORGANELLE_PART	916	31	0.0027238044543982480039102
TCGA-06-5415.7	7	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0027271852629225509442867
TCGA-06-0686.1	7	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	6	0.0027312846695618448258913
TCGA-16-0861.5	4	1_KEGG_MELANOMA	71	3	0.0027347587956296584045524
TCGA-02-0034.5	6	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	3	0.0027358196436129819315020
TCGA-12-5299.5	6	1_KEGG_BLADDER_CANCER	42	3	0.0027358196436129819315020
TCGA-06-0881.7	203	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0027378784526538753330005
TCGA-27-2518.4	6	0_HALLMARK_G2M_CHECKPOINT	174	4	0.0027379043167632438789127
TCGA-19-2624.19	5	2_ESTABLISHMENT_OF_LOCALIZATION	659	5	0.0027508622267822364047818
TCGA-06-2559.11	101	2_CHROMOSOMAL_PART	78	8	0.0027568153390085817569521
TCGA-26-5139.10	163	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0027585356421003445759332
TCGA-27-1838.17	131	2_CELL_CELL_SIGNALING	353	18	0.0027628415279953360758625
TCGA-02-0075.8	128	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0027658660416564691438002
TCGA-15-0742.13	74	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0027663182522523082663979
TCGA-08-0359.5	37	2_PROGRAMMED_CELL_DEATH	390	10	0.0027719434764731467647769
TCGA-02-0007.17	217	2_IDENTICAL_PROTEIN_BINDING	256	20	0.0027731072392214155958312
TCGA-08-0354.5	18	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0027735518870179898427708
TCGA-28-5215.7	192	0_HALLMARK_E2F_TARGETS	169	15	0.0027760234874671945067004
TCGA-06-0176.8	95	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0027854571163431676023015
TCGA-28-5220.7	15	2_REGULATION_OF_KINASE_ACTIVITY	138	5	0.0027897339011021616075880
TCGA-02-0003.9	227	0_HALLMARK_COAGULATION	125	14	0.0027916530750265984919811
TCGA-28-5220.7	15	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0028047737153603230497723
TCGA-06-0173.35	120	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0028109027293320562254642
TCGA-06-0173.35	120	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0028154707568384599973565
TCGA-08-0359.5	37	2_COLLAGEN	23	4	0.0028245535663696413365698
TCGA-02-0048.9	84	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0028296725709964151707076
TCGA-08-0359.5	37	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	10	0.0028370889608726398978256
TCGA-32-2634.10	118	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0028464038320973809696735
TCGA-16-0861.5	4	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	3	0.0028534335207909028615803
TCGA-02-0003.9	227	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0028551319036032754387910
TCGA-32-1986.12	17	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	4	0.0028763730391878081574242
TCGA-06-5411.4	23	2_REGULATION_OF_CELL_CYCLE	160	6	0.0028866290929270921675198
TCGA-02-0115.4	3	1_KEGG_CELL_CYCLE	114	3	0.0028920532216875601341788
TCGA-06-0143.3	3	1_KEGG_CELL_CYCLE	114	3	0.0028920532216875601341788
TCGA-06-0750.9	3	1_KEGG_CELL_CYCLE	114	3	0.0028920532216875601341788
TCGA-27-1834.9	3	1_KEGG_CELL_CYCLE	114	3	0.0028920532216875601341788
TCGA-06-0882.9	3	1_KEGG_CELL_CYCLE	114	3	0.0028920532216875601341788
TCGA-02-0089.5	91	0_HALLMARK_P53_PATHWAY	151	10	0.0028943025197515261787151
TCGA-06-0686.1	7	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	6	0.0029089179030689481936234
TCGA-14-4157.7	101	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0029244310490659699425242
TCGA-32-4213.15	198	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0029248144902439660551552
TCGA-12-5295.8	66	2_CELL_CYCLE_PROCESS	163	9	0.0029265780708817895790219
TCGA-14-3476.17	53	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0029306481157172410180467
TCGA-41-5651.5	112	2_MITOSIS	71	8	0.0029312057870152551444787
TCGA-12-5295.8	66	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0029374594813336880883003
TCGA-06-0211.8	62	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0029374919035105402295716
TCGA-32-1986.8	87	2_COLLAGEN	23	5	0.0029423637997075448996531
TCGA-27-1832.11	88	1_KEGG_FOCAL_ADHESION	195	11	0.0029535854458754323866032
TCGA-06-0649.13	88	1_KEGG_FOCAL_ADHESION	195	11	0.0029535854458754323866032
TCGA-12-0620.1	2	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0029537756297555142932787
TCGA-32-2634.8	2	2_PHOSPHOLIPASE_C_ACTIVATION	13	2	0.0029537756297555142932787
TCGA-06-0133.2	2	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0029537756297555142932787
TCGA-02-0023.1	2	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0029537756297555142932787
TCGA-06-0127.4	2	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0029537756297555142932787
TCGA-08-0355.3	2	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0029537756297555142932787
TCGA-02-0003.9	227	2_AXON	10	5	0.0029579791842637460919097
TCGA-02-0069.12	62	2_NON_MEMBRANE_BOUND_ORGANELLE	476	14	0.0029611393313430265858410
TCGA-02-0069.12	62	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	14	0.0029611393313430265858410
TCGA-12-3653.55	255	2_INTRACELLULAR_ORGANELLE_PART	912	49	0.0029665254625537854429873
TCGA-02-0026.1	61	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0029686175010234698914968
TCGA-19-5960.9	134	1_KEGG_BLADDER_CANCER	42	7	0.0029741669226112268757667
TCGA-06-0744.3	12	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	3	0.0029799153778913580435661
TCGA-28-5220.7	15	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	5	0.0029956666150700822330577
TCGA-06-0148.6	69	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0029958298818349529159255
TCGA-19-5951.10	138	2_EXTRACELLULAR_REGION_PART	269	16	0.0029964011924395435662594
TCGA-19-1790.18	201	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0030093961494004456934392
TCGA-41-4097.6	48	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	5	0.0030178699554404483929027
TCGA-02-2470.4	11	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0030193630537621168885565
TCGA-19-2623.11	153	2_REGULATION_OF_CELL_CYCLE	160	13	0.0030208140938602300561155
TCGA-06-0174.37	141	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	6	0.0030218171014939664356658
TCGA-19-1390.12	10	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	5	0.0030229436588325624482576
TCGA-06-0137.9	53	2_SYNAPTIC_TRANSMISSION	152	8	0.0030278239711610237944184
TCGA-27-1838.17	131	2_DNA_REPLICATION	82	9	0.0030289093773648856355862
TCGA-87-5896.6	131	2_DNA_REPLICATION	82	9	0.0030289093773648856355862
TCGA-08-0245.4	85	1_KEGG_BLADDER_CANCER	42	6	0.0030346173968994437364355
TCGA-19-4068.6	42	2_EXTRACELLULAR_MATRIX	85	6	0.0030346173968994437364355
TCGA-41-3393.5	88	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0030409185950469293582832
TCGA-19-5950.7	113	1_KEGG_DNA_REPLICATION	32	6	0.0030448266613434839256147
TCGA-14-0789.11	3	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	3	0.0030483557188141015455163
TCGA-26-1439.7	3	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	3	0.0030483557188141015455163
TCGA-32-2494.8	3	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	3	0.0030483557188141015455163
TCGA-14-1825.5	3	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	3	0.0030483557188141015455163
TCGA-06-0152.10	19	2_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0030569634529834686584304
TCGA-06-0152.10	19	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0030569634529834686584304
TCGA-32-4211.14	71	2_SYNAPTIC_TRANSMISSION	152	9	0.0030630809991002596985588
TCGA-27-2526.7	71	2_SYNAPTIC_TRANSMISSION	152	9	0.0030630809991002596985588
TCGA-02-0069.12	62	1_KEGG_DNA_REPLICATION	32	5	0.0030670278491158639404268
TCGA-28-2514.9	62	0_HALLMARK_ANGIOGENESIS	32	5	0.0030670278491158639404268
TCGA-06-0214.9	62	0_HALLMARK_ANGIOGENESIS	32	5	0.0030670278491158639404268
TCGA-06-0211.8	62	1_KEGG_DNA_REPLICATION	32	5	0.0030670278491158639404268
TCGA-19-5955.9	110	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0030704482005904686417463
TCGA-06-0645.9	136	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0030747944143343091012721
TCGA-12-5295.8	66	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0030795847585462204215601
TCGA-06-0154.13	76	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0030803129352408764769777
TCGA-41-2572.8	76	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0030803129352408764769777
TCGA-27-2521.10	94	2_EXTRACELLULAR_MATRIX	85	8	0.0030839608386107482916605
TCGA-02-0023.3	24	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0030985086644475146218369
TCGA-19-5958.4	35	1_KEGG_PATHWAYS_IN_CANCER	323	9	0.0031051756078943372474388
TCGA-12-0619.11	123	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0031084300894812398260991
TCGA-06-2563.10	123	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0031084300894812398260991
TCGA-06-0189.3	118	0_HALLMARK_COMPLEMENT	176	12	0.0031134973997800864317642
TCGA-32-2634.10	118	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	14	0.0031139995121492241789141
TCGA-19-5950.7	113	2_DNA_METABOLIC_PROCESS	218	13	0.0031144370151801326063179
TCGA-02-0025.5	88	2_COLLAGEN	23	5	0.0031146411139654022436074
TCGA-27-1832.11	88	2_COLLAGEN	23	5	0.0031146411139654022436074
TCGA-41-3393.5	88	2_COLLAGEN	23	5	0.0031146411139654022436074
TCGA-06-0649.13	88	2_COLLAGEN	23	5	0.0031146411139654022436074
TCGA-19-4068.6	42	1_KEGG_FOCAL_ADHESION	195	8	0.0031176499833446618889510
TCGA-06-0169.5	42	1_KEGG_FOCAL_ADHESION	195	8	0.0031176499833446618889510
TCGA-02-0033.5	144	2_CALCIUM_ION_BINDING	75	9	0.0031196423327494232288770
TCGA-06-5415.7	7	2_CELL_CYCLE_PHASE	146	4	0.0031226977150768343502452
TCGA-06-5408.3	99	2_NUCLEUS	1110	29	0.0031246432748258212534764
TCGA-28-5220.7	15	2_REGULATION_OF_CELL_PROLIFERATION	265	6	0.0031464468094106589485248
TCGA-19-2624.29	130	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0031494424550437835966243
TCGA-12-5299.6	38	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0031517696426228191189378
TCGA-06-2557.11	177	2_EXTRACELLULAR_REGION	346	21	0.0031586980181315909947670
TCGA-32-5222.9	70	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0031749640504052270388591
TCGA-02-0024.6	206	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0031816503948952070887635
TCGA-27-1837.5	85	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0031835702176814554761886
TCGA-06-0188.11	66	2_EXTRACELLULAR_MATRIX	85	7	0.0031835702176814554761886
TCGA-76-4926.9	66	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0031859516728824600548253
TCGA-27-2527.6	79	1_KEGG_MELANOMA	71	7	0.0031910042212712338635661
TCGA-41-2575.49	136	2_CHROMOSOME	102	10	0.0032030092900155265021878
TCGA-02-0038.3	199	2_NUCLEOPLASM	233	18	0.0032088590453623619738743
TCGA-28-5214.11	124	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0032109463931236379222178
TCGA-41-3393.5	88	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0032153882831560923367953
TCGA-06-0649.13	88	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0032153882831560923367953
TCGA-06-2565.10	38	2_DNA_METABOLIC_PROCESS	218	8	0.0032168707664071410218254
TCGA-32-2491.14	244	2_CYTOSKELETON	293	23	0.0032196355969503955701816
TCGA-06-0156.4	80	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0032251882525411311626595
TCGA-32-4209.2	56	2_NEURON_PROJECTION	16	4	0.0032292374053536081375537
TCGA-02-0021.4	170	2_DNA_REPLICATION	82	10	0.0032300916038118412769442
TCGA-41-4097.6	48	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	16	0.0032549764731559767752533
TCGA-08-0358.9	43	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0032653035501609278812296
TCGA-41-5651.5	112	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0032653872300726820634975
TCGA-06-0875.7	78	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0032699878535737687650087
TCGA-06-0686.10	26	2_CHROMOSOMAL_PART	78	5	0.0032699878535737687650087
TCGA-28-5215.7	192	2_CYTOSKELETAL_PART	194	16	0.0032850827638620213114184
TCGA-06-0645.9	136	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0032855024603776284211620
TCGA-06-0152.10	19	2_KINESIN_COMPLEX	13	3	0.0032909762802231182915458
TCGA-06-0152.10	19	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0032909762802231182915458
TCGA-02-0069.8	7	1_KEGG_ALZHEIMERS_DISEASE	148	4	0.0032975184704799112567208
TCGA-32-1970.14	94	2_CELL_CYCLE_GO_0007049	265	13	0.0033217745341228110782239
TCGA-41-2571.7	72	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0033225927957582107076517
TCGA-02-0114.20	132	2_DNA_METABOLIC_PROCESS	218	14	0.0033369099288806120667816
TCGA-14-4157.7	101	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0033416812694031902859770
TCGA-32-4213.15	198	1_KEGG_MELANOMA	71	10	0.0033429085112069421327485
TCGA-02-0060.19	281	2_CELL_CELL_SIGNALING	353	28	0.0033437026546945121906196
TCGA-28-5220.7	15	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0033475823987346021819167
TCGA-19-1790.18	201	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0033520800556223616546714
TCGA-06-0185.13	71	1_KEGG_CELL_CYCLE	114	8	0.0033524164570807209184711
TCGA-27-2526.7	71	1_KEGG_CELL_CYCLE	114	8	0.0033524164570807209184711
TCGA-19-4068.7	14	2_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0033587995550454800494644
TCGA-19-4068.7	14	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0033587995550454800494644
TCGA-06-0185.13	71	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0033619395404748341447954
TCGA-12-3653.55	255	2_ORGANELLE_PART	916	49	0.0033653705087267446645349
TCGA-06-0878.10	115	0_HALLMARK_ANGIOGENESIS	32	6	0.0033748405085906323271072
TCGA-02-0015.16	115	0_HALLMARK_ANGIOGENESIS	32	6	0.0033748405085906323271072
TCGA-06-0750.13	8	2_PLASMA_MEMBRANE	1096	7	0.0033782581802208836579959
TCGA-06-0219.6	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682235938946
TCGA-08-0244.4	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682235938946
TCGA-12-5299.5	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682235938946
TCGA-14-1823.12	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682235938946
TCGA-14-1829.11	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682235938946
TCGA-14-2554.9	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682235938946
TCGA-02-0075.8	128	2_EXTRACELLULAR_MATRIX	85	9	0.0033866030819953646738285
TCGA-26-5135.9	71	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0033868553845205037929056
TCGA-12-0619.11	123	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0033889262985340139200385
TCGA-32-4719.15	123	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0033889262985340139200385
TCGA-41-4097.6	48	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	5	0.0034127002204910402045901
TCGA-76-4928.15	78	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0034200637696945143835514
TCGA-08-0389.4	56	2_CELL_CYCLE_PHASE	146	8	0.0034418846234154846890074
TCGA-06-0132.2	2	2_REGULATION_OF_CYTOKINE_SECRETION	14	2	0.0034460715680489652744389
TCGA-12-3653.55	255	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	9	0.0034604880611357733723177
TCGA-14-0789.11	3	2_ION_CHANNEL_ACTIVITY	121	3	0.0034635267099502268367539
TCGA-26-1439.7	3	2_ION_CHANNEL_ACTIVITY	121	3	0.0034635267099502268367539
TCGA-14-1825.5	3	2_ION_CHANNEL_ACTIVITY	121	3	0.0034635267099502268367539
TCGA-32-2632.16	229	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	10	0.0034635901770467881523319
TCGA-28-2513.12	134	2_NEURON_PROJECTION	16	5	0.0034677240097087495829253
TCGA-06-0882.1	11	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	3	0.0034700599604679839560450
TCGA-12-0821.9	81	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0034708566917014366075278
TCGA-28-1747.5	81	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0034708566917014366075278
TCGA-06-0129.11	110	2_NUCLEUS	1110	31	0.0034740455392948304050305
TCGA-32-1979.4	12	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0034740818045436040045759
TCGA-14-1825.8	80	2_MITOSIS	71	7	0.0034762562213337226679766
TCGA-12-0616.1	20	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0034778800985607407660061
TCGA-06-0122.8	90	2_COLLAGEN	23	5	0.0034830230864349707477212
TCGA-02-2485.14	172	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0034876386183283194716842
TCGA-06-1804.7	47	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0034883174277161471156516
TCGA-19-2624.19	5	2_REGULATION_OF_TRANSPORT	57	3	0.0034889794492714487281204
TCGA-19-5954.17	208	2_EXTRACELLULAR_REGION	346	23	0.0035047850859224916227064
TCGA-06-0216.6	67	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0035050767203385108268521
TCGA-14-1829.14	67	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0035050767203385108268521
TCGA-27-1834.10	39	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0035063154891069080523747
TCGA-08-0355.2	7	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	3	0.0035117759023188034085694
TCGA-02-0026.1	61	2_MITOTIC_CELL_CYCLE	134	8	0.0035121919573872784070545
TCGA-19-4068.7	14	2_REPLICATION_FORK	18	3	0.0035257703429298140052062
TCGA-76-6193.13	271	2_RECEPTOR_ACTIVITY	499	34	0.0035359753095028328799543
TCGA-32-1979.10	116	0_HALLMARK_ANGIOGENESIS	32	6	0.0035504844615046634963285
TCGA-02-0071.12	116	0_HALLMARK_ANGIOGENESIS	32	6	0.0035504844615046634963285
TCGA-32-4208.28	140	0_HALLMARK_APOPTOSIS	150	12	0.0035511000326798364441772
TCGA-02-0114.20	132	1_KEGG_COLORECTAL_CANCER	62	8	0.0035577657005868091114054
TCGA-02-0114.20	132	1_KEGG_GLIOMA	62	8	0.0035577657005868091114054
TCGA-28-1747.5	81	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0035580965696647396008523
TCGA-19-4068.2	11	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	4	0.0035611999642700732128520
TCGA-02-0043.10	184	0_HALLMARK_ANGIOGENESIS	32	7	0.0035721699801174104475787
TCGA-08-0359.5	37	2_REGULATION_OF_APOPTOSIS	309	9	0.0035727127209935196847090
TCGA-06-2565.10	38	2_NUCLEUS	1110	16	0.0035736888115039970245657
TCGA-27-1838.17	131	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0035920489652133944825929
TCGA-06-6389.1	18	2_CELL_CELL_SIGNALING	353	7	0.0036082748318470008602743
TCGA-19-5947.4	267	0_HALLMARK_ANGIOGENESIS	32	8	0.0036128389118364897213131
TCGA-14-0787.6	40	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0036153625492205921851396
TCGA-41-3915.10	109	2_REGULATION_OF_CELL_CYCLE	160	11	0.0036160490080125937129019
TCGA-08-0347.7	25	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	5	0.0036236670201800712763640
TCGA-02-0003.9	227	2_STRUCTURAL_MOLECULE_ACTIVITY	206	18	0.0036318777326502659115459
TCGA-06-5411.3	19	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	4	0.0036323005325307592718043
TCGA-81-5910.12	128	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0036463742615592208660968
TCGA-02-0075.8	128	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0036463742615592208660968
TCGA-32-4213.15	198	1_KEGG_ASTHMA	30	7	0.0036498895489181231062414
TCGA-06-0197.1	57	1_KEGG_FOCAL_ADHESION	195	9	0.0036502137702130749846718
TCGA-19-5952.11	193	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	14	0.0036516342247807933273085
TCGA-08-0359.5	37	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	9	0.0036695140327507825769859
TCGA-28-5220.7	15	2_INTERPHASE	62	4	0.0036740508439093945078358
TCGA-06-0122.8	90	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0036784951216367774151639
TCGA-28-5204.5	5	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0036787007491090764448038
TCGA-14-0871.20	216	1_KEGG_FOCAL_ADHESION	195	17	0.0036820006029119434036445
TCGA-28-5220.7	15	2_CELL_CYCLE_PHASE	146	5	0.0036863664213598159105634
TCGA-14-0871.20	216	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0036913454923971399448956
TCGA-76-6282.11	185	0_HALLMARK_ANGIOGENESIS	32	7	0.0037039613668007494683143
TCGA-06-0686.10	26	2_CELL_CYCLE_PHASE	146	6	0.0037044124044002782643326
TCGA-26-1439.11	10	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0037047090012235091814607
TCGA-06-0197.1	57	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	15	0.0037118977214439692613457
TCGA-08-0347.4	16	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0037226113501349937170981
TCGA-41-3393.5	88	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0037234288997951888594562
TCGA-06-0649.13	88	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0037234288997951888594562
TCGA-06-0649.13	88	0_HALLMARK_COAGULATION	125	9	0.0037266195815002746069555
TCGA-06-6390.9	82	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0037316331894781296259211
TCGA-19-5960.9	134	2_NUCLEAR_PART	466	21	0.0037553191521854114263979
TCGA-02-0089.5	91	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0037560353798982318122845
TCGA-41-2571.7	72	2_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0037613884348057799802967
TCGA-41-2571.7	72	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0037613884348057799802967
TCGA-08-0386.4	73	1_KEGG_FOCAL_ADHESION	195	10	0.0037788595906601959648063
TCGA-14-1825.8	80	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0037869098991682014626603
TCGA-06-0156.4	80	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0037869098991682014626603
TCGA-27-1836.8	49	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0037881001779620083851075
TCGA-06-5413.11	142	0_HALLMARK_COMPLEMENT	176	13	0.0037992408578074437358607
TCGA-14-4157.7	101	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0038098893489154172890820
TCGA-14-0789.11	3	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	125	3	0.0038215695954115051768962
TCGA-26-1439.7	3	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	125	3	0.0038215695954115051768962
TCGA-14-1825.5	3	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	125	3	0.0038215695954115051768962
TCGA-19-2625.9	146	1_KEGG_PATHWAYS_IN_CANCER	323	18	0.0038244100286845047337314
TCGA-14-1825.8	80	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0038246024509568849782115
TCGA-19-2631.15	84	0_HALLMARK_E2F_TARGETS	169	10	0.0038314731150189042935272
TCGA-06-0184.11	108	2_CELL_CELL_SIGNALING	353	16	0.0038444684746797223688641
TCGA-28-2502.9	56	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0038474142508611842115884
TCGA-06-0195.8	56	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0038474142508611842115884
TCGA-02-0007.17	217	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0038485946950770890881421
TCGA-19-2624.29	130	2_EXTRACELLULAR_MATRIX	85	9	0.0038547957633737364550874
TCGA-28-2502.9	56	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	12	0.0038571595061968125262020
TCGA-19-2620.8	6	2_NEUROTRANSMITTER_RECEPTOR_ACTIVITY	47	3	0.0038596125764654154455258
TCGA-27-1833.2	41	2_SIGNAL_TRANSDUCTION	1442	19	0.0038818766405293312141134
TCGA-19-5959.13	92	2_COLLAGEN	23	5	0.0038849173616940621718563
TCGA-06-0216.6	67	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0038860049121493740222066
TCGA-08-0375.6	65	1_KEGG_DNA_REPLICATION	32	5	0.0038869453096738019494405
TCGA-06-0189.3	118	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0039011552458732530815344
TCGA-32-2634.10	118	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0039011552458732530815344
TCGA-19-2631.1	6	2_RECEPTOR_ACTIVITY	499	5	0.0039103290804750464801365
TCGA-19-2620.8	6	2_RECEPTOR_ACTIVITY	499	5	0.0039103290804750464801365
TCGA-19-1790.18	201	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0039137166104861688051275
TCGA-06-0686.6	3	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	3	0.0039147786099337387663577
TCGA-19-5958.2	3	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	3	0.0039147786099337387663577
TCGA-28-5220.7	15	2_KINASE_BINDING	63	4	0.0039194730132158153018684
TCGA-28-5215.7	192	2_CORNIFIED_ENVELOPE	12	5	0.0039224081812682604422649
TCGA-06-0241.8	53	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	6	0.0039228341730862944722324
TCGA-32-2634.10	118	0_HALLMARK_ANGIOGENESIS	32	6	0.0039242121525590182087861
TCGA-28-1753.13	174	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0039386901391261705529523
TCGA-28-1747.5	81	2_CELL_CYCLE_GO_0007049	265	12	0.0039473545889106096545840
TCGA-06-0188.11	66	0_HALLMARK_E2F_TARGETS	169	9	0.0039527248376886965283705
TCGA-06-5418.5	13	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	5	0.0039712723700662594036870
TCGA-15-0742.13	74	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0039721298983413002442466
TCGA-12-0821.9	81	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0039809205697153614636474
TCGA-19-5960.9	134	2_INTERPHASE	62	8	0.0039848363366801146240315
TCGA-12-3653.55	255	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0039881468380622972155769
TCGA-32-4208.28	140	1_KEGG_BLADDER_CANCER	42	7	0.0039905279384881775853189
TCGA-19-1390.12	10	2_CATION_CHANNEL_ACTIVITY	100	4	0.0039938503038238377940150
TCGA-27-1838.17	131	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0040006969709221124401055
TCGA-76-4925.9	83	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0040081130601092073220681
TCGA-08-0355.1	45	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0040081130601092073220681
TCGA-02-0058.1	110	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0040105481001939070548334
TCGA-32-1979.4	12	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0040197443054809977106001
TCGA-19-1790.18	201	1_KEGG_ASTHMA	30	7	0.0040354019385111924642096
TCGA-76-6193.13	271	0_HALLMARK_ANGIOGENESIS	32	8	0.0040383127766192381674637
TCGA-12-3650.17	101	2_DNA_REPLICATION	82	8	0.0040459750247761891786547
TCGA-06-0124.6	55	2_SYNAPTIC_TRANSMISSION	152	8	0.0040478144554716250988480
TCGA-19-5960.9	134	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0040561167945449309521488
TCGA-08-0347.7	25	2_EXTRACELLULAR_MATRIX	85	5	0.0040793436696100514662899
TCGA-27-2523.5	3	2_NUCLEOTIDE_KINASE_ACTIVITY	9	2	0.0040878226487615831538647
TCGA-12-0688.10	93	2_COLLAGEN	23	5	0.0040991043526090028756292
TCGA-08-0244.5	39	2_SYNAPTIC_TRANSMISSION	152	7	0.0041004585356004775650862
TCGA-06-0650.2	82	1_KEGG_MELANOMA	71	7	0.0041110456109104904012796
TCGA-02-0034.5	6	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	3	0.0041159363670717529284926
TCGA-19-2624.29	130	2_CYTOSKELETON	293	16	0.0041172128490140095721794
TCGA-02-0007.17	217	2_DNA_REPLICATION	82	11	0.0041211566196956506483162
TCGA-02-0114.20	132	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0041243075396442674396269
TCGA-06-5413.11	142	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0041259469159524615744505
TCGA-41-2573.4	31	1_KEGG_ASTHMA	30	4	0.0041382704468604838282664
TCGA-02-0011.1	288	0_HALLMARK_IL2_STAT5_SIGNALING	148	17	0.0041404569232748669738164
TCGA-06-0878.10	115	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0041418133157094354224181
TCGA-02-0015.16	115	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0041418133157094354224181
TCGA-27-1838.17	131	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0041496667316652793497389
TCGA-02-0021.4	170	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0041508695225881660564871
TCGA-08-0360.3	144	0_HALLMARK_KRAS_SIGNALING_UP	148	12	0.0041513441359687895670927
TCGA-28-5219.9	47	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	4	0.0041521494657266021927056
TCGA-19-2624.29	130	2_CYTOSKELETAL_PART	194	13	0.0041639790415706565834819
TCGA-14-0871.20	216	2_MICROTUBULE_CYTOSKELETON	117	13	0.0041781441437889867487887
TCGA-41-2575.49	136	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0041821338239841545497688
TCGA-06-0174.37	141	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0041852953531422709687604
TCGA-02-0001.5	117	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0041873959514491200170627
TCGA-06-0188.11	66	0_HALLMARK_ANGIOGENESIS	32	5	0.0041955141030254414907796
TCGA-32-2632.16	229	2_CHROMOSOMAL_PART	78	11	0.0042015286052988504855721
TCGA-12-3650.17	101	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0042068130263485442252303
TCGA-02-0114.20	132	2_MITOTIC_CELL_CYCLE	134	11	0.0042078983619685131692401
TCGA-32-2634.10	118	2_REGULATION_OF_MOLECULAR_FUNCTION	286	15	0.0042110831768217196063864
TCGA-06-0189.3	118	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0042161666717708363646966
TCGA-28-5215.7	192	2_CALCIUM_ION_BINDING	75	10	0.0042296114744068483148887
TCGA-08-0380.4	6	2_CYTOSKELETAL_PART	194	4	0.0042315410502875650325394
TCGA-32-2494.10	173	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0042369053084605964865084
TCGA-06-0939.7	58	1_KEGG_FOCAL_ADHESION	195	9	0.0042444034946417571324551
TCGA-14-0786.4	62	0_HALLMARK_APICAL_JUNCTION	182	9	0.0042661201918598058019372
TCGA-32-4719.15	123	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0042679905907194483349887
TCGA-27-1830.7	57	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0042766594835810332192461
TCGA-32-4719.15	123	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0042954122346616548794307
TCGA-12-0616.7	45	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0043011287528099250571101
TCGA-27-1833.2	41	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0043031896897291243078709
TCGA-06-2558.6	74	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0043273429304483447543905
TCGA-06-0192.10	126	0_HALLMARK_INFLAMMATORY_RESPONSE	170	12	0.0043451616775391586205979
TCGA-06-0157.7	89	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0043477225417713960195498
TCGA-32-2634.10	118	1_KEGG_MELANOMA	71	8	0.0043511262017037338756253
TCGA-19-2619.14	100	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0043565868285836643197806
TCGA-06-0155.10	74	2_SYNAPTIC_TRANSMISSION	152	9	0.0043630159551248329924400
TCGA-06-0128.8	74	2_SYNAPTIC_TRANSMISSION	152	9	0.0043630159551248329924400
TCGA-08-0389.4	56	2_NUCLEUS	1110	20	0.0043680087549140440839057
TCGA-28-2513.12	134	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0043800314807460882793322
TCGA-06-0219.6	6	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0043833193080885851297679
TCGA-08-0244.4	6	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0043833193080885851297679
TCGA-14-1823.12	6	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0043833193080885851297679
TCGA-14-1829.11	6	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0043833193080885851297679
TCGA-19-2620.8	6	2_NEUROTRANSMITTER_BINDING	49	3	0.0043833193080885851297679
TCGA-14-2554.9	6	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0043833193080885851297679
TCGA-02-0052.3	116	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0043897766285082651452343
TCGA-76-4925.9	83	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0043909875219722022815505
TCGA-32-1979.4	12	1_KEGG_SMALL_CELL_LUNG_CANCER	83	4	0.0043909875219722022815505
TCGA-16-0861.5	4	1_KEGG_SMALL_CELL_LUNG_CANCER	83	3	0.0043921203623458453940698
TCGA-02-0033.1	4	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	3	0.0043921203623458453940698
TCGA-26-1439.10	84	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0043940708905652039670264
TCGA-02-0048.9	84	1_KEGG_PANCREATIC_CANCER	70	7	0.0043940708905652039670264
TCGA-19-1390.12	10	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	5	0.0043987531854984274204412
TCGA-06-2570.8	95	2_INTERPHASE	62	7	0.0044020756423379303265420
TCGA-02-0001.5	117	2_SYNAPTIC_TRANSMISSION	152	11	0.0044134774268202066338507
TCGA-06-6391.9	26	2_EXTRACELLULAR_REGION	346	8	0.0044186830097762384850224
TCGA-12-5299.6	38	2_RECEPTOR_ACTIVITY	499	11	0.0044215929376207521034337
TCGA-06-0154.13	76	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0044222405965383283082959
TCGA-41-2572.8	76	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0044222405965383283082959
TCGA-32-2494.10	173	0_HALLMARK_INFLAMMATORY_RESPONSE	170	14	0.0044307764100420124822599
TCGA-06-5415.7	7	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0044333557454556624111142
TCGA-06-2559.11	101	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0044384012970776305292975
TCGA-32-2498.13	133	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0044426426949291490664518
TCGA-06-0174.37	141	2_CHROMOSOME	102	10	0.0044497617144398362784563
TCGA-76-4927.8	93	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0044510229060340140982976
TCGA-14-0871.20	216	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0044515106040777987356227
TCGA-32-2638.17	159	1_KEGG_MELANOMA	71	9	0.0044538342600315729280513
TCGA-41-2575.49	136	2_INTERPHASE	62	8	0.0044547828845204447481554
TCGA-28-2509.6	59	2_REGULATION_OF_APOPTOSIS	309	11	0.0044616495750088320387805
TCGA-26-5135.9	71	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0044630746443062221245901
TCGA-06-0148.6	69	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0044907461781805530984246
TCGA-06-0649.13	88	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0044921937913007759998751
TCGA-02-0014.12	5	1_KEGG_MAPK_SIGNALING_PATHWAY	258	4	0.0044942742760957872169558
TCGA-32-2491.14	244	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	10	0.0044968818376066293368565
TCGA-28-5204.5	5	2_INTERPHASE	62	3	0.0045060840600477242157140
TCGA-02-2483.10	100	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0045098206258047581623805
TCGA-26-5132.7	100	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0045098206258047581623805
TCGA-06-0148.6	69	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0045099419795361127619171
TCGA-02-0083.21	135	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0045122286084282878584895
TCGA-06-5858.19	205	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0045355972658731391958242
TCGA-06-0132.2	2	2_CYTOKINE_SECRETION	16	2	0.0045442701996271607153832
TCGA-32-2494.10	173	2_COLLAGEN	23	6	0.0045527441534528667946291
TCGA-28-2509.5	4	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	3	0.0045544274918195449403102
TCGA-02-0016.4	4	1_KEGG_ECM_RECEPTOR_INTERACTION	84	3	0.0045544274918195449403102
TCGA-06-0126.3	4	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	3	0.0045544274918195449403102
TCGA-28-1753.13	174	2_CELL_CYCLE_PHASE	146	13	0.0045709763900873027694938
TCGA-06-0152.10	19	2_MICROTUBULE_CYTOSKELETON	117	5	0.0045725749769081639947710
TCGA-06-0176.8	95	2_SYNAPTIC_TRANSMISSION	152	10	0.0045745987144796178627826
TCGA-81-5910.12	128	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0045772194669806169284310
TCGA-06-0138.2	30	2_NEUROLOGICAL_SYSTEM_PROCESS	296	8	0.0045791719584139314869198
TCGA-06-0645.9	136	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0045882231083211851355164
TCGA-41-3392.31	136	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0045882231083211851355164
TCGA-06-0168.4	22	0_HALLMARK_APICAL_JUNCTION	182	6	0.0045910839431868586194008
TCGA-28-2509.6	59	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	11	0.0046038267147619120825408
TCGA-06-0879.9	84	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0046073976398457944583797
TCGA-02-0048.9	84	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0046073976398457944583797
TCGA-06-0213.9	74	1_KEGG_CELL_CYCLE	114	8	0.0046086206876759083089778
TCGA-06-0155.10	74	1_KEGG_CELL_CYCLE	114	8	0.0046086206876759083089778
TCGA-08-0245.4	85	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0046113921262633927183883
TCGA-08-0355.1	45	2_EXTRACELLULAR_MATRIX	85	6	0.0046113921262633927183883
TCGA-06-2557.11	177	2_EXTRACELLULAR_REGION_PART	269	18	0.0046188292793986470904932
TCGA-14-1825.8	80	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0046207309948493816703641
TCGA-06-0241.8	53	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	6	0.0046346780509381214907538
TCGA-19-4068.6	42	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0046360823620848852152920
TCGA-12-1597.6	51	1_KEGG_BLADDER_CANCER	42	5	0.0046360823620848852152920
TCGA-06-5411.3	19	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	4	0.0046471927244455214431329
TCGA-06-0645.9	136	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0046473721462292026662677
TCGA-27-2523.12	112	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0046510217565910432629961
TCGA-27-2523.12	112	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0046510217565910432629961
TCGA-19-5947.4	267	2_PATTERN_BINDING	33	8	0.0046532954773451425806163
TCGA-06-0152.11	56	2_SYNAPTIC_TRANSMISSION	152	8	0.0046586799457619737160896
TCGA-02-2483.10	100	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0046625152641838378889116
TCGA-19-1390.12	10	2_GATED_CHANNEL_ACTIVITY	104	4	0.0046737118686757794100428
TCGA-28-5208.28	220	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0046795388568335359938399
TCGA-02-0007.17	217	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0046976319567101857549440
TCGA-02-0024.6	206	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0047035895729663759409767
TCGA-06-5413.11	142	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0047051380420576258134524
TCGA-28-1753.13	174	2_COLLAGEN	23	6	0.0047079925622393716325154
TCGA-02-0115.4	3	2_MITOTIC_CELL_CYCLE	134	3	0.0047155823548296746036690
TCGA-06-0750.9	3	2_MITOTIC_CELL_CYCLE	134	3	0.0047155823548296746036690
TCGA-27-1834.9	3	2_MITOTIC_CELL_CYCLE	134	3	0.0047155823548296746036690
TCGA-06-0882.9	3	2_MITOTIC_CELL_CYCLE	134	3	0.0047155823548296746036690
TCGA-19-1790.1	4	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	85	3	0.0047206755759116340517845
TCGA-02-0033.1	4	2_EXTRACELLULAR_MATRIX	85	3	0.0047206755759116340517845
TCGA-41-2573.4	31	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	6	0.0047272821820474467471862
TCGA-76-4935.7	15	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0047290508865539138821932
TCGA-06-2569.5	144	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0047378851319515710369124
TCGA-06-2569.5	144	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0047378851319515710369124
TCGA-06-0686.10	26	2_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0047476235309308247728444
TCGA-06-0686.10	26	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0047476235309308247728444
TCGA-19-4068.6	42	2_COLLAGEN	23	4	0.0047484962841786255635657
TCGA-19-4068.6	42	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0047484962841786255635657
TCGA-06-0169.5	42	2_COLLAGEN	23	4	0.0047484962841786255635657
TCGA-32-2491.14	244	0_HALLMARK_COMPLEMENT	176	17	0.0047562094515592604274112
TCGA-76-4931.10	86	0_HALLMARK_E2F_TARGETS	169	10	0.0047648445517171752680574
TCGA-06-0174.35	4	2_MICROVILLUS	7	2	0.0047681166929209074789586
TCGA-06-5415.7	7	1_KEGG_BLADDER_CANCER	42	3	0.0047728629658238689095762
TCGA-28-5220.7	15	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	680	8	0.0047739359536855419802182
TCGA-28-5213.9	143	2_NEURON_PROJECTION	16	5	0.0047803310337462476264925
TCGA-02-0033.5	144	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0047814923847133939879828
TCGA-02-2483.10	100	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0047817429218612126501364
TCGA-06-0645.9	136	2_CELL_CELL_SIGNALING	353	18	0.0047913906497773911530302
TCGA-14-4157.7	101	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0048099738752686669457370
TCGA-12-3650.17	101	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0048099738752686669457370
TCGA-08-0360.3	144	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0048179662226806776320620
TCGA-19-5960.9	134	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0048288356861065657305021
TCGA-27-1837.5	85	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0048316312127058818476355
TCGA-02-0086.2	17	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0048457902290965776392895
TCGA-06-0178.2	17	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0048457902290965776392895
TCGA-12-3653.55	255	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	10	0.0048460325861810829572995
TCGA-02-0014.10	70	2_CELL_CYCLE_PROCESS	163	9	0.0048476689030281525441546
TCGA-06-5415.7	7	2_CELL_CYCLE_PROCESS	163	4	0.0048513261405104769405372
TCGA-06-2559.11	101	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0048627161324567022906984
TCGA-02-0043.10	184	2_ORGAN_DEVELOPMENT	460	25	0.0048646735824842942189083
TCGA-06-5859.9	125	2_REGULATION_OF_APOPTOSIS	309	16	0.0048659105055095172587265
TCGA-32-2634.10	118	2_DNA_BINDING	496	20	0.0048665155712605198679022
TCGA-14-4157.7	101	2_NUCLEAR_CHROMOSOME_PART	22	5	0.0048683588187738392402681
TCGA-19-5958.4	35	1_KEGG_GLIOMA	62	5	0.0048701403006692388711341
TCGA-08-0347.4	16	2_INTERPHASE	62	4	0.0048746976546259852478005
TCGA-14-0787.6	40	2_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0048837348344722072979174
TCGA-14-0787.6	40	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0048837348344722072979174
TCGA-06-0125.9	75	2_SYNAPTIC_TRANSMISSION	152	9	0.0048906131333344435643817
TCGA-06-0645.9	136	2_SIGNAL_TRANSDUCTION	1442	42	0.0048948819299416083256071
TCGA-12-0688.10	93	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0049028666395659467255874
TCGA-76-4928.15	78	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0049091686793657288157000
TCGA-32-2634.10	118	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0049230622926767306918316
TCGA-02-0074.5	118	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0049230622926767306918316
TCGA-19-5951.10	138	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0049266690503079468843595
TCGA-06-0143.3	3	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	3	0.0049315386212503975471577
TCGA-19-5960.9	134	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0049326010190655859150022
TCGA-02-0033.5	144	2_NEURON_PROJECTION	16	5	0.0049474363245943005912286
TCGA-02-0034.5	6	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	3	0.0049521819021197746590879
TCGA-12-3653.55	255	2_MICROTUBULE_CYTOSKELETON	117	14	0.0049598618807509724584759
TCGA-06-5412.7	153	2_EXTRACELLULAR_REGION	346	19	0.0049686871930290660986929
TCGA-19-2623.11	153	2_EXTRACELLULAR_REGION	346	19	0.0049686871930290660986929
TCGA-06-0128.8	74	2_CELL_CELL_SIGNALING	353	13	0.0049746556152927045094114
TCGA-19-2631.15	84	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0049869117286422673038238
TCGA-32-2494.10	173	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0049931421789868729588235
TCGA-28-5218.5	208	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	14	0.0049992564990670009320017
TCGA-08-0245.4	85	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0050150418597218618735334
TCGA-02-0001.5	117	2_ENZYME_BINDING	154	11	0.0050160172549124056387559
TCGA-12-5295.8	66	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0050315948520159893553316
TCGA-02-0024.6	206	0_HALLMARK_SPERMATOGENESIS	88	11	0.0050484689200208142725868
TCGA-16-1048.13	97	2_COLLAGEN	23	5	0.0050506702624912701987681
TCGA-06-0211.7	10	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	5	0.0050510700319449626863322
TCGA-14-0787.7	14	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	8	0.0050618465537044313173887
TCGA-06-0154.13	76	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0050651524357555183231128
TCGA-41-2572.8	76	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0050651524357555183231128
TCGA-28-2509.5	4	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	3	0.0050651819510828975309802
TCGA-06-0126.3	4	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	3	0.0050651819510828975309802
TCGA-06-0152.11	56	2_RECEPTOR_BINDING	331	11	0.0050652725604750726065562
TCGA-06-0882.6	21	1_KEGG_FOCAL_ADHESION	195	6	0.0050700353235258229650517
TCGA-28-6450.11	139	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0050709084145949623670391
TCGA-06-5859.9	125	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	16	0.0050740385047048780498002
TCGA-02-0083.21	135	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0050748962442150290230725
TCGA-28-5209.15	194	0_HALLMARK_ANGIOGENESIS	32	7	0.0050846164099028062777208
TCGA-02-2470.4	11	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0050846738761110843451974
TCGA-06-0197.1	57	0_HALLMARK_P53_PATHWAY	151	8	0.0050883225028166912187744
TCGA-28-1753.13	174	0_HALLMARK_COAGULATION	125	12	0.0050954488345862280693210
TCGA-32-5222.9	70	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0050991676758414946832310
TCGA-12-3653.55	255	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	19	0.0051065103034905459308823
TCGA-06-5410.3	3	2_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY	10	2	0.0051094175018648029656942
TCGA-06-5410.3	3	2_CYCLASE_ACTIVITY	10	2	0.0051094175018648029656942
TCGA-06-0882.5	3	2_CASPASE_REGULATOR_ACTIVITY	10	2	0.0051094175018648029656942
TCGA-06-0241.8	53	2_CELL_CYCLE_PROCESS	163	8	0.0051174957686644026444434
TCGA-32-4210.14	109	2_MITOTIC_CELL_CYCLE	134	10	0.0051474643411293869235679
TCGA-76-6191.6	96	2_NUCLEUS	1110	28	0.0051500329210467940890816
TCGA-76-4927.8	93	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0051519605739195149102239
TCGA-06-0143.3	3	2_REGULATION_OF_KINASE_ACTIVITY	138	3	0.0051539894512634383885730
TCGA-76-4934.7	47	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0052104261146729748815920
TCGA-76-4934.7	47	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0052104261146729748815920
TCGA-19-2620.7	47	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0052104261146729748815920
TCGA-19-5954.17	208	1_KEGG_MELANOMA	71	10	0.0052143608285543374680771
TCGA-32-4208.28	140	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0052182661839356835747905
TCGA-19-2623.11	153	1_KEGG_FOCAL_ADHESION	195	14	0.0052226902187012423303680
TCGA-08-0358.9	43	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0052270885250508165864591
TCGA-14-4157.7	101	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0052383483491729339320830
TCGA-27-1837.5	85	1_KEGG_MELANOMA	71	7	0.0052430237960443852249237
TCGA-02-0028.9	182	2_TRANSMISSION_OF_NERVE_IMPULSE	164	14	0.0052729854236153129651288
TCGA-32-2494.10	173	2_EXTRACELLULAR_MATRIX	85	10	0.0052815194186933353548419
TCGA-19-2629.15	146	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0052826657763088953959074
TCGA-19-2625.9	146	1_KEGG_BLADDER_CANCER	42	7	0.0052826657763088953959074
TCGA-06-0139.1	179	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0052993483206542624230906
TCGA-41-2571.7	72	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0053229697091663665670103
TCGA-06-0187.10	55	1_KEGG_MELANOMA	71	6	0.0053244568318342681140232
TCGA-14-4157.7	101	2_NUCLEAR_CHROMOSOME	39	6	0.0053257420287318394530596
TCGA-14-3476.17	53	2_CELL_CELL_SIGNALING	353	11	0.0053302423548233085481840
TCGA-06-0137.9	53	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0053569997231422980879523
TCGA-02-0003.9	227	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	42	0.0053643454215695990719426
TCGA-02-0028.9	182	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0053668962006305819326113
TCGA-02-0099.11	141	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0053687860538478961516806
TCGA-06-0174.37	141	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0053687860538478961516806
TCGA-06-0148.6	69	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0053719613699137278711726
TCGA-06-5411.4	23	0_HALLMARK_MYC_TARGETS_V1	178	6	0.0053729079337755157944057
TCGA-08-0389.4	56	2_REPLICATION_FORK	18	4	0.0053817087518303313026236
TCGA-06-0195.8	56	2_REPLICATION_FORK	18	4	0.0053817087518303313026236
TCGA-06-0140.2	25	2_ESTABLISHMENT_OF_LOCALIZATION	659	10	0.0053819707266809808238195
TCGA-06-0143.3	3	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	3	0.0053830310606260908801168
TCGA-28-5220.7	15	2_REGULATION_OF_METABOLIC_PROCESS	691	8	0.0053897781266350414455801
TCGA-02-0003.9	227	1_KEGG_CELL_CYCLE	114	13	0.0054021805602619092645522
TCGA-02-0003.9	227	2_SYSTEM_DEVELOPMENT	694	37	0.0054094279107652848762045
TCGA-14-1825.8	80	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0054348172168900933318159
TCGA-06-0156.4	80	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0054348172168900933318159
TCGA-19-5959.13	92	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0054376597075851936316515
TCGA-06-0649.13	88	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	7	0.0054554249835485034425542
TCGA-06-0154.13	76	2_SYNAPTIC_TRANSMISSION	152	9	0.0054721965423571742800912
TCGA-32-1982.9	89	2_RECEPTOR_ACTIVITY	499	17	0.0054759797030581947377414
TCGA-32-2615.7	77	0_HALLMARK_APOPTOSIS	150	9	0.0054786908404317368262437
TCGA-14-0787.7	14	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	8	0.0054852261310927340545729
TCGA-06-5859.9	125	1_KEGG_DNA_REPLICATION	32	6	0.0054940224591022955580311
TCGA-28-6450.11	139	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0054988160845680159050097
TCGA-06-0173.35	120	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0055094420663948685812361
TCGA-19-2619.10	8	2_SECRETION	142	4	0.0055225119974815000886692
TCGA-06-0644.16	142	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0055225119974815000886692
TCGA-14-0790.9	104	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0055378449701234426158503
TCGA-14-0790.9	104	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0055378449701234426158503
TCGA-28-1753.13	174	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0055426774362915360791493
TCGA-06-0139.1	179	2_COLLAGEN	23	6	0.0055505840715506862825812
TCGA-12-3650.17	101	2_DNA_METABOLIC_PROCESS	218	12	0.0055605985524379919829330
TCGA-12-5299.5	6	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	3	0.0055680366340468178190659
TCGA-14-1823.12	6	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	3	0.0055680366340468178190659
TCGA-41-3393.5	88	2_EXTRACELLULAR_REGION	346	14	0.0055772913965838246536100
TCGA-28-5218.5	208	2_CATION_BINDING	165	15	0.0055854069347676775503242
TCGA-06-0645.9	136	2_EXTRACELLULAR_MATRIX	85	9	0.0056093949566686117022551
TCGA-41-3392.31	136	2_EXTRACELLULAR_MATRIX	85	9	0.0056093949566686117022551
TCGA-06-0241.8	53	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0056266662153300651960652
TCGA-32-1986.8	87	2_GLYCOSAMINOGLYCAN_BINDING	26	5	0.0056283029607611338024364
TCGA-76-4935.7	15	2_CYTOSKELETON	293	6	0.0056465743341773217897628
TCGA-14-0871.20	216	2_EXTRACELLULAR_MATRIX	85	11	0.0056527406785149740889307
TCGA-28-2501.3	51	0_HALLMARK_MYOGENESIS	172	8	0.0056616981855815342455918
TCGA-02-0046.8	148	2_NEURON_PROJECTION	16	5	0.0056624779562852800909867
TCGA-32-2498.13	133	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0056708332872476251151905
TCGA-76-4931.10	86	1_KEGG_MELANOMA	71	7	0.0056737556582245555342192
TCGA-28-5207.12	188	2_MICROTUBULE_CYTOSKELETON	117	12	0.0056783828759944671160653
TCGA-28-5213.9	143	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0056794882650789170475125
TCGA-06-0190.8	143	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0056794882650789170475125
TCGA-76-6193.13	271	2_INTERLEUKIN_BINDING	24	7	0.0056899877219078846823930
TCGA-14-0817.9	85	2_REGULATION_OF_APOPTOSIS	309	13	0.0057120976955065015309709
TCGA-12-0821.9	81	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0057127680464962487041913
TCGA-76-6193.13	271	2_CYTOKINE_BINDING	44	9	0.0057163216226938599190399
TCGA-08-0357.4	36	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0057252697772341935161799
TCGA-32-4211.14	71	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0057534271331020070405771
TCGA-27-2526.7	71	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0057534271331020070405771
TCGA-06-0139.1	179	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0057618638354957410485646
TCGA-28-2501.3	51	2_CONTRACTILE_FIBER_PART	20	4	0.0057858908882498531409122
TCGA-32-1979.10	116	0_HALLMARK_ALLOGRAFT_REJECTION	190	12	0.0057896173153227864852099
TCGA-28-2513.2	2	2_REPLICATION_FORK	18	2	0.0057939445045269719405945
TCGA-02-2486.8	2	2_REPLICATION_FORK	18	2	0.0057939445045269719405945
TCGA-06-0176.8	95	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0057978590792437788986602
TCGA-06-0221.13	45	2_CELL_CYCLE_GO_0007049	265	9	0.0057991150558084443231155
TCGA-32-2494.10	173	0_HALLMARK_APOPTOSIS	150	13	0.0058022962623656224728785
TCGA-12-5295.8	66	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	6	0.0058043889664017803836638
TCGA-12-3649.15	89	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0058104602073195850409082
TCGA-27-1833.2	41	2_SYNAPTIC_TRANSMISSION	152	7	0.0058342128925559901334030
TCGA-06-2570.8	95	1_KEGG_BLADDER_CANCER	42	6	0.0058358300495812481453739
TCGA-06-2570.8	95	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0058358300495812481453739
TCGA-08-0360.3	144	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0058397593834363095352535
TCGA-02-0033.5	144	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0058397593834363095352535
TCGA-06-2569.5	144	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0058397593834363095352535
TCGA-02-2483.10	100	2_COLLAGEN	23	5	0.0058721356183050708865689
TCGA-32-4213.15	198	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0058789299201944108727580
TCGA-12-3652.19	88	0_HALLMARK_E2F_TARGETS	169	10	0.0058898929340652052613625
TCGA-06-2558.6	74	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0059128129095155556801955
TCGA-14-0817.9	85	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	13	0.0059191665236394512550344
TCGA-06-5859.9	125	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	18	0.0059260949436752471258805
TCGA-06-0152.11	56	1_KEGG_MELANOMA	71	6	0.0059282647448506160109405
TCGA-02-0060.19	281	2_IMMUNE_SYSTEM_PROCESS	283	24	0.0059368724055705911560321
TCGA-06-2563.10	123	1_KEGG_MELANOMA	71	8	0.0059458769042862111287029
TCGA-76-6282.11	185	2_RESPONSE_TO_WOUNDING	163	14	0.0059468666175235751145123
TCGA-19-5952.11	193	2_WOUND_HEALING	46	8	0.0059472742757861705997779
TCGA-06-5412.7	153	0_HALLMARK_INFLAMMATORY_RESPONSE	170	13	0.0059583386822418911085708
TCGA-06-5414.13	102	1_KEGG_CELL_CYCLE	114	9	0.0059796627073133998622745
TCGA-19-2625.9	146	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0059856066573158997132231
TCGA-19-2625.9	146	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0059856066573158997132231
TCGA-76-4934.7	47	2_EXTRACELLULAR_MATRIX	85	6	0.0059924978891117315626946
TCGA-19-2620.7	47	2_EXTRACELLULAR_MATRIX	85	6	0.0059924978891117315626946
TCGA-28-5220.7	15	1_KEGG_PANCREATIC_CANCER	70	4	0.0059938034552194990531304
TCGA-28-5220.7	15	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0059938034552194990531304
TCGA-06-0126.8	15	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	4	0.0059938034552194990531304
TCGA-06-5418.5	13	2_COLLAGEN	23	3	0.0059956846580133740798324
TCGA-02-0010.18	184	2_TRANSMISSION_OF_NERVE_IMPULSE	164	14	0.0059973705572556766305037
TCGA-32-2495.11	67	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0059979705423889749169031
TCGA-41-3393.5	88	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0060161692507866154633334
TCGA-06-5859.9	125	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0060201038347266555908477
TCGA-06-5408.3	99	2_CELL_CYCLE_GO_0007049	265	13	0.0060202226483326085060277
TCGA-28-2513.12	134	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0060338455843511789103428
TCGA-32-2491.14	244	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	34	0.0060340155046004293609707
TCGA-32-4211.14	71	0_HALLMARK_ANGIOGENESIS	32	5	0.0060397344765737801669525
TCGA-06-0130.3	155	2_EXTRACELLULAR_REGION	346	19	0.0060416234331016815603532
TCGA-32-2632.16	229	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	15	0.0060624530637489772166848
TCGA-32-2638.17	159	0_HALLMARK_ALLOGRAFT_REJECTION	190	14	0.0060672272929958590351185
TCGA-08-0244.5	39	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0060677526084913606385651
TCGA-06-0122.8	90	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0060765724058251813222142
TCGA-02-0115.4	3	2_CELL_CYCLE_PHASE	146	3	0.0061106627223796007933321
TCGA-06-0750.9	3	2_CELL_CYCLE_PHASE	146	3	0.0061106627223796007933321
TCGA-27-1834.9	3	2_CELL_CYCLE_PHASE	146	3	0.0061106627223796007933321
TCGA-06-0882.9	3	2_CELL_CYCLE_PHASE	146	3	0.0061106627223796007933321
TCGA-19-1390.12	10	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	5	0.0061131458746305385176800
TCGA-06-0881.7	203	2_ENDOPEPTIDASE_ACTIVITY	91	11	0.0061177173005154987170395
TCGA-19-5952.11	193	2_PATTERN_BINDING	33	7	0.0061283281621953185347440
TCGA-06-0650.2	82	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0061503453774747448082327
TCGA-06-5413.11	142	2_INTERPHASE	62	8	0.0061576045748514924779715
TCGA-41-2571.7	72	2_CELL_CYCLE_PROCESS	163	9	0.0061602196820058057608049
TCGA-14-4157.7	101	1_KEGG_MISMATCH_REPAIR	23	5	0.0061681210848327462301088
TCGA-19-2629.15	146	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0061703656591487630531101
TCGA-87-5896.6	131	2_CELL_CYCLE_GO_0007049	265	15	0.0061704527904440234845063
TCGA-28-1753.13	174	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0061716641968583823424366
TCGA-28-1753.13	174	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0061716641968583823424366
TCGA-08-0245.4	85	2_DNA_METABOLIC_PROCESS	218	11	0.0061804393775475984645906
TCGA-28-1753.13	174	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	13	0.0061860274536289410265977
TCGA-06-0174.37	141	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0061888000015119003574537
TCGA-76-4931.10	86	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0061957850804794873181280
TCGA-08-0354.5	18	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0062018411092972878378982
TCGA-76-6191.6	96	1_KEGG_BLADDER_CANCER	42	6	0.0062045027515965304326651
TCGA-12-5299.5	6	2_GROWTH	55	3	0.0062327161878431396047073
TCGA-02-0011.1	288	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0062403209908602390657006
TCGA-02-0115.4	3	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0062444026245060662433373
TCGA-06-0143.3	3	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0062444026245060662433373
TCGA-06-0750.9	3	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0062444026245060662433373
TCGA-27-1834.9	3	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0062444026245060662433373
TCGA-06-0882.9	3	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0062444026245060662433373
TCGA-27-1831.4	3	2_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY	11	2	0.0062444026245060662433373
TCGA-32-1970.14	94	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0062840796144341118031895
TCGA-12-0616.7	45	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0062904391397632574908783
TCGA-08-0355.1	45	2_COLLAGEN	23	4	0.0062904391397632574908783
TCGA-08-0355.1	45	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0062904391397632574908783
TCGA-06-0173.35	120	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0063000321087170151057588
TCGA-76-4925.9	83	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0063001587846461277325760
TCGA-81-5910.12	128	0_HALLMARK_ANGIOGENESIS	32	6	0.0063074533063609463517940
TCGA-81-5910.12	128	1_KEGG_DNA_REPLICATION	32	6	0.0063074533063609463517940
TCGA-06-0686.10	26	2_REGULATION_OF_CELL_CYCLE	160	6	0.0063122850907889188620814
TCGA-76-6282.11	185	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	18	0.0063225415073250744099620
TCGA-06-2561.5	42	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	7	0.0063250269847175896731351
TCGA-32-1970.14	94	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0063278221857236685229942
TCGA-32-1970.14	94	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0063278221857236685229942
TCGA-08-0345.2	77	2_EXTRACELLULAR_REGION	346	13	0.0063344047628759525894737
TCGA-02-0086.2	17	2_INTERPHASE	62	4	0.0063433298988568647888697
TCGA-06-0178.2	17	2_INTERPHASE	62	4	0.0063433298988568647888697
TCGA-28-5220.7	15	2_CELL_CYCLE_PROCESS	163	5	0.0063438719350543144176457
TCGA-14-0786.2	10	2_CELL_CYCLE_GO_0007049	265	5	0.0063452718359879398818402
TCGA-76-4929.8	91	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0063516255474517216081387
TCGA-41-2575.46	4	2_GABA_RECEPTOR_ACTIVITY	8	2	0.0063565912667072795028123
TCGA-27-2527.6	79	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0063614548328831312801190
TCGA-06-0214.9	62	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0063792261784731026097450
TCGA-06-0238.4	24	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	6	0.0063908935970692672123850
TCGA-08-0347.4	16	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	3	0.0064193398588437101601190
TCGA-32-2634.10	118	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0064208719851089456759352
TCGA-14-0781.7	155	2_CELL_PROJECTION	76	9	0.0064304550359542871421081
TCGA-02-0009.6	188	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	36	0.0064512875925326418694028
TCGA-41-2571.7	72	1_KEGG_DNA_REPLICATION	32	5	0.0064749746747463157725555
TCGA-06-0132.2	2	2_REGULATION_OF_PROTEIN_SECRETION	19	2	0.0064755850344723718536866
TCGA-27-2524.5	75	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0064756248288592929696073
TCGA-76-6193.13	271	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0064853622615816614374595
TCGA-06-0881.7	203	2_SIGNAL_TRANSDUCTION	1442	56	0.0064874115766601183133422
TCGA-06-2563.10	123	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0064976720087558314728482
TCGA-06-2563.10	123	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0064976720087558314728482
TCGA-02-0079.1	5	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	3	0.0065137062581790434317996
TCGA-76-4935.4	5	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	3	0.0065137062581790434317996
TCGA-02-0046.8	148	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0065146925495882454515417
TCGA-02-0007.17	217	2_NUCLEUS	1110	49	0.0065293835784537134631078
TCGA-32-5222.9	70	0_HALLMARK_E2F_TARGETS	169	9	0.0065324384016176000739007
TCGA-12-3649.15	89	0_HALLMARK_E2F_TARGETS	169	10	0.0065341931585799995982344
TCGA-28-2509.6	59	2_APOPTOSIS_GO	389	12	0.0065536995200842209849390
TCGA-06-5413.11	142	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0065608599851161861563065
TCGA-06-0219.6	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494498171
TCGA-08-0244.4	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494498171
TCGA-12-5299.5	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494498171
TCGA-14-1823.12	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494498171
TCGA-14-1829.11	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494498171
TCGA-14-2554.9	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494498171
TCGA-06-2557.11	177	2_DEFENSE_RESPONSE	222	16	0.0065842559322711021255192
TCGA-19-5947.4	267	2_AXON	10	5	0.0065843067269674340064034
TCGA-12-0619.11	123	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0065991785813808313126971
TCGA-06-5418.5	13	1_KEGG_ECM_RECEPTOR_INTERACTION	84	4	0.0066101009660876368020932
TCGA-06-0879.9	84	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0066101009660876368020932
TCGA-02-0048.9	84	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0066101009660876368020932
TCGA-06-0686.6	3	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	3	0.0066304683491728959310318
TCGA-28-5215.7	192	1_KEGG_GLIOMA	62	9	0.0066306418259072102960872
TCGA-06-2562.7	57	2_EXTRACELLULAR_REGION_PART	269	10	0.0066335410357216285232029
TCGA-27-1830.7	57	2_EXTRACELLULAR_REGION_PART	269	10	0.0066335410357216285232029
TCGA-14-0790.9	104	2_EXTRACELLULAR_MATRIX	85	8	0.0066353437781802842437839
TCGA-06-2564.7	92	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0066358123202578727858891
TCGA-14-4157.7	101	1_KEGG_GLIOMA	62	7	0.0066448288216114093085451
TCGA-12-3650.17	101	2_INTERPHASE	62	7	0.0066448288216114093085451
TCGA-06-2559.11	101	2_INTERPHASE	62	7	0.0066448288216114093085451
TCGA-08-0354.5	18	2_MITOTIC_CELL_CYCLE	134	5	0.0066485128454544231355050
TCGA-06-5412.7	153	2_NEURON_PROJECTION	16	5	0.0066681511989227018610826
TCGA-28-5219.9	47	2_RECEPTOR_ACTIVITY	499	12	0.0066860028761547398226672
TCGA-02-0071.12	116	2_REGULATION_OF_CELL_CYCLE	160	11	0.0066903712715342799483009
TCGA-27-1836.8	49	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0066913698637615232067688
TCGA-32-2494.10	173	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0066914618610552489136323
TCGA-41-2575.49	136	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0067044719390088021795937
TCGA-41-2575.49	136	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0067044719390088021795937
TCGA-41-4097.6	48	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	5	0.0067145980441084178805267
TCGA-02-0014.10	70	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0067179132662297663669548
TCGA-28-2509.6	59	2_PROGRAMMED_CELL_DEATH	390	12	0.0067298678089686043979345
TCGA-32-1991.4	7	2_ENDOPLASMIC_RETICULUM	177	4	0.0067409297594131709074894
TCGA-06-0176.8	95	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0067468476012506961927984
TCGA-08-0353.8	100	2_CELL_CYCLE_GO_0007049	265	13	0.0067489534706844734116005
TCGA-06-0644.16	142	2_EXTRACELLULAR_REGION	346	18	0.0067584420048445994697039
TCGA-32-1979.4	12	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0067671869470517275260701
TCGA-06-0187.10	55	1_KEGG_BLADDER_CANCER	42	5	0.0067764377094779630963939
TCGA-06-0174.37	141	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0067819966797365146757293
TCGA-06-0154.13	76	2_CELL_CELL_SIGNALING	353	13	0.0067848263145566375595386
TCGA-06-0210.6	103	2_COLLAGEN	23	5	0.0067952545934942291602776
TCGA-27-1837.5	85	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0067995810739785236820332
TCGA-02-0014.12	5	1_KEGG_MELANOMA	71	3	0.0067999901568567390833242
TCGA-08-0244.5	39	2_TRANSMISSION_OF_NERVE_IMPULSE	164	7	0.0068040255318655845639952
TCGA-06-0877.7	4	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0068228927066983444810200
TCGA-08-0348.3	4	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0068228927066983444810200
TCGA-28-5207.12	188	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0068343289086680823751774
TCGA-06-5414.13	102	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0068374640461581941489055
TCGA-02-0007.17	217	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	6	0.0068557986297837639547148
TCGA-02-0007.17	217	2_INTERMEDIATE_FILAMENT	20	6	0.0068557986297837639547148
TCGA-08-0350.2	46	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0068784307511947752680759
TCGA-02-0113.3	46	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0068784307511947752680759
TCGA-12-5301.7	46	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0068784307511947752680759
TCGA-14-0789.11	3	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	3	0.0069010751655275062027561
TCGA-26-1439.7	3	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	3	0.0069010751655275062027561
TCGA-32-2494.8	3	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	3	0.0069010751655275062027561
TCGA-14-1825.5	3	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	3	0.0069010751655275062027561
TCGA-19-2624.29	130	0_HALLMARK_ANGIOGENESIS	32	6	0.0069023554944424598406316
TCGA-06-5856.13	152	1_KEGG_BLADDER_CANCER	42	7	0.0069073937452836312034243
TCGA-12-0688.10	93	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0069293272329998441272370
TCGA-27-1837.5	85	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0069312135604472774330631
TCGA-28-5216.8	162	2_TISSUE_DEVELOPMENT	115	11	0.0069331750959450363924752
TCGA-06-2558.6	74	2_EXTRACELLULAR_MATRIX	85	7	0.0069422618489320426365952
TCGA-16-0861.4	6	2_REGULATION_OF_TRANSPORT	57	3	0.0069480496590473500920226
TCGA-06-0750.13	8	2_MEMBRANE_PART	1217	7	0.0069571652250359919747447
TCGA-06-0158.4	65	2_CELL_CELL_SIGNALING	353	12	0.0069945985160826066456830
TCGA-02-0071.12	116	2_REGULATION_OF_CELL_PROLIFERATION	265	14	0.0070140299116236200921426
TCGA-32-4210.14	109	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0070164762810079025004417
TCGA-19-5950.7	113	2_PROTEIN_KINASE_BINDING	56	7	0.0070194761785489605265820
TCGA-06-0125.9	75	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0070198377812869996311695
TCGA-02-0021.4	170	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0070223525926939346641920
TCGA-02-0021.4	170	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0070223525926939346641920
TCGA-06-0686.10	26	2_CELL_CYCLE_PROCESS	163	6	0.0070302667639042248914905
TCGA-02-0034.4	88	2_CELL_CELL_SIGNALING	353	14	0.0070426045731627508195150
TCGA-19-1390.12	10	2_CALCIUM_CHANNEL_ACTIVITY	32	3	0.0070438784722486064843183
TCGA-12-5295.8	66	2_INTERPHASE	62	6	0.0070500150028320086870171
TCGA-06-0188.11	66	2_INTERPHASE	62	6	0.0070500150028320086870171
TCGA-06-5412.7	153	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	99	10	0.0070813134396581307525298
TCGA-41-2572.8	76	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0070824165866531646473803
TCGA-41-2572.8	76	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0070824165866531646473803
TCGA-28-5204.5	5	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	3	0.0070945093088014814924902
TCGA-02-0069.12	62	2_CHROMOSOME	102	7	0.0070980525046966920846292
TCGA-14-0817.9	85	2_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0070983864756867538076124
TCGA-14-0817.9	85	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0070983864756867538076124
TCGA-14-0781.7	155	2_NEURON_PROJECTION	16	5	0.0071076964780853266884231
TCGA-06-0130.3	155	2_NEURON_PROJECTION	16	5	0.0071076964780853266884231
TCGA-06-5413.11	142	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0071084145896961282648507
TCGA-06-0219.6	6	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	4	0.0071203352902455474202070
TCGA-08-0244.4	6	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	4	0.0071203352902455474202070
TCGA-14-1829.11	6	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	4	0.0071203352902455474202070
TCGA-14-2554.9	6	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	4	0.0071203352902455474202070
TCGA-14-0790.9	104	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	5	0.0071270607460476101402413
TCGA-06-0124.6	55	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0071454515202953646640927
TCGA-28-5220.7	15	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0071542709217346381680991
TCGA-02-2486.9	141	2_RECEPTOR_ACTIVITY	499	22	0.0071553575904707671095917
TCGA-02-0054.3	93	1_KEGG_LONG_TERM_POTENTIATION	68	7	0.0071644567549591113217455
TCGA-06-0139.1	179	2_EXTRACELLULAR_MATRIX	85	10	0.0071741621305347674439346
TCGA-27-1836.8	49	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0071779446403170297716367
TCGA-06-2570.8	95	2_M_PHASE	94	8	0.0071817291019810238633658
TCGA-02-0075.8	128	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0071900957439840129312159
TCGA-06-0750.4	2	1_KEGG_PROTEIN_EXPORT	20	2	0.0071950944827481704002548
TCGA-76-6191.6	96	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0072102532769370989221280
TCGA-41-2575.49	136	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0072104979051582683904908
TCGA-27-1838.17	131	1_KEGG_DNA_REPLICATION	32	6	0.0072165072338677650407024
TCGA-87-5896.6	131	0_HALLMARK_ANGIOGENESIS	32	6	0.0072165072338677650407024
TCGA-32-2498.13	133	0_HALLMARK_E2F_TARGETS	169	12	0.0072210407019714529380794
TCGA-06-0122.8	90	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	10	0.0072387997188864067546477
TCGA-06-0176.8	95	2_REGULATION_OF_CELL_CYCLE	160	10	0.0072639129841149110630716
TCGA-14-0790.9	104	2_CELL_CYCLE_PHASE	146	10	0.0072796345459139842615226
TCGA-32-5222.9	70	2_SYSTEM_PROCESS	451	14	0.0072824451882001041760906
TCGA-06-2564.7	92	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0073338906012192913927428
TCGA-06-0185.13	71	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0073375545082903894170134
TCGA-08-0347.7	25	2_EXTRACELLULAR_REGION_PART	269	7	0.0073414542108466932651689
TCGA-16-1045.10	81	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0073668519685313096218016
TCGA-02-0009.6	188	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	6	0.0073764076179759557536086
TCGA-28-2509.6	59	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	14	0.0073871615825506185826210
TCGA-08-0389.4	56	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0074165048240072061966344
TCGA-02-0080.3	20	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0074188184080439681725161
TCGA-06-2558.6	74	0_HALLMARK_ANGIOGENESIS	32	5	0.0074192440849760168605775
TCGA-06-2558.6	74	1_KEGG_DNA_REPLICATION	32	5	0.0074192440849760168605775
TCGA-06-0648.6	17	2_REGULATION_OF_CELL_PROLIFERATION	265	6	0.0074201706117182379338071
TCGA-27-2528.10	99	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0074259927828950510544925
TCGA-76-4928.15	78	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	6	0.0074262745482779344077806
TCGA-76-4928.15	78	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0074262745482779344077806
TCGA-06-5412.7	153	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0074379508553660570943644
TCGA-19-2623.11	153	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0074379508553660570943644
TCGA-26-5133.10	75	2_REGULATION_OF_CELL_CYCLE	160	9	0.0074674206175658099093884
TCGA-02-0115.4	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954457959
TCGA-06-0143.3	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954457959
TCGA-06-0750.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954457959
TCGA-27-1834.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954457959
TCGA-06-0882.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954457959
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954457959
TCGA-27-2523.5	3	2_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR	12	2	0.0074927539627462954457959
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954457959
TCGA-08-0354.7	47	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0075061738918002548354158
TCGA-08-0380.5	47	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0075061738918002548354158
TCGA-28-5219.9	47	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0075061738918002548354158
TCGA-15-1444.3	107	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0075120901501736850325308
TCGA-19-5954.17	208	0_HALLMARK_KRAS_SIGNALING_UP	148	14	0.0075121728253067995839665
TCGA-06-0219.6	6	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	4	0.0075137767036245542429107
TCGA-08-0244.4	6	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	4	0.0075137767036245542429107
TCGA-14-1829.11	6	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	4	0.0075137767036245542429107
TCGA-14-2554.9	6	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	4	0.0075137767036245542429107
TCGA-02-0046.8	148	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0075255977744844949547942
TCGA-02-0046.8	148	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0075255977744844949547942
TCGA-08-0246.6	62	1_KEGG_FOCAL_ADHESION	195	9	0.0075300349659340407720842
TCGA-06-0211.8	62	1_KEGG_FOCAL_ADHESION	195	9	0.0075300349659340407720842
TCGA-06-0169.5	42	0_HALLMARK_HYPOXIA	154	7	0.0075338636662901862367514
TCGA-19-5947.4	267	2_DEFENSE_RESPONSE	222	20	0.0075369082896823728565106
TCGA-02-0089.5	91	1_KEGG_PANCREATIC_CANCER	70	7	0.0075369523533362651687706
TCGA-76-6282.11	185	0_HALLMARK_ALLOGRAFT_REJECTION	190	15	0.0075468928535924817771474
TCGA-06-0877.7	4	2_CELL_PROLIFERATION_GO_0008283	436	4	0.0075640845251909241686583
TCGA-08-0348.3	4	2_CELL_PROLIFERATION_GO_0008283	436	4	0.0075640845251909241686583
TCGA-02-0024.6	206	1_KEGG_DNA_REPLICATION	32	7	0.0075735092173445511809504
TCGA-32-2634.10	118	2_NUCLEAR_PART	466	19	0.0075870914294926365684102
TCGA-06-0686.5	14	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	3	0.0076187551043794526223207
TCGA-26-5134.2	14	2_COLLAGEN	23	3	0.0076187551043794526223207
TCGA-06-0139.1	179	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0076202867759166360503431
TCGA-06-0192.10	126	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0076296635399795767473741
TCGA-02-2485.14	172	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	8	0.0076402961732830168214980
TCGA-06-5415.7	7	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0076428028808501313057233
TCGA-14-0871.20	216	2_CELL_CYCLE_PROCESS	163	15	0.0076459994884958805763664
TCGA-08-0357.4	36	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0076868921762575266598549
TCGA-02-0060.19	281	2_HEMOSTASIS	44	9	0.0076930090576564826715389
TCGA-28-5204.3	4	2_CATION_CHANNEL_ACTIVITY	100	3	0.0077191259541365304930327
TCGA-32-4211.14	71	2_EXTRACELLULAR_REGION_PART	269	11	0.0077243034372653949712340
TCGA-02-0052.3	116	2_EXTRACELLULAR_REGION	346	16	0.0077376754833268753322462
TCGA-76-6285.5	106	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0077542097417957625907214
TCGA-02-0086.2	17	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	3	0.0077850091961085780140062
TCGA-02-0033.5	144	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	7	0.0078006871482933703640383
TCGA-12-0688.10	93	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0078118832063597412954103
TCGA-06-0152.10	19	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0078197838095434048233390
TCGA-06-0124.6	55	2_CELL_CELL_SIGNALING	353	11	0.0078244203426148829783049
TCGA-14-0789.10	106	2_COLLAGEN	23	5	0.0078288383727949158868986
TCGA-06-0130.3	155	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0078332117131652695407595
TCGA-06-5412.7	153	0_HALLMARK_KRAS_SIGNALING_UP	148	12	0.0078359896203637219996851
TCGA-08-0389.4	56	2_CELL_CYCLE_PROCESS	163	8	0.0078494604573394449048562
TCGA-06-0195.8	56	2_DNA_BINDING	496	13	0.0078508389496138742541520
TCGA-76-6191.6	96	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0078678130575316352485205
TCGA-08-0353.8	100	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0078741228126796396213916
TCGA-26-5132.7	100	1_KEGG_BLADDER_CANCER	42	6	0.0078741228126796396213916
TCGA-26-5132.7	100	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0078741228126796396213916
TCGA-76-4925.9	83	1_KEGG_THYROID_CANCER	29	5	0.0078793441563003822902811
TCGA-06-6390.9	82	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0079159663397147563002054
TCGA-12-1597.6	51	2_DNA_REPLICATION	82	6	0.0079159663397148569141670
TCGA-41-2571.7	72	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0079297719277020041472870
TCGA-06-0881.7	203	2_INFLAMMATORY_RESPONSE	112	12	0.0079414018228534180576794
TCGA-41-2575.44	7	2_PHOTORECEPTOR_CELL_MAINTENANCE	5	2	0.0079440566444479183277894
TCGA-12-0620.1	2	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0079524728493541290558211
TCGA-06-0133.2	2	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0079524728493541290558211
TCGA-02-0023.1	2	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0079524728493541290558211
TCGA-06-0127.4	2	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0079524728493541290558211
TCGA-08-0355.3	2	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0079524728493541290558211
TCGA-19-2619.14	100	2_EXTRACELLULAR_REGION_PART	269	13	0.0079554502083333551026856
TCGA-02-0052.3	116	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0079674112441984624305436
TCGA-02-0052.3	116	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0079674112441984624305436
TCGA-12-5299.5	6	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	5	0.0079780434362921696933579
TCGA-14-1823.12	6	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	5	0.0079780434362921696933579
TCGA-19-5955.9	110	2_IMMUNE_SYSTEM_PROCESS	283	14	0.0079793875403007703817071
TCGA-06-0139.1	179	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	10	0.0079865332466466792959991
TCGA-06-0139.1	179	2_LOCOMOTORY_BEHAVIOR	86	10	0.0079865332466466792959991
TCGA-06-5413.11	142	2_EXTRACELLULAR_MATRIX	85	9	0.0080119150338045733855674
TCGA-06-0192.10	126	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0080307883393402820781937
TCGA-02-0043.10	184	2_EXTRACELLULAR_SPACE	192	15	0.0080310713977174257027780
TCGA-27-1836.8	49	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0080447335309931210928225
TCGA-19-1790.18	201	0_HALLMARK_HYPOXIA	154	14	0.0080450487702313291937806
TCGA-06-0686.1	7	2_PLASMA_MEMBRANE_PART	901	6	0.0080526197162500354198578
TCGA-06-0130.3	155	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0080554389020561865258907
TCGA-06-0143.3	3	2_REGULATION_OF_CELL_CYCLE	160	3	0.0080571074849944256807133
TCGA-19-2620.6	3	2_REGULATION_OF_CELL_CYCLE	160	3	0.0080571074849944256807133
TCGA-06-0208.3	3	2_REGULATION_OF_CELL_CYCLE	160	3	0.0080571074849944256807133
TCGA-19-5954.17	208	1_KEGG_DNA_REPLICATION	32	7	0.0080736059771261796391695
TCGA-28-5218.5	208	1_KEGG_DNA_REPLICATION	32	7	0.0080736059771261796391695
TCGA-19-2631.15	84	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0081125013684716605621983
TCGA-08-0354.5	18	2_INTERPHASE	62	4	0.0081157016396813958653000
TCGA-08-0360.3	144	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0081408022736204552205486
TCGA-08-0360.3	144	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0081408022736204552205486
TCGA-27-1833.7	17	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0081592732620871435272880
TCGA-06-0178.2	17	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0081592732620871435272880
TCGA-06-0155.10	74	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0081670464883385023024953
TCGA-06-0128.8	74	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0081670464883385023024953
TCGA-16-1048.13	97	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0081702555566141379927991
TCGA-41-4097.6	48	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	4	0.0081753624907465131249618
TCGA-76-4934.7	47	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0081917370729915426480483
TCGA-19-5960.9	134	2_REGULATION_OF_CELL_PROLIFERATION	265	15	0.0081946943714236129829853
TCGA-16-1048.13	97	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0082006217794408677035367
TCGA-12-0618.5	41	2_REGULATION_OF_CELL_CYCLE	160	7	0.0082029578831965873492171
TCGA-06-2567.9	156	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0082070569351734064950099
TCGA-06-0152.11	56	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0082145021283997199379456
TCGA-19-2619.14	100	0_HALLMARK_HYPOXIA	154	10	0.0082268493989360643586783
TCGA-19-5960.9	134	1_KEGG_DNA_REPLICATION	32	6	0.0082295915140679614524499
TCGA-19-2625.9	146	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0082480687939355899068739
TCGA-19-2625.9	146	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0082480687939355899068739
TCGA-27-2521.10	94	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0082529524903975845506743
TCGA-28-5220.7	15	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0082759960815100321041005
TCGA-32-1986.8	87	2_POLYSACCHARIDE_BINDING	28	5	0.0082881383041541311501588
TCGA-06-5412.7	153	2_RECEPTOR_ACTIVITY	499	23	0.0082949684558209519497085
TCGA-02-0001.5	117	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	12	0.0082967523573289174432244
TCGA-28-1753.13	174	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0082995822540614001827652
TCGA-26-5136.6	160	2_NEURON_PROJECTION	16	5	0.0083068014340530633987658
TCGA-41-2572.8	76	2_EXTRACELLULAR_MATRIX	85	7	0.0083124269309579872783145
TCGA-27-2521.10	94	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0083149285603055927973415
TCGA-06-0145.19	81	1_KEGG_ASTHMA	30	5	0.0083232937350913287904985
TCGA-41-3393.5	88	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0083293814197913790264849
TCGA-06-0649.13	88	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0083293814197913790264849
TCGA-12-3649.15	89	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0083325598453574782620290
TCGA-14-4157.7	101	1_KEGG_BLADDER_CANCER	42	6	0.0083440220128860407428073
TCGA-12-3650.17	101	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0083440220128860407428073
TCGA-06-2559.11	101	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0083440220128860407428073
TCGA-19-4068.7	14	2_DNA_REPLICATION	82	4	0.0083461678231836009672628
TCGA-32-1979.10	116	2_EXTRACELLULAR_REGION_PART	269	14	0.0083470292374649198569037
TCGA-06-0184.11	108	0_HALLMARK_COMPLEMENT	176	11	0.0083526767616148005907162
TCGA-76-6193.13	271	2_EXTRACELLULAR_MATRIX	85	12	0.0083716854804114521765301
TCGA-08-0345.2	77	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0083844523645019222723995
TCGA-06-0139.1	179	2_PLASMA_MEMBRANE	1096	42	0.0084336914977232047690991
TCGA-02-0060.19	281	2_AXON	10	5	0.0084637738256851113849422
TCGA-06-0154.13	76	0_HALLMARK_ANGIOGENESIS	32	5	0.0084684329921983162586807
TCGA-02-0075.8	128	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0084721258161701198247107
TCGA-06-0649.13	88	0_HALLMARK_COMPLEMENT	176	10	0.0084745453112666478678872
TCGA-12-3649.15	89	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0084842322736516720405042
TCGA-02-0024.6	206	0_HALLMARK_P53_PATHWAY	151	14	0.0085002666574023871132182
TCGA-02-0115.4	3	2_CELL_CYCLE_PROCESS	163	3	0.0085218416179170981827884
TCGA-06-0750.9	3	2_CELL_CYCLE_PROCESS	163	3	0.0085218416179170981827884
TCGA-27-1834.9	3	2_CELL_CYCLE_PROCESS	163	3	0.0085218416179170981827884
TCGA-06-0882.9	3	2_CELL_CYCLE_PROCESS	163	3	0.0085218416179170981827884
TCGA-76-6191.6	96	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0085295073156021385812897
TCGA-76-6191.6	96	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0085295073156021385812897
TCGA-19-1390.12	10	2_ION_CHANNEL_ACTIVITY	121	4	0.0085602155677569208291899
TCGA-19-5952.11	193	2_COLLAGEN	23	6	0.0085855168857268265858451
TCGA-06-0743.14	63	1_KEGG_FOCAL_ADHESION	195	9	0.0086300800959227784436845
TCGA-02-2485.14	172	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0086398731478270276995524
TCGA-02-2485.14	172	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0086398731478270276995524
TCGA-76-6282.11	185	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0086423283480129182987373
TCGA-76-6285.5	106	2_CELL_CYCLE_PHASE	146	10	0.0086533590408670695015569
TCGA-06-5411.4	23	2_CELL_PROLIFERATION_GO_0008283	436	8	0.0086625998389592770432266
TCGA-28-2501.3	51	2_CONTRACTILE_FIBER	22	4	0.0086662317487616984112986
TCGA-32-2638.17	159	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0086703264710030480966196
TCGA-28-5218.5	208	2_CALCIUM_ION_BINDING	75	10	0.0086705248713155342460412
TCGA-28-5204.3	4	2_GATED_CHANNEL_ACTIVITY	104	3	0.0086903757698100284057041
TCGA-06-2570.8	95	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0086952532490252813085485
TCGA-06-0176.8	95	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0086952532490252813085485
TCGA-32-5222.9	70	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0086984060238111705898323
TCGA-27-1836.8	49	2_NUCLEUS	1110	18	0.0087057955408567332111769
TCGA-06-0122.8	90	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0087134408416410305542321
TCGA-06-2565.10	38	0_HALLMARK_MITOTIC_SPINDLE	175	7	0.0087153803095331196237883
TCGA-02-0054.3	93	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	7	0.0087189595222544706565326
TCGA-19-5954.17	208	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0087236125951008474527226
TCGA-02-0003.9	227	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0087344799760633636681595
TCGA-28-5220.7	15	0_HALLMARK_G2M_CHECKPOINT	174	5	0.0087420814262025494517649
TCGA-12-0620.1	2	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0087477201342904507830323
TCGA-12-0620.3	2	2_PHOSPHOINOSITIDE_METABOLIC_PROCESS	22	2	0.0087477201342904507830323
TCGA-12-0620.2	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-0644.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-26-1439.2	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-19-2629.3	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-28-2502.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-16-1045.2	2	2_PHOSPHOINOSITIDE_METABOLIC_PROCESS	22	2	0.0087477201342904507830323
TCGA-76-4928.2	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-0169.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-0877.5	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-27-2524.3	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-08-0380.1	2	2_PHOSPHOINOSITIDE_METABOLIC_PROCESS	22	2	0.0087477201342904507830323
TCGA-02-0009.3	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-0133.2	2	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0087477201342904507830323
TCGA-06-0750.3	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-12-0692.1	2	2_PHOSPHOINOSITIDE_METABOLIC_PROCESS	22	2	0.0087477201342904507830323
TCGA-32-1986.6	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-02-0023.2	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-02-0023.1	2	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0087477201342904507830323
TCGA-28-5208.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-14-0787.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-2563.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-19-5952.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-27-1834.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-02-0083.2	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-02-0064.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-5415.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-02-0071.3	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-0214.2	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-0211.2	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-0882.3	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-0743.6	2	2_PHOSPHOINOSITIDE_METABOLIC_PROCESS	22	2	0.0087477201342904507830323
TCGA-06-0743.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-06-0127.4	2	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0087477201342904507830323
TCGA-06-0127.1	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-08-0355.3	2	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0087477201342904507830323
TCGA-14-2554.2	2	2_MRNA_BINDING	22	2	0.0087477201342904507830323
TCGA-19-1390.13	110	2_NUCLEAR_CHROMOSOME	39	6	0.0087602700760903221000042
TCGA-26-5134.2	14	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	4	0.0087613000918710208508866
TCGA-27-2519.7	113	0_HALLMARK_E2F_TARGETS	169	11	0.0087926361073973145071614
TCGA-08-0347.4	16	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0087926725929789138758164
TCGA-32-2491.14	244	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0087956428895505280735057
TCGA-32-2491.14	244	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0087956428895505280735057
TCGA-02-0009.6	188	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0088190778596288280088977
TCGA-06-2563.10	123	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	10	0.0088299348377520823355491
TCGA-06-0156.4	80	1_KEGG_FOCAL_ADHESION	195	10	0.0088347503861285342496856
TCGA-08-0386.4	73	2_CELL_CYCLE_GO_0007049	265	11	0.0088423858465420633601095
TCGA-06-6390.9	82	1_KEGG_ASTHMA	30	5	0.0088441733274838892769898
TCGA-06-2564.7	92	0_HALLMARK_E2F_TARGETS	169	10	0.0088479428915820487744348
TCGA-06-5856.13	152	2_CELL_CYCLE_GO_0007049	265	16	0.0088529145078917875766322
TCGA-02-0115.4	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560395979
TCGA-15-0742.12	3	2_REGULATION_OF_ACTION_POTENTIAL	13	2	0.0088544474626462560395979
TCGA-06-0143.3	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560395979
TCGA-06-0750.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560395979
TCGA-27-1834.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560395979
TCGA-06-0882.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560395979
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560395979
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560395979
TCGA-02-0024.6	206	2_KINESIN_COMPLEX	13	5	0.0088559937564590025804723
TCGA-06-0139.1	179	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	10	0.0088774780992224092135423
TCGA-26-5136.6	160	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0088895944299730890458822
TCGA-27-2528.10	99	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0088974277321398412277098
TCGA-06-0166.5	35	0_HALLMARK_ANGIOGENESIS	32	4	0.0089098079952415112220399
TCGA-19-5958.4	35	0_HALLMARK_ANGIOGENESIS	32	4	0.0089098079952415112220399
TCGA-08-0357.4	36	2_CELL_CYCLE_GO_0007049	265	8	0.0089125324161032012937333
TCGA-06-0744.10	36	2_CELL_CYCLE_GO_0007049	265	8	0.0089125324161032012937333
TCGA-08-0350.2	46	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	5	0.0089142728339331872566831
TCGA-06-0152.10	19	2_MITOTIC_CELL_CYCLE	134	5	0.0089205888825599575359115
TCGA-06-2564.7	92	1_KEGG_MELANOMA	71	7	0.0089263598583066688235688
TCGA-12-5299.5	6	1_KEGG_GLIOMA	62	3	0.0089699653212804118795898
TCGA-14-1823.12	6	1_KEGG_GLIOMA	62	3	0.0089699653212804118795898
TCGA-27-1838.17	131	2_CELL_CYCLE_PHASE	146	11	0.0090264580370034187828399
TCGA-08-0345.2	77	0_HALLMARK_ANGIOGENESIS	32	5	0.0090349076817780038517469
TCGA-06-0189.3	118	1_KEGG_FOCAL_ADHESION	195	12	0.0090711293610277136251208
TCGA-41-4097.6	48	2_SYSTEM_DEVELOPMENT	694	14	0.0090878949475252379652801
TCGA-76-4929.8	91	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0091070767240048530050123
TCGA-41-4097.6	48	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	5	0.0091071884969651326763307
TCGA-06-0127.2	23	1_KEGG_FOCAL_ADHESION	195	6	0.0091122709883949253723001
TCGA-19-2625.9	146	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0091176095416351382594300
TCGA-06-0137.9	53	2_SYSTEM_PROCESS	451	12	0.0091302442939852537090450
TCGA-06-0125.9	75	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0091441886533667002950887
TCGA-76-4928.15	78	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0091454763422796139793469
TCGA-76-4928.15	78	2_CELL_CELL_SIGNALING	353	13	0.0091552892993127816395615
TCGA-76-6191.6	96	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0091559590630540949041105
TCGA-02-0115.1	36	2_SYSTEM_DEVELOPMENT	694	12	0.0091729754217751997141805
TCGA-02-0071.12	116	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0091785093712186665432240
TCGA-12-5301.1	14	1_KEGG_ECM_RECEPTOR_INTERACTION	84	4	0.0091915399170264013017917
TCGA-06-5417.5	79	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0091941470331722389974782
TCGA-32-2632.16	229	2_DNA_METABOLIC_PROCESS	218	18	0.0092030165387292275219755
TCGA-19-1390.13	110	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0092411603183712113379622
TCGA-06-0122.8	90	2_CELL_CELL_SIGNALING	353	14	0.0092479908924552097632121
TCGA-08-0353.8	100	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0092618372974614671111482
TCGA-19-2619.14	100	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0092618372974614671111482
TCGA-02-2483.10	100	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0092618372974614671111482
TCGA-28-2514.9	62	0_HALLMARK_APOPTOSIS	150	8	0.0092638003752820961833603
TCGA-26-1439.11	10	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0092792822898188909164219
TCGA-02-0115.1	36	2_ORGAN_DEVELOPMENT	460	10	0.0092913324823767264731833
TCGA-28-2509.6	59	2_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0092948492853432047866580
TCGA-28-2509.6	59	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0092948492853432047866580
TCGA-06-0650.2	82	0_HALLMARK_APOPTOSIS	150	9	0.0093034927303562910821944
TCGA-06-0650.2	82	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	9	0.0093034927303562910821944
TCGA-06-2558.6	74	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0093137468498041137143773
TCGA-27-1830.7	57	2_EXTRACELLULAR_REGION	346	11	0.0093164224376065182808837
TCGA-28-5218.5	208	2_CYTOSKELETAL_PART	194	16	0.0093262298491462846533606
TCGA-06-0178.2	17	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0093324412426659848762700
TCGA-06-0648.6	17	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0093324412426659848762700
TCGA-28-5216.8	162	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0093404605566380534409365
TCGA-06-0145.19	81	2_SYNAPTIC_TRANSMISSION	152	9	0.0093585024537628826168945
TCGA-19-2624.29	130	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0093907505120831603895315
TCGA-19-5955.9	110	2_COLLAGEN	23	5	0.0093948489574754538711243
TCGA-06-2569.5	144	2_DNA_METABOLIC_PROCESS	218	14	0.0093965132429991160556426
TCGA-06-0219.6	6	2_KINASE_BINDING	63	3	0.0094162107706102678161830
TCGA-08-0244.4	6	2_KINASE_BINDING	63	3	0.0094162107706102678161830
TCGA-12-5299.5	6	2_KINASE_BINDING	63	3	0.0094162107706102678161830
TCGA-14-1823.12	6	2_KINASE_BINDING	63	3	0.0094162107706102678161830
TCGA-14-1829.11	6	2_KINASE_BINDING	63	3	0.0094162107706102678161830
TCGA-14-2554.9	6	2_KINASE_BINDING	63	3	0.0094162107706102678161830
TCGA-32-2632.16	229	2_REGULATION_OF_APOPTOSIS	309	22	0.0094330849005256414696596
TCGA-02-0099.11	141	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0094356576622242581409150
TCGA-19-1390.13	110	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0094618236810910215373038
TCGA-32-2632.16	229	2_CELL_DEVELOPMENT	511	30	0.0094710528510178106781359
TCGA-32-1979.4	12	2_NEGATIVE_REGULATION_OF_GROWTH	29	3	0.0094901065475660704995331
TCGA-28-5218.5	208	0_HALLMARK_P53_PATHWAY	151	14	0.0095103156825723737105571
TCGA-06-2564.7	92	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0095137404866459437252635
TCGA-32-2498.13	133	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	7	0.0095348843934858172610713
TCGA-76-4925.9	83	1_KEGG_ENDOMETRIAL_CANCER	52	6	0.0095393846367414977804877
TCGA-02-0011.1	288	2_AXON	10	5	0.0095499933694856396770856
TCGA-32-2634.10	118	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0095676196102444932556352
TCGA-19-5958.4	35	1_KEGG_MELANOMA	71	5	0.0095677075194255424561707
TCGA-26-5139.10	163	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0095721578168251955642809
TCGA-14-4157.7	101	2_CHROMATIN	25	5	0.0095752983258878474059905
TCGA-02-2485.14	172	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	9	0.0095763483582631606094715
TCGA-27-1833.5	2	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0095808363375570280290328
TCGA-02-0115.3	2	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0095808363375570280290328
TCGA-27-2524.7	2	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0095808363375570280290328
TCGA-12-3653.7	2	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0095808363375570280290328
TCGA-28-5207.12	188	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	12	0.0096046457138111891727039
TCGA-02-0048.9	84	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0096172220664347829455210
TCGA-28-2509.6	59	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0096254530909664799687153
TCGA-28-2514.9	62	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0096261103544653114916230
TCGA-12-3650.17	101	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0096371957555366361686255
TCGA-26-5134.2	14	2_EXTRACELLULAR_MATRIX	85	4	0.0096372380718436016083794
TCGA-19-2623.11	153	2_CELL_CYCLE_GO_0007049	265	16	0.0096414806456089820890787
TCGA-06-0130.3	155	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	20	0.0096419946554536332949947
TCGA-06-2559.11	101	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0096574377379735568821539
TCGA-27-1833.2	41	2_TRANSMISSION_OF_NERVE_IMPULSE	164	7	0.0096593645273012843782690
TCGA-41-5651.5	112	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0096595309034312650670051
TCGA-12-0692.6	11	1_KEGG_DNA_REPLICATION	32	3	0.0096630403283965785043996
TCGA-08-0350.2	46	2_CELL_CELL_SIGNALING	353	10	0.0096685105126759034177564
TCGA-12-5301.7	46	2_CELL_CELL_SIGNALING	353	10	0.0096685105126759034177564
TCGA-06-0645.9	136	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	16	0.0097095973019493166111804
TCGA-14-0786.4	62	2_SIGNAL_TRANSDUCTION	1442	24	0.0097096029895490879729758
TCGA-02-0024.6	206	2_M_PHASE	94	11	0.0097147276481301531037005
TCGA-06-0145.4	7	2_CYTOSKELETAL_PART	194	4	0.0097148706133272921814381
TCGA-19-1390.12	10	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	125	4	0.0097453076076368209956780
TCGA-19-5951.10	138	1_KEGG_DNA_REPLICATION	32	6	0.0097576494113625813348056
TCGA-76-4927.8	93	0_HALLMARK_E2F_TARGETS	169	10	0.0097627125999757025792691
TCGA-27-1837.5	85	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0097663667823339097434632
TCGA-02-0011.1	288	2_CELL_CYCLE_GO_0007049	265	23	0.0097807961634290129654401
TCGA-02-0021.4	170	2_REGULATION_OF_CELL_CYCLE	160	13	0.0097850300135169654414113
TCGA-02-0001.5	117	2_CATION_BINDING	165	11	0.0097998238291811725492186
TCGA-06-6391.9	26	2_EXTRACELLULAR_REGION_PART	269	7	0.0098036487679113715199009
TCGA-14-0789.11	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370721704111
TCGA-26-1439.7	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370721704111
TCGA-19-5959.2	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370721704111
TCGA-19-2623.13	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370721704111
TCGA-32-2494.8	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370721704111
TCGA-06-5410.3	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370721704111
TCGA-06-1804.4	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370721704111
TCGA-14-1825.5	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370721704111
TCGA-06-0649.14	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370721704111
TCGA-02-0033.5	144	2_SIGNAL_TRANSDUCTION	1442	43	0.0098745452465089696841849
TCGA-27-1838.17	131	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0098802913148401377146923
TCGA-87-5896.6	131	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0098802913148401377146923
TCGA-02-0009.6	188	2_SYSTEM_DEVELOPMENT	694	32	0.0098932400936978925204413
TCGA-28-5216.8	162	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	12	0.0099163520365787554550208
TCGA-28-5220.7	15	1_KEGG_PATHWAYS_IN_CANCER	323	6	0.0099309175049431784587650
TCGA-12-0688.10	93	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0099337076403622232706470
TCGA-32-2632.16	229	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	22	0.0099375127850643563132138
TCGA-08-0350.2	46	2_CELL_CYCLE_PHASE	146	7	0.0099533518103560834899834
TCGA-12-0692.6	11	2_NON_MEMBRANE_BOUND_ORGANELLE	476	6	0.0099669365764700600801573
TCGA-12-0692.6	11	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	6	0.0099669365764700600801573
TCGA-02-0014.10	70	2_INTERPHASE	62	6	0.0099686179571164754142920
TCGA-28-5207.12	188	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0099739608869460014833885
TCGA-06-0156.4	80	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0100049344612411911237260
TCGA-08-0350.2	46	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0100505763044780437737158
TCGA-19-5954.17	208	2_DNA_METABOLIC_PROCESS	218	17	0.0100537313624524914101865
TCGA-19-2625.9	146	2_EXTRACELLULAR_MATRIX	85	9	0.0100646199401350326663174
TCGA-14-0817.9	85	2_CELL_CYCLE_PHASE	146	9	0.0100646199401350344010408
TCGA-02-0014.10	70	2_MITOTIC_CELL_CYCLE	134	8	0.0101164814957373661724604
TCGA-14-1825.8	80	2_MICROTUBULE_CYTOSKELETON	117	8	0.0101344471809773264275867
TCGA-27-2519.7	113	2_IMMUNE_RESPONSE	206	12	0.0101407506303058825986030
TCGA-12-3650.17	101	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0101616418288940479203175
TCGA-08-0347.4	16	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0101704766235597016121872
TCGA-28-6450.11	139	1_KEGG_DNA_REPLICATION	32	6	0.0101736429274410043049892
TCGA-02-0060.19	281	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0101794681003488565046444
TCGA-06-5415.3	8	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	6	0.0101873100976081765178805
TCGA-06-0221.4	8	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	6	0.0101873100976081765178805
TCGA-06-5418.4	24	2_NEUROLOGICAL_SYSTEM_PROCESS	296	7	0.0102049239410744087969141
TCGA-06-0129.11	110	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0102092613498143500866400
TCGA-06-0168.3	4	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	10	2	0.0102130652672037993550225
TCGA-32-2632.1	4	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	10	2	0.0102130652672037993550225
TCGA-32-2491.13	4	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	10	2	0.0102130652672037993550225
TCGA-06-0154.13	76	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0102199162287495183554231
TCGA-14-0786.4	62	2_SYNAPTIC_TRANSMISSION	152	8	0.0102203728598241651293055
TCGA-08-0246.6	62	2_SYNAPTIC_TRANSMISSION	152	8	0.0102203728598241651293055
TCGA-06-0152.10	19	2_INTERPHASE	62	4	0.0102294663847523944338880
TCGA-12-3653.55	255	2_CELL_PROLIFERATION_GO_0008283	436	29	0.0102391470517260961548001
TCGA-08-0347.4	16	2_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0102483534745600127907617
TCGA-08-0347.4	16	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0102483534745600127907617
TCGA-06-5856.13	152	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0102881641667085729774378
TCGA-06-0744.10	36	1_KEGG_PANCREATIC_CANCER	70	5	0.0102966049453401993496460
TCGA-14-0781.7	155	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0103067102966555336485133
TCGA-06-0124.6	55	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0103341585408147727115358
TCGA-02-0086.2	17	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0103344018098571327479718
TCGA-32-1986.12	17	1_KEGG_LEISHMANIA_INFECTION	70	4	0.0103344018098571327479718
TCGA-32-1986.12	17	1_KEGG_VIRAL_MYOCARDITIS	70	4	0.0103344018098571327479718
TCGA-06-0648.6	17	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0103344018098571327479718
TCGA-12-0616.4	7	2_NON_MEMBRANE_BOUND_ORGANELLE	476	5	0.0103727800439277796640258
TCGA-12-0616.4	7	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	5	0.0103727800439277796640258
TCGA-26-5136.6	160	2_CHROMOSOMAL_PART	78	9	0.0103830373013022309036657
TCGA-06-0157.7	89	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0103899386078080274709023
TCGA-12-5299.5	6	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	4	0.0103940670992407804135160
TCGA-08-0354.5	18	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0104354938722547758989112
TCGA-06-0213.9	74	0_HALLMARK_E2F_TARGETS	169	9	0.0104427207476537903946268
TCGA-08-0244.5	39	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0104573513756062771301591
TCGA-27-1834.10	39	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0104573513756062771301591
TCGA-02-0011.1	288	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0104866679176576441806512
TCGA-06-0173.35	120	2_CELL_CYCLE_GO_0007049	265	14	0.0104925170110445921400899
TCGA-19-5960.9	134	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0105200572131891843807860
TCGA-02-2483.10	100	1_KEGG_FOCAL_ADHESION	195	11	0.0105351286966172651149432
TCGA-26-5132.7	100	1_KEGG_FOCAL_ADHESION	195	11	0.0105351286966172651149432
TCGA-02-0074.5	118	2_MITOTIC_CELL_CYCLE	134	10	0.0105620164265343239456962
TCGA-27-2528.10	99	2_REGULATION_OF_CELL_CYCLE	160	10	0.0105678769396133284685924
TCGA-26-5136.6	160	2_PROTEIN_HOMODIMERIZATION_ACTIVITY	99	10	0.0105678769396133458158271
TCGA-41-5651.5	112	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0105720685404434838056131
TCGA-28-5215.7	192	2_CATION_BINDING	165	14	0.0105876938491645273404673
TCGA-14-0813.5	5	2_GABA_RECEPTOR_ACTIVITY	8	2	0.0105898322740181453915920
TCGA-28-1753.13	174	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0105902915458147683230861
TCGA-28-1753.13	174	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0105902915458147683230861
TCGA-32-1970.14	94	2_NUCLEUS	1110	27	0.0105932259035110901135290
TCGA-02-0099.11	141	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0106007808136843236640479
TCGA-06-1804.6	30	2_NUCLEAR_CHROMOSOME	39	4	0.0106285222911852387378540
TCGA-02-0011.1	288	2_DNA_REPLICATION	82	12	0.0106480358681166498852066
TCGA-27-1833.7	17	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0106615582506913823823691
TCGA-02-0086.2	17	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0106615582506913823823691
TCGA-06-0648.6	17	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0106615582506913823823691
TCGA-14-0813.10	53	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0106821919930231660350595
TCGA-02-0060.19	281	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0107007362841338559550364
TCGA-06-5858.19	205	2_MITOTIC_CELL_CYCLE	134	13	0.0107491244941758361947093
TCGA-06-2557.11	177	1_KEGG_MELANOMA	71	9	0.0107571205508150847390825
TCGA-28-5218.5	208	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0107751240568154642990306
TCGA-32-2632.16	229	2_CELL_CYCLE_GO_0007049	265	20	0.0107804732565718285053347
TCGA-26-5135.9	71	1_KEGG_GLIOMA	62	6	0.0108335077467000533840702
TCGA-08-0246.6	62	1_KEGG_MELANOMA	71	6	0.0108335077467000533840702
TCGA-06-5415.3	8	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	6	0.0108414328219537392516969
TCGA-06-0221.4	8	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	6	0.0108414328219537392516969
TCGA-12-5299.5	6	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0108427549916041161132130
TCGA-14-1823.12	6	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0108427549916041161132130
TCGA-28-5220.7	15	2_POSITIVE_REGULATION_OF_PHOSPHORYLATION	24	3	0.0108562957661053061109158
TCGA-12-5299.5	6	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	5	0.0108654540117802175108741
TCGA-14-1823.12	6	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	5	0.0108654540117802175108741
TCGA-02-0027.3	81	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0108743503891396871285924
TCGA-16-1045.10	81	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0108743503891396871285924
TCGA-02-0107.3	71	2_ORGAN_DEVELOPMENT	460	14	0.0109071138993987511861539
TCGA-28-5204.5	5	1_KEGG_SMALL_CELL_LUNG_CANCER	83	3	0.0109105716366615940887685
TCGA-06-0126.7	5	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	3	0.0109105716366615940887685
TCGA-26-5136.6	160	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0109452057422240265488478
TCGA-28-5207.12	188	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0109592933098945806424940
TCGA-06-0192.10	126	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	10	0.0109641093616896882767531
TCGA-06-0169.5	42	2_RESPONSE_TO_WOUNDING	163	7	0.0109716702829699627730342
TCGA-02-0115.1	36	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	13	0.0109906336181896241432909
TCGA-06-2567.9	156	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0110147887576338733561787
TCGA-14-0789.10	106	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	10	0.0110189024521298879061293
TCGA-14-4157.7	101	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	6	0.0110360654423391144063338
TCGA-06-0744.10	36	1_KEGG_MELANOMA	71	5	0.0110463280119942018620005
TCGA-06-0876.9	106	1_KEGG_BLADDER_CANCER	42	6	0.0110487755575225232024250
TCGA-02-0099.11	141	0_HALLMARK_ANGIOGENESIS	32	6	0.0110489547300975585186755
TCGA-32-4210.14	109	1_KEGG_GLIOMA	62	7	0.0110500668345317638874281
TCGA-32-4210.14	109	2_INTERPHASE	62	7	0.0110500668345317638874281
TCGA-06-2570.8	95	2_MITOSIS	71	7	0.0110601615958817282858728
TCGA-06-2570.8	95	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	7	0.0110601615958817282858728
TCGA-06-5417.5	79	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	6	0.0110946659215119935310012
TCGA-06-5413.11	142	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0111079106938184509617562
TCGA-41-2573.4	31	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	5	0.0111192781731287472501979
TCGA-02-2485.14	172	2_REGULATION_OF_CELL_CYCLE	160	13	0.0111264002227892920549035
TCGA-14-0787.7	14	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	358	6	0.0111303495343254826160928
TCGA-12-0692.7	23	2_SYSTEM_PROCESS	451	8	0.0111322792769760516018440
TCGA-06-0216.6	67	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0111369122484125705752067
TCGA-06-0129.11	110	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0111414168151066274997651
TCGA-41-2575.49	136	2_MICROTUBULE_CYTOSKELETON	117	10	0.0111709990343902033915757
TCGA-02-2483.10	100	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0111938992689870984303946
TCGA-19-5960.9	134	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0111988488229478409113904
TCGA-02-0114.20	132	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	8	0.0112036380101955268528968
TCGA-28-5216.8	162	2_EPIDERMIS_DEVELOPMENT	59	8	0.0112058367434247803384739
TCGA-19-1790.18	201	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0112153819435333746562522
TCGA-41-3393.5	88	2_EXTRACELLULAR_REGION_PART	269	12	0.0112231732931209575443443
TCGA-19-2629.15	146	2_MITOTIC_CELL_CYCLE	134	11	0.0112412934397642001738138
TCGA-26-5139.10	163	0_HALLMARK_E2F_TARGETS	169	13	0.0112504332465372652166691
TCGA-76-6191.6	96	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0112762220651054026476778
TCGA-06-0881.7	203	2_CELL_CELL_SIGNALING	353	22	0.0112843261435381665008792
TCGA-06-0750.12	52	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0113015078170798765472282
TCGA-06-5411.4	23	1_KEGG_ENDOMETRIAL_CANCER	52	4	0.0113015078170798765472282
TCGA-02-0021.4	170	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0113156627582956612748655
TCGA-02-0024.6	206	2_MITOTIC_CELL_CYCLE	134	13	0.0113358570624509345792230
TCGA-16-1045.10	81	2_EXTRACELLULAR_REGION	346	13	0.0113362759374781608967542
TCGA-02-0060.19	281	2_WOUND_HEALING	46	9	0.0113474417918608804639602
TCGA-02-0052.3	116	0_HALLMARK_E2F_TARGETS	169	11	0.0113507259063556735501077
TCGA-06-0210.6	103	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0113579676384684101486666
TCGA-02-2470.4	11	2_CELL_CYCLE_GO_0007049	265	5	0.0113668669512342994376564
TCGA-02-2470.4	11	2_REGULATION_OF_CELL_PROLIFERATION	265	5	0.0113668669512342994376564
TCGA-06-0213.9	74	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	6	0.0113786703670147749251074
TCGA-06-0686.1	7	2_INTEGRAL_TO_MEMBRANE	956	6	0.0114389677644259214056577
TCGA-32-2494.10	173	2_REGULATION_OF_CELL_PROLIFERATION	265	17	0.0114497544595600006522851
TCGA-06-0879.9	84	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0114548178149316576962535
TCGA-02-0048.9	84	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0114548178149316576962535
TCGA-15-0742.13	74	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0114707912746657911262638
TCGA-06-5415.7	7	2_PROTEIN_KINASE_BINDING	56	3	0.0114734277470675063992367
TCGA-06-0211.7	10	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0114762596630372162159750
TCGA-76-4927.8	93	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0114937482901718637795518
TCGA-02-0089.5	91	0_HALLMARK_COMPLEMENT	176	10	0.0114994515886000445159532
TCGA-27-2521.10	94	2_MITOTIC_CELL_CYCLE	134	9	0.0115084260449343517979104
TCGA-06-5413.11	142	1_KEGG_DNA_REPLICATION	32	6	0.0115090275779559311764011
TCGA-19-5947.4	267	0_HALLMARK_HYPOXIA	154	16	0.0115474743146233346097196
TCGA-41-5651.5	112	2_EXTRACELLULAR_MATRIX	85	8	0.0115565078071204700022045
TCGA-19-5952.11	193	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	21	0.0115649504332079357260543
TCGA-06-0184.11	108	0_HALLMARK_KRAS_SIGNALING_UP	148	10	0.0115691781268759587980588
TCGA-19-5952.6	8	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	4	0.0115827217990933737518100
TCGA-02-0009.6	188	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0115964795799838610995680
TCGA-16-1045.10	81	0_HALLMARK_ANGIOGENESIS	32	5	0.0116048766406199269779487
TCGA-28-1747.5	81	1_KEGG_DNA_REPLICATION	32	5	0.0116048766406199269779487
TCGA-06-0648.6	17	2_REGULATION_OF_CELL_CYCLE	160	5	0.0116075524286710536625566
TCGA-02-0060.19	281	2_SYSTEM_DEVELOPMENT	694	42	0.0116295889826141651129943
TCGA-02-0038.3	199	1_KEGG_PYRIMIDINE_METABOLISM	64	9	0.0116394102600277764281156
TCGA-32-1979.4	12	2_REGULATION_OF_CELL_GROWTH	31	3	0.0116576406469521155068181
TCGA-02-0069.13	16	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	3	0.0116839708176868471711796
TCGA-76-6285.5	106	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0116856525399557983208032
TCGA-06-0878.10	115	2_COLLAGEN	23	5	0.0116872121772456684374308
TCGA-02-0015.16	115	2_COLLAGEN	23	5	0.0116872121772456684374308
TCGA-02-2485.14	172	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	8	0.0116892992252349160048341
TCGA-02-0060.19	281	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	47	0.0116957121316466888111263
TCGA-32-4213.12	5	1_KEGG_GAP_JUNCTION	85	3	0.0117248707198181530836356
TCGA-06-0126.7	5	2_EXTRACELLULAR_MATRIX	85	3	0.0117248707198181530836356
TCGA-19-5947.4	267	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0117300176422175696233641
TCGA-06-0156.4	80	2_EXTRACELLULAR_MATRIX	85	7	0.0117338309969815986211206
TCGA-06-0129.11	110	2_INTERPHASE	62	7	0.0117408397163829177067829
TCGA-28-5208.28	220	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0117472078737870470194204
TCGA-16-1048.13	97	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0117522078236000828560526
TCGA-81-5910.12	128	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0117526062266667830763511
TCGA-14-4157.7	101	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0117550142625936354656702
TCGA-12-3650.17	101	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0117550142625936354656702
TCGA-06-2559.11	101	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0117550142625936354656702
TCGA-41-2571.7	72	1_KEGG_GLIOMA	62	6	0.0117583630159406524184895
TCGA-41-2571.7	72	2_INTERPHASE	62	6	0.0117583630159406524184895
TCGA-06-0197.1	57	0_HALLMARK_E2F_TARGETS	169	8	0.0117591548777075012577331
TCGA-12-0616.1	20	2_MITOTIC_CELL_CYCLE	134	5	0.0117591778863900420920574
TCGA-08-0349.1	31	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0117958531659095259419567
TCGA-12-3653.55	255	2_CHROMOSOMAL_PART	78	11	0.0118468376161047633798873
TCGA-02-2485.14	172	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0118544325462235193568983
TCGA-76-6191.6	96	1_KEGG_MELANOMA	71	7	0.0118593379854811074858301
TCGA-02-0114.20	132	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0118687898935566013558507
TCGA-28-2513.12	134	0_HALLMARK_COMPLEMENT	176	12	0.0118745009638758693831795
TCGA-08-0354.7	47	2_CELL_CELL_SIGNALING	353	10	0.0118790046673800612359040
TCGA-02-0033.5	144	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	19	0.0118904427249128877286388
TCGA-32-2634.10	118	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0118959053307203920651913
TCGA-02-0083.21	135	1_KEGG_MELANOMA	71	8	0.0119049200221402542987370
TCGA-32-1991.4	7	2_OLIGOSACCHARYL_TRANSFERASE_COMPLEX	6	2	0.0119118795373995244035736
TCGA-12-5299.5	6	2_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS	7	2	0.0119118795373995244035736
TCGA-26-1439.7	3	2_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX	15	2	0.0119177647316685338813036
TCGA-06-5415.5	3	2_NITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS	15	2	0.0119177647316685338813036
TCGA-06-5858.19	205	0_HALLMARK_MYC_TARGETS_V1	178	15	0.0119232620935520571697763
TCGA-02-0025.5	88	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0119539038494113920158002
TCGA-41-3393.5	88	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0119539038494113920158002
TCGA-06-0649.13	88	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0119539038494113920158002
TCGA-06-0649.13	88	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0119539038494113920158002
TCGA-76-4935.8	21	2_CELL_CELL_SIGNALING	353	7	0.0119623975858476460504276
TCGA-12-3653.55	255	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0119707941232832862366031
TCGA-28-5214.11	124	2_CHROMOSOME	102	9	0.0119750005957489687874462
TCGA-06-0190.8	143	0_HALLMARK_ANGIOGENESIS	32	6	0.0119845590975264943561784
TCGA-02-0099.11	141	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0120231359247492761849196
TCGA-02-0099.11	141	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0120231359247492761849196
TCGA-28-5204.3	4	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	3	0.0120840112724314215769672
TCGA-02-0024.6	206	1_KEGG_PATHWAYS_IN_CANCER	323	21	0.0121433411314324571361745
TCGA-06-2570.8	95	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0121516177983755635505503
TCGA-06-0176.8	95	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0121516177983755635505503
TCGA-06-5858.19	205	2_COLLAGEN	23	6	0.0121567465853696429073372
TCGA-12-0619.11	123	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0121651096461907227974653
TCGA-06-0686.1	7	2_INTRINSIC_TO_MEMBRANE	966	6	0.0121658197161422336474157
TCGA-08-0360.3	144	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0121829146686858718479085
TCGA-28-5209.15	194	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0121830163527340152446188
TCGA-02-0052.3	116	2_COLLAGEN	23	5	0.0121941677167503766121559
TCGA-02-0071.12	116	2_COLLAGEN	23	5	0.0121941677167503766121559
TCGA-14-3476.17	53	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0122043863550215792024289
TCGA-19-2629.15	146	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0122138609016603106455223
TCGA-06-0188.11	66	2_CELL_CYCLE_PHASE	146	8	0.0122173529174427978466477
TCGA-02-0113.4	9	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	4	0.0122188506942084839507201
TCGA-02-0054.2	9	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	4	0.0122188506942084839507201
TCGA-76-6193.13	271	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0122299063460164104261141
TCGA-27-2521.10	94	2_CHROMOSOME	102	8	0.0122409195186377571518133
TCGA-06-0241.8	53	2_CELL_CYCLE_ARREST_GO_0007050	49	5	0.0122441289549941826481083
TCGA-06-2558.6	74	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	16	0.0122578565584233814544923
TCGA-76-4928.15	78	2_NEURON_PROJECTION	16	4	0.0122629501418323530459453
TCGA-12-0620.1	2	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0123073984573378054224735
TCGA-06-0133.2	2	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0123073984573378054224735
TCGA-02-0023.1	2	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0123073984573378054224735
TCGA-06-0127.4	2	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0123073984573378054224735
TCGA-08-0355.3	2	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0123073984573378054224735
TCGA-02-2483.10	100	2_NUCLEUS	1110	28	0.0123094074703200013348736
TCGA-02-0085.1	45	2_ORGAN_DEVELOPMENT	460	11	0.0123148208458459060971046
TCGA-28-2514.9	62	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0123199372044629894967782
TCGA-32-1991.11	82	0_HALLMARK_ANGIOGENESIS	32	5	0.0123289472080292759198494
TCGA-06-0650.2	82	0_HALLMARK_ANGIOGENESIS	32	5	0.0123289472080292759198494
TCGA-02-0102.8	82	1_KEGG_DNA_REPLICATION	32	5	0.0123289472080292759198494
TCGA-27-1833.7	17	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0123312357829346002507931
TCGA-02-0086.2	17	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0123312357829346002507931
TCGA-06-0648.6	17	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0123312357829346002507931
TCGA-06-0686.10	26	2_CHROMOSOME	102	5	0.0123379553699647752373902
TCGA-06-6389.1	18	2_SYNAPTIC_TRANSMISSION	152	5	0.0123394241540986937533120
TCGA-06-0168.4	22	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0123430596687741991890341
TCGA-14-0790.9	104	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0123459106183262893458030
TCGA-08-0390.3	6	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	3	0.0124057607347347331749887
TCGA-32-1979.4	12	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	5	0.0124736079554504594724129
TCGA-06-0877.7	4	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0124808724916065944682275
TCGA-16-0861.5	4	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0124808724916065944682275
TCGA-06-2561.7	4	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0124808724916065944682275
TCGA-08-0348.3	4	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0124808724916065944682275
TCGA-19-1790.1	4	2_REGULATION_OF_TRANSCRIPTION	494	4	0.0124860038424335472589943
TCGA-02-0007.17	217	2_NERVOUS_SYSTEM_DEVELOPMENT	307	21	0.0124868491854915556610317
TCGA-41-2573.4	31	2_EXTRACELLULAR_MATRIX	85	5	0.0125042844075492227268187
TCGA-06-0877.8	61	2_EXTRACELLULAR_REGION_PART	269	10	0.0125296424509980693084987
TCGA-02-0052.3	116	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0125453214883116462297075
TCGA-06-5417.5	79	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0125827108627064362250669
TCGA-19-5952.11	193	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0125901550476272515444176
TCGA-12-3653.55	255	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0125904178331143114938362
TCGA-27-2524.5	75	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	16	0.0126037024844515063021211
TCGA-06-2559.11	101	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0126245021953671522629836
TCGA-06-0645.9	136	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0126586521179066959635895
TCGA-06-0645.9	136	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0126586521179066959635895
TCGA-12-3650.17	101	2_REGULATION_OF_CELL_CYCLE	160	10	0.0126598608578467643204224
TCGA-06-0875.7	78	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0126716373420057894921831
TCGA-06-5856.13	152	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0126750380798038072421852
TCGA-06-5856.13	152	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0126750380798038072421852
TCGA-14-1034.7	97	1_KEGG_MELANOMA	71	7	0.0127059590640778083403539
TCGA-06-5411.4	23	2_MICROTUBULE_CYTOSKELETON	117	5	0.0127182160487322760966666
TCGA-12-0616.1	20	1_KEGG_GLIOMA	62	4	0.0127241218300225018139615
TCGA-02-2470.4	11	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0127266115908144222118592
TCGA-28-5207.12	188	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	8	0.0127336472293018230367290
TCGA-27-2528.10	99	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0127486245965757818976449
TCGA-16-1045.10	81	2_EXTRACELLULAR_MATRIX	85	7	0.0127511319785767185397418
TCGA-12-3649.15	89	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0127656640435073100853236
TCGA-32-1982.9	89	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0127656640435073100853236
TCGA-02-0069.12	62	2_CELL_CYCLE_GO_0007049	265	10	0.0127668038344390007143847
TCGA-06-0211.8	62	2_CELL_CYCLE_GO_0007049	265	10	0.0127668038344390007143847
TCGA-08-0354.5	18	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0127755861150595350500536
TCGA-28-5214.11	124	2_REGULATION_OF_CELL_CYCLE	160	11	0.0128120521332625407484596
TCGA-26-1439.11	10	2_MITOTIC_CELL_CYCLE	134	4	0.0128527702707583024038795
TCGA-41-3393.4	12	1_KEGG_DNA_REPLICATION	32	3	0.0128544008380830319937527
TCGA-28-5214.11	124	2_CHROMOSOMAL_PART	78	8	0.0128973070385776499707786
TCGA-02-0034.5	6	1_KEGG_LEISHMANIA_INFECTION	70	3	0.0129581408419112333735290
TCGA-02-0034.5	6	1_KEGG_VIRAL_MYOCARDITIS	70	3	0.0129581408419112333735290
TCGA-12-5299.5	6	1_KEGG_PANCREATIC_CANCER	70	3	0.0129581408419112333735290
TCGA-14-1823.12	6	1_KEGG_PANCREATIC_CANCER	70	3	0.0129581408419112333735290
TCGA-14-1823.12	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	3	0.0129581408419112333735290
TCGA-19-1790.18	201	2_IMMUNE_RESPONSE	206	16	0.0129854370865293937409302
TCGA-41-3915.10	109	1_KEGG_BLADDER_CANCER	42	6	0.0129871940244149115806227
TCGA-41-3915.10	109	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0129871940244149115806227
TCGA-06-0184.11	108	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	10	0.0130373753185188574754694
TCGA-76-6282.11	185	2_ENZYME_REGULATOR_ACTIVITY	277	18	0.0130542107861009760993998
TCGA-41-2572.8	76	0_HALLMARK_E2F_TARGETS	169	9	0.0130551737697593081555247
TCGA-19-5960.9	134	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0131083423946202065613065
TCGA-02-0011.1	288	2_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0131168651578276555802471
TCGA-02-0011.1	288	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0131168651578276555802471
TCGA-32-2634.10	118	2_NUCLEAR_CHROMOSOME	39	6	0.0131567328757690830964844
TCGA-06-0184.11	108	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	15	0.0131630556653888515505901
TCGA-06-2562.7	57	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0131796475260502910648031
TCGA-06-0197.1	57	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0131796475260502910648031
TCGA-08-0354.5	18	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0132129452020004964363231
TCGA-02-0014.10	70	2_REPLICATION_FORK	18	4	0.0132129452020004964363231
TCGA-06-0157.7	89	2_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0132134532919343395535039
TCGA-06-0157.7	89	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0132134532919343395535039
TCGA-28-5218.5	208	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	6	0.0132161391463665543050121
TCGA-02-0060.19	281	0_HALLMARK_KRAS_SIGNALING_UP	148	16	0.0132230318860317372364754
TCGA-02-2486.9	141	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	8	0.0132289485669529593286908
TCGA-08-0352.2	59	2_EXTRACELLULAR_REGION	346	11	0.0132336952413826380164918
TCGA-14-4157.7	101	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0132459048257064088138790
TCGA-02-0010.18	184	2_SYNAPTIC_TRANSMISSION	152	13	0.0132459751725166312991133
TCGA-87-5896.6	131	0_HALLMARK_APICAL_JUNCTION	182	12	0.0132484520549962254271081
TCGA-08-0353.8	100	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0132696387906946992180091
TCGA-19-2619.14	100	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0132696387906946992180091
TCGA-02-2483.10	100	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0132696387906946992180091
TCGA-19-5954.6	8	2_ENDOPLASMIC_RETICULUM	177	4	0.0132846019857911501471648
TCGA-06-2567.9	156	1_KEGG_ASTHMA	30	6	0.0133068606537230030295582
TCGA-02-0071.12	116	2_STRUCTURAL_MOLECULE_ACTIVITY	206	12	0.0133286460058815430657075
TCGA-27-2524.5	75	2_EXTRACELLULAR_REGION_PART	269	11	0.0133586640328760518359186
TCGA-06-0221.13	45	2_CHROMOSOME	102	6	0.0133659751929123670616262
TCGA-02-0052.3	116	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	7	0.0133692453589346321035647
TCGA-32-2638.17	159	0_HALLMARK_APOPTOSIS	150	12	0.0134021430785017884451671
TCGA-28-5219.9	47	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	358	10	0.0134500672244899418389386
TCGA-19-2625.9	146	0_HALLMARK_ANGIOGENESIS	32	6	0.0135078779774455530471311
TCGA-02-0114.20	132	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0135172143191406145951161
TCGA-14-0781.7	155	0_HALLMARK_HYPOXIA	154	12	0.0135216342423850593296164
TCGA-12-5299.5	6	1_KEGG_MELANOMA	71	3	0.0135265855205309454278861
TCGA-14-1823.12	6	1_KEGG_MELANOMA	71	3	0.0135265855205309454278861
TCGA-32-2498.13	133	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0135622583159006153408210
TCGA-14-0790.9	104	2_GLYCOSAMINOGLYCAN_BINDING	26	5	0.0135717421056793501737969
TCGA-06-0122.8	90	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0136216078585455670907356
TCGA-26-1439.11	10	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	4	0.0136326013403722228617410
TCGA-02-0060.19	281	2_LOCOMOTORY_BEHAVIOR	86	12	0.0137328608362835870304597
TCGA-32-2494.10	173	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0137377757387137366951180
TCGA-06-0142.3	8	2_EXTRACELLULAR_MATRIX_PART	51	3	0.0137606712705851778888455
TCGA-06-0213.9	74	1_KEGG_GLIOMA	62	6	0.0138005467487041129370784
TCGA-06-2558.6	74	1_KEGG_GLIOMA	62	6	0.0138005467487041129370784
TCGA-06-2558.6	74	2_INTERPHASE	62	6	0.0138005467487041129370784
TCGA-12-3650.17	101	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0138062496936144953052494
TCGA-26-5136.6	160	2_CHROMOSOME	102	10	0.0138338691260273278366144
TCGA-19-1390.13	110	2_MICROTUBULE_CYTOSKELETON	117	9	0.0138459323307141245196217
TCGA-02-2486.9	141	2_PLASMA_MEMBRANE	1096	35	0.0138461364205829020462835
TCGA-19-2625.9	146	2_REGULATION_OF_MOLECULAR_FUNCTION	286	16	0.0138695100654243688720335
TCGA-02-0071.12	116	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0138827550754979951036505
TCGA-26-1439.10	84	0_HALLMARK_ANGIOGENESIS	32	5	0.0138830949616285254100134
TCGA-06-0879.9	84	0_HALLMARK_ANGIOGENESIS	32	5	0.0138830949616285254100134
TCGA-06-0143.6	63	2_ENZYME_ACTIVATOR_ACTIVITY	111	7	0.0138908831570620887319034
TCGA-06-0139.1	179	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0138910827196969104829760
TCGA-28-5220.7	15	2_POSITIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	26	3	0.0139192576946834765255767
TCGA-28-5220.7	15	2_REGULATION_OF_PROTEIN_AMINO_ACID_PHOSPHORYLATION	26	3	0.0139192576946834765255767
TCGA-28-5220.7	15	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0139192576946834765255767
TCGA-06-0169.5	42	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	7	0.0139215344429568111533913
TCGA-19-5951.10	138	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0139383595738483915399408
TCGA-76-6193.13	271	2_PROTEOLYSIS	154	16	0.0139470175012972024547464
TCGA-27-2519.7	113	1_KEGG_CELL_CYCLE	114	9	0.0139555370281807238769245
TCGA-14-0786.2	10	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0139685839176205417455634
TCGA-41-2571.7	72	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0139757772234321044069194
TCGA-41-2575.49	136	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	8	0.0139757772234321044069194
TCGA-06-2563.10	123	1_KEGG_FOCAL_ADHESION	195	12	0.0139759434409178536634633
TCGA-28-5207.12	188	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	7	0.0139779419124459389212056
TCGA-06-0192.10	126	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0139805028303789623256304
TCGA-27-1831.9	85	2_SYNAPTIC_TRANSMISSION	152	9	0.0139835671129845007937265
TCGA-08-0347.4	16	0_HALLMARK_MYC_TARGETS_V1	178	5	0.0139977545154224020801381
TCGA-27-2519.7	113	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	7	0.0140322221884025058469270
TCGA-27-2518.5	20	0_HALLMARK_GLYCOLYSIS	139	5	0.0140676991826821570774619
TCGA-16-1045.10	81	2_CELL_CELL_SIGNALING	353	13	0.0140839436676646993784612
TCGA-28-5215.7	192	0_HALLMARK_COAGULATION	125	12	0.0140967593671923359377463
TCGA-12-5299.5	6	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	3	0.0141113197215965747999267
TCGA-14-1823.12	6	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	3	0.0141113197215965747999267
TCGA-76-6192.6	43	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	14	0.0141320144287861680643115
TCGA-06-2563.10	123	2_CELL_CYCLE_PROCESS	163	11	0.0141558897707829613871189
TCGA-06-0124.6	55	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0141687557249057967390105
TCGA-06-0187.10	55	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0141687557249057967390105
TCGA-06-0745.4	55	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0141687557249057967390105
TCGA-28-2513.12	134	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0142371440444068308311953
TCGA-32-2634.10	118	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0142421419207483992280805
TCGA-02-0074.5	118	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0142421419207483992280805
TCGA-12-0616.7	45	2_NEUROLOGICAL_SYSTEM_PROCESS	296	9	0.0142906174811477035269114
TCGA-26-5136.6	160	0_HALLMARK_COMPLEMENT	176	13	0.0143053043621782210309545
TCGA-02-0024.6	206	2_SPINDLE	35	7	0.0143135670445891389351845
TCGA-12-0620.3	2	2_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	28	2	0.0143144511288428172290921
TCGA-16-1045.2	2	2_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	28	2	0.0143144511288428172290921
TCGA-08-0380.1	2	2_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	28	2	0.0143144511288428172290921
TCGA-12-0692.1	2	2_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	28	2	0.0143144511288428172290921
TCGA-06-0132.2	2	2_PROTEIN_SECRETION	28	2	0.0143144511288428172290921
TCGA-06-0743.6	2	2_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	28	2	0.0143144511288428172290921
TCGA-19-5960.9	134	2_INTRACELLULAR_ORGANELLE_PART	912	30	0.0143570601570135424063235
TCGA-32-2491.14	244	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0143803028490765236885318
TCGA-19-2624.29	130	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0143803397850755035336512
TCGA-14-0789.10	106	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0143873903956656251645896
TCGA-14-4157.7	101	2_DNA_DEPENDENT_DNA_REPLICATION	46	6	0.0143934392855863731858213
TCGA-32-5222.9	70	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0143947579541317607909612
TCGA-06-0173.35	120	2_COLLAGEN	23	5	0.0143970557082784018226862
TCGA-28-5219.9	47	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	7	0.0144145842686621960399007
TCGA-06-0744.10	36	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	4	0.0144422903345281777170994
TCGA-26-1439.11	10	2_REGULATION_OF_KINASE_ACTIVITY	138	4	0.0144469586254390748580878
TCGA-06-0168.4	22	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	5	0.0144547970566450204032982
TCGA-06-0195.8	56	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	7	0.0144625354779255796411341
TCGA-02-0009.6	188	0_HALLMARK_APOPTOSIS	150	13	0.0144798939383516487439119
TCGA-02-0089.5	91	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0145235431984878180650123
TCGA-19-1390.13	110	1_KEGG_PYRIMIDINE_METABOLISM	64	7	0.0145497932215095521213399
TCGA-27-2523.12	112	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0145502309947192765005042
TCGA-19-1390.13	110	2_CHROMATIN	25	5	0.0145612559931603720297932
TCGA-14-1829.3	8	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	3	0.0145973471639897454943391
TCGA-02-0046.8	148	0_HALLMARK_ANGIOGENESIS	32	6	0.0146081184314188917278132
TCGA-12-1597.3	3	1_KEGG_FOCAL_ADHESION	195	3	0.0146351983814863445543253
TCGA-02-0107.3	71	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	19	0.0146379708132280857146856
TCGA-08-0375.6	65	2_SYNAPTIC_TRANSMISSION	152	8	0.0146479204895051933615902
TCGA-06-0219.6	6	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0146754065904296602390611
TCGA-08-0244.4	6	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0146754065904296602390611
TCGA-12-5299.5	6	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0146754065904296602390611
TCGA-14-1829.11	6	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0146754065904296602390611
TCGA-14-2554.9	6	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0146754065904296602390611
TCGA-14-1825.8	80	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0146854908545549518034123
TCGA-08-0245.4	85	1_KEGG_DNA_REPLICATION	32	5	0.0147155843527695569250557
TCGA-27-1837.5	85	1_KEGG_DNA_REPLICATION	32	5	0.0147155843527695569250557
TCGA-27-1831.9	85	0_HALLMARK_ANGIOGENESIS	32	5	0.0147155843527695569250557
TCGA-08-0359.5	37	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	7	0.0147471189085540497348825
TCGA-02-0099.11	141	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0147497206777054395282489
TCGA-08-0354.5	18	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0147751626096169833002314
TCGA-02-0089.5	91	1_KEGG_ASTHMA	30	5	0.0147764990553585738586317
TCGA-28-2502.9	56	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0147939711572063464090077
TCGA-06-0646.4	63	2_CELL_CYCLE_GO_0007049	265	10	0.0148055180314029723870339
TCGA-08-0347.7	25	2_EXTRACELLULAR_MATRIX_PART	51	4	0.0148086962635740320565203
TCGA-02-0028.9	182	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0148390215789217481956452
TCGA-28-6450.11	139	2_AXON	10	4	0.0148673880982080411361501
TCGA-19-5960.9	134	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0149261649656223394783128
TCGA-06-0137.9	53	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0149560262894650516235506
TCGA-19-1790.1	4	2_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_ACTIVITY	12	2	0.0149749317560417972289288
TCGA-16-0861.5	4	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0149749317560417972289288
TCGA-06-2561.7	4	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0149749317560417972289288
TCGA-02-0052.3	116	2_EXTRACELLULAR_MATRIX	85	8	0.0149977671130435349922116
TCGA-27-1837.5	85	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0150064303878541804859736
TCGA-27-1837.5	85	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0150064303878541804859736
TCGA-19-2624.29	130	2_DNA_METABOLIC_PROCESS	218	13	0.0150203261979982658630428
TCGA-26-1439.11	10	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0150629747150833655927604
TCGA-19-5950.7	113	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0150738960406858954477194
TCGA-14-4157.7	101	1_KEGG_PANCREATIC_CANCER	70	7	0.0151053338893358431171965
TCGA-06-0152.10	19	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0151493277950033276846309
TCGA-12-3650.17	101	2_NUCLEUS	1110	28	0.0151562884655821288049093
TCGA-06-2559.11	101	2_NUCLEUS	1110	28	0.0151562884655821288049093
TCGA-02-0054.3	93	2_CELL_PROJECTION	76	7	0.0151571812051563802048459
TCGA-12-5301.9	11	0_HALLMARK_COAGULATION	125	4	0.0151574135424941917188457
TCGA-41-5651.5	112	1_KEGG_BLADDER_CANCER	42	6	0.0151930930294407341013541
TCGA-06-2562.7	57	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0152059351406819490137856
TCGA-32-2632.16	229	2_HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_ACTIVITY	32	7	0.0152114716097576044978590
TCGA-28-2502.9	56	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	4	0.0152340762295701363793210
TCGA-06-0152.11	56	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0152340762295701363793210
TCGA-19-5954.17	208	2_SPINDLE	35	7	0.0152502081390854301451432
TCGA-06-0154.13	76	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0152513909609012458107324
TCGA-41-2572.8	76	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0152513909609012458107324
TCGA-14-0871.20	216	2_M_PHASE	94	11	0.0152774083668110044476052
TCGA-14-0789.10	106	2_EXTRACELLULAR_REGION_PART	269	13	0.0152887458514075931514942
TCGA-26-1439.11	10	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	4	0.0152968147903862188713431
TCGA-14-0789.11	3	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	3	0.0153247165765272377879747
TCGA-26-1439.7	3	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	3	0.0153247165765272377879747
TCGA-32-2494.8	3	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	3	0.0153247165765272377879747
TCGA-14-1825.5	3	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	3	0.0153247165765272377879747
TCGA-08-0245.4	85	1_KEGG_FOCAL_ADHESION	195	10	0.0153539903352426440608092
TCGA-19-5955.9	110	0_HALLMARK_APOPTOSIS	150	10	0.0153679998451983247653718
TCGA-12-0620.1	2	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0153747808420905494181108
TCGA-06-0133.2	2	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0153747808420905494181108
TCGA-02-0023.1	2	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0153747808420905494181108
TCGA-06-0127.4	2	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0153747808420905494181108
TCGA-08-0355.3	2	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0153747808420905494181108
TCGA-02-0099.11	141	2_CELL_CYCLE_GO_0007049	265	15	0.0153869192745621254092558
TCGA-76-4931.10	86	2_SYNAPTIC_TRANSMISSION	152	9	0.0154059858395051048340907
TCGA-27-2523.5	3	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_KINASE_ACTIVITY	17	2	0.0154341620000586175753821
TCGA-02-0043.10	184	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0154970967945581832719837
TCGA-02-0010.18	184	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0154970967945581832719837
TCGA-28-2509.5	4	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	3	0.0155061707333225985011582
TCGA-06-0126.3	4	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	3	0.0155061707333225985011582
TCGA-06-5413.11	142	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0155388616320136577209077
TCGA-06-2557.11	177	2_CELL_CYCLE_GO_0007049	265	17	0.0155633250366736669567658
TCGA-41-2571.7	72	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0155662312854340546819376
TCGA-06-0189.3	118	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0155788329433229726095345
TCGA-27-1835.6	86	0_HALLMARK_ANGIOGENESIS	32	5	0.0155866651386228904918596
TCGA-28-5207.12	188	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0155878213138063749509943
TCGA-02-2485.14	172	1_KEGG_BLADDER_CANCER	42	7	0.0156273336127960016384009
TCGA-19-5950.7	113	2_KINASE_BINDING	63	7	0.0156317836106510815730175
TCGA-76-4926.9	66	1_KEGG_MELANOMA	71	6	0.0156380076749006863279234
TCGA-06-0237.4	66	1_KEGG_MELANOMA	71	6	0.0156380076749006863279234
TCGA-19-5960.9	134	2_ORGANELLE_PART	916	30	0.0156609470924296348415261
TCGA-02-0083.21	135	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0156751397265389585955475
TCGA-02-0099.11	141	2_AXON	10	4	0.0157353621138483570907063
TCGA-02-0047.8	185	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0158341346502044316713054
TCGA-76-6282.11	185	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0158341346502044316713054
TCGA-06-0241.8	53	2_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0158482303093580509378846
TCGA-06-0241.8	53	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0158482303093580509378846
TCGA-08-0354.5	18	2_REGULATION_OF_CELL_CYCLE	160	5	0.0158529789340873389358322
TCGA-06-0184.11	108	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0158531940386251214702984
TCGA-06-0197.1	57	0_HALLMARK_COMPLEMENT	176	8	0.0158561293881384936244050
TCGA-32-2615.7	77	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0158615632478320937870375
TCGA-19-5954.6	8	2_OLIGOSACCHARYL_TRANSFERASE_COMPLEX	6	2	0.0158780213275490286739533
TCGA-19-5955.8	6	1_KEGG_ONE_CARBON_POOL_BY_FOLATE	8	2	0.0158780213275490286739533
TCGA-02-0071.9	6	2_PROTEIN_TARGETING_TO_MEMBRANE	8	2	0.0158780213275490286739533
TCGA-19-2620.8	6	2_GABA_RECEPTOR_ACTIVITY	8	2	0.0158780213275490286739533
TCGA-15-1444.3	107	0_HALLMARK_ALLOGRAFT_REJECTION	190	11	0.0158868034979970859654763
TCGA-41-2571.7	72	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0159444314602157598270704
TCGA-06-5418.4	24	2_SYSTEM_PROCESS	451	8	0.0160068636672056618941440
TCGA-06-0152.11	56	2_GROWTH_FACTOR_ACTIVITY	49	5	0.0161091686650098042665746
TCGA-06-5414.13	102	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0161237073494411610463661
TCGA-02-0014.10	70	2_CHROMOSOME	102	7	0.0161237073494411610463661
TCGA-06-0878.10	115	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0161629211743262897471585
TCGA-02-0015.16	115	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0161629211743262897471585
TCGA-19-1790.18	201	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0161645199981335190020371
TCGA-32-2491.14	244	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	11	0.0161750152656438168918829
TCGA-06-0650.2	82	2_CELL_CELL_SIGNALING	353	13	0.0161815168337561265943236
TCGA-26-1439.11	10	1_KEGG_BLADDER_CANCER	42	3	0.0162126319897864176744484
TCGA-27-1835.6	86	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0162212768641039860317843
TCGA-32-2494.10	173	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0162331460609749164691884
TCGA-32-2494.10	173	1_KEGG_BLADDER_CANCER	42	7	0.0162331460609749164691884
TCGA-41-3392.31	136	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0162405183305037829899486
TCGA-12-0619.11	123	2_COLLAGEN	23	5	0.0162448714696858016737213
TCGA-06-2563.10	123	2_COLLAGEN	23	5	0.0162448714696858016737213
TCGA-08-0245.4	85	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0162525651352391185822110
TCGA-27-1831.9	85	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0162525651352391185822110
TCGA-06-5415.7	7	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	4	0.0163091383022820196613267
TCGA-02-0003.9	227	2_NON_MEMBRANE_BOUND_ORGANELLE	476	28	0.0163240313250915675125086
TCGA-02-0003.9	227	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	28	0.0163240313250915675125086
TCGA-87-5896.6	131	2_DNA_METABOLIC_PROCESS	218	13	0.0163397106020314285268480
TCGA-06-2562.7	57	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0163574207641641843069547
TCGA-06-0171.7	57	2_COLLAGEN	23	4	0.0163574207641641843069547
TCGA-06-0171.7	57	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0163574207641641843069547
TCGA-02-0048.9	84	2_CYTOSKELETON	293	12	0.0163796218213093057458618
TCGA-06-5415.7	7	2_KINASE_BINDING	63	3	0.0163999142432300626381902
TCGA-14-0871.20	216	2_COLLAGEN	23	6	0.0164132973245232280379291
TCGA-06-2562.7	57	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0164192102852993987438524
TCGA-06-0197.1	57	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0164192102852993987438524
TCGA-14-3476.17	53	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	9	0.0164192836805759599660970
TCGA-06-0237.4	66	2_SYNAPTIC_TRANSMISSION	152	8	0.0164434695822824952782248
TCGA-19-5955.9	110	2_DEFENSE_RESPONSE	222	12	0.0164496320412370611308006
TCGA-32-2491.14	244	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0164624251828067585945448
TCGA-76-4927.8	93	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0164728649761770595816301
TCGA-27-2523.12	112	2_DNA_METABOLIC_PROCESS	218	12	0.0164848927722901460179994
TCGA-28-5216.8	162	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	6	0.0165302214188399812511143
TCGA-02-2485.14	172	2_DNA_METABOLIC_PROCESS	218	15	0.0165400920762469247349280
TCGA-12-0618.5	41	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0165634833392322641798522
TCGA-12-3650.17	101	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	7	0.0166119850767925993084706
TCGA-06-2559.11	101	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	7	0.0166119850767925993084706
TCGA-19-5952.11	193	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0166251943471498360438421
TCGA-06-0152.10	19	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0166430211711257949880327
TCGA-06-5411.3	19	1_KEGG_LEISHMANIA_INFECTION	70	4	0.0166430211711257949880327
TCGA-06-5411.3	19	1_KEGG_VIRAL_MYOCARDITIS	70	4	0.0166430211711257949880327
TCGA-32-1991.11	82	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0166443464947431049583138
TCGA-06-0648.6	17	2_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0166693479961515129972316
TCGA-06-0648.6	17	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0166693479961515129972316
TCGA-41-2575.44	7	2_MICROVILLUS	7	2	0.0166707456218041852324951
TCGA-06-5418.5	13	0_HALLMARK_ANGIOGENESIS	32	3	0.0166722637013269510408708
TCGA-06-0749.1	13	0_HALLMARK_ANGIOGENESIS	32	3	0.0166722637013269510408708
TCGA-27-2521.10	94	2_DNA_METABOLIC_PROCESS	218	11	0.0166743980123802461312810
TCGA-76-6285.5	106	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0166940993470733461956357
TCGA-02-0071.12	116	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0167287484496176641624032
TCGA-76-6285.5	106	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0167337564376920308606422
TCGA-28-5207.12	188	2_SYNAPTIC_TRANSMISSION	152	13	0.0167347209993693180063445
TCGA-26-1439.11	10	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0167430562680257015439889
TCGA-06-5413.11	142	2_CELL_CYCLE_GO_0007049	265	15	0.0167780339911606096725549
TCGA-12-5295.8	66	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0167936665593672145024851
TCGA-06-0188.11	66	1_KEGG_BLADDER_CANCER	42	5	0.0167936665593672145024851
TCGA-28-5208.28	220	0_HALLMARK_APOPTOSIS	150	14	0.0167972755664642682538190
TCGA-06-5413.11	142	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0168219280058152335921573
TCGA-14-1034.7	97	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0168302003268659544632513
TCGA-06-0646.4	63	2_REGULATION_OF_CELL_CYCLE	160	8	0.0168570897728082917665926
TCGA-28-5207.12	188	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0168779179003365441269491
TCGA-02-0009.6	188	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0168779179003365441269491
TCGA-28-5209.15	194	2_EXTRACELLULAR_REGION_PART	269	18	0.0168936228164458350498034
TCGA-28-5214.11	124	2_COLLAGEN	23	5	0.0169004002772633887818898
TCGA-02-0001.5	117	2_KINASE_REGULATOR_ACTIVITY	41	6	0.0169172168233109737611741
TCGA-32-1979.4	12	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0169257268091008473975823
TCGA-06-5856.13	152	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0169503385263376944724900
TCGA-14-4157.7	101	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0169507443504863276884098
TCGA-08-0344.1	18	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	3	0.0169711965401612326076464
TCGA-06-0132.1	18	2_COLLAGEN	23	3	0.0169711965401612326076464
TCGA-02-0079.1	5	2_FOCAL_ADHESION_FORMATION	10	2	0.0170121645632280125981506
TCGA-28-5204.5	5	2_NF_KAPPAB_BINDING	10	2	0.0170121645632280125981506
TCGA-32-2634.10	118	2_EXTRACELLULAR_MATRIX	85	8	0.0170199115875969454736438
TCGA-02-0074.5	118	2_EXTRACELLULAR_MATRIX	85	8	0.0170199115875969454736438
TCGA-06-5856.13	152	0_HALLMARK_ANGIOGENESIS	32	6	0.0170272140073565968199087
TCGA-06-5856.13	152	1_KEGG_DNA_REPLICATION	32	6	0.0170272140073565968199087
TCGA-02-0046.8	148	2_CATION_BINDING	165	12	0.0170637009869020125907291
TCGA-02-2483.10	100	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0170797835164081847347806
TCGA-32-4210.14	109	2_CONDENSED_CHROMOSOME	26	5	0.0170816558754624189808702
TCGA-32-4210.14	109	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0170816558754624189808702
TCGA-27-1832.11	88	1_KEGG_CELL_CYCLE	114	8	0.0170866731826100730351481
TCGA-08-0347.4	16	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0171001201303383372487321
TCGA-19-1790.1	4	2_REGULATION_OF_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	535	4	0.0171924148287936652546026
TCGA-06-5415.7	7	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	4	0.0172058743950531112254509
TCGA-08-0360.3	144	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0172245823789416094284910
TCGA-02-0033.5	144	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	8	0.0172245823789416094284910
TCGA-12-0688.10	93	2_CELL_CYCLE_GO_0007049	265	12	0.0172410973904572988046890
TCGA-14-1825.8	80	2_SPINDLE	35	5	0.0172489904490644510581809
TCGA-02-0058.1	110	2_SYNAPTIC_TRANSMISSION	152	10	0.0172789269501162461029065
TCGA-06-0644.16	142	1_KEGG_MELANOMA	71	8	0.0172921448910258006292917
TCGA-41-2571.7	72	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0173070060188168055315128
TCGA-06-0124.6	55	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0173078782183631249558253
TCGA-08-0345.2	77	2_EXTRACELLULAR_REGION_PART	269	11	0.0173267668298988999908694
TCGA-02-0043.10	184	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0173460373825498198607775
TCGA-02-0010.18	184	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0173460373825498198607775
TCGA-26-1439.7	3	2_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY	18	2	0.0173622054991678514968001
TCGA-06-5410.3	3	2_ADENYLATE_CYCLASE_ACTIVATION	18	2	0.0173622054991678514968001
TCGA-32-2495.11	67	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	4	0.0173645895064731270451830
TCGA-06-0145.19	81	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0173785299007921355263218
TCGA-06-5859.9	125	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0174042918840973184768650
TCGA-76-4925.9	83	2_REGULATION_OF_CELL_CYCLE	160	9	0.0174113047375804713690073
TCGA-28-5216.8	162	2_DNA_REPLICATION	82	9	0.0174170729904054959191750
TCGA-06-0744.3	12	2_PLASMA_MEMBRANE	1096	8	0.0174206272083010441087403
TCGA-06-0214.9	62	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0174292241576172769745856
TCGA-06-0221.13	45	1_KEGG_GLIOMA	62	5	0.0174292241576172769745856
TCGA-02-0085.1	45	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	5	0.0174292241576172769745856
TCGA-12-1597.6	51	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0174316255893899423046189
TCGA-08-0360.3	144	0_HALLMARK_INFLAMMATORY_RESPONSE	170	12	0.0174765336258578783679152
TCGA-06-0152.10	19	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0175190406357734924924774
TCGA-32-2615.7	77	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0175214771358337961792984
TCGA-02-0009.6	188	0_HALLMARK_COMPLEMENT	176	14	0.0175234550766685051592653
TCGA-27-2521.10	94	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0175241138332306659042281
TCGA-76-6282.11	185	2_IMMUNE_SYSTEM_PROCESS	283	18	0.0175400244408230460146925
TCGA-06-0939.7	58	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0175407742976069445928200
TCGA-14-0787.6	40	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	5	0.0175640683866673287527593
TCGA-19-5958.4	35	0_HALLMARK_GLYCOLYSIS	139	6	0.0175737656530403525689810
TCGA-02-0046.8	148	2_CYTOSKELETAL_PART	194	13	0.0175818149098243732553204
TCGA-27-1837.5	85	2_EXTRACELLULAR_MATRIX	85	7	0.0175833779182293648002400
TCGA-12-0620.1	2	2_REGULATION_OF_CELL_GROWTH	31	2	0.0176090470235762200368335
TCGA-08-0356.3	2	1_KEGG_BASE_EXCISION_REPAIR	31	2	0.0176090470235762200368335
TCGA-06-0133.2	2	2_REGULATION_OF_CELL_GROWTH	31	2	0.0176090470235762200368335
TCGA-02-0023.1	2	2_REGULATION_OF_CELL_GROWTH	31	2	0.0176090470235762200368335
TCGA-06-0127.4	2	2_REGULATION_OF_CELL_GROWTH	31	2	0.0176090470235762200368335
TCGA-08-0355.3	2	2_REGULATION_OF_CELL_GROWTH	31	2	0.0176090470235762200368335
TCGA-76-6193.13	271	2_INTERLEUKIN_RECEPTOR_ACTIVITY	19	6	0.0176405244454919951646588
TCGA-19-5960.9	134	2_CHROMOSOME_ORGANIZATION_AND_BIOGENESIS	99	9	0.0176425255493342890422692
TCGA-02-0107.3	71	2_SYSTEM_DEVELOPMENT	694	17	0.0176466159251904737559347
TCGA-06-0176.8	95	2_CELL_CELL_SIGNALING	353	14	0.0176540993923547349930825
TCGA-06-5412.7	153	0_HALLMARK_ANGIOGENESIS	32	6	0.0176801217077181965775523
TCGA-19-2623.11	153	2_BASEMENT_MEMBRANE	32	6	0.0176801217077181965775523
TCGA-16-0861.5	4	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0176951469975573476289821
TCGA-06-2561.7	4	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0176951469975573476289821
TCGA-02-0010.5	4	2_REGULATION_OF_ACTION_POTENTIAL	13	2	0.0176951469975573476289821
TCGA-12-5301.9	11	2_BLOOD_COAGULATION	39	3	0.0177254125432762324465763
TCGA-12-5301.9	11	2_COAGULATION	39	3	0.0177254125432762324465763
TCGA-19-5955.9	110	2_EXTRACELLULAR_REGION	346	15	0.0177330374519067343608292
TCGA-76-6282.11	185	2_SIGNAL_TRANSDUCTION	1442	51	0.0177524580272546139703138
TCGA-32-2634.10	118	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0177667207315344195805995
TCGA-19-1390.13	110	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0178617796485543052498191
TCGA-06-5412.7	153	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0178755560234462387847465
TCGA-19-5950.7	113	0_HALLMARK_APICAL_JUNCTION	182	11	0.0178767648458831480973164
TCGA-12-0616.1	20	2_CELL_CYCLE_PHASE	146	5	0.0178808449058183993596316
TCGA-06-6389.1	18	2_TRANSMISSION_OF_NERVE_IMPULSE	164	5	0.0178810387577265327008202
TCGA-14-0786.4	62	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0178996457960845650747572
TCGA-08-0246.6	62	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0178996457960845650747572
TCGA-19-1790.18	201	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0179186077542005176010953
TCGA-19-1790.18	201	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0179186077542005176010953
TCGA-02-0024.6	206	2_DNA_REPLICATION	82	10	0.0179791980349303902320113
TCGA-06-2565.10	38	2_SPINDLE	35	4	0.0180030599398880199191186
TCGA-06-5408.3	99	2_CHROMOSOME	102	8	0.0180095947411113045666387
TCGA-27-2527.6	79	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	9	0.0180141163368691056834159
TCGA-02-0007.17	217	2_CHROMOSOMAL_PART	78	10	0.0180500827610885518359485
TCGA-06-0241.8	53	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	5	0.0181165336538592104675960
TCGA-02-0058.1	110	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	16	0.0181463979456051027749908
TCGA-32-4211.14	71	2_CELL_CELL_SIGNALING	353	12	0.0181664522237529879600260
TCGA-06-0185.13	71	2_CELL_CELL_SIGNALING	353	12	0.0181664522237529879600260
TCGA-02-0021.4	170	2_CELL_PROLIFERATION_GO_0008283	436	22	0.0181750433858974824730126
TCGA-06-0939.7	58	2_NEUROLOGICAL_SYSTEM_PROCESS	296	10	0.0181997061510350797985947
TCGA-02-0089.5	91	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0182301926008573873805307
TCGA-06-0158.4	65	1_KEGG_PATHWAYS_IN_CANCER	323	11	0.0182377259256038190549098
TCGA-06-0877.7	4	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	3	0.0182496833801096720872881
TCGA-08-0348.3	4	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	3	0.0182496833801096720872881
TCGA-19-5947.4	267	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0182562578311947880382871
TCGA-28-5207.12	188	2_NEURON_PROJECTION	16	5	0.0182726756733657645648261
TCGA-06-0192.10	126	2_COLLAGEN	23	5	0.0182735454886129092266778
TCGA-32-4209.2	56	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0182802866302445125856746
TCGA-28-5215.7	192	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0183479621647857082944455
TCGA-32-1982.9	89	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	9	0.0183623396156020607383752
TCGA-02-0064.3	26	2_NEUROLOGICAL_SYSTEM_PROCESS	296	7	0.0183766500350056039003732
TCGA-32-2495.11	67	2_SYNAPTIC_TRANSMISSION	152	8	0.0184212211481347074015780
TCGA-26-5139.10	163	1_KEGG_PATHWAYS_IN_CANCER	323	18	0.0184316358843330703465302
TCGA-08-0360.3	144	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0184396886799191514483276
TCGA-32-1982.9	89	2_HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_ACTIVITY	32	5	0.0184442318163669100039570
TCGA-06-2570.8	95	2_DNA_METABOLIC_PROCESS	218	11	0.0184808487322103698335951
TCGA-06-0176.8	95	2_DNA_METABOLIC_PROCESS	218	11	0.0184808487322103698335951
TCGA-32-2634.10	118	2_DNA_REPAIR	113	9	0.0184989387047033958244580
TCGA-26-5139.10	163	0_HALLMARK_P53_PATHWAY	151	12	0.0185007231944983516203074
TCGA-32-1980.1	24	2_ORGAN_DEVELOPMENT	460	8	0.0185094432162501085215034
TCGA-06-0877.8	61	2_EXTRACELLULAR_REGION	346	11	0.0185139373972204417106990
TCGA-02-0001.5	117	1_KEGG_CELL_CYCLE	114	9	0.0185456283287772534518201
TCGA-06-2569.5	144	2_MICROTUBULE_CYTOSKELETON	117	10	0.0185652511863848047879433
TCGA-02-0071.12	116	1_KEGG_BLADDER_CANCER	42	6	0.0185976968311803020350581
TCGA-02-0071.12	116	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0185976968311803020350581
TCGA-06-2557.11	177	2_CELL_CYCLE_PROCESS	163	13	0.0186243260588137803102082
TCGA-02-0025.5	88	2_SYNAPTIC_TRANSMISSION	152	9	0.0186251005633489424839766
TCGA-27-1832.11	88	2_SYNAPTIC_TRANSMISSION	152	9	0.0186251005633489424839766
TCGA-16-0861.5	4	2_MITOTIC_CELL_CYCLE	134	3	0.0186661172578103766450663
TCGA-06-2561.7	4	2_MITOTIC_CELL_CYCLE	134	3	0.0186661172578103766450663
TCGA-32-2634.10	118	1_KEGG_COLORECTAL_CANCER	62	7	0.0186723570968449770202113
TCGA-76-6285.5	106	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	9	0.0187161335618737413588608
TCGA-19-5952.11	193	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0187298408090708252971002
TCGA-06-0169.5	42	0_HALLMARK_ANGIOGENESIS	32	4	0.0187326402743685851981503
TCGA-06-2561.5	42	0_HALLMARK_ANGIOGENESIS	32	4	0.0187326402743685851981503
TCGA-06-0875.7	78	1_KEGG_GLIOMA	62	6	0.0187489199431840232457080
TCGA-06-0875.7	78	2_INTERPHASE	62	6	0.0187489199431840232457080
TCGA-02-0069.12	62	2_CHROMOSOMAL_PART	78	6	0.0187489199431842730458886
TCGA-28-5214.11	124	2_DNA_REPLICATION	82	8	0.0187656784021487769986702
TCGA-06-0210.6	103	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0187793309070535228977317
TCGA-27-1833.5	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-28-2513.2	2	1_KEGG_DNA_REPLICATION	32	2	0.0187829834918144984723387
TCGA-28-2502.3	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-02-0115.3	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-16-1045.3	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-32-1991.7	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-27-2524.7	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-06-0747.3	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-06-2565.8	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-76-4926.6	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-41-2572.4	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-27-1834.8	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144984723387
TCGA-02-2486.8	2	1_KEGG_DNA_REPLICATION	32	2	0.0187829834918144984723387
TCGA-08-0352.2	59	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0187861493499641742099815
TCGA-14-2554.5	59	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0187861493499641742099815
TCGA-27-2526.7	71	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0188363211110329498154670
TCGA-32-2491.14	244	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0188653231162056768399626
TCGA-06-5415.7	7	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0188799684167058959283203
TCGA-27-1832.11	88	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0188966501261906873188057
TCGA-06-0174.37	141	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0189242057766142342256632
TCGA-26-5139.10	163	2_INTRACELLULAR_ORGANELLE_PART	912	34	0.0189399147712370728713349
TCGA-32-1977.11	107	0_HALLMARK_COAGULATION	125	9	0.0189410451965114530470391
TCGA-14-1034.7	97	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0189482459097450872675950
TCGA-06-2565.3	60	2_CELL_CELL_SIGNALING	353	11	0.0189525778409363361565187
TCGA-26-1439.10	84	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0189677191610978790325959
TCGA-41-3393.4	12	2_CELL_CYCLE_GO_0007049	265	5	0.0190405368841608385599429
TCGA-14-0781.7	155	0_HALLMARK_ANGIOGENESIS	32	6	0.0190469168303320085522401
TCGA-02-0046.8	148	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	5	0.0191066120532056328562565
TCGA-02-0046.8	148	2_INTERMEDIATE_FILAMENT	20	5	0.0191066120532056328562565
TCGA-28-5209.15	194	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0191175814626509607552229
TCGA-14-1829.3	8	2_CYTOSKELETAL_PART	194	4	0.0191175814626509607552229
TCGA-02-2470.4	11	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0191504165047285991596571
TCGA-28-2502.9	56	2_REGULATION_OF_APOPTOSIS	309	10	0.0191513846891487662937870
TCGA-16-1045.10	81	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0192643210367407086147651
TCGA-06-0145.19	81	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0192643210367407086147651
TCGA-06-0241.8	53	1_KEGG_FOCAL_ADHESION	195	8	0.0192769127991912203601288
TCGA-02-0046.8	148	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	7	0.0192864829471013667083756
TCGA-06-2562.7	57	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0192881733160967759610482
TCGA-19-2619.10	8	2_REGULATION_OF_TRANSPORT	57	3	0.0192881733160967759610482
TCGA-32-1986.8	87	2_PATTERN_BINDING	33	5	0.0193033678838259205312600
TCGA-06-2564.7	92	2_CELL_CYCLE_PHASE	146	9	0.0193761682535164049545617
TCGA-28-2501.3	51	2_EXTRACELLULAR_REGION_PART	269	9	0.0193862462491928462526847
TCGA-14-0790.9	104	2_CELL_CYCLE_PROCESS	163	10	0.0193979406043595752062725
TCGA-27-1831.4	3	2_CHANNEL_REGULATOR_ACTIVITY	19	2	0.0194034468363017548186988
TCGA-08-0350.2	46	1_KEGG_GLIOMA	62	5	0.0194566024002891801991666
TCGA-41-2571.7	72	2_CHROMOSOME	102	7	0.0194674114300783518416438
TCGA-19-5955.9	110	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0194829418878909518819675
TCGA-76-4935.7	15	2_M_PHASE	94	4	0.0194920685472198748633410
TCGA-06-0939.7	58	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0194926722605409524780029
TCGA-19-5960.9	134	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0194987086039137731685589
TCGA-41-5651.5	112	2_CONDENSED_CHROMOSOME	26	5	0.0195055745860195604846066
TCGA-41-5651.5	112	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0195055745860195604846066
TCGA-27-2523.12	112	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0195055745860195604846066
TCGA-32-1980.1	24	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0195143817477960689055205
TCGA-06-0877.7	4	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	3	0.0195178237375286910137984
TCGA-16-0861.5	4	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	3	0.0195178237375286910137984
TCGA-08-0348.3	4	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	3	0.0195178237375286910137984
TCGA-27-1833.7	17	0_HALLMARK_MYC_TARGETS_V1	178	5	0.0195286045526082592538319
TCGA-02-0086.2	17	0_HALLMARK_MYC_TARGETS_V1	178	5	0.0195286045526082592538319
TCGA-28-5215.7	192	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0195583289310519402304234
TCGA-02-0038.3	199	2_REGULATION_OF_CELL_PROLIFERATION	265	18	0.0195614263121210128770766
TCGA-32-2491.14	244	2_CHROMOSOME	102	12	0.0195750899099495882793587
TCGA-06-5413.11	142	2_CELL_CYCLE_PHASE	146	11	0.0196158974418621512292304
TCGA-19-2624.29	130	2_NUCLEUS	1110	33	0.0196538898352524686596876
TCGA-28-2502.9	56	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	10	0.0197006183989647011556290
TCGA-81-5910.12	128	2_COLLAGEN	23	5	0.0197325555887298068058477
TCGA-02-0075.8	128	2_COLLAGEN	23	5	0.0197325555887298068058477
TCGA-12-3652.19	88	2_NEURON_PROJECTION	16	4	0.0198436439680074426517020
TCGA-12-5299.5	6	2_REGULATION_OF_MOLECULAR_FUNCTION	286	4	0.0198709657738589326458900
TCGA-19-5952.11	193	2_BLOOD_COAGULATION	39	7	0.0198900225268963497249342
TCGA-19-5952.11	193	2_COAGULATION	39	7	0.0198900225268963497249342
TCGA-32-4213.15	198	0_HALLMARK_E2F_TARGETS	169	14	0.0198982832994363083300993
TCGA-14-0790.9	104	2_POLYSACCHARIDE_BINDING	28	5	0.0199256482332760033460151
TCGA-14-0787.7	14	2_PLASMA_MEMBRANE_PART	901	8	0.0199546799302311728130377
TCGA-02-0011.1	288	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0199890635939753251448803
TCGA-06-0747.12	80	0_HALLMARK_E2F_TARGETS	169	9	0.0199895871156260118706172
TCGA-06-0132.2	2	2_REGULATION_OF_SECRETION	33	2	0.0199947888783829699765882
TCGA-19-1790.18	201	2_EXTRACELLULAR_MATRIX	85	10	0.0200416020895273529200953
TCGA-28-2509.6	59	2_CELL_DEVELOPMENT	511	13	0.0200623321855538626345972
TCGA-08-0359.5	37	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0200648991211045645000066
TCGA-06-0154.13	76	2_ENZYME_REGULATOR_ACTIVITY	277	11	0.0200943687603297865829077
TCGA-06-2565.3	60	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0200955857158376105520148
TCGA-06-2565.3	60	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	4	0.0200955857158376105520148
TCGA-02-0043.10	184	0_HALLMARK_APICAL_JUNCTION	182	14	0.0201163728336517175221410
TCGA-02-0007.17	217	2_SPINDLE	35	7	0.0201208165405898468935941
TCGA-06-0648.3	19	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	3	0.0201213000899234453755504
TCGA-02-0021.4	170	2_CELL_CYCLE_PHASE	146	12	0.0201237867006313110584959
TCGA-06-0122.8	90	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	9	0.0201295233446175565739100
TCGA-06-0645.9	136	0_HALLMARK_COAGULATION	125	10	0.0201502047054821706306704
TCGA-27-2523.12	112	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0201507264885397822939961
TCGA-14-0790.9	104	1_KEGG_MELANOMA	71	7	0.0201548538252366259138082
TCGA-19-2625.9	146	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0201845547676319861385430
TCGA-76-6282.11	185	2_IMMUNE_RESPONSE	206	15	0.0201977440030341980070627
TCGA-16-1048.13	97	1_KEGG_ASTHMA	30	5	0.0202071348643853392068603
TCGA-19-5947.4	267	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0202445105620655020628451
TCGA-06-0241.8	53	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0203497391688481736593541
TCGA-06-0157.7	89	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0203656166692943382812153
TCGA-06-0877.7	4	2_REGULATION_OF_KINASE_ACTIVITY	138	3	0.0203949556104787294019687
TCGA-16-0861.5	4	2_REGULATION_OF_KINASE_ACTIVITY	138	3	0.0203949556104787294019687
TCGA-08-0348.3	4	2_REGULATION_OF_KINASE_ACTIVITY	138	3	0.0203949556104787294019687
TCGA-76-6282.2	9	2_OLIGOSACCHARYL_TRANSFERASE_COMPLEX	6	2	0.0204088341522304095310147
TCGA-12-5299.5	6	2_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS	9	2	0.0204088341522304095310147
TCGA-06-0129.11	110	2_INTRACELLULAR_ORGANELLE_PART	912	26	0.0204195781156396999334035
TCGA-02-0011.1	288	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0204360424129145304417143
TCGA-02-2485.14	172	1_KEGG_FOCAL_ADHESION	195	14	0.0204505657257448292263291
TCGA-06-5858.19	205	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0204584200928362401616933
TCGA-06-0649.13	88	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0204601688941410883582073
TCGA-26-1439.9	3	2_DNA_METABOLIC_PROCESS	218	3	0.0204821216871570142836756
TCGA-32-1986.3	3	2_DNA_METABOLIC_PROCESS	218	3	0.0204821216871570142836756
TCGA-06-0649.4	3	2_DNA_METABOLIC_PROCESS	218	3	0.0204821216871570142836756
TCGA-32-2634.10	118	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0205180536088799790606085
TCGA-02-0074.5	118	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0205180536088799790606085
TCGA-32-2634.10	118	2_CHROMATIN	25	5	0.0205225515604783304013381
TCGA-08-0350.2	46	2_CELL_CYCLE_PROCESS	163	7	0.0205424818704322657836325
TCGA-06-0190.8	143	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0206181827666706112001105
TCGA-19-1790.1	4	2_NEGATIVE_REGULATION_OF_DNA_BINDING	14	2	0.0206414221684808468770811
TCGA-02-2470.4	11	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0206491451609283546697604
TCGA-14-0786.2	10	0_HALLMARK_P53_PATHWAY	151	4	0.0206501377708134883914859
TCGA-02-0069.8	7	1_KEGG_LONG_TERM_POTENTIATION	68	3	0.0206640098570438149327977
TCGA-19-1390.13	110	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0206645968498414336900204
TCGA-06-0166.5	35	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0206673362169661062326398
TCGA-19-5952.11	193	0_HALLMARK_P53_PATHWAY	151	13	0.0206838386407869924410452
TCGA-06-5858.19	205	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0206954050134174442898694
TCGA-12-3652.19	88	2_MICROTUBULE_CYTOSKELETON	117	8	0.0206976864958645888348254
TCGA-02-0086.2	17	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0207265268499660648693350
TCGA-06-0178.2	17	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0207265268499660648693350
TCGA-32-4213.15	198	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0207283264323933000272682
TCGA-19-5947.4	267	2_PEPTIDE_BINDING	79	11	0.0207709557066902972266575
TCGA-06-0241.8	53	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	13	0.0207812275282292791001026
TCGA-06-2559.11	101	2_MITOTIC_CELL_CYCLE	134	9	0.0207813977386886623854867
TCGA-76-6285.5	106	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0207854170887802544576139
TCGA-19-2624.19	5	2_REGULATION_OF_HORMONE_SECRETION	11	2	0.0207882412895869402025273
TCGA-28-5204.5	5	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0207882412895869402025273
TCGA-26-5139.10	163	2_ORGANELLE_PART	916	34	0.0207979767017065220180427
TCGA-02-0011.1	288	2_CHROMOSOME	102	13	0.0208007512359323284978352
TCGA-27-2523.12	112	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0208251841144279394024696
TCGA-06-0877.8	61	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0208396755527208224489932
TCGA-06-0173.35	120	1_KEGG_GLIOMA	62	7	0.0208539533094387920242330
TCGA-02-2486.9	141	0_HALLMARK_KRAS_SIGNALING_UP	148	11	0.0208740352304294871088608
TCGA-08-0245.4	85	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0208742080619576074462795
TCGA-14-0817.9	85	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0208742080619576074462795
TCGA-28-5218.5	208	2_KERATINOCYTE_DIFFERENTIATION	15	5	0.0208994970993100284695210
TCGA-06-0148.6	69	1_KEGG_BLADDER_CANCER	42	5	0.0209125250578680380031393
TCGA-32-4213.15	198	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0209238762564734753768292
TCGA-19-5950.7	113	2_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0211034005652434020205988
TCGA-19-5950.7	113	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0211034005652434020205988
TCGA-14-0781.7	155	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	31	0.0211045830551618261716751
TCGA-06-2563.10	123	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0211096384995801134021320
TCGA-32-4719.15	123	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0211096384995801134021320
TCGA-02-0038.3	199	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0211462510037583768796043
TCGA-12-0619.11	123	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0211592575277165760583298
TCGA-06-2563.10	123	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0211592575277165760583298
TCGA-06-2563.10	123	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0211592575277165760583298
TCGA-06-0686.5	14	0_HALLMARK_ANGIOGENESIS	32	3	0.0211704150256216694359068
TCGA-26-5134.2	14	0_HALLMARK_ANGIOGENESIS	32	3	0.0211704150256216694359068
TCGA-12-0688.10	93	2_CELL_CYCLE_PHASE	146	9	0.0211731565491731082984117
TCGA-06-0145.17	11	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	4	0.0211836729723278993642310
TCGA-14-0817.9	85	2_REGULATION_OF_CELL_CYCLE	160	9	0.0211895062069178199970487
TCGA-27-1834.10	39	1_KEGG_FOCAL_ADHESION	195	7	0.0212750775001594311097719
TCGA-14-1034.7	97	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0212900697187628981654761
TCGA-06-0877.7	4	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	3	0.0212978811757053507203175
TCGA-16-0861.5	4	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	3	0.0212978811757053507203175
TCGA-08-0348.3	4	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	3	0.0212978811757053507203175
TCGA-02-0028.9	182	2_CALCIUM_ION_BINDING	75	9	0.0213003391903642536053809
TCGA-27-1833.2	41	1_KEGG_MELANOMA	71	5	0.0213278836450542380598350
TCGA-06-5859.9	125	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0213423103822848563015935
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	3	0.0213434210892201360609821
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	3	0.0213434210892201360609821
TCGA-06-5858.19	205	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0213561773332203753972269
TCGA-19-1390.12	10	1_KEGG_TYPE_II_DIABETES_MELLITUS	46	3	0.0213902406713405157656638
TCGA-08-0350.2	46	2_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0214087631476059039870030
TCGA-08-0350.2	46	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0214087631476059039870030
TCGA-08-0352.2	59	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0214128445438139837497804
TCGA-32-1986.12	17	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	4	0.0214136738088639214105946
TCGA-06-0877.8	61	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0214711501891702745414836
TCGA-06-0875.7	78	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0214835446327001945709956
TCGA-32-2494.10	173	0_HALLMARK_E2F_TARGETS	169	13	0.0215149649164531678313672
TCGA-14-2554.5	59	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0215462406860290854593298
TCGA-06-0645.5	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202967695304
TCGA-12-0619.3	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202967695304
TCGA-12-0688.1	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202967695304
TCGA-08-0375.1	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202967695304
TCGA-16-0861.1	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202967695304
TCGA-06-0747.2	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202967695304
TCGA-14-0817.5	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202967695304
TCGA-06-0137.6	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202967695304
TCGA-02-0048.3	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202967695304
TCGA-27-1831.4	3	2_AUXILIARY_TRANSPORT_PROTEIN_ACTIVITY	20	2	0.0215578619575202967695304
TCGA-02-0047.8	185	2_CYTOPLASMIC_PART	912	37	0.0215723835332547637932965
TCGA-19-5950.7	113	2_CELL_MATRIX_JUNCTION	13	4	0.0215728515640125628749502
TCGA-19-5950.7	113	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0215728515640125628749502
TCGA-02-2483.10	100	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0216003580211093886009888
TCGA-28-5219.9	47	1_KEGG_GLIOMA	62	5	0.0216636026463798911367853
TCGA-08-0389.4	56	2_MITOTIC_CELL_CYCLE	134	7	0.0216774629941044391645555
TCGA-12-5299.5	6	1_KEGG_SMALL_CELL_LUNG_CANCER	83	3	0.0216826178227995484959489
TCGA-14-1823.12	6	1_KEGG_SMALL_CELL_LUNG_CANCER	83	3	0.0216826178227995484959489
TCGA-19-5959.13	92	0_HALLMARK_ANGIOGENESIS	32	5	0.0216961246269063989799974
TCGA-19-5959.13	92	1_KEGG_DNA_REPLICATION	32	5	0.0216961246269063989799974
TCGA-14-1825.8	80	2_INTERPHASE	62	6	0.0217129058288024583134312
TCGA-02-0003.9	227	0_HALLMARK_E2F_TARGETS	169	15	0.0217318886575778337511000
TCGA-08-0347.7	25	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	6	0.0217414312633437897814837
TCGA-06-2565.10	38	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0217691593672661685976433
TCGA-12-3653.55	255	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0218227445339688602699013
TCGA-19-5954.17	208	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0218290281626699125827606
TCGA-08-0380.4	6	2_CYTOSKELETON	293	4	0.0218734601326029676204854
TCGA-32-4211.14	71	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	4	0.0218930395767810356821848
TCGA-12-0616.1	20	1_KEGG_MELANOMA	71	4	0.0218930395767810356821848
TCGA-02-0089.5	91	1_KEGG_CELL_CYCLE	114	8	0.0219244590093409345843423
TCGA-02-0074.5	118	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0219480471442861056752260
TCGA-08-0349.1	31	2_CELL_CELL_SIGNALING	353	8	0.0219961047227496091227561
TCGA-19-1790.18	201	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0220007994434615640477748
TCGA-02-0060.19	281	0_HALLMARK_HYPOXIA	154	16	0.0220063385855382119549173
TCGA-08-0375.6	65	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0220128889522128862177297
TCGA-28-1753.13	174	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0220205734527530276600782
TCGA-06-5859.9	125	2_NUCLEUS	1110	32	0.0220395144107605849004283
TCGA-32-5222.9	70	1_KEGG_MELANOMA	71	6	0.0220400501942334715865801
TCGA-26-5135.9	71	1_KEGG_PANCREATIC_CANCER	70	6	0.0220400501942334715865801
TCGA-12-3649.15	89	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0220486462715680717194822
TCGA-32-2494.10	173	2_DEFENSE_RESPONSE	222	15	0.0220721490629105301928270
TCGA-06-0129.11	110	2_ORGANELLE_PART	916	26	0.0220778394454666133939202
TCGA-27-1838.17	131	2_COLLAGEN	23	5	0.0220903643986992900827282
TCGA-06-0141.1	45	2_SYSTEM_DEVELOPMENT	694	13	0.0221094309573351237296901
TCGA-32-1977.11	107	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0221106080020623263493462
TCGA-27-1832.11	88	2_EXTRACELLULAR_MATRIX	85	7	0.0221293933061317282806613
TCGA-02-0003.9	227	2_CELL_DEVELOPMENT	511	29	0.0221964846054518612217255
TCGA-02-0052.3	116	2_CYTOSKELETON	293	14	0.0222130151996393909730187
TCGA-02-0071.12	116	2_CYTOSKELETON	293	14	0.0222130151996393909730187
TCGA-06-0145.17	11	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	3	0.0222233917700391490901435
TCGA-02-2470.4	11	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	3	0.0222233917700391490901435
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	3	0.0222285338911221569402343
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	3	0.0222285338911221569402343
TCGA-28-5208.28	220	2_CENTRAL_NERVOUS_SYSTEM_DEVELOPMENT	96	11	0.0222952626096726384818947
TCGA-06-0152.10	19	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0223063686335892227829980
TCGA-06-0750.13	8	2_SIGNAL_TRANSDUCTION	1442	7	0.0223360425544987563351018
TCGA-02-0099.11	141	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0223463805211003285755567
TCGA-06-0750.13	8	2_MEMBRANE	1443	7	0.0224425236679955640572981
TCGA-06-0145.17	11	2_REGULATION_OF_KINASE_ACTIVITY	138	4	0.0224452752005350891773006
TCGA-76-6193.13	271	2_RESPONSE_TO_STRESS	427	29	0.0224503015922660267844613
TCGA-02-0034.5	6	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	3	0.0224802915598785943429583
TCGA-06-5859.9	125	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0225036433795830735637988
TCGA-19-2624.29	130	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0225159404160429586772008
TCGA-12-0620.1	2	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	2	0.0225320064065098434047396
TCGA-06-0133.2	2	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	2	0.0225320064065098434047396
TCGA-02-0023.1	2	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	2	0.0225320064065098434047396
TCGA-06-0127.4	2	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	2	0.0225320064065098434047396
TCGA-08-0355.3	2	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	2	0.0225320064065098434047396
TCGA-12-0619.11	123	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0225492592629507500323616
TCGA-06-5859.9	125	2_APOPTOSIS_GO	389	17	0.0225544742562787184358974
TCGA-02-0069.8	7	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	3	0.0225561985980800502882282
TCGA-14-1823.15	87	2_SYSTEM_PROCESS	451	15	0.0225594154494795119669792
TCGA-41-5651.5	112	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0225617842266679184681788
TCGA-06-0140.2	25	2_SYSTEM_PROCESS	451	8	0.0225651342767130280719812
TCGA-28-5209.15	194	1_KEGG_MELANOMA	71	9	0.0226012664402746969727342
TCGA-02-0074.5	118	2_CELL_CYCLE_PHASE	146	10	0.0226099950400385982240969
TCGA-06-2561.5	42	0_HALLMARK_APICAL_JUNCTION	182	7	0.0226187195605660300301576
TCGA-02-2485.14	172	2_CELL_CYCLE_PHASE	146	12	0.0226592831629543328686438
TCGA-76-4935.8	21	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	6	0.0227256021587186642085587
TCGA-06-0878.10	115	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	10	0.0228281597181830865628260
TCGA-06-0875.7	78	2_MITOTIC_CELL_CYCLE	134	8	0.0228476263508339064167707
TCGA-14-0789.10	106	1_KEGG_MELANOMA	71	7	0.0228480792888553808916985
TCGA-28-5213.9	143	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0228687732500854057349216
TCGA-32-2638.17	159	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0228750777179924577597880
TCGA-06-0881.7	203	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0228806775986438865055916
TCGA-06-0173.35	120	1_KEGG_PROSTATE_CANCER	87	8	0.0229059934634840735301342
TCGA-08-0356.2	23	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	4	0.0229149362894579197713618
TCGA-02-0069.12	62	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0229149362894579197713618
TCGA-14-0786.4	62	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0229149362894579197713618
TCGA-08-0246.6	62	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0229149362894579197713618
TCGA-06-0214.9	62	2_COLLAGEN	23	4	0.0229149362894579197713618
TCGA-06-0211.8	62	2_COLLAGEN	23	4	0.0229149362894579197713618
TCGA-76-6285.5	106	2_CELL_CYCLE_PROCESS	163	10	0.0229833491140999934820854
TCGA-19-5954.17	208	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0230090437345700990490194
TCGA-02-0024.6	206	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	13	0.0231005089208397053346378
TCGA-06-0192.10	126	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0231040736942074963200522
TCGA-06-0192.10	126	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0231040736942074963200522
TCGA-32-2634.10	118	1_KEGG_PYRIMIDINE_METABOLISM	64	7	0.0231055080017864671038108
TCGA-06-0877.7	4	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	4	0.0231185101856021639477046
TCGA-16-0861.5	4	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	4	0.0231185101856021639477046
TCGA-08-0348.3	4	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	4	0.0231185101856021639477046
TCGA-06-0878.10	115	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0231274657972220104573680
TCGA-02-0015.16	115	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0231274657972220104573680
TCGA-12-0616.1	20	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	4	0.0231493822501545182257487
TCGA-06-0190.8	143	0_HALLMARK_COMPLEMENT	176	12	0.0231501142782447252854716
TCGA-12-3649.15	89	1_KEGG_FOCAL_ADHESION	195	10	0.0232287255474499451657344
TCGA-32-1977.11	107	2_ENZYME_REGULATOR_ACTIVITY	277	13	0.0232365774482345202600619
TCGA-12-3650.17	101	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0232968464487418487618431
TCGA-06-2559.11	101	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0232968464487418487618431
TCGA-06-5859.9	125	2_PROGRAMMED_CELL_DEATH	390	17	0.0233219032605714374217776
TCGA-06-5412.7	153	2_DEFENSE_RESPONSE	222	14	0.0233875129560040008469546
TCGA-14-0789.11	3	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	3	0.0234462886186571142776991
TCGA-26-1439.7	3	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	3	0.0234462886186571142776991
TCGA-32-2494.8	3	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	3	0.0234462886186571142776991
TCGA-14-1825.5	3	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	3	0.0234462886186571142776991
TCGA-02-2483.10	100	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0234502307200747210635949
TCGA-06-0214.9	62	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	14	0.0234763129586008714722034
TCGA-28-5209.15	194	2_SYNAPTIC_TRANSMISSION	152	13	0.0234874713739763735231847
TCGA-06-0184.11	108	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0235050544787332726937024
TCGA-19-1390.13	110	2_DNA_DEPENDENT_DNA_REPLICATION	46	6	0.0235409268104924719600124
TCGA-76-6282.2	9	2_ENDOPLASMIC_RETICULUM	177	4	0.0235626037691598066992071
TCGA-02-0089.5	91	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0235883508981111975066902
TCGA-02-0089.5	91	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0235883508981111975066902
TCGA-06-0124.6	55	2_GLYCOSAMINOGLYCAN_BINDING	26	4	0.0236131623029517782874631
TCGA-06-5408.3	99	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0236280556535006097673701
TCGA-12-0692.7	23	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	3	0.0236345362368201444835947
TCGA-02-0080.3	20	2_COLLAGEN	23	3	0.0236345362368201444835947
TCGA-28-2502.9	56	2_APOPTOSIS_GO	389	11	0.0236654795454591428127689
TCGA-32-4213.15	198	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0236702416256536450622772
TCGA-02-0009.6	188	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0236757369464228803468409
TCGA-02-0007.17	217	0_HALLMARK_MYC_TARGETS_V1	178	15	0.0236824666621256764431624
TCGA-28-2501.3	51	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	4	0.0236843696692201136078104
TCGA-06-0877.8	61	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0236868077699547256720347
TCGA-06-0686.1	7	2_CELL_SURFACE_RECEPTOR_LINKED_SIGNAL_TRANSDUCTION_GO_0007166	563	5	0.0237052320503579674881856
TCGA-19-1390.13	110	0_HALLMARK_DNA_REPAIR	125	9	0.0237269115778676979722217
TCGA-12-5295.8	66	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0237332191223759217391098
TCGA-76-4931.10	86	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0237359435808351462715571
TCGA-28-5208.28	220	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	18	0.0237487257168413970487286
TCGA-06-0145.17	11	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	4	0.0237615892990717461619177
TCGA-06-5415.7	7	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	4	0.0237625702072300042100306
TCGA-02-0028.9	182	2_CELL_PROJECTION	76	9	0.0237654040832181341624807
TCGA-32-4209.2	56	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	5	0.0238101426220167257385985
TCGA-19-1790.1	4	2_NEGATIVE_REGULATION_OF_BINDING	15	2	0.0238136612364194498459025
TCGA-02-0115.4	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847372120131
TCGA-06-0143.3	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847372120131
TCGA-06-0750.9	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847372120131
TCGA-27-1834.9	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847372120131
TCGA-06-0882.9	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847372120131
TCGA-19-2620.6	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847372120131
TCGA-06-0208.3	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847372120131
TCGA-08-0357.4	36	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0238361283315568391050210
TCGA-06-0157.7	89	2_EXTRACELLULAR_MATRIX	85	7	0.0238452677906111111527654
TCGA-28-2502.3	2	2_LIGAND_GATED_CHANNEL_ACTIVITY	36	2	0.0238574185480684326787770
TCGA-32-1991.7	2	2_LIGAND_GATED_CHANNEL_ACTIVITY	36	2	0.0238574185480684326787770
TCGA-08-0386.2	2	2_LIGAND_GATED_CHANNEL_ACTIVITY	36	2	0.0238574185480684326787770
TCGA-41-2572.4	2	2_LIGAND_GATED_CHANNEL_ACTIVITY	36	2	0.0238574185480684326787770
TCGA-26-5135.9	71	1_KEGG_MELANOMA	71	6	0.0239327958783594717251386
TCGA-02-0033.5	144	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0239344747408219947482078
TCGA-02-0071.12	116	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0239350708993448096917334
TCGA-12-5295.8	66	2_REGULATION_OF_CELL_CYCLE	160	8	0.0239471204231384467153720
TCGA-02-0015.16	115	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0239725326462920489134500
TCGA-06-2561.5	42	1_KEGG_MELANOMA	71	5	0.0240694335283841605310773
TCGA-08-0347.7	25	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0241421425091404052987176
TCGA-14-0781.7	155	2_RESPONSE_TO_WOUNDING	163	12	0.0241421539564717728409970
TCGA-16-0861.5	4	2_CELL_CYCLE_PHASE	146	3	0.0241650993481844524046753
TCGA-06-2561.7	4	2_CELL_CYCLE_PHASE	146	3	0.0241650993481844524046753
TCGA-28-5215.7	192	0_HALLMARK_HYPOXIA	154	13	0.0242032136013602267032852
TCGA-27-1831.9	85	2_CELL_CELL_SIGNALING	353	13	0.0242164377577070780156454
TCGA-41-3392.31	136	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0242180286723335073950647
TCGA-28-2502.9	56	2_PROGRAMMED_CELL_DEATH	390	11	0.0242433453592336561888132
TCGA-02-0024.6	206	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0242490395979626481570701
TCGA-02-0010.18	184	1_KEGG_BLADDER_CANCER	42	7	0.0242889947100729704232425
TCGA-16-1045.10	81	1_KEGG_ALLOGRAFT_REJECTION	37	5	0.0242912177991100285134873
TCGA-32-1977.11	107	1_KEGG_MELANOMA	71	7	0.0243025365489216854664178
TCGA-02-2483.10	100	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0243048815101076232103594
TCGA-19-1790.18	201	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0243554288555431833196430
TCGA-32-2638.17	159	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0243851971178853654809160
TCGA-08-0347.7	25	1_KEGG_PATHWAYS_IN_CANCER	323	7	0.0244215448168875227941133
TCGA-28-6450.11	139	0_HALLMARK_COAGULATION	125	10	0.0244227112069266352745167
TCGA-06-0143.6	63	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0244290639893613263644578
TCGA-06-0646.4	63	2_COLLAGEN	23	4	0.0244290639893613263644578
TCGA-06-0646.4	63	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0244290639893613263644578
TCGA-06-0743.14	63	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0244290639893613263644578
TCGA-02-0026.1	61	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0244304248197188614288855
TCGA-14-0789.10	106	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0244757491637412061269430
TCGA-19-1790.1	4	2_REGULATION_OF_GENE_EXPRESSION	585	4	0.0246015943792660465860855
TCGA-14-0817.9	85	2_CELL_CYCLE_PROCESS	163	9	0.0246091919666609447447936
TCGA-28-6450.11	139	2_CELL_PROJECTION	76	8	0.0246166424863923094523699
TCGA-32-1986.12	17	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	4	0.0246212694433850971809097
TCGA-06-0875.7	78	0_HALLMARK_MYC_TARGETS_V1	178	9	0.0246302006287410051033060
TCGA-02-0021.4	170	0_HALLMARK_COAGULATION	125	11	0.0246423677347781429347595
TCGA-02-0071.12	116	0_HALLMARK_APOPTOSIS	150	10	0.0246459997343331446706394
TCGA-12-0821.9	81	2_CELL_CYCLE_GO_0007049	265	11	0.0247030399801645116075743
TCGA-81-5910.12	128	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0247206992764572204557272
TCGA-19-5954.17	208	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0247272358936872944934482
TCGA-06-0141.1	45	0_HALLMARK_ANGIOGENESIS	32	4	0.0247589220381118947644783
TCGA-02-0085.1	45	0_HALLMARK_ANGIOGENESIS	32	4	0.0247589220381118947644783
TCGA-08-0389.4	56	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	18	0.0247761864350784996591237
TCGA-06-0195.8	56	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	18	0.0247761864350784996591237
TCGA-08-0354.5	18	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0248264313147486398447583
TCGA-08-0354.5	18	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	4	0.0248475556823249121851660
TCGA-02-0033.5	144	0_HALLMARK_COMPLEMENT	176	12	0.0248503381977231603550127
TCGA-14-0786.4	62	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0248813056335427940091165
TCGA-28-5204.5	5	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0249406052421289499421153
TCGA-06-0155.1	5	2_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_ACTIVITY	12	2	0.0249406052421289499421153
TCGA-06-1804.6	30	2_CELL_CYCLE_GO_0007049	265	7	0.0249636115190772396588148
TCGA-02-0034.5	6	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	3	0.0249893619370755715181076
TCGA-06-0133.6	57	2_SIGNAL_TRANSDUCTION	1442	22	0.0249913904389719929155511
TCGA-08-0353.8	100	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0250335183259282646750510
TCGA-02-2483.10	100	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0250335183259282646750510
TCGA-26-5132.7	100	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0250335183259282646750510
TCGA-06-0211.8	62	2_DNA_REPLICATION	82	6	0.0250450196027425867062455
TCGA-32-2615.7	77	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0250550304642287481604601
TCGA-06-0744.4	11	2_SECRETION	142	4	0.0251341159604884373246492
TCGA-02-0028.9	182	2_RESPONSE_TO_WOUNDING	163	13	0.0251500684162210275118809
TCGA-32-2634.10	118	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0251565265833357080971222
TCGA-32-2491.14	244	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0251797766214462148681719
TCGA-19-5954.17	208	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0251943515547278333588377
TCGA-28-5218.5	208	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0251943515547278333588377
TCGA-19-2623.11	153	2_CYTOSKELETAL_PART	194	13	0.0252119990573863445026959
TCGA-02-0058.1	110	2_CYTOSKELETAL_PART	194	11	0.0252503446690631357107737
TCGA-19-1790.18	201	2_NEURON_PROJECTION	16	5	0.0252907882901313822709977
TCGA-02-0052.3	116	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0253725390074983903065942
TCGA-06-2570.8	95	1_KEGG_DNA_REPLICATION	32	5	0.0253797717489338062191173
TCGA-08-0389.4	56	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0253821463674158941115078
TCGA-26-5139.10	163	1_KEGG_DNA_REPLICATION	32	6	0.0253986211963304828187482
TCGA-14-0787.6	40	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0254589360378588425160018
TCGA-41-2575.49	136	2_CHROMOSOMAL_PART	78	8	0.0254655182871791202492417
TCGA-12-5299.5	6	2_AGING	10	2	0.0255038385357461983016236
TCGA-06-0143.6	63	2_EXTRACELLULAR_REGION	346	11	0.0255371224828837978249041
TCGA-14-3476.17	53	2_RECEPTOR_ACTIVITY	499	12	0.0255388455389756290070391
TCGA-19-2625.9	146	2_CELL_CYCLE_PHASE	146	11	0.0255423964894031484129666
TCGA-08-0375.6	65	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0255673473810236751013747
TCGA-02-0014.10	70	2_SYNAPTIC_TRANSMISSION	152	8	0.0255983486508498496447839
TCGA-06-5856.13	152	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0255983486508498496447839
TCGA-06-5856.13	152	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0255983486508498496447839
TCGA-12-5301.9	11	2_HEMOSTASIS	44	3	0.0256055881027338026745266
TCGA-06-0686.1	7	2_PLASMA_MEMBRANE	1096	6	0.0256621783987742539678845
TCGA-06-0187.9	4	1_KEGG_WNT_SIGNALING_PATHWAY	149	3	0.0256901058880807525719447
TCGA-41-3392.31	136	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0256903249220525389806546
TCGA-06-6391.6	30	0_HALLMARK_MITOTIC_SPINDLE	175	6	0.0257078999883612081822637
TCGA-02-0047.8	185	2_CYTOPLASM	1461	51	0.0257240559748201334799855
TCGA-27-1833.7	17	0_HALLMARK_SPERMATOGENESIS	88	4	0.0257652079374858233862255
TCGA-02-0003.9	227	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	9	0.0257847556324734029919998
TCGA-06-6390.9	82	1_KEGG_ALLOGRAFT_REJECTION	37	5	0.0257954777325723645653444
TCGA-06-0197.1	57	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	13	0.0257976396332109877973515
TCGA-41-3393.5	88	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0258072953952650577247319
TCGA-06-0213.9	74	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	4	0.0258205996007586022211733
TCGA-06-6391.6	30	2_CHROMOSOME	102	5	0.0258287029006259889751806
TCGA-27-2526.7	71	0_HALLMARK_APOPTOSIS	150	8	0.0258398815582789355416171
TCGA-27-1831.9	85	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0258490187103131464907424
TCGA-28-5214.11	124	1_KEGG_GLIOMA	62	7	0.0258540655067500020625193
TCGA-28-2513.12	134	0_HALLMARK_ALLOGRAFT_REJECTION	190	12	0.0258737597026900724428433
TCGA-27-1838.17	131	2_CELL_CYCLE_PROCESS	163	11	0.0258808611377219881244383
TCGA-26-1439.11	10	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0259180248147695101168519
TCGA-14-0786.2	10	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0259180248147695101168519
TCGA-26-1439.11	10	2_REGULATION_OF_CELL_CYCLE	160	4	0.0259700797769711888562938
TCGA-08-0359.5	37	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0260140063824797866665062
TCGA-19-5958.4	35	1_KEGG_PROSTATE_CANCER	87	5	0.0260240377687215897195561
TCGA-12-0619.11	123	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0260294255044958948441813
TCGA-06-2563.10	123	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0260294255044958948441813
TCGA-02-0010.18	184	2_CELL_CYCLE_GO_0007049	265	17	0.0260335878129025720395529
TCGA-06-0143.6	63	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0261149625630409179533054
TCGA-02-0026.1	61	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0261785000842998452630361
TCGA-02-0115.4	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548267994412
TCGA-26-5139.4	3	2_MRNA_BINDING	22	2	0.0262061173364548267994412
TCGA-06-0143.3	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548267994412
TCGA-06-0750.9	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548267994412
TCGA-27-1834.9	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548267994412
TCGA-06-0882.9	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548267994412
TCGA-19-2620.6	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548267994412
TCGA-06-0208.3	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548267994412
TCGA-14-1823.15	87	2_NEUROLOGICAL_SYSTEM_PROCESS	296	12	0.0262092183870243772281228
TCGA-12-1597.6	51	2_SYNAPTIC_TRANSMISSION	152	7	0.0262608799439488886651173
TCGA-06-5856.13	152	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0262608799439492286709186
TCGA-19-5947.4	267	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0263189641412750405247145
TCGA-02-0007.17	217	2_PROTEIN_HOMODIMERIZATION_ACTIVITY	99	11	0.0263565212358250651469849
TCGA-14-0790.9	104	2_MITOTIC_CELL_CYCLE	134	9	0.0263782467117041480308970
TCGA-06-0747.12	80	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0264660624390326074117930
TCGA-14-1825.8	80	0_HALLMARK_MITOTIC_SPINDLE	175	9	0.0264660624390326074117930
TCGA-02-0058.1	110	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	11	0.0265016478406066846584821
TCGA-19-1390.13	110	1_KEGG_FOCAL_ADHESION	195	11	0.0265016478406066846584821
TCGA-06-0645.9	136	2_COLLAGEN	23	5	0.0265043000021544308819621
TCGA-41-3392.31	136	2_COLLAGEN	23	5	0.0265043000021544308819621
TCGA-41-2575.49	136	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	5	0.0265043000021544308819621
TCGA-19-1390.13	110	1_KEGG_PANCREATIC_CANCER	70	7	0.0265130405345932879113136
TCGA-06-5415.7	7	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	5	0.0265181096002835015035259
TCGA-28-5209.15	194	2_CELL_DEVELOPMENT	511	26	0.0265846732795448625896739
TCGA-08-0354.5	18	0_HALLMARK_MYC_TARGETS_V1	178	5	0.0266285806050122197952135
TCGA-26-5134.6	18	0_HALLMARK_MYC_TARGETS_V1	178	5	0.0266285806050122197952135
TCGA-02-2486.9	141	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	99	9	0.0266339150880548942990078
TCGA-02-0015.16	115	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0266689651003901677384089
TCGA-19-1790.18	201	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0267023515701484449869074
TCGA-76-6191.6	96	0_HALLMARK_ANGIOGENESIS	32	5	0.0267103527731613749063300
TCGA-32-1986.12	17	0_HALLMARK_ALLOGRAFT_REJECTION	190	5	0.0268117205988593794441233
TCGA-76-4925.9	83	1_KEGG_GLIOMA	62	6	0.0268595375335749335377056
TCGA-06-2558.6	74	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	16	0.0268610149656003625862066
TCGA-14-0813.10	53	2_EXTRACELLULAR_REGION_PART	269	9	0.0268670982134290581289093
TCGA-02-0099.11	141	2_SYNAPTIC_TRANSMISSION	152	11	0.0268784749489470557726190
TCGA-02-0007.17	217	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	8	0.0269173220934847273744239
TCGA-06-5412.7	153	2_MEMBRANE_PART	1217	39	0.0269221636078089895938170
TCGA-02-0001.5	117	2_SIGNAL_TRANSDUCTION	1442	36	0.0269431338267472654524060
TCGA-28-5220.7	15	2_CHROMOSOME	102	4	0.0269600618191137321455475
TCGA-28-2514.9	62	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	14	0.0269615945119516704775453
TCGA-06-5418.4	24	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	3	0.0269744403085637081407544
TCGA-02-0060.19	281	2_ORGAN_DEVELOPMENT	460	31	0.0269933716311087298911353
TCGA-19-5958.4	35	1_KEGG_BLADDER_CANCER	42	4	0.0270137036842340479136926
TCGA-19-5954.17	208	2_EXTRACELLULAR_MATRIX	85	10	0.0270283576375070638819764
TCGA-28-5209.15	194	0_HALLMARK_HYPOXIA	154	13	0.0270468556163608840614554
TCGA-32-2634.10	118	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	6	0.0270544076863930768594990
TCGA-28-1753.13	174	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0270684197629888038949542
TCGA-28-5208.28	220	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	13	0.0271115132469654587787922
TCGA-76-4934.4	20	2_TRANSPORT	600	8	0.0271511386588309359957361
TCGA-32-2494.10	173	2_IMMUNE_SYSTEM_PROCESS	283	17	0.0271938527233067488253493
TCGA-06-0171.7	57	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0272468833541430824340956
TCGA-28-5204.3	4	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	3	0.0272776960460178533041109
TCGA-28-5216.8	162	2_AXON	10	4	0.0272779166593763930381833
TCGA-02-2483.10	100	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0272932014845755181731146
TCGA-19-5960.9	134	2_NUCLEAR_CHROMOSOME	39	6	0.0273124489271820633518040
TCGA-08-0359.5	37	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	5	0.0273714761638222704720480
TCGA-06-5412.7	153	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0274073405616095770731544
TCGA-12-0692.6	11	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0274171005872328732433374
TCGA-02-2470.4	11	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0274171005872328732433374
TCGA-06-0188.11	66	2_CELL_CYCLE_PROCESS	163	8	0.0274208383288783233422414
TCGA-26-5139.10	163	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0274208383288786702869366
TCGA-32-1979.4	12	2_REGULATION_OF_GROWTH	41	3	0.0274491943317552791747893
TCGA-32-1979.4	12	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0274491943317552791747893
TCGA-19-5960.9	134	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0274499442154947856375991
TCGA-06-0744.10	36	2_KINASE_REGULATOR_ACTIVITY	41	4	0.0274821371078044704439058
TCGA-02-0060.19	281	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0275052540775322026944671
TCGA-06-0192.10	126	2_EXTRACELLULAR_MATRIX	85	8	0.0275689176070342649438327
TCGA-76-6193.13	271	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0275805459144768810864079
TCGA-28-1753.13	174	2_INTERPHASE	62	8	0.0275834948355460386759663
TCGA-08-0386.4	73	1_KEGG_BLADDER_CANCER	42	5	0.0275865797821405536738304
TCGA-06-0169.5	42	2_EXTRACELLULAR_REGION	346	9	0.0275886102428799621921751
TCGA-32-1979.4	12	2_REGULATION_OF_MOLECULAR_FUNCTION	286	5	0.0275897927489065393491519
TCGA-08-0357.4	36	2_CELL_CYCLE_PHASE	146	6	0.0275933378017017665040367
TCGA-02-0089.5	91	2_EXTRACELLULAR_MATRIX	85	7	0.0276084592228192232665762
TCGA-08-0375.6	65	2_COLLAGEN	23	4	0.0276769547199569310169665
TCGA-08-0375.6	65	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0276769547199569310169665
TCGA-06-0158.4	65	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0276769547199569310169665
TCGA-02-0052.3	116	2_SYNAPTIC_TRANSMISSION	152	10	0.0276787377834672512766367
TCGA-06-0152.10	19	0_HALLMARK_E2F_TARGETS	169	5	0.0276828895154963075531107
TCGA-02-0043.10	184	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0277373312183948166065317
TCGA-02-0010.18	184	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0277909629247263707807480
TCGA-02-0010.18	184	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0277909629247263707807480
TCGA-12-3650.17	101	0_HALLMARK_MITOTIC_SPINDLE	175	10	0.0278623192253490761793877
TCGA-06-0650.2	82	2_SIGNAL_TRANSDUCTION	1442	28	0.0278859564317045643955240
TCGA-12-0616.1	20	2_REGULATION_OF_CELL_CYCLE	160	5	0.0279102127189761739511908
TCGA-26-5139.10	163	2_AXON	10	4	0.0279497892458735186504981
TCGA-06-0878.10	115	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0279544150712939393210732
TCGA-27-2523.12	112	2_CELL_CELL_SIGNALING	353	15	0.0280932942707507321555838
TCGA-02-0025.5	88	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0281420518875829112070974
TCGA-06-0649.13	88	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0281420518875829112070974
TCGA-15-0742.13	74	2_CELL_CELL_SIGNALING	353	12	0.0281485444392821325398923
TCGA-02-0001.5	117	0_HALLMARK_P53_PATHWAY	151	10	0.0281794043553331569063047
TCGA-76-4935.8	21	2_SYNAPTIC_TRANSMISSION	152	5	0.0281848871213757519449405
TCGA-02-2485.14	172	2_DNA_REPLICATION	82	9	0.0282154433034696866533508
TCGA-06-2565.10	38	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0282213268303839262540755
TCGA-02-0003.9	227	2_CYTOSKELETAL_PART	194	16	0.0282236772743277124220196
TCGA-02-0084.1	25	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	5	0.0282426023103538072211993
TCGA-28-5208.28	220	2_MICROTUBULE_CYTOSKELETON	117	12	0.0283298717359507790103379
TCGA-06-0877.7	4	2_ENZYME_BINDING	154	3	0.0283714692935312720600827
TCGA-08-0348.3	4	2_ENZYME_BINDING	154	3	0.0283714692935312720600827
TCGA-06-0143.3	3	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	3	0.0284081953381820143111902
TCGA-08-0358.5	5	1_KEGG_CELL_CYCLE	114	3	0.0284130855179195000725922
TCGA-16-1045.10	81	2_EXTRACELLULAR_REGION_PART	269	11	0.0284260353800721010664176
TCGA-06-0169.5	42	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	8	0.0284378681892485662974224
TCGA-76-4931.10	86	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0284459736261262578771447
TCGA-19-5951.10	138	2_COLLAGEN	23	5	0.0284512661301550735803989
TCGA-02-0024.6	206	2_NEURON_PROJECTION	16	5	0.0284914990090760419927385
TCGA-28-2501.3	51	0_HALLMARK_HYPOXIA	154	7	0.0285949469461538527403910
TCGA-06-5412.1	28	2_INFLAMMATORY_RESPONSE	112	5	0.0285971547827364031002517
TCGA-06-0184.11	108	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0286142171540830839160385
TCGA-08-0245.4	85	2_REPLICATION_FORK	18	4	0.0286620454700956019122859
TCGA-14-0817.9	85	2_REPLICATION_FORK	18	4	0.0286620454700956019122859
TCGA-06-0237.4	66	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0286691077427411976363825
TCGA-14-0789.11	3	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0286999094862919953974334
TCGA-41-3392.4	3	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0286999094862919953974334
TCGA-19-2623.13	3	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0286999094862919953974334
TCGA-06-1804.4	3	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0286999094862919953974334
TCGA-02-0080.1	3	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0286999094862919953974334
TCGA-27-2521.10	94	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0287056498054606978875825
TCGA-26-1439.10	84	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	6	0.0287788248906247594305352
TCGA-06-0879.9	84	1_KEGG_GLIOMA	62	6	0.0287788248906247594305352
TCGA-02-0048.9	84	1_KEGG_GLIOMA	62	6	0.0287788248906247594305352
TCGA-08-0246.6	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0287788248906247594305352
TCGA-06-0221.13	45	1_KEGG_PATHWAYS_IN_CANCER	323	9	0.0288217215409141136461812
TCGA-06-0213.9	74	2_NEUROLOGICAL_SYSTEM_PROCESS	296	11	0.0288499334018800547563277
TCGA-06-0190.8	143	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0288899382847980015776024
TCGA-06-0195.8	56	2_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0288947070695707540488595
TCGA-06-0195.8	56	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0288947070695707540488595
TCGA-02-0071.12	116	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	20	0.0289440559930628088514126
TCGA-06-0130.3	155	2_CYTOSKELETAL_PART	194	13	0.0289980170233705737692365
TCGA-28-5209.15	194	2_KINASE_REGULATOR_ACTIVITY	41	7	0.0290442820256603881357016
TCGA-32-4208.28	140	2_CELL_CELL_SIGNALING	353	17	0.0290915446971655548835667
TCGA-32-2632.16	229	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0291204389023001740388619
TCGA-19-1390.13	110	1_KEGG_MELANOMA	71	7	0.0291333473850450899722553
TCGA-02-0114.20	132	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0291503592605680608706997
TCGA-32-2634.10	118	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	29	0.0291852049178759481717904
TCGA-06-0192.10	126	2_CELL_CELL_SIGNALING	353	16	0.0292185529496770124424643
TCGA-14-0871.20	216	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0292508326672666352230578
TCGA-12-0688.10	93	2_SYNAPTIC_TRANSMISSION	152	9	0.0292837755830600739159753
TCGA-32-4209.2	56	1_KEGG_FOCAL_ADHESION	195	8	0.0293019399549772768809319
TCGA-12-5301.9	11	2_WOUND_HEALING	46	3	0.0293112565607940266099174
TCGA-76-4926.9	66	2_COLLAGEN	23	4	0.0294150875298671496405056
TCGA-76-4926.9	66	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0294150875298671496405056
TCGA-06-0237.4	66	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0294150875298671496405056
TCGA-12-5295.8	66	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0294150875298671496405056
TCGA-06-0188.11	66	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0294150875298671496405056
TCGA-06-0152.10	19	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0294275740997699160328427
TCGA-06-0148.4	5	2_REGULATION_OF_ACTION_POTENTIAL	13	2	0.0294690166449979133733716
TCGA-28-2513.5	5	2_KINESIN_COMPLEX	13	2	0.0294690166449979133733716
TCGA-19-5954.5	5	2_KINESIN_COMPLEX	13	2	0.0294690166449979133733716
TCGA-19-2624.19	5	2_HORMONE_SECRETION	13	2	0.0294690166449979133733716
TCGA-28-5204.5	5	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0294690166449979133733716
TCGA-32-4211.7	5	2_KINESIN_COMPLEX	13	2	0.0294690166449979133733716
TCGA-32-4213.12	5	2_KINESIN_COMPLEX	13	2	0.0294690166449979133733716
TCGA-06-0138.3	5	2_KINESIN_COMPLEX	13	2	0.0294690166449979133733716
TCGA-14-0789.11	3	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	3	0.0294778619888376829105692
TCGA-26-1439.7	3	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	3	0.0294778619888376829105692
TCGA-32-2494.8	3	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	3	0.0294778619888376829105692
TCGA-14-1825.5	3	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	3	0.0294778619888376829105692
TCGA-06-0646.4	63	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0294800545329577182163128
TCGA-06-0646.4	63	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0294800545329577182163128
TCGA-06-0743.14	63	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0294800545329577182163128
TCGA-06-2558.6	74	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0294890432386015789723022
TCGA-76-4934.7	47	0_HALLMARK_ANGIOGENESIS	32	4	0.0294990557084694529632607
TCGA-76-4934.7	47	1_KEGG_DNA_REPLICATION	32	4	0.0294990557084694529632607
TCGA-06-1804.7	47	0_HALLMARK_ANGIOGENESIS	32	4	0.0294990557084694529632607
TCGA-06-0148.6	69	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0295307118596308711133691
TCGA-12-0620.1	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043943343551
TCGA-06-0133.2	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043943343551
TCGA-02-0023.1	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043943343551
TCGA-06-0127.4	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043943343551
TCGA-08-0355.3	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043943343551
TCGA-02-2483.10	100	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0295843374977138411086042
TCGA-02-2483.10	100	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0295843374977138411086042
TCGA-06-5415.3	8	2_PLASMA_MEMBRANE_PART	901	6	0.0295980269921324798398921
TCGA-06-0221.4	8	2_PLASMA_MEMBRANE_PART	901	6	0.0295980269921324798398921
TCGA-32-1979.4	12	2_MITOTIC_CELL_CYCLE	134	4	0.0296338655206708941058924
TCGA-06-0210.6	103	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0296605628956279586405653
TCGA-06-0877.7	4	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	4	0.0296746730768696620472724
TCGA-16-0861.5	4	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	4	0.0296746730768696620472724
TCGA-08-0348.3	4	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	4	0.0296746730768696620472724
TCGA-19-2631.1	6	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	5	0.0296911989040185286814477
TCGA-19-2620.8	6	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	5	0.0296911989040185286814477
TCGA-06-5858.19	205	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0296912900206575056105684
TCGA-19-1790.18	201	0_HALLMARK_APOPTOSIS	150	13	0.0297571694487097394843378
TCGA-32-1986.8	87	2_RESPONSE_TO_WOUNDING	163	9	0.0297680746519623819212885
TCGA-02-0007.17	217	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0297898860043201950398295
TCGA-76-6285.5	106	2_CHROMOSOME	102	8	0.0298152790577167169094874
TCGA-06-0879.9	84	0_HALLMARK_E2F_TARGETS	169	9	0.0298507293046445625062102
TCGA-06-2561.5	42	0_HALLMARK_ALLOGRAFT_REJECTION	190	7	0.0299251911112038415652137
TCGA-28-5214.11	124	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0299974266448539556018105
TCGA-06-0139.1	179	2_RESPONSE_TO_STRESS	427	22	0.0300126461876302035036712
TCGA-06-0237.4	66	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0300569817098825242673854
TCGA-32-1977.3	8	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0300569817098825277368324
TCGA-32-1982.6	8	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0300569817098825277368324
TCGA-06-0192.10	126	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	8	0.0300602585265403107750437
TCGA-06-2563.10	123	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0301851656380469936247213
TCGA-32-4719.15	123	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0301851656380469936247213
TCGA-06-2557.11	177	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0302495554684388233412928
TCGA-14-0871.20	216	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0302711523568688148366768
TCGA-19-2625.9	146	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0303373692841092598704300
TCGA-06-2558.6	74	1_KEGG_MELANOMA	71	6	0.0304131306854982970400147
TCGA-19-2625.9	146	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	13	0.0304450138166463095401593
TCGA-28-5208.28	220	2_NEUROLOGICAL_SYSTEM_PROCESS	296	20	0.0305297354854789509959190
TCGA-12-0616.1	20	2_CELL_CYCLE_PROCESS	163	5	0.0305401029823035817523103
TCGA-02-0033.5	144	2_ION_BINDING	210	13	0.0305931252502582781693796
TCGA-06-0140.2	25	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	3	0.0306113994383935862642065
TCGA-02-0033.5	144	2_REGULATION_OF_APOPTOSIS	309	16	0.0306252659871849505779373
TCGA-06-0130.3	155	2_CELL_CELL_SIGNALING	353	18	0.0306385708385166141698441
TCGA-08-0359.5	37	2_CELL_DEVELOPMENT	511	10	0.0306924331481436100943494
TCGA-27-1838.17	131	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0307143920756421592854757
TCGA-87-5896.6	131	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0307143920756421592854757
TCGA-06-0154.2	5	2_MICROTUBULE_CYTOSKELETON	117	3	0.0307220441228683825707346
TCGA-32-4211.7	5	2_MICROTUBULE_CYTOSKELETON	117	3	0.0307220441228683825707346
TCGA-08-0359.5	37	2_EXTRACELLULAR_MATRIX	85	5	0.0307483380261754160600596
TCGA-12-5299.6	38	2_NEUROLOGICAL_SYSTEM_PROCESS	296	8	0.0307548031949340695823114
TCGA-06-0184.11	108	2_GROWTH_FACTOR_ACTIVITY	49	6	0.0307614946539774558598168
TCGA-28-2509.6	59	2_MITOTIC_CELL_CYCLE	134	7	0.0307805399847745284058753
TCGA-06-0143.6	63	2_CELL_CELL_SIGNALING	353	11	0.0308006887132501634696258
TCGA-06-0743.14	63	2_CELL_CELL_SIGNALING	353	11	0.0308006887132501634696258
TCGA-08-0245.4	85	2_INTERPHASE	62	6	0.0308073816639807887551861
TCGA-27-1837.5	85	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	6	0.0308073816639807887551861
TCGA-27-1837.5	85	2_INTERPHASE	62	6	0.0308073816639807887551861
TCGA-27-1831.9	85	1_KEGG_GLIOMA	62	6	0.0308073816639807887551861
TCGA-06-5859.9	125	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0308891351339018460642194
TCGA-32-1986.8	87	0_HALLMARK_COAGULATION	125	8	0.0308891351339018460642194
TCGA-32-2634.10	118	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0309008129851857070435894
TCGA-06-2567.9	156	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0309304967037717266908903
TCGA-06-2565.10	38	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0309734259749390138105607
TCGA-41-3393.4	12	2_CYTOSKELETON	293	5	0.0310245103172351946452245
TCGA-27-2528.10	99	0_HALLMARK_ANGIOGENESIS	32	5	0.0310313093865767532231192
TCGA-06-5408.3	99	1_KEGG_DNA_REPLICATION	32	5	0.0310313093865767532231192
TCGA-14-0787.7	14	2_INTEGRAL_TO_MEMBRANE	956	8	0.0310462828495043086096672
TCGA-12-0620.1	2	2_REGULATION_OF_GROWTH	41	2	0.0310525130308136713963574
TCGA-12-0620.1	2	2_KINASE_REGULATOR_ACTIVITY	41	2	0.0310525130308136713963574
TCGA-76-4931.4	2	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	41	2	0.0310525130308136713963574
TCGA-32-2634.8	2	2_G_PROTEIN_SIGNALING_COUPLED_TO_IP3_SECOND_MESSENGERPHOSPHOLIPASE_C_ACTIVATING	41	2	0.0310525130308136713963574
TCGA-06-0133.2	2	2_REGULATION_OF_GROWTH	41	2	0.0310525130308136713963574
TCGA-06-0133.2	2	2_KINASE_REGULATOR_ACTIVITY	41	2	0.0310525130308136713963574
TCGA-02-0023.1	2	2_REGULATION_OF_GROWTH	41	2	0.0310525130308136713963574
TCGA-02-0023.1	2	2_KINASE_REGULATOR_ACTIVITY	41	2	0.0310525130308136713963574
TCGA-02-0064.2	2	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	41	2	0.0310525130308136713963574
TCGA-06-0127.4	2	2_REGULATION_OF_GROWTH	41	2	0.0310525130308136713963574
TCGA-06-0127.4	2	2_KINASE_REGULATOR_ACTIVITY	41	2	0.0310525130308136713963574
TCGA-08-0355.3	2	2_REGULATION_OF_GROWTH	41	2	0.0310525130308136713963574
TCGA-08-0355.3	2	2_KINASE_REGULATOR_ACTIVITY	41	2	0.0310525130308136713963574
TCGA-06-0126.9	2	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	41	2	0.0310525130308136713963574
TCGA-02-2485.14	172	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0311580821884803287058485
TCGA-06-0219.6	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513426273493
TCGA-16-0861.4	6	2_REGULATION_OF_HORMONE_SECRETION	11	2	0.0311625552311513426273493
TCGA-08-0244.4	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513426273493
TCGA-12-5299.5	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513426273493
TCGA-14-1823.12	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513426273493
TCGA-14-1829.11	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513426273493
TCGA-14-2554.9	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513426273493
TCGA-19-5954.17	208	0_HALLMARK_ALLOGRAFT_REJECTION	190	15	0.0311970612716078073145543
TCGA-27-2521.10	94	2_NUCLEOPLASM	233	11	0.0311981298873511767033584
TCGA-06-0216.6	67	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0312323009627943834476405
TCGA-14-1829.14	67	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0312323009627943834476405
TCGA-32-2495.11	67	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0312323009627943834476405
TCGA-02-0010.18	184	2_REPLICATION_FORK	18	5	0.0312697860679294406538453
TCGA-28-2509.6	59	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0312765883522959572959898
TCGA-19-2631.1	6	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	5	0.0312874223930922831793389
TCGA-19-2620.8	6	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	5	0.0312874223930922831793389
TCGA-06-5410.3	3	2_G_PROTEIN_SIGNALING_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY	24	2	0.0313067792044568679599159
TCGA-32-2494.10	173	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0313384476983860696397421
TCGA-41-2575.49	136	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0314211681626601208039418
TCGA-32-1979.4	12	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	4	0.0314211681626605579542577
TCGA-28-5208.28	220	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0314512210926766316854142
TCGA-41-5651.5	112	1_KEGG_FOCAL_ADHESION	195	11	0.0314705944736433512742835
TCGA-26-5133.10	75	1_KEGG_BLADDER_CANCER	42	5	0.0314922806059099447129057
TCGA-26-5133.10	75	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0314922806059099447129057
TCGA-02-0068.1	72	2_SYNAPTIC_TRANSMISSION	152	8	0.0315858294311422149736046
TCGA-32-5222.9	70	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0316901438248445993517421
TCGA-19-5947.4	267	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0317250674606158258872490
TCGA-28-5208.28	220	2_REGULATION_OF_KINASE_ACTIVITY	138	13	0.0317401057344196962928251
TCGA-06-5858.19	205	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0317785421399446599277638
TCGA-27-2523.12	112	2_REGULATION_OF_CELL_CYCLE	160	10	0.0317951423990469259073244
TCGA-06-0877.7	4	2_REGULATION_OF_CELL_CYCLE	160	3	0.0318266408848765017247651
TCGA-16-0861.5	4	2_REGULATION_OF_CELL_CYCLE	160	3	0.0318266408848765017247651
TCGA-08-0348.3	4	2_REGULATION_OF_CELL_CYCLE	160	3	0.0318266408848765017247651
TCGA-02-0089.5	91	2_APOPTOSIS_GO	389	14	0.0318340328965490554358198
TCGA-02-0033.5	144	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	16	0.0318742911084763658191576
TCGA-06-0241.8	53	1_KEGG_THYROID_CANCER	29	4	0.0319294394959756464014156
TCGA-02-2486.9	141	2_CELL_CELL_SIGNALING	353	17	0.0319719475791199955749811
TCGA-08-0245.4	85	2_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0319783691822775953395031
TCGA-08-0245.4	85	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0319783691822775953395031
TCGA-06-6390.9	82	2_EXTRACELLULAR_REGION_PART	269	11	0.0320135489959585128882935
TCGA-19-2625.9	146	0_HALLMARK_MYC_TARGETS_V1	178	12	0.0320191447320727004544061
TCGA-19-5954.17	208	2_CELL_CYCLE_PHASE	146	13	0.0320482256390555303449119
TCGA-06-0124.6	55	2_POLYSACCHARIDE_BINDING	28	4	0.0320615364162070912157354
TCGA-32-2495.11	67	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0320811797457751790574321
TCGA-02-0011.1	288	0_HALLMARK_ALLOGRAFT_REJECTION	190	18	0.0321298010437417180806818
TCGA-06-0189.3	118	2_SYNAPTIC_TRANSMISSION	152	10	0.0321727317251054023561352
TCGA-06-5859.9	125	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION_RESULTING_IN_INDUCTION_OF_APOPTOSIS	13	4	0.0321730133008122087812097
TCGA-06-5859.9	125	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0321730133008122087812097
TCGA-19-1790.18	201	2_CELL_CELL_SIGNALING	353	21	0.0321820915485842781733616
TCGA-19-5952.11	193	2_RESPONSE_TO_STRESS	427	23	0.0321959821374650234648840
TCGA-12-5299.5	6	1_KEGG_PATHWAYS_IN_CANCER	323	4	0.0321978006081273249172625
TCGA-06-0176.8	95	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0322495385431663464381735
TCGA-14-4157.7	101	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0323067950386391397610275
TCGA-06-2559.11	101	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0323067950386391397610275
TCGA-32-1979.10	116	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	13	0.0323185834371348471028007
TCGA-02-0010.18	184	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	8	0.0323468630567728052116472
TCGA-12-1597.6	51	2_DNA_METABOLIC_PROCESS	218	8	0.0323613262913917051899482
TCGA-02-0060.19	281	2_REGULATION_OF_BODY_FLUID_LEVELS	52	9	0.0324067200989394330057358
TCGA-02-0069.13	16	0_HALLMARK_ANGIOGENESIS	32	3	0.0324201581449730658057717
TCGA-19-1790.1	4	2_NEGATIVE_REGULATION_OF_TRANSCRIPTION	161	3	0.0324283364351023659089002
TCGA-12-1597.6	51	1_KEGG_GLIOMA	62	5	0.0325146069377441893077929
TCGA-28-2514.9	62	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0325146069377441893077929
TCGA-06-0214.9	62	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0325146069377441893077929
TCGA-02-0069.12	62	0_HALLMARK_MYC_TARGETS_V1	178	8	0.0325340867815244391691998
TCGA-08-0353.8	100	0_HALLMARK_ANGIOGENESIS	32	5	0.0325865582431348263514614
TCGA-26-5132.7	100	0_HALLMARK_ANGIOGENESIS	32	5	0.0325865582431348263514614
TCGA-02-2486.1	2	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	2	0.0326051386823529715242032
TCGA-41-3393.5	88	2_RESPONSE_TO_WOUNDING	163	9	0.0326751577047995414582182
TCGA-06-5413.11	142	2_COLLAGEN	23	5	0.0326795337600033347635886
TCGA-02-0089.5	91	2_PROGRAMMED_CELL_DEATH	390	14	0.0327623418563233667621937
TCGA-06-5858.19	205	2_CYTOSKELETON	293	19	0.0327928322850718004244364
TCGA-14-0781.7	155	1_KEGG_MELANOMA	71	8	0.0328074782135617179501530
TCGA-41-3393.5	88	2_ORGAN_DEVELOPMENT	460	15	0.0328755607357947149393951
TCGA-27-1831.9	85	0_HALLMARK_E2F_TARGETS	169	9	0.0328793089513890746111713
TCGA-26-1439.11	10	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	3	0.0328812302044254947674951
TCGA-06-0744.4	11	2_SYNAPTIC_TRANSMISSION	152	4	0.0328936470545088399664024
TCGA-06-0882.1	11	2_SYNAPTIC_TRANSMISSION	152	4	0.0328936470545088399664024
TCGA-02-0038.3	199	2_NUCLEAR_LUMEN	302	19	0.0329050487669533195389526
TCGA-32-2491.14	244	2_COLLAGEN	23	6	0.0329077998465846233155929
TCGA-06-2558.6	74	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	6	0.0329737286813117577710663
TCGA-14-0787.6	40	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0329994754730336195547302
TCGA-14-0781.7	155	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	30	0.0330334339825125375411652
TCGA-19-5947.4	267	2_GROWTH_FACTOR_BINDING	31	7	0.0330507566426396504066787
TCGA-19-5952.11	193	1_KEGG_BLADDER_CANCER	42	7	0.0331255350801419809481096
TCGA-06-0174.37	141	2_CHROMOSOMAL_PART	78	8	0.0331371763014245493406129
TCGA-06-0128.8	74	1_KEGG_FOCAL_ADHESION	195	9	0.0331406088536535109456693
TCGA-06-5858.7	5	2_RNA_PROCESSING	120	3	0.0331520143320469667935768
TCGA-06-2562.7	57	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0331573796544493148985566
TCGA-27-1830.7	57	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0331573796544493148985566
TCGA-06-0197.1	57	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0331573796544493148985566
TCGA-14-4157.7	101	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0332104711280645018001145
TCGA-06-2559.11	101	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0332104711280645018001145
TCGA-19-5954.17	208	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	10	0.0332595765697195761001481
TCGA-32-1979.4	12	2_REGULATION_OF_KINASE_ACTIVITY	138	4	0.0332867996532204071802319
TCGA-19-5951.10	138	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0332867996532204141191258
TCGA-28-1753.13	174	0_HALLMARK_MITOTIC_SPINDLE	175	13	0.0332902218556034440455349
TCGA-16-1048.13	97	0_HALLMARK_KRAS_SIGNALING_UP	148	9	0.0332955667849653483281180
TCGA-28-6450.11	139	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0334413591422059522373367
TCGA-28-6450.11	139	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0334413591422059522373367
TCGA-06-5415.7	7	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0334868332356718992337541
TCGA-76-6285.5	106	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0334912877916897638863603
TCGA-76-6285.5	106	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0334912877916897638863603
TCGA-08-0350.2	46	2_MICROTUBULE_CYTOSKELETON	117	6	0.0335096928433249105494518
TCGA-14-0787.7	14	2_INTRINSIC_TO_MEMBRANE	966	8	0.0335442783643831107798228
TCGA-06-5418.4	24	2_RECEPTOR_ACTIVITY	499	8	0.0335549606993084809092309
TCGA-12-0821.9	81	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0335563086474521335422772
TCGA-28-1747.5	81	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0335563086474521335422772
TCGA-41-2572.8	76	1_KEGG_BLADDER_CANCER	42	5	0.0336000231096091686588956
TCGA-06-0219.6	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555326975795
TCGA-08-0244.4	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555326975795
TCGA-12-5299.5	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555326975795
TCGA-14-1823.12	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555326975795
TCGA-14-1829.11	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555326975795
TCGA-14-2554.9	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555326975795
TCGA-02-0058.1	110	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0336390117661829884943003
TCGA-16-0861.5	4	2_CELL_CYCLE_PROCESS	163	3	0.0336542818791223385943567
TCGA-06-2561.7	4	2_CELL_CYCLE_PROCESS	163	3	0.0336542818791223385943567
TCGA-02-0089.5	91	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	14	0.0337144980110341968559950
TCGA-06-0646.4	63	2_EXTRACELLULAR_MATRIX	85	6	0.0338069613302584281999685
TCGA-06-0743.14	63	2_EXTRACELLULAR_MATRIX	85	6	0.0338069613302584281999685
TCGA-02-0089.5	91	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0338285342119449064512970
TCGA-28-5213.9	143	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	6	0.0338825280527880606795676
TCGA-02-0102.8	82	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0338888457894677974646669
TCGA-06-0650.2	82	0_HALLMARK_COMPLEMENT	176	9	0.0339088102055608159313138
TCGA-06-0185.13	71	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0339706816056931787395357
TCGA-06-0221.13	45	1_KEGG_MELANOMA	71	5	0.0339706816056932064951113
TCGA-32-1986.3	3	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	2	0.0340267024370096982099909
TCGA-02-0060.19	281	2_CELL_DEVELOPMENT	511	33	0.0340625368219682131409876
TCGA-28-5219.9	47	1_KEGG_LONG_TERM_POTENTIATION	68	5	0.0341297993852604647502247
TCGA-06-0132.3	2	1_KEGG_PROTEASOME	43	2	0.0341956332522223363512559
TCGA-06-2559.11	101	0_HALLMARK_ANGIOGENESIS	32	5	0.0342019299126508080632902
TCGA-06-0744.3	12	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0342277582665007559792336
TCGA-27-2519.7	113	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	11	0.0342444569334933793247622
TCGA-26-5139.10	163	1_KEGG_LONG_TERM_POTENTIATION	68	8	0.0342744207838610523420009
TCGA-02-0025.5	88	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0343115878675180965839964
TCGA-27-1832.11	88	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0343115878675180965839964
TCGA-28-5218.5	208	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	126	12	0.0343378303525287975617175
TCGA-28-5218.5	208	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0343378303525287975617175
TCGA-76-4927.8	93	1_KEGG_FOCAL_ADHESION	195	10	0.0343609124483700636987216
TCGA-06-0155.1	5	2_NEGATIVE_REGULATION_OF_DNA_BINDING	14	2	0.0343732357986305872565858
TCGA-06-0157.7	89	2_REPLICATION_FORK	18	4	0.0343985027796720327364355
TCGA-06-0189.3	118	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0344087000759306996244824
TCGA-87-5896.6	131	2_EXTRACELLULAR_REGION_PART	269	14	0.0344603456709286840031758
TCGA-28-5207.12	188	2_CELL_CYCLE_GO_0007049	265	17	0.0345062021871725965738165
TCGA-27-2518.5	20	2_GLYCOSAMINOGLYCAN_BINDING	26	3	0.0345574839004615594340031
TCGA-12-0616.1	20	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0345574839004615594340031
TCGA-14-0871.20	216	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	7	0.0345656306601928517419076
TCGA-28-2502.9	56	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	13	0.0346178919613045477099433
TCGA-02-0015.16	115	2_ENZYME_INHIBITOR_ACTIVITY	96	8	0.0346838176656936378328133
TCGA-06-2557.11	177	0_HALLMARK_KRAS_SIGNALING_UP	148	12	0.0347086442484346446857302
TCGA-19-5950.7	113	1_KEGG_MELANOMA	71	7	0.0347325193968295795055035
TCGA-28-5220.7	15	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0347395363672943630062306
TCGA-76-4935.7	15	2_SPINDLE	35	3	0.0347395363672943630062306
TCGA-14-0781.7	155	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	12	0.0347545600664434309323703
TCGA-06-0210.6	103	0_HALLMARK_COMPLEMENT	176	10	0.0348200067762580653396576
TCGA-06-0184.11	108	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	19	0.0348863941085175571776844
TCGA-02-0083.21	135	2_DNA_REPLICATION	82	8	0.0349600994678232329659906
TCGA-08-0360.3	144	2_COLLAGEN	23	5	0.0349696527873333481983842
TCGA-06-2569.5	144	1_KEGG_MISMATCH_REPAIR	23	5	0.0349696527873333481983842
TCGA-06-2569.5	144	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	5	0.0349696527873333481983842
TCGA-02-0052.3	116	2_CELL_CYCLE_GO_0007049	265	13	0.0350186328960326101467082
TCGA-02-0038.3	199	2_BIOPOLYMER_METABOLIC_PROCESS	1367	51	0.0350591317868897897613856
TCGA-06-0141.1	45	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	14	0.0350604665960207104169477
TCGA-06-0644.16	142	2_CELL_CELL_SIGNALING	353	17	0.0351037436808205177696252
TCGA-06-0148.6	69	2_COLLAGEN	23	4	0.0351129873514772275489015
TCGA-06-0148.6	69	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0351129873514772275489015
TCGA-06-0241.8	53	2_CHROMOSOME	102	6	0.0351355926199646978469460
TCGA-06-0646.4	63	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0351744622296814857254077
TCGA-06-0743.14	63	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0351744622296814857254077
TCGA-19-2624.29	130	2_INTERPHASE	62	7	0.0351858523214066618023388
TCGA-32-2638.17	159	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0351912124223623112850845
TCGA-14-0813.5	5	2_PLASMA_MEMBRANE	1096	5	0.0352153345328339376085758
TCGA-06-5859.2	5	2_PLASMA_MEMBRANE	1096	5	0.0352153345328339376085758
TCGA-32-1979.4	12	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	4	0.0352329194988013627565238
TCGA-06-0188.11	66	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0352697035173785491957155
TCGA-76-6193.13	271	1_KEGG_BLADDER_CANCER	42	8	0.0353269462177599261054617
TCGA-81-5910.12	128	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0353336780805344613520802
TCGA-06-0158.4	65	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0353403099141801485538750
TCGA-14-0871.20	216	2_CONDENSED_CHROMOSOME	26	6	0.0353456180702922118097575
TCGA-08-0350.2	46	1_KEGG_PANCREATIC_CANCER	70	5	0.0353514929489730234113409
TCGA-06-0877.8	61	2_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION	9	3	0.0353667571923798051969356
TCGA-32-2491.14	244	2_CELL_PROLIFERATION_GO_0008283	436	27	0.0354140119309849926709788
TCGA-02-0114.20	132	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0354656015222799339547954
TCGA-02-2470.4	11	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0355072572748806811193667
TCGA-27-1836.8	49	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	3	0.0355072572748806880582606
TCGA-19-5947.4	267	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	99	12	0.0355109204126806202173050
TCGA-32-2638.17	159	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0355173777840732951549541
TCGA-27-1832.11	88	2_CELL_CELL_SIGNALING	353	13	0.0355646333754059476572884
TCGA-06-5859.9	125	2_IMMUNE_SYSTEM_PROCESS	283	14	0.0355724236323599271591966
TCGA-02-0003.9	227	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0355936164032487414865535
TCGA-02-0025.5	88	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0356136836065549591823221
TCGA-41-3393.5	88	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0356136836065549591823221
TCGA-06-0237.4	66	0_HALLMARK_E2F_TARGETS	169	8	0.0356524581339148285974439
TCGA-32-4210.14	109	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0356711750476520275676684
TCGA-06-0686.1	7	2_METABOTROPIC_GLUTAMATEGABA_B_LIKE_RECEPTOR_ACTIVITY	10	2	0.0356852135313086848977804
TCGA-19-2624.29	130	1_KEGG_BLADDER_CANCER	42	6	0.0356989293322648934547736
TCGA-32-2491.14	244	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0357185147886886211754387
TCGA-32-2615.7	77	1_KEGG_BLADDER_CANCER	42	5	0.0358160789092043588266456
TCGA-12-0620.3	2	2_PHOSPHOLIPID_METABOLIC_PROCESS	44	2	0.0358239967404215126078881
TCGA-16-1045.2	2	2_PHOSPHOLIPID_METABOLIC_PROCESS	44	2	0.0358239967404215126078881
TCGA-32-2634.8	2	2_PHOSPHOINOSITIDE_MEDIATED_SIGNALING	44	2	0.0358239967404215126078881
TCGA-08-0380.1	2	2_PHOSPHOLIPID_METABOLIC_PROCESS	44	2	0.0358239967404215126078881
TCGA-12-0692.1	2	2_PHOSPHOLIPID_METABOLIC_PROCESS	44	2	0.0358239967404215126078881
TCGA-06-0743.6	2	2_PHOSPHOLIPID_METABOLIC_PROCESS	44	2	0.0358239967404215126078881
TCGA-06-5414.13	102	0_HALLMARK_ANGIOGENESIS	32	5	0.0358790562191773701461450
TCGA-16-1048.13	97	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0358867389812064230270039
TCGA-32-5222.9	70	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0358981190269426139738407
TCGA-32-2494.10	173	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0359836129605733967551373
TCGA-06-5415.7	7	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	5	0.0359917504554645092951226
TCGA-32-4211.14	71	1_KEGG_ENDOCYTOSIS	157	8	0.0360056686285288862769960
TCGA-02-0102.8	82	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0360086931971543566799454
TCGA-14-0789.11	3	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	3	0.0360497710229460907593868
TCGA-26-1439.7	3	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	3	0.0360497710229460907593868
TCGA-32-2494.8	3	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	3	0.0360497710229460907593868
TCGA-14-1825.5	3	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	3	0.0360497710229460907593868
TCGA-14-0786.2	10	0_HALLMARK_G2M_CHECKPOINT	174	4	0.0361738249966255948075755
TCGA-28-1753.13	174	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	4	0.0361738249966260944079366
TCGA-06-0878.10	115	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	9	0.0362411937984601292828124
TCGA-08-0389.4	56	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	7	0.0362567450401486274236262
TCGA-06-2570.8	95	2_MICROTUBULE_CYTOSKELETON	117	8	0.0364235146265702858237034
TCGA-28-5216.8	162	2_DNA_METABOLIC_PROCESS	218	14	0.0365100095989140185914756
TCGA-02-0060.19	281	1_KEGG_ASTHMA	30	7	0.0365143427783499938121814
TCGA-27-1838.17	131	2_EXTRACELLULAR_MATRIX	85	8	0.0366156435893711176832177
TCGA-87-5896.6	131	2_EXTRACELLULAR_MATRIX	85	8	0.0366156435893711176832177
TCGA-02-0007.17	217	2_NEURON_PROJECTION	16	5	0.0366490105790045692102375
TCGA-06-2565.10	38	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	6	0.0366670150676522352273246
TCGA-06-5858.19	205	0_HALLMARK_APOPTOSIS	150	13	0.0366967405157609463661750
TCGA-81-5910.12	128	2_ENZYME_REGULATOR_ACTIVITY	277	14	0.0367093182047371555110082
TCGA-02-0075.8	128	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0367164073121081860340276
TCGA-28-1753.13	174	0_HALLMARK_ANGIOGENESIS	32	6	0.0368297843687730094841548
TCGA-02-0115.4	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117078464602
TCGA-06-0750.9	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117078464602
TCGA-27-1834.9	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117078464602
TCGA-06-0649.4	3	2_CHROMOSOME_SEGREGATION	26	2	0.0368596551300117078464602
TCGA-06-0882.9	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117078464602
TCGA-19-2620.6	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117078464602
TCGA-06-0208.3	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117078464602
TCGA-02-0115.4	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170016039
TCGA-02-0115.4	3	2_REGULATION_OF_CELL_PROLIFERATION	265	3	0.0368816644842981170016039
TCGA-06-0143.3	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170016039
TCGA-06-0750.9	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170016039
TCGA-06-0750.9	3	2_REGULATION_OF_CELL_PROLIFERATION	265	3	0.0368816644842981170016039
TCGA-27-1834.9	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170016039
TCGA-27-1834.9	3	2_REGULATION_OF_CELL_PROLIFERATION	265	3	0.0368816644842981170016039
TCGA-06-0882.9	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170016039
TCGA-06-0882.9	3	2_REGULATION_OF_CELL_PROLIFERATION	265	3	0.0368816644842981170016039
TCGA-19-2620.6	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170016039
TCGA-06-0208.3	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170016039
TCGA-06-0213.9	74	0_HALLMARK_P53_PATHWAY	151	8	0.0369004893007628537171527
TCGA-02-0021.4	170	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0369161388442567905965319
TCGA-27-1838.17	131	2_INTERPHASE	62	7	0.0369825135803019955371695
TCGA-08-0351.1	10	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	4	0.0370009650442499268829799
TCGA-28-5208.28	220	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	13	0.0370480668220050518568698
TCGA-08-0360.3	144	0_HALLMARK_HYPOXIA	154	11	0.0370739916816765074925044
TCGA-19-5960.9	134	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0371239193540929338088752
TCGA-32-4210.14	109	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0371528021756706294809192
TCGA-08-0389.4	56	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0371723091777262856783004
TCGA-06-5411.4	23	1_KEGG_PANCREATIC_CANCER	70	4	0.0371810309914580930379380
TCGA-06-2562.7	57	2_REGULATION_OF_TRANSPORT	57	5	0.0372306565523174981535703
TCGA-06-0644.16	142	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0372617111540135617642200
TCGA-06-5413.11	142	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0372617111540135617642200
TCGA-27-2523.12	112	2_CELL_CYCLE_PROCESS	163	10	0.0373687192531794512562193
TCGA-06-0141.1	45	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0373708283429909013384496
TCGA-02-0115.1	36	0_HALLMARK_HYPOXIA	154	6	0.0373824750142011108522411
TCGA-06-0744.10	36	2_ENZYME_BINDING	154	6	0.0373824750142011108522411
TCGA-87-5896.6	131	2_EXTRACELLULAR_REGION	346	16	0.0373959030421258664667050
TCGA-32-2498.13	133	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0374654746148279371720236
TCGA-32-4211.14	71	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0374669198521472221474760
TCGA-26-5135.9	71	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0374669198521472221474760
TCGA-12-0620.1	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508264221133
TCGA-12-0620.3	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508264221133
TCGA-16-1045.2	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508264221133
TCGA-06-0210.3	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508264221133
TCGA-08-0380.1	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508264221133
TCGA-06-0133.2	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508264221133
TCGA-12-0692.1	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508264221133
TCGA-02-0023.1	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508264221133
TCGA-06-0137.8	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508264221133
TCGA-06-0743.6	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508264221133
TCGA-06-0127.4	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508264221133
TCGA-08-0355.3	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508264221133
TCGA-32-4208.19	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508264221133
TCGA-32-1979.10	116	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0375083004156193736133851
TCGA-06-0877.7	4	0_HALLMARK_E2F_TARGETS	169	3	0.0375158387711221757987445
TCGA-02-0113.1	4	0_HALLMARK_E2F_TARGETS	169	3	0.0375158387711221757987445
TCGA-06-2561.7	4	0_HALLMARK_E2F_TARGETS	169	3	0.0375158387711221757987445
TCGA-08-0348.3	4	0_HALLMARK_E2F_TARGETS	169	3	0.0375158387711221757987445
TCGA-06-0210.6	103	0_HALLMARK_ANGIOGENESIS	32	5	0.0376195937897114626724537
TCGA-27-1834.10	39	2_NEUROLOGICAL_SYSTEM_PROCESS	296	8	0.0376510599390746103498628
TCGA-02-0089.5	91	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	6	0.0376646003921656605251123
TCGA-02-0003.9	227	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	39	0.0377279641712986307799937
TCGA-27-2521.10	94	1_KEGG_FOCAL_ADHESION	195	10	0.0377705259859192482574386
TCGA-27-1834.10	39	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0378027272909334383088620
TCGA-28-2502.9	56	2_CELL_CYCLE_GO_0007049	265	9	0.0378536851012380645697952
TCGA-28-2502.9	56	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0378536851012380645697952
TCGA-08-0357.4	36	1_KEGG_PATHWAYS_IN_CANCER	323	8	0.0378787962319279969403141
TCGA-06-0744.10	36	1_KEGG_PATHWAYS_IN_CANCER	323	8	0.0378787962319279969403141
TCGA-08-0350.2	46	1_KEGG_MELANOMA	71	5	0.0378921858206048636774632
TCGA-28-2502.9	56	2_CELL_CYCLE_PHASE	146	7	0.0379092919676089906699801
TCGA-06-0195.8	56	2_CELL_CYCLE_PHASE	146	7	0.0379092919676089906699801
TCGA-06-0744.4	11	2_TRANSPORT	600	6	0.0379404247312271278302909
TCGA-06-0882.1	11	2_TRANSPORT	600	6	0.0379404247312271278302909
TCGA-28-5207.12	188	2_TRANSMISSION_OF_NERVE_IMPULSE	164	13	0.0379683670414805718440476
TCGA-02-0009.6	188	2_TRANSMISSION_OF_NERVE_IMPULSE	164	13	0.0379683670414805718440476
TCGA-02-0080.3	20	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	9	0.0379872252821363484698303
TCGA-06-0211.8	62	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0381214758035259421165009
TCGA-14-0787.6	40	2_DNA_REPLICATION	82	5	0.0381539788639522689517314
TCGA-08-0347.7	25	2_EXTRACELLULAR_REGION	346	7	0.0381721814727416924872827
TCGA-06-0211.8	62	0_HALLMARK_APICAL_JUNCTION	182	8	0.0382120449722460064911900
TCGA-06-0174.37	141	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0382298767033390773928403
TCGA-32-2615.7	77	1_KEGG_MELANOMA	71	6	0.0382411118643349035028933
TCGA-06-5412.1	28	2_RESPONSE_TO_STRESS	427	8	0.0385110786503468152663920
TCGA-19-5954.17	208	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0385111932996210840074447
TCGA-76-6193.13	271	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0385516504983826197028307
TCGA-08-0390.1	54	2_SYNAPTIC_TRANSMISSION	152	7	0.0385828938804423648978315
TCGA-06-6391.6	30	2_REPLICATION_FORK	18	3	0.0385830313708215785761801
TCGA-76-4926.9	66	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0386035930016442874190830
TCGA-06-0188.11	66	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0386035930016442874190830
TCGA-14-0781.7	155	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0386336855278581539629990
TCGA-32-5222.9	70	2_CELL_CYCLE_GO_0007049	265	10	0.0386659215528803515415923
TCGA-32-5222.9	70	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0386659215528803515415923
TCGA-02-0014.10	70	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0386659215528803515415923
TCGA-06-0143.6	63	2_GTPASE_ACTIVATOR_ACTIVITY	52	5	0.0387177942573288871863646
TCGA-06-0878.10	115	2_CELL_CELL_SIGNALING	353	15	0.0387443039335419736612920
TCGA-02-0026.1	61	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	9	0.0387544892356942935474073
TCGA-14-1034.7	97	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0388238327533100835431412
TCGA-27-2524.5	75	0_HALLMARK_APOPTOSIS	150	8	0.0388398274309619748190237
TCGA-26-1439.11	10	2_PROTEIN_KINASE_BINDING	56	3	0.0388433771246084261208331
TCGA-32-1979.10	116	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	9	0.0388526547076666270430501
TCGA-02-0114.20	132	2_INTERPHASE	62	7	0.0388542994615642400813016
TCGA-27-1835.3	4	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0388654804350540492019483
TCGA-14-0790.1	4	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0388654804350540492019483
TCGA-06-0878.10	115	1_KEGG_MELANOMA	71	7	0.0389375194235959815047821
TCGA-02-0015.16	115	1_KEGG_MELANOMA	71	7	0.0389375194235959815047821
TCGA-12-5301.7	46	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0389483853084105074993104
TCGA-27-1830.7	57	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	16	0.0389563924140294351450287
TCGA-32-2491.14	244	2_STRUCTURAL_MOLECULE_ACTIVITY	206	17	0.0390053802807551475151371
TCGA-14-1034.7	97	0_HALLMARK_P53_PATHWAY	151	9	0.0390864627547864995626981
TCGA-12-0619.11	123	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0391479538790850123408660
TCGA-06-2563.10	123	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0391479538790850123408660
TCGA-32-4719.15	123	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0391479538790850123408660
TCGA-27-1833.7	17	1_KEGG_DNA_REPLICATION	32	3	0.0392767620707011183567303
TCGA-06-0178.2	17	1_KEGG_DNA_REPLICATION	32	3	0.0392767620707011183567303
TCGA-06-5411.4	23	2_MITOSIS	71	4	0.0393372960988377928792659
TCGA-32-4211.14	71	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0393372960988377928792659
TCGA-02-0107.3	71	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0393372960988377928792659
TCGA-27-2526.7	71	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0393372960988377928792659
TCGA-26-5135.9	71	2_COLLAGEN	23	4	0.0393372960988377928792659
TCGA-26-5135.9	71	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0393372960988377928792659
TCGA-02-0024.6	206	2_NUCLEUS	1110	45	0.0393405034907122405640756
TCGA-27-1837.5	85	2_CELL_CYCLE_GO_0007049	265	11	0.0393665667428181945131094
TCGA-02-0048.9	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0394322201150851953110887
TCGA-32-2632.16	229	2_APOPTOSIS_GO	389	24	0.0394428635175595801443116
TCGA-06-0143.3	3	2_PHOSPHORYLATION	271	3	0.0394539326108679158644499
TCGA-06-5411.3	19	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	4	0.0395372246175941660650821
TCGA-02-0033.1	4	0_HALLMARK_MYOGENESIS	172	3	0.0395522167582792669171532
TCGA-19-5960.9	134	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0395592285513641714334021
TCGA-06-2570.8	95	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0395658737532512128076689
TCGA-26-1439.11	10	0_HALLMARK_MYC_TARGETS_V1	178	4	0.0395662726311373572074537
TCGA-06-6391.7	5	2_SPINDLE_MICROTUBULE	15	2	0.0396530230797492791450232
TCGA-06-0155.1	5	2_NEGATIVE_REGULATION_OF_BINDING	15	2	0.0396530230797492791450232
TCGA-02-0001.5	117	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	7	0.0396624062948363886871306
TCGA-32-2632.16	229	2_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY	50	8	0.0397382127267134621639855
TCGA-32-4210.14	109	2_REGULATION_OF_MOLECULAR_FUNCTION	286	13	0.0399287873181157285107368
TCGA-28-5207.12	188	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0399421992549760240809320
TCGA-28-5207.12	188	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0399421992549760240809320
TCGA-06-0875.7	78	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0400163965720893230471056
TCGA-06-5413.11	142	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0400217663553223829131511
TCGA-02-0007.17	217	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	13	0.0402031606640789115902912
TCGA-06-0157.7	89	2_CELL_CELL_SIGNALING	353	13	0.0402661812517924322385454
TCGA-06-0145.17	11	2_REGULATION_OF_CELL_CYCLE	160	4	0.0402723659758339180836373
TCGA-02-2470.4	11	2_REGULATION_OF_CELL_CYCLE	160	4	0.0402723659758339180836373
TCGA-41-3392.31	136	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0403314409364684961500913
TCGA-26-1439.10	84	2_EXTRACELLULAR_REGION_PART	269	11	0.0403798339784573190325290
TCGA-32-2494.10	173	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0403918055428435923692732
TCGA-06-0241.8	53	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	13	0.0404137969968988500224505
TCGA-06-5858.19	205	2_CELL_PROLIFERATION_GO_0008283	436	24	0.0404190871215178090802844
TCGA-19-2619.14	100	2_DNA_REPLICATION	82	7	0.0404367123156119459559399
TCGA-28-5208.28	220	2_ENZYME_REGULATOR_ACTIVITY	277	19	0.0404422778459001194817368
TCGA-76-4925.9	83	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0404743550227065693181139
TCGA-06-0158.4	65	2_EXTRACELLULAR_MATRIX	85	6	0.0405127253256778799284099
TCGA-06-0171.7	57	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0405564569040093442220396
TCGA-08-0350.2	46	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	5	0.0405727897023140382515294
TCGA-06-2557.11	177	0_HALLMARK_ANGIOGENESIS	32	6	0.0405780691638063101267520
TCGA-06-2557.11	177	1_KEGG_DNA_REPLICATION	32	6	0.0405780691638063101267520
TCGA-76-4934.4	20	2_NEUROLOGICAL_SYSTEM_PROCESS	296	6	0.0406285252703951563213458
TCGA-16-1045.10	81	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	5	0.0406564976452885584734531
TCGA-76-4935.8	21	2_TRANSMISSION_OF_NERVE_IMPULSE	164	5	0.0407126836727636429169586
TCGA-02-0080.3	20	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	4	0.0407356439613131351973330
TCGA-08-0386.4	73	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0407389574774763146836065
TCGA-27-1836.8	49	2_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0407596803961143075434315
TCGA-27-1836.8	49	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0407596803961143075434315
TCGA-06-0129.11	110	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0407655917665188383125496
TCGA-06-5418.4	24	2_SECRETION	142	5	0.0407827447716107016617570
TCGA-27-2527.6	79	1_KEGG_PANCREATIC_CANCER	70	6	0.0408322153280805330566317
TCGA-28-2514.11	4	0_HALLMARK_G2M_CHECKPOINT	174	3	0.0409497479382751744525493
TCGA-19-1390.12	10	2_PLASMA_MEMBRANE	1096	7	0.0409845668246639968645972
TCGA-06-0211.7	10	2_PLASMA_MEMBRANE	1096	7	0.0409845668246639968645972
TCGA-06-0158.4	65	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0410006288962179513135631
TCGA-06-5408.3	99	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0410054195777568505909549
TCGA-02-0083.21	135	2_CELL_CYCLE_GO_0007049	265	14	0.0410519152864712577599704
TCGA-02-0010.18	184	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0411187497669634957619955
TCGA-32-2632.16	229	2_PROGRAMMED_CELL_DEATH	390	24	0.0411345374331303567649876
TCGA-06-0192.10	126	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0411763564628957676183596
TCGA-76-4928.15	78	1_KEGG_MELANOMA	71	6	0.0411840708554659165607781
TCGA-06-2563.10	123	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	10	0.0412305111847223459964340
TCGA-06-0174.37	141	2_INTRACELLULAR_ORGANELLE_PART	912	30	0.0412347751217859229133644
TCGA-19-5947.4	267	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0412534115887414204459915
TCGA-08-0360.3	144	2_RESPONSE_TO_STRESS	427	19	0.0412773070443485309843901
TCGA-12-1597.6	51	2_CELL_CYCLE_PROCESS	163	7	0.0413322736118436062646708
TCGA-19-2631.15	84	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0413471417339731847628848
TCGA-02-0010.18	184	2_CYTOSKELETAL_PART	194	14	0.0414384162644867645730606
TCGA-27-1831.9	85	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0414770145166326181795924
TCGA-06-5858.19	205	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0415059042768266897582841
TCGA-32-1979.4	12	2_CELL_CYCLE_PHASE	146	4	0.0415761621937782571700737
TCGA-19-2629.15	146	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0415761621937782571700737
TCGA-02-0068.1	72	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0415841286962998005205527
TCGA-06-5411.4	23	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	4	0.0415841286962998005205527
TCGA-06-0213.9	74	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	5	0.0415868097169330430684653
TCGA-06-2558.6	74	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0415868097169330430684653
TCGA-02-0034.4	88	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	5	0.0416244316027229860344150
TCGA-19-1790.1	4	2_TRANSCRIPTION	667	4	0.0416286942640039583918288
TCGA-06-0219.2	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	3	0.0416606337696162482009399
TCGA-02-0033.1	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	3	0.0416606337696162482009399
TCGA-02-0016.4	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	3	0.0416606337696162482009399
TCGA-02-0003.9	227	2_EXTRACELLULAR_REGION_PART	269	19	0.0416884825526865204770033
TCGA-76-4929.8	91	2_NEUROLOGICAL_SYSTEM_PROCESS	296	12	0.0416888917556290511390316
TCGA-06-2558.6	74	2_NUCLEUS	1110	22	0.0417012906599406527052842
TCGA-06-1804.7	47	1_KEGG_PATHWAYS_IN_CANCER	323	9	0.0417280463065513029796705
TCGA-28-2509.6	59	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	11	0.0417415756636428519898985
TCGA-32-2491.14	244	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	31	0.0417873834944900088284037
TCGA-32-2634.10	118	0_HALLMARK_DNA_REPAIR	125	9	0.0418087869472038506368783
TCGA-06-5415.3	8	2_INTEGRAL_TO_MEMBRANE	956	6	0.0418172466617442728509246
TCGA-06-0221.4	8	2_INTEGRAL_TO_MEMBRANE	956	6	0.0418172466617442728509246
TCGA-08-0375.6	65	2_CELL_CELL_SIGNALING	353	11	0.0418712280767255945468364
TCGA-19-1390.13	110	2_NUCLEAR_PART	466	17	0.0419053711474963175298569
TCGA-32-2634.10	118	1_KEGG_PANCREATIC_CANCER	70	7	0.0419176203249487719371125
TCGA-02-0026.1	61	2_REGULATION_OF_APOPTOSIS	309	10	0.0419620587728707361563352
TCGA-76-6191.6	96	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0420045806805275229178775
TCGA-76-4934.7	47	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0421262237515068124760198
TCGA-19-5960.9	134	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0421528407688084513771365
TCGA-06-1804.7	47	1_KEGG_MELANOMA	71	5	0.0421570167940513579329931
TCGA-28-5219.9	47	1_KEGG_MELANOMA	71	5	0.0421570167940513579329931
TCGA-02-0028.9	182	2_NERVOUS_SYSTEM_DEVELOPMENT	307	18	0.0422115740650016169066561
TCGA-32-2494.10	173	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0422215856153615523571609
TCGA-12-3653.55	255	1_KEGG_MISMATCH_REPAIR	23	6	0.0422556836093221990791058
TCGA-12-0688.10	93	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0422563241460211375111200
TCGA-02-0089.5	91	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	17	0.0422575857502395929587991
TCGA-02-0099.11	141	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0424258878229750585608926
TCGA-06-0155.10	74	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0424433948667860619363701
TCGA-12-5301.9	11	2_REGULATION_OF_BODY_FLUID_LEVELS	52	3	0.0425104701586711680727504
TCGA-26-1442.5	27	1_KEGG_PATHWAYS_IN_CANCER	323	7	0.0425311094111926954464131
TCGA-28-6450.11	139	2_CYTOSKELETON	293	15	0.0426476780328550811316468
TCGA-08-0347.4	16	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0426478195790247413543561
TCGA-06-0875.7	78	2_CELL_CYCLE_PHASE	146	8	0.0426655870168431428091083
TCGA-02-0060.19	281	2_MEMBRANE	1443	69	0.0427095646588030938839431
TCGA-26-5133.10	75	2_SYNAPTIC_TRANSMISSION	152	8	0.0427460387775662822851253
TCGA-02-0011.1	288	1_KEGG_ASTHMA	30	7	0.0428031290176131909430701
TCGA-19-5960.9	134	1_KEGG_GLIOMA	62	7	0.0428330240302346385017351
TCGA-76-4935.7	15	2_INTRACELLULAR_ORGANELLE_PART	912	8	0.0428612590921049335657145
TCGA-32-2632.16	229	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	24	0.0428915438333245316315789
TCGA-02-0024.6	206	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0429033066370303473036074
TCGA-76-6282.11	185	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	8	0.0429977834573892353509095
TCGA-12-1597.6	51	2_TRANSMISSION_OF_NERVE_IMPULSE	164	7	0.0429983873306318958862349
TCGA-06-0168.3	4	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	2	0.0430609549672630320671374
TCGA-32-2632.1	4	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	2	0.0430609549672630320671374
TCGA-02-0003.1	4	1_KEGG_PROTEIN_EXPORT	20	2	0.0430609549672630320671374
TCGA-32-2491.13	4	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	2	0.0430609549672630320671374
TCGA-02-0026.1	61	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	10	0.0431445807703424999424158
TCGA-06-2559.11	101	2_DNA_REPLICATION	82	7	0.0431466608372673907090267
TCGA-06-0156.4	80	1_KEGG_BLADDER_CANCER	42	5	0.0431533640788741151839147
TCGA-08-0245.4	85	2_MITOTIC_CELL_CYCLE	134	8	0.0431538757051569202283225
TCGA-06-2557.11	177	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0431581232538593498326840
TCGA-06-6390.9	82	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	5	0.0431590164266232589884709
TCGA-06-0876.9	106	1_KEGG_DNA_REPLICATION	32	5	0.0432386130167234303267598
TCGA-76-6285.5	106	1_KEGG_DNA_REPLICATION	32	5	0.0432386130167234303267598
TCGA-06-0139.1	179	0_HALLMARK_ANGIOGENESIS	32	6	0.0432437123459877142961361
TCGA-02-0052.3	116	2_REGULATION_OF_CELL_CYCLE	160	10	0.0432476230160242849920316
TCGA-32-1982.9	89	2_INTERLEUKIN_RECEPTOR_ACTIVITY	19	4	0.0432586650661373264825649
TCGA-06-0168.4	22	2_EXTRACELLULAR_REGION_PART	269	6	0.0432628193506289435155132
TCGA-06-0241.8	53	2_DNA_METABOLIC_PROCESS	218	8	0.0432940528416005318557147
TCGA-02-0114.20	132	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0433294918097578002358361
TCGA-12-5301.9	11	2_RESPONSE_TO_WOUNDING	163	4	0.0433312537512027876052123
TCGA-27-2518.5	20	2_POLYSACCHARIDE_BINDING	28	3	0.0434249680067028825947162
TCGA-02-0099.11	141	2_REGULATION_OF_CELL_CYCLE	160	11	0.0435073034305145309175167
TCGA-28-2502.9	56	2_STRUCTURAL_MOLECULE_ACTIVITY	206	8	0.0435706606974802165832550
TCGA-27-1832.11	88	0_HALLMARK_E2F_TARGETS	169	9	0.0435814560681950860510092
TCGA-06-5415.7	7	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0435998655566067136457598
TCGA-41-4097.6	48	1_KEGG_LEISHMANIA_INFECTION	70	5	0.0436564978482496465761464
TCGA-41-4097.6	48	1_KEGG_VIRAL_MYOCARDITIS	70	5	0.0436564978482496465761464
TCGA-08-0353.8	100	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0437820491517615928422913
TCGA-08-0353.8	100	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0437820491517615928422913
TCGA-26-5132.7	100	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0437820491517615928422913
TCGA-19-1790.1	4	2_NEGATIVE_REGULATION_OF_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	178	3	0.0438423177555505513836032
TCGA-06-0171.7	57	2_CELL_CYCLE_GO_0007049	265	9	0.0438634389963123982880688
TCGA-32-1979.10	116	1_KEGG_FOCAL_ADHESION	195	11	0.0438748577587205340622134
TCGA-14-1825.8	80	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	6	0.0438871372046481661444162
TCGA-02-0010.18	184	1_KEGG_FOCAL_ADHESION	195	14	0.0438920954165342436237296
TCGA-08-0386.4	73	2_COLLAGEN	23	4	0.0439238986118415247750235
TCGA-41-5651.5	112	2_NUCLEUS	1110	29	0.0440176114701843479437571
TCGA-14-0790.9	104	2_DNA_METABOLIC_PROCESS	218	11	0.0440187194778548715468069
TCGA-27-1835.6	86	2_CELL_CYCLE_GO_0007049	265	11	0.0440353590615281190179253
TCGA-76-4931.10	86	2_CELL_CYCLE_GO_0007049	265	11	0.0440353590615281190179253
TCGA-41-2575.49	136	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0440424601634705273345283
TCGA-06-0129.11	110	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	5	0.0440476871428828395393928
TCGA-14-0781.7	155	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	15	0.0440744166862010386398474
TCGA-28-5219.9	47	2_SIGNAL_TRANSDUCTION	1442	19	0.0441558149992154966301250
TCGA-06-0187.8	6	2_KINESIN_COMPLEX	13	2	0.0441692097132310654283849
TCGA-02-0034.5	6	2_REGULATION_OF_ACTION_POTENTIAL	13	2	0.0441692097132310654283849
TCGA-15-0742.7	6	2_KINESIN_COMPLEX	13	2	0.0441692097132310654283849
TCGA-16-0861.4	6	2_HORMONE_SECRETION	13	2	0.0441692097132310654283849
TCGA-06-0125.9	75	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0441942433552662619633544
TCGA-26-5133.10	75	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0441942433552662619633544
TCGA-02-0083.21	135	1_KEGG_BLADDER_CANCER	42	6	0.0442364343945357493814718
TCGA-28-5207.12	188	2_CELL_DEVELOPMENT	511	25	0.0442368539073416458529131
TCGA-76-4926.9	66	2_EXTRACELLULAR_MATRIX	85	6	0.0442456408364733447258210
TCGA-06-0750.12	52	2_BASEMENT_MEMBRANE	32	4	0.0442459162279842874165858
TCGA-19-5955.9	110	2_IMMUNE_RESPONSE	206	11	0.0442471498894710102423034
TCGA-19-5955.9	110	2_STRUCTURAL_MOLECULE_ACTIVITY	206	11	0.0442471498894710102423034
TCGA-76-4935.7	15	2_ORGANELLE_PART	916	8	0.0442676306656603069100697
TCGA-06-0644.16	142	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0443180035761451818210332
TCGA-19-5947.4	267	2_PLASMA_MEMBRANE	1096	54	0.0443200517643725366845331
TCGA-06-0744.4	11	2_TRANSMISSION_OF_NERVE_IMPULSE	164	4	0.0443879322006386634047459
TCGA-06-0882.1	11	2_TRANSMISSION_OF_NERVE_IMPULSE	164	4	0.0443879322006386634047459
TCGA-28-5220.7	15	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	5	0.0443900057489099233998253
TCGA-02-0014.10	70	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0444302265873108004345937
TCGA-06-5415.3	8	2_INTRINSIC_TO_MEMBRANE	966	6	0.0444303900422031577965853
TCGA-06-0221.4	8	2_INTRINSIC_TO_MEMBRANE	966	6	0.0444303900422031577965853
TCGA-06-0176.8	95	2_REPLICATION_FORK	18	4	0.0445316737274248503064555
TCGA-12-0620.1	2	2_CELL_CYCLE_ARREST_GO_0007050	49	2	0.0445338479563702760444244
TCGA-08-0389.3	2	2_REGULATION_OF_CELL_DIFFERENTIATION	49	2	0.0445338479563702760444244
TCGA-06-5858.9	2	2_GROWTH_FACTOR_ACTIVITY	49	2	0.0445338479563702760444244
TCGA-06-0133.2	2	2_CELL_CYCLE_ARREST_GO_0007050	49	2	0.0445338479563702760444244
TCGA-02-0023.1	2	2_CELL_CYCLE_ARREST_GO_0007050	49	2	0.0445338479563702760444244
TCGA-06-0127.4	2	2_CELL_CYCLE_ARREST_GO_0007050	49	2	0.0445338479563702760444244
TCGA-08-0355.3	2	2_CELL_CYCLE_ARREST_GO_0007050	49	2	0.0445338479563702760444244
TCGA-19-5954.17	208	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0445681866130557546856750
TCGA-41-3392.31	136	2_CELL_CYCLE_GO_0007049	265	14	0.0446319286380856133922279
TCGA-41-2571.7	72	2_CHROMOSOMAL_PART	78	6	0.0446354076307664757172766
TCGA-02-0080.3	20	2_EXTRACELLULAR_MATRIX	85	4	0.0447627618927979309404463
TCGA-19-2625.9	146	2_CHROMOSOME	102	9	0.0448170091444309512396238
TCGA-19-5951.10	138	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0448287332295431717454903
TCGA-06-0174.37	141	2_ORGANELLE_PART	916	30	0.0448420295721302930580521
TCGA-19-5952.11	193	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0448579133328168913608103
TCGA-41-2575.49	136	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0448802122845944270745910
TCGA-02-0083.21	135	1_KEGG_GLIOMA	62	7	0.0449449888722914456251623
TCGA-06-2570.8	95	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0449603702662094567577000
TCGA-19-1790.1	4	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	680	4	0.0449779907393258945869086
TCGA-06-0241.8	53	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	3	0.0450324139562053790686313
TCGA-14-1829.14	67	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0450937337467030435744775
TCGA-06-0155.1	5	2_TRANSCRIPTION_REPRESSOR_ACTIVITY	133	3	0.0451535210427900998708672
TCGA-28-2502.9	56	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	7	0.0451549891098207631379147
TCGA-32-2634.10	118	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0451574476243609829184678
TCGA-32-1977.11	107	0_HALLMARK_ANGIOGENESIS	32	5	0.0452498589725404895545147
TCGA-06-5415.7	7	2_REGULATION_OF_MOLECULAR_FUNCTION	286	4	0.0452600680792458742729423
TCGA-26-5139.10	163	2_CATION_BINDING	165	12	0.0452708862001477418957052
TCGA-02-0024.6	206	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	22	0.0452870567372050669696648
TCGA-06-0210.6	103	2_CELL_CELL_SIGNALING	353	14	0.0453313795920839979203265
TCGA-08-0245.4	85	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0454437657199110722761048
TCGA-19-5952.11	193	2_HEMOSTASIS	44	7	0.0454553565395460976161779
TCGA-02-0003.9	227	2_NEURON_PROJECTION	16	5	0.0455524140536296417991480
TCGA-02-0058.1	110	2_CELL_PROJECTION	76	7	0.0456593435727772681276271
TCGA-27-1836.8	49	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	12	0.0456727356196048803194110
TCGA-27-2521.10	94	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0456935971890208639245579
TCGA-12-0618.5	41	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0457797573209215089007351
TCGA-14-1456.4	41	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0457797573209215089007351
TCGA-16-1045.10	81	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	5	0.0458422971611958385285135
TCGA-12-0821.9	81	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0458422971611958385285135
TCGA-28-1747.5	81	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0458422971611958385285135
TCGA-32-1986.8	87	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	11	0.0458507068637542883338121
TCGA-08-0345.2	77	1_KEGG_FOCAL_ADHESION	195	9	0.0458616068712936475471054
TCGA-02-0114.20	132	1_KEGG_PROSTATE_CANCER	87	8	0.0458994849898939766275063
TCGA-19-4068.7	14	2_CELL_CYCLE_GO_0007049	265	5	0.0459564986004090750282280
TCGA-06-0154.13	76	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0459921007217419033907824
TCGA-08-0375.6	65	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0460085838849794495630796
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0460364494323195760916434
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0460364494323195760916434
TCGA-32-2491.14	244	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0460405200410073517369725
TCGA-02-0047.8	185	2_AXON	10	4	0.0460605594823019007244547
TCGA-14-0790.9	104	2_PATTERN_BINDING	33	5	0.0460613372945733526298007
TCGA-27-2521.10	94	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0461129363518771664964824
TCGA-41-2575.49	136	1_KEGG_BLADDER_CANCER	42	6	0.0461264774068807989482188
TCGA-02-0010.18	184	2_ENZYME_REGULATOR_ACTIVITY	277	17	0.0461276332713310491251413
TCGA-28-5204.5	5	2_MITOTIC_CELL_CYCLE	134	3	0.0461801646003470803170110
TCGA-12-0619.11	123	2_SYNAPTIC_TRANSMISSION	152	10	0.0462420007631705390349630
TCGA-06-0878.10	115	1_KEGG_ASTHMA	30	5	0.0462423165962909596404806
TCGA-32-2491.14	244	0_HALLMARK_KRAS_SIGNALING_UP	148	14	0.0463156774320375858033927
TCGA-15-0742.13	74	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0463589992214815324600430
TCGA-06-0213.9	74	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0463589992214815324600430
TCGA-06-2558.6	74	2_COLLAGEN	23	4	0.0463589992214815324600430
TCGA-06-0155.10	74	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0463589992214815324600430
TCGA-06-0128.8	74	2_COLLAGEN	23	4	0.0463589992214815324600430
TCGA-06-0128.8	74	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0463589992214815324600430
TCGA-32-2634.8	2	2_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY	50	2	0.0463894249545511588861402
TCGA-14-0787.6	40	1_KEGG_BLADDER_CANCER	42	4	0.0463973559358683979025884
TCGA-06-0143.3	3	2_REGULATION_OF_MOLECULAR_FUNCTION	286	3	0.0464017325533472718701589
TCGA-76-6191.6	96	2_REPLICATION_FORK	18	4	0.0464125355705201220191114
TCGA-08-0347.4	16	2_REGULATION_OF_MITOSIS	36	3	0.0464768432537030068418815
TCGA-06-0130.3	155	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0465034181584294131761581
TCGA-76-6282.11	185	1_KEGG_FOCAL_ADHESION	195	14	0.0466354821976094902069576
TCGA-02-0028.9	182	0_HALLMARK_COAGULATION	125	11	0.0466751612578947816523112
TCGA-32-1982.9	89	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	358	13	0.0466793537591443097323207
TCGA-19-1390.13	110	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0467011402943875442161925
TCGA-02-0047.8	185	2_GLYCOPROTEIN_METABOLIC_PROCESS	46	7	0.0467285759191804414558469
TCGA-06-0173.35	120	1_KEGG_PANCREATIC_CANCER	70	7	0.0467461160255879110136945
TCGA-06-5412.7	153	2_COLLAGEN	23	5	0.0468699032895574657642257
TCGA-19-2623.11	153	2_COLLAGEN	23	5	0.0468699032895574657642257
TCGA-19-2623.11	153	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	5	0.0468699032895574657642257
TCGA-76-6282.11	185	0_HALLMARK_INFLAMMATORY_RESPONSE	170	13	0.0469005115716533485525908
TCGA-02-0023.3	24	1_KEGG_MELANOMA	71	4	0.0469376215636570573441766
TCGA-08-0354.5	18	1_KEGG_DNA_REPLICATION	32	3	0.0470236848562999298906107
TCGA-02-0054.3	93	2_CYTOSKELETON	293	12	0.0470786401706747986706247
TCGA-02-0027.3	81	1_KEGG_VIRAL_MYOCARDITIS	70	6	0.0471234586552133141723608
TCGA-27-1836.8	49	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0471703011137011227194016
TCGA-06-0187.10	55	1_KEGG_GLIOMA	62	5	0.0471925026805698269449785
TCGA-32-2491.14	244	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0473249641441825796839282
TCGA-06-0154.13	76	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0473593345672863388906570
TCGA-41-2572.8	76	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0473593345672863388906570
TCGA-19-5951.10	138	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0475368859127874993086849
TCGA-19-2619.10	8	2_NEUROTRANSMITTER_SECRETION	10	2	0.0475534190944951334900637
TCGA-06-0750.13	8	2_METABOTROPIC_GLUTAMATEGABA_B_LIKE_RECEPTOR_ACTIVITY	10	2	0.0475534190944951334900637
TCGA-19-5952.6	8	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	10	2	0.0475534190944951334900637
TCGA-06-5415.3	8	2_METABOTROPIC_GLUTAMATEGABA_B_LIKE_RECEPTOR_ACTIVITY	10	2	0.0475534190944951334900637
TCGA-06-0221.4	8	2_METABOTROPIC_GLUTAMATEGABA_B_LIKE_RECEPTOR_ACTIVITY	10	2	0.0475534190944951334900637
TCGA-06-0686.1	7	2_MEMBRANE_PART	1217	6	0.0475816676565092508410793
TCGA-16-0861.5	4	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0475869615927705172375717
TCGA-06-2561.7	4	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0475869615927705172375717
TCGA-02-0016.2	29	2_SIGNAL_TRANSDUCTION	1442	14	0.0476438143989191820182327
TCGA-14-0813.10	53	0_HALLMARK_ANGIOGENESIS	32	4	0.0477443844293630598185629
TCGA-06-0241.8	53	1_KEGG_DNA_REPLICATION	32	4	0.0477443844293630598185629
TCGA-26-5136.6	160	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	12	0.0477526468824592820183739
TCGA-19-5960.9	134	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0477556110965481270258515
TCGA-06-2569.5	144	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0478011393215236474185659
TCGA-41-5651.5	112	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0478325108753670097394561
TCGA-06-0141.1	45	0_HALLMARK_ALLOGRAFT_REJECTION	190	7	0.0478360003268892483574426
TCGA-02-0115.1	36	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	12	0.0478789642655046074337655
TCGA-06-5408.3	99	2_EXTRACELLULAR_MATRIX	85	7	0.0479232489463259567208375
TCGA-19-1790.1	4	2_REGULATION_OF_METABOLIC_PROCESS	691	4	0.0479664745098075731566389
TCGA-06-5417.5	79	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	6	0.0480154884625289130051229
TCGA-28-2509.6	59	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0480406212243636859815510
TCGA-32-1970.14	94	2_REGULATION_OF_CELL_CYCLE	160	9	0.0480773352306995555016655
TCGA-06-2570.8	95	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	6	0.0481548516434163603738838
TCGA-76-4934.7	47	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0482392374056662825987374
TCGA-19-2620.7	47	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0482392374056662825987374
TCGA-02-0010.18	184	2_DNA_REPLICATION	82	9	0.0482736585001385110071936
TCGA-19-2624.29	130	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	22	0.0483178726791501228499115
TCGA-06-2564.7	92	2_INTERPHASE	62	6	0.0484712421670811799412348
TCGA-14-1456.4	41	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0485226094699029095180798
TCGA-27-2528.10	99	2_SYNAPTIC_TRANSMISSION	152	9	0.0485558895346326416242455
TCGA-06-0237.4	66	2_CELL_CELL_SIGNALING	353	11	0.0485923110535418992239620
TCGA-12-5295.8	66	2_CELL_CELL_SIGNALING	353	11	0.0485923110535418992239620
TCGA-08-0354.7	47	0_HALLMARK_APICAL_JUNCTION	182	7	0.0486161062567943696999251
TCGA-06-1804.7	47	0_HALLMARK_APICAL_JUNCTION	182	7	0.0486161062567943696999251
TCGA-06-0650.2	82	1_KEGG_BLADDER_CANCER	42	5	0.0486597419324949209684661
TCGA-06-6390.9	82	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	5	0.0486597419324949209684661
TCGA-28-5209.15	194	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0487564907639172345765743
TCGA-06-0188.11	66	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0488855560676359421345971
TCGA-06-0125.9	75	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0488918471932992745876412
TCGA-26-5133.10	75	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0488918471932992745876412
TCGA-06-5858.19	205	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0488999656790120029725699
TCGA-19-1790.18	201	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	12	0.0489360199720797472977551
TCGA-12-3652.19	88	2_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0490819020879918466171432
TCGA-12-3652.19	88	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0490819020879918466171432
TCGA-81-5910.12	128	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0490856814020888196359316
TCGA-08-0245.4	85	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0490924566601431827672641
TCGA-06-5412.7	153	2_EXTRACELLULAR_REGION_PART	269	15	0.0491784933019739148307714
TCGA-06-0189.3	118	2_EXTRACELLULAR_REGION_PART	269	13	0.0492955791026815429156649
TCGA-19-5960.8	3	1_KEGG_ASTHMA	30	2	0.0493212794277251911911897
TCGA-02-0107.3	71	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0493415662005384225707871
TCGA-26-5134.2	14	2_EXTRACELLULAR_REGION_PART	269	5	0.0493992640899181961744446
TCGA-32-2638.17	159	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0494548549977350190842706
TCGA-12-0616.1	20	2_NUCLEUS	1110	10	0.0494873034727393371068338
TCGA-41-3915.10	109	0_HALLMARK_ANGIOGENESIS	32	5	0.0494903590655870612158296
TCGA-28-5214.11	124	2_SYNAPTIC_TRANSMISSION	152	10	0.0496130773311924261337325
TCGA-06-0875.7	78	2_NON_MEMBRANE_BOUND_ORGANELLE	476	14	0.0496362476096895155475153
TCGA-06-0875.7	78	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	14	0.0496362476096895155475153
TCGA-14-0817.9	85	0_HALLMARK_MYC_TARGETS_V1	178	9	0.0496670714051625564189330
TCGA-06-0221.13	45	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0497021400134846080831608
TCGA-32-1979.4	12	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0497208392519993339075945
TCGA-06-2565.10	38	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0497745423989952792687141
TCGA-06-0145.4	7	2_CYTOSKELETON	293	4	0.0497910042045328626869605
TCGA-14-1034.7	97	1_KEGG_FOCAL_ADHESION	195	10	0.0497974266437015908315367
TCGA-06-0148.6	69	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0498762512862392093371255
TCGA-14-0781.7	155	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	5	0.0498975395705597013495947
TCGA-26-5132.7	100	0_HALLMARK_P53_PATHWAY	151	9	0.0499512094210445983799573
TCGA-02-2470.4	11	0_HALLMARK_E2F_TARGETS	169	4	0.0499587815258596065759455
TCGA-27-1836.8	49	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0499703492464302276299115
